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FOREWORD 
 
 
 
This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic 
Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA).  The 
original guidelines were published in the Federal Register on April 17, 1987.  Each profile will be revised 
and republished as necessary. 
 
The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects 
information for these toxic substances described therein.  Each peer-reviewed profile identifies and 
reviews the key literature that describes a substance's toxicologic properties.  Other pertinent literature is 
also presented, but is described in less detail than the key studies.  The profile is not intended to be an 
exhaustive document; however, more comprehensive sources of specialty information are referenced. 
 
The focus of the profiles is on health and toxicologic information; therefore, each toxicological profile 
begins with a public health statement that describes, in nontechnical language, a substance's relevant 
toxicological properties.  Following the public health statement is information concerning levels of 
significant human exposure and, where known, significant health effects.  The adequacy of information to 
determine a substance's health effects is described in a health effects summary.  Data needs that are of 
significance to protection of public health are identified by ATSDR and EPA. 
 
Each profile includes the following: 
 
(A) The examination, summary, and interpretation of available toxicologic information and 
epidemiologic evaluations on a toxic substance to ascertain the levels of significant human 
exposure for the substance and the associated acute, subacute, and chronic health effects; 
 
(B) A determination of whether adequate information on the health effects of each substance is 
available or in the process of development to determine levels of exposure that present a 
significant risk to human health of acute, subacute, and chronic health effects; and 
 
(C) Where appropriate, identification of toxicologic testing needed to identify the types or levels 
of exposure that may present significant risk of adverse health effects in humans. 
 
The principal audiences for the toxicological profiles are health professionals at the Federal, State, and 
local levels; interested private sector organizations and groups; and members of the public.  We plan to 
revise these documents in response to public comments and as additional data become available.  
Therefore, we encourage comments that will make the toxicological profile series of the greatest use. 
 
Electronic comments may be submitted via: www.regulations.gov. 
Follow the on-line instructions for submitting comments. 
 
Written comments may also be sent to:  
 Agency for Toxic Substances and Disease Registry 
 Division of Toxicology and Human Health Sciences 
Environmental Toxicology Branch
Regular Mailing Address: Physical Mailing Address:
1600 Clifton Road, N.E. 4770 Buford Highway
Mail Stop F-57 Building 102, 1st floor, MS F-57
Atlanta, Georgia 30329-4027 Chamblee, Georgia 30341
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The toxicological profiles are developed under the Comprehensive Environmental Response, 
Compensation, and Liability Act of 1980, as amended (CERCLA or Superfund).  CERCLA section 
104(i)(1) directs the Administrator of ATSDR to “…effectuate and implement the health related
authorities” of the statute.  This includes the preparation of toxicological profiles for hazardous
substances most commonly found at facilities on the CERCLA National Priorities List and that pose the
most significant potential threat to human health, as determined by ATSDR and the EPA.
Section 104(i)(3) of CERCLA, as amended, directs the Administrator of ATSDR to prepare a
toxicological profile for each substance on the list.  In addition, ATSDR has the authority to prepare
toxicological profiles for substances not found at sites on the National Priorities List, in an effort to 
“…establish and maintain inventory of literature, research, and studies on the health effects of toxic
substances” under CERCLA Section 104(i)(1)(B), to respond to requests for consultation under section 
104(i)(4), and as otherwise necessary to support the site-specific response actions conducted by ATSDR. 
This profile reflects ATSDR’s assessment of all relevant toxicologic testing and information that has been 
peer-reviewed.  Staffs of the Centers for Disease Control and Prevention and other Federal scientists have 
also reviewed the profile.  In addition, this profile has been peer-reviewed by a nongovernmental panel
and is being made available for public review.  Final responsibility for the contents and views expressed 
in this toxicological profile resides with ATSDR.
Patrick N. Breysse, Ph.D., CIH
 
Director, National Center for Environmental Health and
 
Agency for Toxic Substances and Disease Registry
 
Centers for Disease Control and Prevention
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QUICK REFERENCE FOR HEALTH CARE PROVIDERS
Toxicological Profiles are a unique compilation of toxicological information on a given hazardous
substance. Each profile reflects a comprehensive and extensive evaluation, summary, and interpretation
of available toxicologic and epidemiologic information on a substance.  Health care providers treating
patients potentially exposed to hazardous substances will find the following information helpful for fast
answers to often-asked questions.
Primary Chapters/Sections of Interest
Chapter 1: Public Health Statement: The Public Health Statement can be a useful tool for educating
patients about possible exposure to a hazardous substance.  It explains a substance’s relevant
toxicologic properties in a nontechnical, question-and-answer format, and it includes a review of
the general health effects observed following exposure.
Chapter 2:  Relevance to Public Health: The Relevance to Public Health Section evaluates, interprets,
and assesses the significance of toxicity data to human health.
Chapter 3:  Health Effects: Specific health effects of a given hazardous compound are reported by type
of health effect (death, systemic, immunologic, reproductive), by route of exposure, and by length 
of exposure (acute, intermediate, and chronic).  In addition, both human and animal studies are
reported in this section.
NOTE: Not all health effects reported in this section are necessarily observed in the clinical
setting.  Please refer to the Public Health Statement to identify general health effects observed
following exposure.
Pediatrics:  Four new sections have been added to each Toxicological Profile to address child health
issues:
Chapter 1 How Can (Chemical X) Affect Children?
 
Chapter 1 How Can Families Reduce the Risk of Exposure to (Chemical X)?
 
Section 3.7 Children’s Susceptibility
 
Section 6.6 Exposures of Children
 
Other Sections of Interest:
Section 3.8 Biomarkers of Exposure and Effect
Section 3.11 Methods for Reducing Toxic Effects
ATSDR Information Center
Phone: 1-800-CDC-INFO (800-232-4636) or 1-888-232-6348 (TTY)
Internet:  http://www.atsdr.cdc.gov
The following additional material is available online at www.atsdr.cdc.gov:
Case Studies in Environmental Medicine—Case Studies are self-instructional publications designed to 
increase primary care provider’s knowledge of a hazardous substance in the environment and to
aid in the evaluation of potentially exposed patients.  
Managing Hazardous Materials Incidents is a three-volume set of recommendations for on-scene 
(prehospital) and hospital medical management of patients exposed during a hazardous materials 
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incident.  Volumes I and II are planning guides to assist first responders and hospital emergency
department personnel in planning for incidents that involve hazardous materials.  Volume III— 
Medical Management Guidelines for Acute Chemical Exposures—is a guide for health care 
professionals treating patients exposed to hazardous materials.
Fact Sheets (ToxFAQs™) provide answers to frequently asked questions about toxic substances.
Other Agencies and Organizations
The National Center for Environmental Health (NCEH) focuses on preventing or controlling disease, 
injury, and disability related to the interactions between people and their environment outside the
workplace.  Contact:  NCEH, Mailstop F-29, 4770 Buford Highway, NE, Atlanta,
GA 30341-3724 • Phone: 770-488-7000 • FAX: 770-488-7015.
The National Institute for Occupational Safety and Health (NIOSH) conducts research on occupational
diseases and injuries, responds to requests for assistance by investigating problems of health and
safety in the workplace, recommends standards to the Occupational Safety and Health
Administration (OSHA) and the Mine Safety and Health Administration (MSHA), and trains
professionals in occupational safety and health.  Contact: NIOSH, 395 E Street, S.W., Suite 9200, 
Patriots Plaza Building, Washington, DC 20201 • Phone: (202) 245-0625 or 1-800-CDC-INFO 
(800-232-4636).
The National Institute of Environmental Health Sciences (NIEHS) is the principal federal agency for
biomedical research on the effects of chemical, physical, and biologic environmental agents on 
human health and well-being.  Contact:  NIEHS, PO Box 12233, 104 T.W. Alexander Drive, 
Research Triangle Park, NC 27709 • Phone: 919-541-3212.
Clinical Resources
The Association of Occupational and Environmental Clinics (AOEC) has developed a network of clinics 
in the United States to provide expertise in occupational and environmental issues.  Contact:
AOEC, 1010 Vermont Avenue, NW, #513, Washington, DC 20005 • Phone: 202-347-4976 
• FAX:  202-347-4950 • e-mail: AOEC@AOEC.ORG • Web Page:  http://www.aoec.org/.
The American College of Occupational and Environmental Medicine (ACOEM) is an association of
physicians and other health care providers specializing in the field of occupational and 
environmental medicine.  Contact:  ACOEM, 25 Northwest Point Boulevard, Suite 700, Elk
Grove Village, IL 60007-1030 • Phone:  847-818-1800 • FAX:  847-818-9266.
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CONTRIBUTORS
CHEMICAL MANAGER(S)/AUTHOR(S):
John Risher, Ph.D.
 
Obaid Faroon, Ph.D.
 
ATSDR, Division of Toxicology and Human Health Sciences, Atlanta, GA
 
Fernando Llados, Ph.D.
 
Lisa Ingerman, Ph.D.
 
Mario Citra, Ph.D.
 
SRC, Inc., North Syracuse, NY
 
THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS:
1.	 Health Effects Review. The Health Effects Review Committee examines the health effects 
chapter of each profile for consistency and accuracy in interpreting health effects and classifying
end points.
2.	 Minimal Risk Level Review.  The Minimal Risk Level Workgroup considers issues relevant to
substance-specific Minimal Risk Levels (MRLs), reviews the health effects database of each
profile, and makes recommendations for derivation of MRLs.
3.	 Data Needs Review. The Environmental Toxicology Branch reviews data needs sections to
assure consistency across profiles and adherence to instructions in the Guidance.
4.	 Green Border Review.  Green Border review assures the consistency with ATSDR policy.
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PEER REVIEW
 
A peer review panel was assembled for JP-5,JP-8, and Jet A fuels.  The panel consisted of the following
members:
1.	 Errol Zeiger, Ph.D., J.D., A.T.S., Errol Zeiger Consulting, Chapel Hill, North Carolina;
2.	 Luis Haro Garcia, M.D., MSc, Ph.D., Departamento de Salud Pública, Facultad de Medicina, 
Universidad Nacional Autónoma de México, México DF, México; and
3.	 Wayne G. Landis, Ph.D., Western Washington University, Huxley College of Environmental
Studies, Bellingham, Washington.
These experts collectively have knowledge of JP-5, JP-8, and Jet A fuel’s physical and chemical
properties, toxicokinetics, key health end points, mechanisms of action, human and animal exposure, and 
quantification of risk to humans.  All reviewers were selected in conformity with the conditions for peer
review specified in Section 104(I)(13) of the Comprehensive Environmental Response, Compensation, 
and Liability Act, as amended.
Scientists from the Agency for Toxic Substances and Disease Registry (ATSDR) have reviewed the peer
reviewers' comments and determined which comments will be included in the profile.  A listing of the
peer reviewers' comments not incorporated in the profile, with a brief explanation of the rationale for their
exclusion, exists as part of the administrative record for this compound. 
The citation of the peer review panel should not be understood to imply its approval of the profile's final
content.  The responsibility for the content of this profile lies with the ATSDR.
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1JP-5 AND JP-8
1. PUBLIC HEALTH STATEMENT FOR JP-5, JP-8, and JET A FUELS
This Public Health Statement summarizes the Division of Toxicology and Human Health Science’s
findings on JP-5, JP-8, and Jet A fuels, tells you about them, the effects of exposure, and describes what
you can do to limit that exposure.
WHAT ARE JP-5, JP-8, AND JET A FUELS?
JP-5 and JP-8 stand for jet propellant-5 and jet propellant-8. Propellants are substances that move other
objects or give thrust. JP-5 and JP-8 are used as military aircraft fuels.  They can also be used for fueling
land vehicles and as a fuel source for heaters and lights.  Jet A is the type of fuel used in civilian aircraft; 
however, the U.S. Air Force has recently started using Jet A (plus certain additives) for flying in the 
continental United States.  JP-5, JP-8, and Jet A fuels are colorless liquids that are flammable and smell
like kerosene. The fuels are made from chemical compounds called hydrocarbons, which are found 
naturally in the earth as crude oil.  Hydrocarbons are compounds that contain only carbon and hydrogen.  
The crude oil is refined into a number of different types of fuel. Jet A, JP-5, and JP-8 fuels may also
contain various additives such as antioxidants and additives to prevent icing in the fuel lines. More 
information on the chemical and physical properties of these fuels is found in Chapter 4.  More 
information on the production and use of these fuels is found in Chapter 5.
The U.S. Environmental Protection Agency (EPA) identifies the most serious hazardous waste sites in the 
nation. These sites make up the National Priorities List (NPL) and are sites targeted for long-term federal
clean-up activities.  U.S. EPA has found JP-5 and JP-8 in at least 23 of the 1,699 current or former NPL
sites; however, it is unknown how many of the 1,699 current or former NPL sites have been evaluated for
the presence of JP-5, JP-8, or Jet A fuels.  As more sites are evaluated, the sites at which JP-5, JP-8, or
Jet A fuels are found may increase.  This information is important because these future sites may be 
sources of exposure, and exposure to JP-5, JP-8, and Jet A fuels may be harmful.
If you are exposed to JP-5, JP-8, or Jet A fuels, many factors determine whether you’ll be harmed.  These
include how much you are exposed to (dose), how long you are exposed to it (duration), and how you are
exposed (route of exposure).  You must also consider the other chemicals you are exposed to and your
age, sex, diet, family traits, lifestyle, and state of health.
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2JP-5, JP-8, AND JET A FUELS
1.  PUBLIC HEALTH STATEMENT
WHAT HAPPENS TO JP-5, JP-8, AND JET A FUELS WHEN THEY ENTER THE 
ENVIRONMENT?
JP-5, JP-8, and Jet A fuels are made up of hundreds of hydrocarbon compounds; many of these 
hydrocarbons are also present in gasoline.  These hydrocarbons can be grouped into several classes of
chemicals which have similar chemical properties. The different chemical classes can behave differently
when they enter the environment.  For example, some of these can easily evaporate into the air during 
aircraft loading and unloading operations or as a result of their normal use as a jet fuel for civilian or
military aircraft.  Some may also evaporate when jet fuels are spilled accidentally onto soils or surface 
waters.  Other chemical classes are more likely to dissolve in water following spills to surface waters or
leaks from underground storage tanks.  Some chemical classes found in jet fuels may slowly move down 
through the soil to the groundwater, while others may readily attach to particles in the soil or water.  Once 
attached in water, these particles may sink down into the sediment.  
HOW MIGHT I BE EXPOSED TO JP-5, JP-8, AND JET A FUELS?
It is unlikely that you will be exposed to JP-5, JP-8, or Jet A fuels unless you work with jet fuels or live
very close to where they are used or were spilled.  Exposure to jet fuels can occur if you have skin contact
with soil or water contaminated from a spill or leak.  You may also be exposed to JP-5, JP-8, or Jet A
fuels if you swim in waters where jet fuels have been spilled.  If jet fuels have leaked from underground 
storage tanks and entered groundwater, you may be exposed from contaminated well water.  You might
breathe in some of the chemicals evaporating from a spill or leak site if you are in an area where an 
accident has occurred.
The chemicals that evaporate may break down into other substances in air by reacting with sunlight or
other chemicals in the air.  The chemicals that dissolve in water may also be broken down into other
substances by microorganisms found water and sediment.  However, this may take many years to occur, 
depending on the environmental conditions.  Some chemicals that attach to soil or other matter (for
example, marsh sediment) may remain in the environment for more than a decade.  Some of the 
chemicals in jet fuels may be detected in fish and aquatic organisms after an accidental release into a lake,
river, or stream. These hydrocarbons are not expected to persist in aquatic organisms.  For more
information on what happens to JP-5, JP-8, and Jet A fuels when they enter the environment, see
Chapter 6.
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3JP-5, JP-8, AND JET A FUELS
1.  PUBLIC HEALTH STATEMENT
Workers involved in making or transporting jet fuels, aircraft or fuel tank maintenance, or in refueling
aircraft that use JP-5, JP-8, or Jet A fuels may be exposed to some of the chemicals that have evaporated 
from the fuel.  Workers in the vicinity of an aircraft during cold engine startup may also be exposed to 
airborne jet fuels.  Some workers may be exposed to JP-5, JP-8, or Jet A fuels through their skin if they
come into contact with them without adequate protection from gloves, boots, coveralls, or other protective
clothing.  For more information on how you might be exposed to JP-5, JP-8, or Jet A fuels, see Chapter 6.
HOW CAN JP-5, JP-8, AND JET A FUELS ENTER AND LEAVE MY BODY?
The chemicals in JP-5, JP-8, and Jet A fuels can enter your body through your lungs, digestive tract, or
skin.  We do not have information on how much of the chemicals in JP-5, JP-8, or Jet A fuels can enter
your body, but we do know that large amounts of some of the chemicals in jet fuels can easily enter the 
body.  Studies examining the absorption of jet fuels through the skin have shown that damage to the skin 
and the longer jet fuels stays on your skin will increase the amount chemicals that will enter your body.  
Once jet fuels enter your body, the chemicals in the fuel will be distributed throughout your body.  A
number of the chemicals in jet fuels were found in the blood, fat, brain, lungs, and liver following
exposure to JP-8 in air.  Some of the chemicals in JP-5, JP-8, or Jet A fuels will be broken down in the
body to form other chemicals. The chemicals in JP-5, JP-8, or Jet A fuels will be eliminated from the
body in the urine, feces, or breath.
HOW JP-5, JP-8, AND JET A FUELS CAN AFFECT YOUR HEALTH?
The health effects of JP-5, JP-8, and Jet A fuels depend on how much of these fuels you are exposed to 
and for how long.  We know very little about the human health effects caused by JP-5, JP-8, or Jet A
fuels.  A few studies of military personnel have provided suggestive evidence that JP-8 can affect the 
nervous system.  Some of the effects that have been observed in humans include changes in reaction time
and other tests of neurological function.  A number of effects have been reported in humans who 
accidentally ingested kerosene, a fuel oil similar in composition to JP-5, JP-8, and Jet A fuels, suffered 
harmful effects on the respiratory tract, gastrointestinal tract, and nervous system. The observed effects 
included cough and difficulty breathing, abdominal pain and vomiting, drowsiness, restlessness, and 
convulsions.
Studies in laboratory animals have examined the toxicity of JP-5, JP-8, and Jet A fuels following
inhalation, ingestion, or dermal contact.  In most cases, the levels tested in laboratory animals are higher
than levels the public might encounter through contact or through water or soil.  Health effects of JP-5, 
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4JP-5, JP-8, AND JET A FUELS
1.  PUBLIC HEALTH STATEMENT
JP-8, or Jet A fuels observed in these studies include damage to the liver, decreased immune response, 
impaired performance on neurological function tests, and impaired hearing.  Dermatitis and damage to the 
skin have also been observed in laboratory animals following dermal contact.
There are no reliable studies of cancer in humans exposed to JP-5, JP-8, or Jet A fuels.  A few studies that
examined the possible association between exposure to various types of jet fuels or to kerosene and 
various types of cancer did not provide conclusive results.  Because the studies involved exposure to
several fuel types and there was no information on exposure concentrations, these studies were not
considered adequate to assess the carcinogenicity of JP-5, JP-8, or Jet A fuels.  
No inhalation or oral studies evaluated the carcinogenicity of JP-5, JP-8, or Jet A.  No increases in tumor
incidences were observed in rats administered kerosene by a feeding tube for 2 years.  JP-5 applied to the
skin for 2 years was not carcinogenic in mice. Increases in skin tumors were observed in mice dermally
exposed to Jet A for 52–62 weeks; however, tumors were only observed at concentrations resulting in 
damage to the skin.  Similarly, increased numbers of skin tumors were observed in mice that received
applications of undiluted kerosene on the skin for 2 years, but this occurred only in the presence of skin 
damage.
The U.S. Department of Health and Human Services (DHHS) and the EPA have not classified JP-5, JP-8, 
or Jet A fuels as to their carcinogenicity.  The International Agency for Research on Cancer (IARC) has 
classified JP-5, JP-8, and Jet A as Group 3 carcinogens (not classifiable as to their carcinogenicity to
humans). 
See Chapters 2 and 3 for more information on health effects of JP-5, JP-8, and Jet A fuels.
HOW CAN JP-5, JP-8, AND JET A FUELS AFFECT CHILDREN?
Exposure JP-5, JP-8, or Jet A fuels mainly occurs in occupational settings where children are unlikely to 
be exposed. No studies examining the health effects of JP-5, JP-8, or Jet A fuels in children were found.  
There are a number of reports of accidental kerosene ingestion in children in developing countries where
kerosene is usually stored in containers and places easily accessible to children.  Some of the more 
commonly reported effects include coughing, pneumonia, shortness of breath, vomiting, fever, 
unconsciousness, drowsiness, and irritability.  These effects are similar to the effects seen in adults who
ingest kerosene.
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5JP-5, JP-8, AND JET A FUELS
1.  PUBLIC HEALTH STATEMENT
Studies in laboratory animals exposed to JP-8 during pregnancy did not find birth defects in the newborn 
animals.  However, some effects on muscle coordination and immune function were found in the
offspring.
HOW CAN FAMILIES REDUCE THE RISK OF EXPOSURE TO JP-5, JP-8, AND JET A 
FUELS?
If your doctor finds that you have been exposed to significant amounts of JP-5, JP-8, or Jet A fuels, ask
whether your children or unborn baby might be at risk.  Your doctor might need to ask your state health
department to investigate. It is unlikely that you or your family will be exposed to JP-5, JP-8, or Jet A
fuels.  Jet fuels are not likely to be common contaminants in foods or drinking water. If you get JP-5, 
JP-8, or Jet A fuels on your work clothes, you should change your clothes before leaving your job and 
returning home.
ARE THERE MEDICAL TESTS TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO
JP-5, JP-8, AND JET A FUELS? 
Many of the individual chemicals found in JP-5, JP-8, and Jet A fuels and their breakdown products
(metabolites) can be measured in blood and urine.  Finding these chemicals does not mean that you were 
exposed to jet fuels because these chemicals may have come from a different source including exposure
to gasoline fumes when pumping gas.  The levels of these chemicals in your body cannot predict the kind 
of health effects that might occur or whether you will have any effects. JP-5, JP-8, and Jet A fuels and
their metabolites leave the body fairly rapidly and tests to detect these chemicals need to be conducted 
within days of exposure.
WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT
HUMAN HEALTH?
The federal government develops regulations and recommendations to protect public health.  Regulations
can be enforced by law.  Federal agencies that develop regulations for toxic substances include the
Environmental Protection Agency (EPA), the Occupational Safety and Health Administration (OSHA),
and the Food and Drug Administration (FDA).  Recommendations provide valuable guidelines to protect
public health but cannot be enforced by law.  Federal organizations that develop recommendations for
For more information on the different substances formed by JP-5, JP-8, and Jet A fuels breakdown and on 
tests to detect these substances in the body, see Chapters 3 and 7.
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6JP-5, JP-8, AND JET A FUELS
1. PUBLIC HEALTH STATEMENT
toxic substances include the Agency for Toxic Substances and Disease Registry (ATSDR) and the 
National Institute for Occupational Safety and Health (NIOSH).
Regulations and recommendations can be expressed as “not-to-exceed” levels; that is, levels of a toxic 
substance in air, water, soil, or food that do not exceed a critical value usually based on levels that affect
animals; levels are then adjusted to help protect humans.  Sometimes these not-to-exceed levels differ
among federal organizations.  Different organizations use different exposure times (an 8-hour workday or
a 24-hour day), different animal studies, or emphasize some factors over others, depending on their
mission.
Recommendations and regulations are also updated periodically as more information becomes available.
For the most current information, check with the federal agency or organization that issued the regulation
or recommendation.
OSHA has not set a legal limit for jet fuels in workroom air.  NIOSH has set a recommended limit of
100 mg/m3 for kerosene in air averaged over a 10-hour work day. The EPA does not have recommended 
drinking water guidelines for jet fuels.
WHERE CAN I GET MORE INFORMATION?
If you have any questions or concerns, please contact your community or state health or environmental
quality department, or contact ATSDR at the address and phone number below. ATSDR can also provide
publically available information regarding medical specialists with expertise and experience recognizing, 
evaluating, treating, and managing patients exposed to hazardous substances.
• Call the toll-free information and technical assistance number at
1-800-CDCINFO (1-800-232-4636) or
• Write to:
Agency for Toxic Substances and Disease Registry

Division of Toxicology and Human Health Sciences
 
1600 Clifton Road NE
 
Mailstop F-57
 
Atlanta, GA 30329-4027
 
Toxicological profiles and other information are available on ATSDR’s web 
site:  http://www.atsdr.cdc.gov. 
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7JP-5, JP-8, AND JET A FUELS
2. RELEVANCE TO PUBLIC HEALTH
 
2.1  	 BACKGROUND AND ENVIRONMENTAL EXPOSURES TO JP-5, JP-8, AND JET A
FUELS IN THE UNITED STATES
JP-5, JP-8, and Jet A are kerosene-based jet fuels. They are refined by a straight distillation of crude or
shale oil, or a distillation of crude or shale oil in the presence of a catalyst.  The jet fuels are, however,
refined under more stringent conditions and contain various additives not found in kerosene; Jet A serves
as the base fuel for JP-8.  The performance-enhancing additives found in JP-5, JP-8, and Jet A include
antioxidants (including phenolic antioxidants), static inhibitors, corrosion inhibitors, fuel system icing
inhibitors, lubrication improvers, biocides, and thermal stability improvers.  These additives are used in 
specified amounts as governed by commercial and military specifications.  Jet fuels are composed of
more than 200 aliphatic and aromatic hydrocarbons (C6-C17+); the exact composition of a jet fuel is also
dependent upon the crude oil from which it is refined.  Because of this inherent variability, little
information exists on the exact chemical and physical properties of jet fuels.
Many of the constituents of JP-5, JP-8, and Jet A fuels are volatile and will evaporate into the air when jet
fuels are spilled accidentally onto soils or surface waters.  Other components of these jet fuels are more 
likely to dissolve in water following spills to surface waters or leaks from underground storage tanks.  
Some of the chemicals in jet fuels may slowly move down through the soil to the groundwater.  The
chemicals that evaporate will undergo photodegradation by atmospheric oxidants such as hydroxyl
radicals. The photooxidation half-life range for a group of representative chemicals of kerosene, JP-5, 
JP-8, and Jet A was reported as 0.2–1.1 days.  In soil and water, the constituents of JP-5, JP-8, and Jet A
fuels are biodegraded at varying rates. Exposure to JP-5, JP-8, and Jet A fuels by the general population 
is expected to be low and could occur through atmospheric, soil, or groundwater contamination.  Military
or civilian personnel who are employed in jet fuel storage or re-fueling activities will have the greatest
exposure via inhalation and dermal routes to these substances.  Occupational exposure could involve
exposure to raw fuel, vapor phase, aerosol phase, a mixture of vapors and aerosols, or fuel combustion 
exhaust.  General population exposure is most likely to occur in populations living near military
installations using JP-5 or JP-8 or commercial airports using Jet A.  Airborne exposure to jet fuel vapors
and/or aerosols can result from fuel spillage, engine cold starts, and high-altitude fuel jettisoning.  Jet fuel 
spills can also result in exposure via contaminated groundwater or soil.
Because JP-5, JP-8, and Jet A fuels are complex mixtures of both aliphatic and aromatic hydrocarbons, 
exposure is typically measured by monitoring the total hydrocarbon concentration (THC) and the levels of
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8JP-5, JP-8, AND JET A FUELS
2. RELEVANCE TO PUBLIC HEALTH
certain aromatic substances, such as benzene, toluene, ethylbenzene, xylene, and naphthalene, that are
present in jet fuels.  Since there are multiple sources of these components in the environment, exposure
studies usually include a control population that has had little or no exposure to jet fuels in order to 
establish a baseline level of these substances that would exist in the absence of jet fuel exposure.  In a 
study of Air Force personnel exposed to JP-8 during regular work shifts, the geometric mean
concentration of THC in the breathing zone of a high exposure group was 4.4 mg/m3, while that of a low
exposure group was 0.9 mg/m3. The geometric mean concentrations of naphthalene were reported as 
4.8 and 0.7 µg/m3 for the high and low exposure groups, respectively. See Chapter 6 for more
information on levels of exposure and environmental fate of JP-5 and JP-8. 
2.2  SUMMARY OF HEALTH EFFECTS 
Although JP-5 and Jet A fuels have been used for over 60 years and JP-8 was identified by the
Department of Defense as its single military fuel over 30 years ago, there are very little data on the 
toxicity of kerosene-based jet fuels in humans.  Most of the studies focused on the potential neurotoxicity
of JP-8 fuel.  Single studies in humans exposed to JP-8 fuel reported increases in white blood cell 
neutrophil and monocyte levels with no change in lymphocyte subpopulations and an inverse association
between aliphatic hydrocarbons in exhaled breath and serum levels of luteinizing hormone (LH).  
However, exposure to JP-8 was not associated with higher odds of menstrual disorders. Limited
information is available on the carcinogenic potential of jet fuels in humans.  Studies in laboratory 
animals have examined the toxicity of JP-5, JP-8, and Jet A fuels following inhalation, oral, or dermal
exposure and have reported a number of targets of toxicity, including the lungs, liver, skin, 
immunological system, nervous system, and developing organism.  Although renal effects have also been 
observed in male rats exposed to JP-5 or JP-8, the lesions are considered to be characteristic of alpha2u­
globulin nephropathy, which is only observed in male rats and is not considered to be toxicologically
relevant to humans.  JP-5 was not carcinogenic in mice in a 2-year dermal bioassay. Increases in skin
tumors were observed in mice dermally exposed to Jet A for 52–62 weeks; however, tumors were only
observed at concentrations resulting in significant skin damage (inflammation and necrosis).  Similarly,
increased numbers of skin tumors were observed in mice that received applications of undiluted kerosene 
on the skin for 2 years, but this occurred only in the presence of moderate-to-marked skin damage.  No 
inhalation or oral studies evaluated the carcinogenicity of JP-5, JP-8, or Jet A in laboratory animals; no 
increases in tumor incidences were observed in rats administered kerosene by gavage for 2 years.
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Neurological Effects. Studies in subjects occupationally exposed to JP-8 have reported alterations in 
balance associated with cumulative exposure to benzene, a component of JP-8, and alterations in 
neuropsychological test results in workers with daily exposures to <10 mg/m3 JP-8.  Another study of
workers did not find an association between daily exposures to JP-8 and balance.  A study of veterans
found alterations in reaction time on divided attention tests following 3 weekly 7-minute exposures to 
0.00057 ppm JP-8 vapor.  Kerosene induces neurological effects in humans, as evidenced in many reports
of acute accidental ingestion of this fuel.  Neurological effects noted most frequently reported in these
cases included unconsciousness or semiconsciousness, drowsiness, restlessness, and irritability. There are
limited data that suggest that the central nervous system effects following ingestion of kerosene are due to
hypoxia from kerosene-induced respiratory impairment.  In laboratory animals, JP-5 and JP-8 caused
alterations in performance in a battery of tests in rats exposed to 1,200 mg/m3 JP-5 vapor or 1,000 mg/m3 
JP-8 vapor in intermediate-duration inhalation studies.  Exposure to 1,000 mg/m3 JP-8 vapor also resulted 
in impaired performance on higher cognitive tests, but not on simple memory tests.  Another study found
hyperlocomotive activity and increased arousal levels in rats exposed to aerosolized JP-8 for 4 weeks.  In 
contrast, lethargy was observed in mice administered Jet A gavage doses of 100 mg/kg/day and was 
observed once in most rats exposed to 500 mg/kg/day.  In addition to the central nervous system effects,
exposure to JP-8 can result in auditory effects.  Acute- and intermediate-duration exposure to JP-8 
followed by exposure to noise resulted in alterations in the peripheral auditory system and the central
auditory processing area.
Respiratory Effects. No human studies have examined the potential of JP-5, JP-8, or Jet A to induce
respiratory effects.  Respiratory effects are a common finding in humans ingesting kerosene; the observed
effects include bronchopneumonia, bronchitis, pneumonitis, lung infiltrates and effusions, cough, 
dyspnea, and tachypnea.  However, these effects are likely attributable to aspiration of the kerosene. The 
results of studies in laboratory animals suggest that the respiratory tract is a target for airborne JP-8.  Most
of this information comes from a series of studies conducted at the University of Arizona in which rats
and mice were exposed to aerosolized JP-8 1 hour/day for 1 or 7 days.  There are several limitations to
these studies: the primary limitation being that only the aerosol component of the test atmosphere was 
measured, resulting in a large underestimation of the JP-8 exposure (the studies’ limitations are discussed
in greater detail in Section 3.2.1).  These studies reported an increase in respiratory permeability, 
increased lung resistance, and terminal bronchiole lesions. These effects were usually accompanied by
increased biomarkers of inflammation in broncheoalveolar lavage fluid (BALF).  In contrast, an acute-
duration study in which rats were exposed to Jet A aerosols and vapors and most intermediate-duration 
inhalation studies involving exposure to JP-5 or JP-8 vapor did not report respiratory effects.  The
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10JP-5, JP-8, AND JET A FUELS
2. RELEVANCE TO PUBLIC HEALTH
exception is the finding of enlarged alveolar capillaries in rats exposed to 500 mg/m3 JP-8 vapor
6 hours/day for 90 days; the no-observed-adverse-effect level (NOAEL) was 250 mg/m3. No histological
alterations were observed in the respiratory tracts of rats exposed to ≤1,980 mg/m3 Jet A aerosols and
vapors 4 hours/day, 5 days/week for 14 days, in rats continuously exposed to ≤1,000 mg/m3 JP-8 vapor
for 90 days, or in rats, mice, and dogs continuously exposed to ≤750 mg/m3 JP-5 vapor for 90 days.  One 
possible explanation for the conflicting results between studies is the differences in the composition of the 
test atmosphere.  For example, a vapor test atmosphere could contain a higher percentage of low
molecular weight, more volatile compounds than the raw fuel and aerosolizing the jet fuel could generate
liquid droplets enriched in higher molecular weight n-alkanes.
Hepatic Effects. Several studies in laboratory animals provide evidence that the liver is a sensitive 
target of jet fuel toxicity; however, the findings are not consistent across studies, which may be due to
species or strain differences or differences in the physical properties of the fuel (e.g., aerosols versus 
vapor).  Continuous exposure to ≥150 mg/m3 JP-5 vapor resulted in hepatocellular fatty changes and 
vacuolization in mice.  In similarly exposed rats and dogs, exposure to 750 mg/m3 JP-5 vapor resulted in 
no effects in rats and mild diffuse hepatocellular swelling in dogs.  Dilated sinusoids and fatty
hepatocytes were observed in rats exposed to ≥500 mg/m3 JP-8 vapor for 91 days; another 90-day study
found no histological alterations in rats exposed to 1,000 mg/m3 JP-8 vapor.  A 14-day exposure to 
1,980 mg/m3 Jet A vapor and aerosol also did not result in histological alterations or changes in alanine 
aminotransferase (ALT) levels.  In acute-duration gavage studies, increases in ALT and aspartate 
aminotransferase (AST) levels were observed in rats administered a single gavage dose of 19 mg/kg JP-5
or single or repeated gavage doses of >18,000 mg/kg JP-5.  Intermediate-duration gavage administration 
of ≥750 mg/kg/day JP-8 for 90 days in rats resulted in non-dose-related increases in ALT and AST; this
study also found an increase in total bilirubin levels at ≥750 mg/kg/day, but no histological alterations.  A
90-day gavage exposure to 500 mg/kg/day Jet A also did not result in histological alterations in the livers
of rats or mice; the exposure did result in an increase liver weight and enlarged livers in rats.  Chronic
dermal exposure to 500 mg/kg/day JP-5 resulted in liver amyloidosis in mice.
Dermal Effects.  Studies in rats, mice, rabbits, and pigs demonstrate the dermal toxicity of topically
applied JP-5, JP-8, and Jet A.  Similar effects have been observed for all three fuel types, although the
results of one study suggests that Jet A may be slightly more irritating than JP-8 in pigs exposed for
5 hours.  Single 1-hour exposures to low concentrations did not result in visible damage to the skin; 
however, evidence of inflammation (increased granulocyte infiltration and increased levels of
inflammatory biomarkers) was observed.  Additionally, ultrastructural changes suggest that jet fuel
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2. RELEVANCE TO PUBLIC HEALTH
exposure alters the epidermal-dermal barrier, which could result in increased absorption.  Overt signs of
dermal toxicity have been observed following repeated exposures; effects ranged from erythema and
edema to dermatitis to ulceration.  The severity of the lesions increased with duration and concentration.  
Other factors that can affect the dermal toxicity include the test vehicle and whether the application site is 
occluded.  At a given dose, undiluted jet fuel resulted in more severe erythema and desquamation, as
compared to jet fuel diluted in mineral oil or acetone:olive oil.  Occluding the application site resulted in
moderate-to-severe erythema and moderate edema as compared to slight erythema when the application
site was not occluded.
Immunological Effects. Inhalation, oral, and dermal studies in animals have shown that exposure to
JP-8 and Jet A can affect immune parameters; immunotoxicity has not be adequately evaluated in JP-5 
studies.  A number of alterations in immune parameters were reported in a series of acute-duration studies
in which mice were exposed to JP-8 vapors and aerosols 1 hour/day.  However, most of the studies only
measured the aerosol component of the test atmosphere, which underestimated the JP-8 exposure, and the
animals were likely exposed to plasticizers (see Section 3.2.1 for discussion of the limitations of this
series of studies conducted by the University of Arizona).  Effects included decreased viable immune 
cells in the thymus, lymph nodes, and peripheral blood; impaired response to stimulation with the T cell
mitogen concanavalin A; increased severity in the response to influenza virus infection; and suppressed
immune response to injected tumor cells.  A later study by this group in which the vapor and aerosol
components of the test atmosphere were measured found decreased thymus weight and the proliferative 
response to stimulation with antigens at ≥1,000 mg/m3 JP-8 vapor and aerosol (1 hour/day for 7 days); at 
higher concentrations, decreases in viable immune cells were observed in the thymus, spleen, peripheral
blood, and bone marrow.  Decreases in spleen and thymus weights and an impaired response to 
concanavalin A were observed in mice exposed to aerosolized Jet A in another University of Arizona
study.  A study of Jet A by another investigator did not find alterations in spleen weights or splenocyte
phenotypes in rats exposed to Jet A aerosols and vapors for 14 days. The results of the two Jet A studies 
cannot be directly compared because the first study did not measure the vapor component of the test
atmosphere.  In acute-duration (14-day) oral studies that assessed multiple immune parameters in mice,
JP-8 suppressed humoral immunity, as evidenced by an altered response to sheep red blood cells (SRBCs)
at the lowest dose tested, 500 mg/kg/day. Dermal exposure to ≥50 µL JP-8 inhibited contact and delayed 
hypersensitivity in mice and ≥25 µL suppressed immune memory in mice previously exposed to Candida 
albicans.  Dermal exposure to Jet A also resulted in suppression of delayed type hypersensitivity in mice.  
Production of prostaglandin E2 by mast cells and of suppressive cytokines, presumably by epidermal
cells, were proposed as possible mechanisms involved in the immunotoxicity of dermally applied JP-8.  
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2. RELEVANCE TO PUBLIC HEALTH
JP-8 was also shown to be a weak skin sensitizer; however, neither JP-8+100 nor Jet A were skin 
sensitizers.  Intermediate-duration dermal exposure to Jet A did not result in alterations in spleen or
thymus weights, spleen lymphocyte phenotypes, or response to SRBCs.
The issue of which component or components in JP-8 are responsible for the immune effects of this fuel
has been explored in a few studies.  Acute inhalation exposure of mice to a synthetic fuel (S8) with no 
polycyclic aromatic hydrocarbons (PAHs) induced immune effects similar to JP-8, suggesting that the
PAHs in JP-8 are not responsible for the immune effects.  Exposure of mice to vapors of jet fuel kerosene
(Jet A free of performance additives) and in the same range of concentrations as in the studies mentioned
above did not suppress innate, humoral, or cell-mediated immunity, suggesting that the additives, at least 
in part, are responsible for the effects of JP-8 on immune parameters.  In yet a third study, dermal
exposure of mice to S8 did not induce immune suppression, as measured by the delayed-type
hypersensitivity reaction (DTH).  However, when a cocktail of seven of the most prevalent aromatic 
hydrocarbons in JP-8 were added to S8, exposure to the latter resulted in suppression of DTH. 
Developmental Toxicity. Assessment of standard developmental end points showed that JP-8 was 
not embryotoxic or teratogenic in rats exposed orally during gestation, although fetal weight was
decreased with doses (≥1,000 mg/kg/day; administered via gavage) that significantly reduced (≥31%)
maternal body weight gain during gestation and pup body weights were decreased on postnatal days
(PNDs) 4 and 11 at maternal gavage dose of 1,500 mg/kg/day.  Inhalation (University of Arizona study, 
which only measured the aerosol component) or oral (1,000 mg/kg/day) exposure of pregnant mice to 
JP-8 resulted in suppressed immune function in the offspring when assessed before 8 weeks of age.  JP-8 
also induced a transient delay in motor coordination in offspring from rats exposed to ≥325 mg/kg/day 
before and during gestation and during lactation.  The developmental toxicity of JP-5 and Jet A has not
been evaluated.
2.3  MINIMAL RISK LEVELS (MRLs)
Estimates of exposure levels posing minimal risk to humans (MRLs) have been made for JP-5, JP-8, and 
Jet A fuels.  An MRL is defined as an estimate of daily human exposure to a substance that is likely to be 
without an appreciable risk of adverse effects (noncarcinogenic) over a specified duration of exposure.
MRLs are derived when reliable and sufficient data exist to identify the target organ(s) of effect or the
most sensitive health effect(s) for a specific duration within a given route of exposure. MRLs are based
on noncancerous health effects only and do not consider carcinogenic effects.  MRLs may be derived for
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acute, intermediate, and chronic duration exposures for inhalation and oral routes.  Appropriate
methodology does not exist to develop MRLs for dermal exposure.
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990), 
uncertainties are associated with these techniques.  Furthermore, ATSDR acknowledges additional
uncertainties inherent in the application of the procedures to derive less than lifetime MRLs.  As an
example, acute inhalation MRLs may not be protective for health effects that are delayed in development
or are acquired following repeated acute insults, such as hypersensitivity reactions, asthma, or chronic 
bronchitis.  As these kinds of health effects data become available and methods to assess levels of
significant human exposure improve, these MRLs may be revised.
Inhalation MRLs
Acute-Duration Inhalation MRL
JP-5.  Information on the acute toxicity of airborne JP-5 is limited to a study in mice that estimated a 
concentration resulting in a 50% reduction in respiratory rate (RD50) following a 30-minute exposure to 
JP-5 vapor and aerosol (Whitman and Hinz 2001); the RD50 was 3,338 mg/m3. This study is not
considered a suitable basis for an acute-duration inhalation MRL because a limited number of end points
were examined and because of the short exposure duration.
JP-8.  Although a number of studies have examined the acute toxicity of airborne JP-8, the studies
focused on a small number of potential targets of toxicity.  The studies reported signs of respiratory and 
ocular irritation, immunotoxicity, and altered auditory function.  Signs of upper respiratory irritation and 
ocular irritation have been observed in rats following a 4-hour exposure to 3,430 mg/m3 JP-8 vapor or
3,570 mg/m3 JP-8+100 vapor (Wolfe et al. 1996).  However, no signs of respiratory or ocular irritation 
were observed in rats following a 4-hour exposure to 4,440 mg/m3 JP-8 vapor and aerosol or 4,540 mg/m3 
JP-8+100 vapor and aerosol (Wolfe et al. 1996).  RD50 values of 2,876 and 1,629 mg/m3 were calculated
for a 30-minute exposure to JP-8 or JP-8+100 vapor, respectively (Whitman and Hinz 2001).  Wong et al. 
(2008) reported significant increases in inspiratory and expiratory lung resistance in mice exposed to 
53 mg/m3 JP-8 vapor and aerosol 1 hour/day for 7 days (Wong et al. 2008).  However, Herrin et al. (2006)
did not find significant alterations in lung function in mice exposed to 45 or 267 mg/m3 JP-8 vapor and 
aerosol 1 hour/day for 7 days, but did find a decrease in inspiratory dynamic lung compliance at
406 mg/m3. It is unclear why the studies found conflicting results for lung function.  Both studies found 
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ultrastructural changes in the morphology of alveolar type II cells, particularly increases in lamellar body
volume density at all tested concentrations. Suppression of the immune response to mitogens was
observed in mice exposed to 1,000 mg/m3 JP-8 vapor and aerosol 1 hour/day for 7 days (Hilgaertner et al. 
2011).  At higher concentrations, decreases in the number of viable immune cells were observed in the 
thymus (2,000 mg/m3), spleen, and peripheral blood (4,000 mg/m3), and bone marrow (8,000 mg/m3).  
Exposure of rats to 1,000 mg/m3 JP-8 mostly vapors for 4 hours/day for 1 or 5 days did not result in 
auditory impairment or damage to cochlear hair cells (Fechter et al. 2007); however, a loss of cochlear
hair cell function was observed in rats exposed to 2,000 mg/m3 JP-8 vapor 4 hours/day for 5 days (Fechter
et al. 2010).  Exposure to 1,000 mg/m3 for 1 or 5 days followed by a 1- or 4-hour exposure to noise with 
an intensity of 97–105 dB resulted in impaired hair cell function, as compared to rats exposed only to 
noise or only to JP-8 (Fechter et al. 2007, 2010); no alterations were observed in rats exposed to 
500 mg/m3 JP-8 followed by 4 hours of noise with 97–99 dB intensity (Fechter et al. 2010).  
In addition to these acute-duration inhalation studies, investigators at the University of Arizona conducted 
a number of respiratory toxicity and immunotoxicity studies.  However, the interpretation of these studies
is limited by an inaccurate measurement of the concentration of JP-8 in the test atmosphere and the
possible exposure to plasticizers (see Section 3.2.1 for a more complete discussion of these studies).  The 
studies involved nose-only exposure for 1 hour/day for 1 or 7 days, and only reported exposure levels for
the aerosol component of the test atmosphere.  These studies found lung tissue damage and impaired lung
function (Hays et al. 1995; Pfaff et al. 1995, 1996; Robledo and Witten 1998; Robledo et al. 2000; Wong
et al. 2004) and immunosuppression (Harris et al. 1997a, 1997b, 1997c; 2007b, 2007c, 2008).  The
observed effects in rats and mice included increases in inspiratory resistance and inspiratory dynamic
pulmonary compliance (Pfaff et al. 1995), an increase in lung permeability (Hays et al. 1995; Pfaff et al. 
1995; Robledo and Witten 1998), congestion with hemorrhaging in the distal lung (Hays et al. 1995; Pfaff
et al. 1996; Robledo and Witten 1998), and ectasia of respiratory bronchioles and alveoli (Wong et al. 
2004).  Electron microscopic examination also revealed breaks in the alveolar capillary membrane,
congestion of small blood vessels and capillaries, and changes in type II cells, which included swollen
mitochondria, fused lamellar bodies, and short irregular microvilli (Hays et al. 1995).  The immunological
effects included decreases in the number of viable immune cells in the thymus and spleen (Harris et al.
1997a, 1997b), alterations in the number of viable immune cells in the lymph nodes, peripheral blood, and
bone marrow (Harris et al. 1997a, 1997b), an impaired immune response to concanavalin A (Harris et al.
1997a, 1997c), an increased severity of influenza virus infection (Harris et al. 2008) and suppression of
the immune response to injected tumor cells (Harris et al. 2007c). This group also found a decrease in the
number of viable immune cells in the thymus and spleen, as well as suppressed immune function in the at
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6–8-week-old offspring of rats exposed to JP-8 on gestation days (GDs) 7–21 or 15–21 (Harris et al. 
2007b).  
Although the available database on the acute toxicity of JP-8 consists of a number of studies providing
evidence that the lungs and immune system are targets of toxicity, there is some uncertainty as to whether
these are the most sensitive targets of toxicity for JP-8.  No acute studies were identified that examined all
regions of the respiratory tract, other systemic targets such as the liver or neurological end points (outside
of the potential auditory effects); findings from longer-term JP-8 inhalation or oral studies suggest that 
these may be potential targets of toxicity.  Additionally, the Herrin et al. (2006), Hilgaertner et al. (2011), 
and Wong et al. (2008) studies, which identified the lowest adverse effect levels, all involved a 1 hour/day
exposure to JP-8 for 7 days; there is considerable uncertainty in extrapolating from a 1-hour exposure to 
continuous exposure and concern that the resulting MRL would be overly conservative.  Thus, the
database was considered inadequate for derivation of an acute-duration inhalation MRL for JP-8.
Jet A.  Information on the acute toxicity of Jet A is limited to two studies conducted by Sweeney et al. 
(2013) in which rats were exposed to Jet A aerosol and vapor 4 hours/day, 5 days/week for 14 days.  
Although these studies found some subclinical alterations, such as alterations in bronchioalveolar lavage 
fluid parameters that could be indicative of lung inflammation, the findings were not consistent across 
studies or concentration-related.  The study did not find any histological alterations at exposure levels as
high as 1,980 mg/m3. Additionally, no alterations in spleen organ weights or immune cell population 
were found.  The Sweeney et al. (2013) studies are well-designed studies that examined a number of
potential targets of Jet A toxicity. However, they are not suitable as the basis of an acute-duration 
inhalation MRL because the highest tested concentration is a NOAEL and it is ATSDR practice to not 
derive MRLs based on free-standing NOAEL values.
Intermediate-Duration Inhalation MRL
JP-5
•	 An MRL of 2 mg/m3 has been derived for intermediate-duration inhalation exposure (15–
 
365 days) to JP-5 vapor.
 
Information on the toxicity of JP-5 following intermediate-duration inhalation exposure comes from a
study in which rats, mice, and dogs were continuously exposed to JP-5 vapors for 90 days (Gaworski et
al. 1984).  In mice and dogs, the liver was the most sensitive target of toxicity.  Hepatocellular fatty
changes and vacuolization were observed in female mice exposed to ≥150 mg/m3 JP-5 vapor (Gaworski
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et al. 1984) and diffuse hepatocellular swelling was observed in male and female dogs exposed to
750 mg/m3 JP-5 vapor (Gaworski et al. 1984).  Gaworski et al. (1984) also reported a significant increase
in the occurrence of hyaline droplets in the proximal renal tubules of male rats exposed to ≥150 mg/m3 
JP-5 vapor; no renal lesions were observed in female rats, female mice, or male and female dogs 
(Gaworski et al. 1984). The renal effects observed in the male rats is likely due to an accumulation of
alpha2u-globulin in hyaline droplets, which can lead to cell necrosis, regeneration of tubule cells, and
tubular hyperplasia (EPA 1991c; Hard et al. 1993). The production of alpha2u-globulin appears to be
unique to male rats and the accumulation of alpha2u-globulin in hyaline droplets and subsequent renal
damage is not considered to be relevant to humans (EPA 1991c; Flamm and Lehman-McKeeman 1991;
Hard et al. 1993; Swenberg 1993).  A neurobehavioral study found an increase in forelimb grip strength 
in rats exposed to 1,200 mg/m3 JP-5 vapor 6 hours/day, 5 days/week for 6 weeks (Rossi et al. 2001); no 
other alterations in performance on the neurobehavioral battery tests were observed.
The available data on the intermediate-duration toxicity of JP-5 vapors have identified two targets: the
liver in mice and dogs and the nervous system in rats. These end points are consistent with the results of
intermediate-duration vapor exposure studies with JP-8 (Hanas et al. 2010; Ritchie et al. 2001; Rossi et al. 
2001).  Immunotoxicity has also been identified as a sensitive end point following acute inhalation 
exposure to JP-8 and is likely a target for JP-5 toxicity.  The lowest reliable LOAEL for immunotoxicity
following inhalation exposure to JP-8 was 1,000 mg/m3 in rats exposed 1 hour/day for 7 days (Hilgaertner
et al. 2011).  This LOAEL is much higher than the LOAEL for liver effects, suggesting that an MRL
based on liver effects would be protective for potential immune effects.
The 150 mg/m3 concentration that resulted in hepatocellular fatty changes and vacuolization in mice 
continuously exposed to JP-5 vapor for 90 days (Gaworski et al. 1984) was selected as the point of
departure for the MRL; the effects were considered minimally adverse and the concentration was 
identified as a minimal LOAEL.  A human equivalent concentration of the LOAEL (LOAELHEC) was 
calculated by multiplying the LOAEL by the ratio of the human to mouse blood:gas partition coefficient
ratio. Because human and mouse blood:gas partition coefficients are not measurable for a complex
mixture such as JP-5, a default value of 1 was used for the human-animal blood:gas partition coefficient
ratio; thus, the LOAELHEC was 150 mg/m3. The minimal LOAELHEC of 150 mg/m3 was divided by an 
uncertainty factor of 90 (3 for the use of a minimal LOAEL, 3 for extrapolation from animals to humans
with dosimetric adjustment, and 10 for human variability), resulting in an intermediate-duration inhalation
MRL of 2 mg/m3 for vapor exposure.
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JP-8
•	 An MRL of 3 mg/m3 has been derived for intermediate-duration inhalation exposure (15–
 
365 days) to JP-8 vapor.
 
In a well-designed intermediate-duration inhalation study, no systemic effects were observed in rats
continuously exposed to concentrations of JP-8 vapor as high as 1,000 mg/m3 for 90 days (Mattie et al. 
1991).  However, another study involving a 91-day intermittent exposure to JP-8 vapors (6 hours/day, 
7 days/week) reported a number of systemic effects in two of the three rats exposed to 500 mg/m3 
including enlarged alveolar capillaries, myocardial scarring, 50% reduction in fat cells in the bone
marrow, and dilated hepatic sinusoids with fatty hepatocytes (Hanas et al. 2010).  It is unclear why these
studies found conflicting results.  Both studies also reported kidney effects in the male rats.  Mattie et al.
(1991) reported hyaline nephropathy in males exposed to ≥500 mg/m3 JP-8 vapor and Hanas et al. (2010)
reported proximal tubule damage in males exposed to ≥250 mg/m3 JP-8 vapor; no renal lesions were 
observed in the female rats in the Mattie et al. (1991) study.  As noted in the discussion of the
intermediate-duration JP-5 data, the renal effects were likely due to an accumulation of alpha2u-globulin 
in hyaline droplets and the effect is not considered relevant to humans.  A number of studies have
reported neurobehavioral alterations and auditory effects in rats following exposure to JP-8 vapor.  
Impaired learning of moderately difficult tasks was observed in rats exposed to1,000 mg/m3 JP-8 vapor
6 hours/day, 5 days/week for 6 weeks (Ritchie et al. 2001); this effect was not observed at 500 mg/m3.  A 
similar exposure to 1,000 mg/m3 JP-8 vapor also resulted in an alteration in a novel appetitive stimulus
test, which was hypothesized to quantify dopamine system sensitization in rats (Rossi et al. 2001); no 
other alterations in performance on the neurobehavioral battery tests were found. Intermediate-duration 
exposure to JP-8 vapor also results in damage to the auditory system. Exposure to 1,000 mg/m3 JP-8 
vapor also resulted in central auditory processing dysfunction, but no damage to cochlear hair cells, in rats
exposed 6 hours/day, 5 days/week for 4 weeks (Guthrie et al. 2014).  Another study found significant
alterations in auditory function in rats exposed to 1,500 mg/m3 JP-8 vapor 6 hours/day, 5 days/week for
4 weeks (Fechter et al. 2012).  However, simultaneous exposure to JP-8 and non-damaging noise (85 dB)
resulted in impaired auditory function, as compared to the control group; exposure to 85 dB noise alone
did not significantly impair auditory function.  In addition to these studies, three University of Arizona
studies have reported edema and inflammation of the terminal bronchioles in rats exposed 1 hour/day for
28 or 56 days to JP-8 aerosols and vapors (Hays et al. 1995; Pfaff et al. 1995, 1996).  Hays et al. (1995)
also found increased lung epithelial permeability and alveolar permeability.  
The Hanas et al. (2010) study identified the lowest LOAEL (500 mg/m3) for JP-8 vapors; however, the 
alveolar capillary, cardiac, and bone marrow effects have not been observed in other JP-8 studies or in 
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studies with JP-5 or Jet A. The liver effects are similar to those observed in mice exposed to JP-5 vapors
(Gaworksi et al. 1984); however, no liver effects have been observed in rats exposed to JP-8 vapor
(Mattie et al. 1991), JP-5 vapor (Gaworski et al. 1984), or administered JP-8 via gavage (Mattie et al.
1995).  Given the small number of animals tested (3/group) and the conflicting results with more robust
studies, the Hanas et al. (2010) study was not selected as the basis of an MRL.  Rather, the NOAEL of
500 mg/m3 for neurotoxicity identified in the Ritchie et al. (2001) study was selected as the point of
departure. The NOAEL was adjusted for intermittent exposure (6 hours/day, 5 days/week) resulting in a
NOAELADJ of 89 mg/m3.  The NOAELHEC of 89 mg/m3 was calculated by multiplying the NOAELADJ by 
the default human to rat blood:gas partition coefficient ratio of 1 (blood:gas partition coefficients are not
measurable for a complex mixture such as JP-8).  Dividing the NOAELHEC by an uncertainty factor of
30 (3 for animal to human extrapolation with dosimetric adjustment and 10 for human variability) results
in a JP-8 intermediate-duration inhalation MRL of 3 mg/m3 for vapor exposure.
Jet A.  No intermediate-duration studies evaluated the inhalation toxicity of Jet A precluding derivation of
an MRL.
Chronic-Duration Inhalation MRL
Oral MRLs
Acute-Duration Oral MRL
Chronic-duration inhalation MRLs for JP-5, JP-8, and Jet A fuels were not derived due to the lack of
reliable chronic-duration studies.
JP-5.  Data on the acute oral toxicity of JP-5 are limited to two single exposure studies in rats.  A single
gavage dose of 18,912 mg/kg/day JP-5 resulted in an increase in white blood cell levels, hepatocyte 
vacuolization, and weight loss (Parker et al. 1981).  Another study by Parker et al. (1981) reported
hepatocellular vacuolization and hyaline droplet in renal tubular epithelial cells in male rats administered
via gavage 47,280 mg/kg/day.  An acute-duration oral MRL was not derived for JP-5 due to the lack of
repeated exposure studies.
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JP-8
•	 An MRL of 3 mg/kg/day has been derived for acute-duration oral exposure (≤14 days days) to 
JP-8.
Acute-duration studies evaluating the oral toxicity of JP-8 (administered via gavage) have primarily
focused on immunological and developmental toxicity.  Suppressed humoral immunity, specifically an 
impaired response to SRBCs, has been observed in mice administered 1,000 mg/kg/day JP-8 for 7 days
(Dudley et al. 2001) or 500 mg/kg/day JP-8 for 14 days (Keil et al. 2004; Peden-Adams et al. 2001); the
NOAEL identified in the 14-day study was 250 mg/kg/day.  At 2,000 mg/kg/day, decreases in thymus
weight and cellularity were observed (Dudley et al. 2001); no other immune effects were found.  The
three immunotoxicity studies also reported significant increases in liver weight at 1,000 mg/kg/day 
(Dudley et al. 2001; Keil et al. 2004; Peden-Adams et al. 2001); the studies did not include a histological 
examination of the liver.  A developmental study also conducted by this group found decreases in the
plaque-forming response to SRBCs in the offspring of mice administered 1,000 mg/kg/day on GDs 6–15 
(Keil et al. 2003).  A small decrease (4–6%) in fetal weights was observed in a study in which rat dams
were administered 1,000 mg/kg/day JP-8 on GDs 6–15 (Cooper and Mattie 1996); decreases in maternal
weight gain and maternal deaths were also observed at this dose level.
The lowest-adverse-effect level identified in the acute-duration JP-8 oral database is 500 mg/kg/day for
altered immune function in mice (Keil et al. 2004).  The immunotoxicity NOAEL of 250 mg/kg/day was
selected as the point of departure for the MRL.  Although the systemic toxicity of JP-8 has not been 
adequately addressed in the available acute-duration oral studies, intermediate-duration oral studies
(Mattie et al. 1995, 2000) suggest that liver or other systemic effects are not likely to occur at doses lower
than the lowest LOAEL for immunotoxicity (500 mg/kg/day).  An additional end point that has not been
adequately addressed in the acute oral studies is the potential for neurodevelopmental effects; this was the 
most sensitive end point following intermediate oral exposure.  However, the LOAEL (350 mg/kg/day)
from the intermediate study (Mattie et al. 2001) is similar to the lowest acute-duration LOAEL
(500 mg/kg/day) and it is likely that the MRL using 250 mg/kg/day point of departure would be
protective of neurodevelopmental effects.
The acute-duration oral MRL for JP-8 of 3 mg/kg/day was derived by dividing the NOAEL for
immunological effects (Keil et al. 2004) by an uncertainty factor of 100 (10 for extrapolation from
animals to humans and 10 for human variability).
Jet A.  No acute-duration oral studies were identified for Jet A precluding derivation of an MRL.
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Intermediate-Duration Oral MRL  
JP-8
•	 An MRL of 0.3 mg/kg/day has been derived for intermediate-duration oral exposure (15–
 
365 days) to JP-8.

Three studies have examined the toxicity of JP-8 following intermediate-duration oral exposure
(administered via gavage).  Administration of 750 mg/kg/day JP-8 to male rats for 90 days resulted in 
stomach hyperplasia, increases in serum ALT and AST activities, perianal dermatitis, hypoglycemia, and
hyaline droplet formation in the kidneys (Mattie et al. 1995).  In a 90-day study in female rats, stomach
hyperplasia was observed at 750 mg/kg/day and perianal dermatitis was observed at 1,500 mg/kg/day; no 
alterations in blood glucose levels were observed (Mattie et al. 2000).  The Mattie et al. (2000) study also 
found no effects on male or female fertility.  Maternal exposure to JP-8 for 90 days prior to mating and 
during gestation resulted in an 11% decrease in pup body weight on postnatal day (PND) 4 (Mattie et al. 
2000) and a dose-related decrease in coordinated motor movements on a swimming test at
≥325 mg/kg/day (Mattie et al. 2001).  This effect was only observed at ≥325 mg/kg/day on PND 8 and at
≥750 mg/kg/day on PND 14; no alterations were observed on PND 10, 12, 16, or 18.  The investigators
suggested that the effect was due to a delay in motor coordination related to delayed neurodevelopment of
the cerebellum and noted that PND 8 corresponds with maturation of the basket cells in the cerebellum
and PND 14 corresponds with eye opening time and the final days of cellular organization and
development of functional integrity in the cerebellum (Mattie et al. 2001).  No other alterations in 
performance on neurobehavioral tests were observed in the offspring.
JP-5.  No studies examined the toxicity of JP-5 following intermediate oral exposure precluding
derivation of an MRL.
The intermediate-duration toxicity of ingested JP-8 has been investigated in systemic toxicity,
reproductive toxicity, and developmental toxicity studies. The most sensitive effect appears to
neurodevelopmental.  The intermediate-duration database is lacking immunotoxicity studies; however, a
comparison of the NOAEL (250 mg/kg/day) and LOAEL (500 mg/kg/day) values from an acute-duration 
oral study (Keil et al. 2004) with the LOAEL (325 mg/kg/day) from the Mattie et al. (2001)
neurodevelopmental study suggests that an MRL based on this LOAEL should be protective for
immunological effects.  An intermediate-duration oral MRL of JP-8 was calculated by dividing the
LOAEL of 325mg/kg/day by an uncertainty factor of 1,000 (10 for the use of a LOAEL, 10 for
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extrapolation from animals to humans, and 10 for human variability) resulting in an MRL of
0.3 mg/kg/day.
Jet A.  Information on the intermediate-duration oral toxicity of Jet A comes from a 90-day gavage study 
in rats and mice. Significant increases in absolute and relative liver weights and enlarged liver were
observed in female rats administered 500 mg/kg/day Jet A for 90 days (Smith et al. 1999); no histological
alterations were observed. Increases in salivation and a shoveling behavior were also observed in rats 
exposed to 100 or 500 mg/kg/day; the investigators suggested that these effects were likely due to mouth
irritation.  No other biologically-relevant effects were observed in rats.  No systemic effects were 
observed in similarly exposed male mice; the highest tested concentration was 500 mg/kg/day (Smith et 
al. 1999).  However, lethargy and hunched posture were observed in mice administered 100 or
500 mg/kg/day; lethargy was also observed in mice administered 20 mg/kg/day, but was only observed 
once in 5 of the 15 exposed mice.  Similarly, lethargy was observed in rats administered 500 mg/kg/day, 
but in most rats it was only observed once in the 90-day exposure period (Smith et al. 1999).
There are limited data evaluating the toxicity of Jet A following intermediate-duration oral exposure.  The
most sensitive effects were signs of mouth irritation in rats and lethargy and hunched posture in mice
administered ≥100 mg/kg/day Jet A (Smith et al. 1999).  These clinical observations have not been
observed in Jet A inhalation studies (Sweeney et al. 2013) and it is not known whether the effects were 
seen because the animals received the Jet A as a bolus dose and would not occur if the Jet A fuel was 
administered in drinking water or food, which are relevant routes of human exposure.  In the absence of
additional information on the mechanisms involved in the induction of lethargy or mouth irritation, the
database was not considered adequate for derivation of a Jet A intermediate-duration oral MRL.
Chronic-Duration Oral MRL 
Chronic-duration oral MRLs for JP-5, JP-8, and Jet A were not derived due to the lack of reliable chronic-
duration studies.
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3. HEALTH EFFECTS
3.1  INTRODUCTION 
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and 
other interested individuals and groups with an overall perspective on the toxicology of JP-5, JP-8, and 
Jet A fuels.  It contains descriptions and evaluations of toxicological studies and epidemiological
investigations and provides conclusions, where possible, on the relevance of toxicity and toxicokinetic
data to public health.
JP-5, JP-8, and Jet A fuels are kerosene-based jet fuels (NRC 2003; Ritchie et al. 2003).  The components
of jet fuels are primarily aliphatic and aromatic hydrocarbons of length C8–C17+ (NRC 2003).  There is no 
single formula for JP-5, JP-8, or Jet A fuels and the exact composition of the jet fuel varies depending on 
the crude oil from which it is refined. The fuels are refined by a straight distillation of crude or shale oil, 
or by a distillation of crude oil in the presence of a catalyst.  Although the jet fuels are kerosene based, 
they are refined under more stringent conditions than kerosene and contain various additives not found in 
kerosene; Jet A is the base fuel for the production of JP-8 (NRC 2003).  Typical additives to JP-5 and 
JP-8 include antioxidants (including phenolic antioxidants), static inhibitors, corrosion inhibitors, fuel
system icing inhibitors, lubrication improvers, biocides, and thermal stability improvers. These additives 
are used in specified amounts only, as governed by commercial and military specifications.
The discussion of health effects is focused on exposure to JP-5, JP-8, and Jet A fuel rather than exposure
to individual components of the fuel mixture.  For information concerning the possible toxicity associated 
with exposure to some of the individual components of jet fuels, the reader is referred to the ATSDR
toxicological profiles on these compounds, for example benzene (Agency for Toxic Substances and 
Disease Registry 2007a), toluene (Agency for Toxic Substances and Disease Registry 2015), total xylenes
(Agency for Toxic Substances and Disease Registry 2007b), ethylbenzene (Agency for Toxic Substances 
and Disease Registry 2010), and naphthalene, 1-methylnaphthalene, and 2-methylnaphthalene (Agency 
for Toxic Substances and Disease Registry 2005).  In addition, the health effects associated with exposure
to jet fuel exhaust or combustion products will not be discussed because these products contain other
substances that are not constituents of JP-5, JP-8, and Jet A fuel itself.  However, when needed to fill in 
data gaps, information on the toxicity of kerosene is presented because JP-5, JP-8, and Jet A are kerosene-
based fuels and it is likely that jet fuels and kerosene will have similar toxicological effects.
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile.
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
 
   
 
     
     
 
      
     
 
  
   
     
        
   
    
  
       
 
   
    
        
    
  
   
 
 
 
 
   
   
   
 
 
 
 
 
  
24JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
3.2  DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
To help public health professionals and others address the needs of persons living or working near
hazardous waste sites, the information in this section is organized first by route of exposure (inhalation, 
oral, and dermal) and then by health effect (death, systemic, immunological, neurological, reproductive, 
developmental, genotoxic, and carcinogenic effects). These data are discussed in terms of three exposure 
periods:  acute (14 days or less), intermediate (15–364 days), and chronic (365 days or more).
Levels of significant exposure for each route and duration are presented in tables and illustrated in 
figures.  The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest-
observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the studies.
LOAELs have been classified into “less serious” or “serious” effects. “Serious” effects are those that
evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute respiratory distress
or death).  “Less serious” effects are those that are not expected to cause significant dysfunction or death, 
or those whose significance to the organism is not entirely clear.  ATSDR acknowledges that a 
considerable amount of judgment may be required in establishing whether an end point should be
classified as a NOAEL, “less serious” LOAEL, or “serious” LOAEL, and that in some cases, there will be 
insufficient data to decide whether the effect is indicative of significant dysfunction.  However, the 
Agency has established guidelines and policies that are used to classify these end points.  ATSDR
believes that there is sufficient merit in this approach to warrant an attempt at distinguishing between
“less serious” and “serious” effects. The distinction between “less serious” effects and “serious” effects is 
considered to be important because it helps the users of the profiles to identify levels of exposure at which
major health effects start to appear.  LOAELs or NOAELs should also help in determining whether or not
the effects vary with dose and/or duration, and place into perspective the possible significance of these 
effects to human health.
The significance of the exposure levels shown in the Levels of Significant Exposure (LSE) tables and 
figures may differ depending on the user's perspective.  Public health officials and others concerned with 
appropriate actions to take at hazardous waste sites may want information on levels of exposure 
associated with more subtle effects in humans or animals (LOAELs) or exposure levels below which no
adverse effects (NOAELs) have been observed.  Estimates of levels posing minimal risk to humans
(Minimal Risk Levels or MRLs) may be of interest to health professionals and citizens alike.
***DRAFT FOR PUBLIC COMMENT***
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 JP-5, JP-8, AND JET A FUELS
3.  HEALTH EFFECTS 
A User's Guide has been provided at the end of this profile (see Appendix B).  This guide should aid in 
the interpretation of the tables and figures for Levels of Significant Exposure and the MRLs. 
3.2.1 Inhalation Exposure 
The human and laboratory animal studies discussed in this section involve exposure to jet fuels vapors or 
a mixed exposure to vapors and aerosols.  The method used to generate the test atmosphere can result in 
very different chemical compositions (NRC 2003).  Heating the fuel can result in complete volatilization 
and generation of a test atmosphere with a similar composition to that of the raw fuel.  Other methods of 
vapor generation could produce a test atmosphere that is enriched with low molecular weight, more 
volatile compounds, as compared to the raw fuel.  Aerosolization of the jet fuels could lead to inhalation 
of vapors enriched with low molecular weight compounds and respiratory tract surface deposition of 
liquid droplets enriched in higher molecular weight n-alkanes.  The differences in test atmosphere 
generation methods and differences of the chemical composition of the raw fuels complicate comparisons 
of the results across studies. 
The toxicity of JP-8 aerosols has been examined in a number of studies conducted by the University of 
Arizona (Baldwin et al. 2001, 2007; Harris et al. 1997a, 1997b, 1997c, 2000a, 2000b, 2000c, 2002, 
2007a, 2007c, 2008; Hays et al. 1995; Herrin et al. 2006; Hilgaertner et al. 2011; McGuire et al. 2000; 
Pfaff et al. 1995, 1996; Robledo and Witten 1998, 1999; Robledo et al. 2000; Wang et al. 2001; Wong et
al. 2004, 2008). However, the interpretation of most of these studies and comparison of the results to 
other studies are limited by several methodological issues:  underestimating the exposure levels and 
possible exposure to plasticizing chemicals.  With the exception of the Herrin et al. (2006), Hilgaertner et 
al. (2011), and Wong et al. (2008) studies, JP-8 was aerosolized via a DeVilbiss Ultra-Neb nebulizer and 
aerosol concentrations were measured after each exposure using a seven-stage cascade impactor.  
However, this system was only capable of measuring aerosol concentrations; the JP-8 vapor 
concentrations were not quantified. Hilgaertner et al. (2011) compared this generation/measurement 
methodology to one in which a Lovelace jet nebulizer was used to aerosolize the jet fuel, and vapor and 
aerosol concentrations were measured using an in-line, real-time total hydrocarbon analysis system.  The 
study found that a total exposure to 1,000 mg/m3 JP-8 represents an exposure to 125 mg/m3 aerosolized 
JP-8 and 875 mg/m3 JP-8 vapor; the vapor/aerosol distribution is likely to vary with the JP-8 
concentration. Thus, reporting only the aerosol levels underestimated the actual exposure to JP-8.  As 
noted in a memorandum from the Air Force Research Laboratory to ATSDR (Mattie 2013), a site visit to 
the University of Arizona laboratory revealed that the generation of the test atmosphere using the 
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26 JP-5, JP-8, AND JET A FUELS
3.  HEALTH EFFECTS 
DeVilbiss nebulizer involved using plastic cups as reservoirs for the liquid JP-8.  The plastic cups began 
to disintegrate during generation of the test atmosphere and needed to be replaced every 15 minutes; 
replacing the cup required a shutdown of the test generation and re-equilibration of the exposure chamber; 
thus compromising the exposure concentration and duration of exposure.  Additionally, it is noted that the 
test atmosphere may have contained particles of plastic or plastic components dissolved by JP-8 test 
atmosphere (Mattie 2013).  While pertinent to the understanding of the toxicity of JP-8, most of the 
studies are not considered key studies due to significant dose quantification limitations and the potential 
co-exposure to plasticizing chemicals.  The studies are considered supporting data and are discussed 
throughout the document.  Exposure levels are not reported for the studies that only reported the 
concentration of the aerosol component of the test atmosphere and these studies not included in Table 3-1 
and Figure 3-1.
3.2.1.1 Death 
No studies were located regarding death in humans after inhalation exposure to JP-5, JP-8, or Jet A fuels. 
3.2.1.2 Systemic Effects  
The highest NOAEL values and all LOAEL values from each reliable study for systemic effects in each 
species and duration category are recorded in Table 3-1 and plotted in Figure 3-1.
No deaths occurred in rats exposed to 5,000 mg/m3 kerosene (physical form not specified) for 4 hours 
(Vernot et al. 1990c). There was no treatment-related lethality associated with exposure to JP-8 in an 
aerosol/vapor mixture when male Fischer-344 rats were exposed nose-only to concentrations of 
520 mg/m3 (aerosol component only) for 1 hour/day for 7 days or 495 mg/m3 for 1 hour/day for 28 days
(Pfaff et al. 1995). No deaths occurred in male or female F-344 rats exposed whole-body to 4,440 mg/m3 
JP-8 combination of vapors and aerosol or to 3,430 mg/m3 vapors for 4 hours (Wolfe et al. 1996). 
There were no deaths among rats, mice, or dogs exposed continuously whole-body to up to 750 mg/m3 
JP-5 vapors for 90 days (Gaworski et al. 1984).
Respiratory Effects. No studies were located regarding respiratory effects in humans during or 
following inhalation exposure to JP-5, JP-8, or Jet A fuels.  There was no throat irritation in six volunteers 
following a 15-minute exposure to a concentration reported to be 140 mg/m3 of deodorized kerosene 
***DRAFT FOR PUBLIC COMMENT*** 
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels  - Inhalation 
Exposure/ 
Duration/
a 
Key to Species Frequency 
Figure (Strain) (Route) 
ACUTE EXPOSURE 
Systemic 
1 Rat 4 hr/d 
5 d/wk(Sprague-
14 dDawley) 
2 Rat	 4 hr/d 
5 d/wk(Sprague-
14 dDawley) 
System 
Resp 
Cardio 
Gastro 
Hemato 
Hepatic 
Renal 
Bd Wt 
Resp 
Cardio 
Gastro 
Hemato 
Hepatic 
Renal 
Bd Wt 
LOAEL 
NOAEL 
(mg/m³) 
Less Serious 
(mg/m³) 
Serious 
(mg/m³) 
Reference 
Chemical Form Comments 
1662 F Sweeney et al. 2013 
Jet A 
Vapor and aerosol 
exposure 
1662 F 
1662 F 
1662 F 
1662 F 
1662 F 
1662 F 
1980 F Sweeney et al. 2013 
Jet A 
Vapor and aerosol 
exposure 
1980 F 
1980 F 
1980 F 
1980 F 
1980 F 
1980 F 
27
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1980
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959
3430
3430
960
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation	 (continued) 
a 
Key to 
Figure 
3 
4 
5 
6 
Exposure/
 
Duration/
 
Frequency
Species (Route)(Strain) 
Rat	 4 hr/d 
5 d/wk(F344) 
14 d 
Rat 4 hr 
(Fischer- 344) 
Rat 4 hr 
(Fischer- 344) 
Rat 4 hr 
(Fischer- 344) 
System 
Resp 
Cardio 
Gastro 
Hemato 
Hepatic 
Renal 
Bd Wt 
Resp 
Ocular 
Resp 
Ocular 
Resp 
Ocular 
NOAEL 
(mg/m³) 
1980 F 
1980 F 
1980 F 
1980 F 
1980 F 
1980 F 
1980 F 
4440 
4440 
Less Serious 
(mg/m³) 
3430	 (signs of upper 
respiratory irritation) 
3430	 (signs of eye irritation) 
3570	 (signs of respiratory 
irritation) 
3570	 (signs of eye irritation) 
LOAEL 
Serious 
(mg/m³) 
Reference 
Chemical Form 
Sweeney et al. 2013 
Jet A 
Wolfe et al. 1996 
JP-8 
Wolfe et al. 1996 
JP-8 
Wolfe et al. 1996 
JP-8+100 
Comments 
Vapor and aerosol 
exposure 
Vapor exposure 
Aerosol/vapor 
exposure 
NOAELs for eye and 
respiratory irritation 
Vapor exposure 
28
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4540
4540
924
45
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2876
980
1629
932
3338
928
53
1056
1662
JP
-5, JP
-8, A
N
D
 JE
T A
 FU
E
LS
***D
R
A
FT FO
R
 P
U
B
LIC
 C
O
M
M
E
N
T***
3.  H
E
A
LTH
 E
FFE
C
TS
Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/m³) 
Less Serious 
(mg/m³) 
LOAEL 
Serious 
(mg/m³) 
Reference 
Chemical Form Comments 
7 Rat 
(Fischer- 344) 
4 hr Resp 4540 Wolfe et al. 1996 
JP-8+100 
Aerosol/vapor exposure 
NOAELs for eye and 
respiratory irritation 
Ocular 4540 
8 Mouse 
(C57BL/6N) 
7 d 
1 hr/d Resp 45 M Herrin et al. 2006 
JP-8 
Aerosol/vapor 
exposure 
9 Mouse 
(Swiss-
Webster) 
30 min Resp 2876 M (RD50) Whitman and Hinz 2001 
JP-8 
Mostly vapor exposure 
10 Mouse 
(Swiss-
Webster) 
30 min Resp 1629 M (RD50) Whitman and Hinz 2001 
JP-8+100 
Mostly vapor exposure 
11 Mouse 
(Swiss-
Webster) 
30 min Resp 3338 M (RD50) Whitman and Hinz 2004 
JP-5 
Aerosol/vapor 
exposure; except 804 
mg/m3 concentration 
which was vapor 
exposure 
12 Mouse 
(C57BL/6N) 
7 d 
1 x/d Resp 53 M (increased lung resistance) 
Wong et al. 2008 
JP-8 
Aerosol/vapor 
exposure 
Immuno/ Lymphoret 
13 Rat 
(Sprague-
Dawley) 
4 hr/d 
5 d/wk 
14 d 
1662 F Sweeney et al. 2013 
Jet A 
Vapor and aerosol 
exposure 
29
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/m³) 
Less Serious 
(mg/m³) 
LOAEL 
Serious 
(mg/m³) 
Reference 
Chemical Form Comments 
14 Rat 
(Sprague-
Dawley) 
4 hr/d 
5 d/wk 
14 d 
1980 F Sweeney et al. 2013 
Jet A 
Vapor and aerosol 
exposure 
15 Rat 
(F344) 
4 hr/d 
5 d/wk 
14 d 
1980 F Sweeney et al. 2013 
Jet A 
Vapor and aerosol 
exposure 
16 Mouse 
(C57BL/6N) 
7 d 
1 hr/d 1000 (decreased splenic immune function and 
immune organ weight) 
Hilgaertner et al. 2011 
JP-8 
Aerosol/vapor 
exposure 
Neurological 
17 Rat 
(Long- Evans) 
1-5 d 
4 hr/d 1000 M Fechter et al. 2007 
JP-8 
Mostly vapor exposure 
NOAELfor auditory 
impairment. 
18 Rat 
(Long- Evans) 
4 hr/d 
5 d 1000 M 2000 M (transient decrease in auditory function) 
Fechter et al. 2010 
JP-8 
Vapor exposure 
30
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
INTERMEDIATE EXPOSURE 
Systemic 
19 Rat 
(Fischer- 344) 
90 d 
24 hr/d 
System 
Resp 
NOAEL 
(mg/m³) 
750 
Less Serious 
(mg/m³) 
LOAEL 
Serious 
(mg/m³) 
Reference 
Chemical Form 
Gaworski et al. 1984, 1985 
JP-5 
Comments 
Vapor exposure; 
observed renal effects 
in male rats are not 
relevant to humans 
Cardio 750 
Gastro 750 
Hemato 750 
Musc/skel 750 
Hepatic 750 
Renal 750 F 150 M (hyaline droplets in 
tubular epithelium) 
Endocr 750 
Dermal 750 
Bd Wt 750 F 150 M (15-19% reduced final 
body weight) 
Metab 750 
Other 750 
31
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500
250
952
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1000
1000
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/m³) 
Less Serious 
(mg/m³) 
LOAEL 
Serious 
(mg/m³) 
Reference 
Chemical Form Comments 
20 Rat 
(Sprague-
Dawley) 
91 d 
6 hr/d Resp 250 M 500 M (enlarged alveolar capillaries) 
Hanas et al. 2010 
JP-8 
Vapor exposure 
Cardio 250 M 500 M (myocardial scarring in 
2/3 rats) 
Hemato 250 M 500 M (50% reduction in fat 
cells/globules in bone 
marrow) 
Hepatic 250 M 500 M (dilated sinusoids, fatty 
hepatocytes in 2/3 rats) 
Renal 250 M (proximal tubule damage 
in 2/3 rats) 
21 Rat 
(Fischer- 344) 
90 d 
24 hr/d Resp 1000 Mattie et al. 1991 
JP-8 
Vapor exposure; 
observed renal effects 
in male rats are not 
relevant to humans 
Hemato 1000 
Hepatic 
Renal 
Bd Wt 
1000 
1000 F 
1000 
500 M (hyaline nephropathy) 
22 Rat 
(Sprague-
Dawley) 
6 wk 
5 d/wk 
6 hr/d 
Bd Wt 1000 M Witzmann et al. 2000 
JP-8 
Vapor exposure 
32
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/m³) 
Less Serious 
(mg/m³) 
LOAEL 
Serious 
(mg/m³) 
Reference 
Chemical Form Comments 
23 Mouse 
(C57BL/6N) 
90 d 
24 hr/d Resp 
Cardio 
750 F 
750 F 
Gaworski et al. 1984, 1985 
JP-5 
Vapor exposure 
Gastro 750 F 
Musc/skel 
Hepatic 
750 F 
b 
150 F (hepatocyte fatty change 
and vacuolization) 
Renal 750 F 
Endocr 750 F 
Dermal 750 F 
Bd Wt 750 F 
Other 750 F 
33
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750
750
750
750
750
150
750
750
750
750
750
750
750
1020
750
1024
750
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation	 (continued) 
Exposure/ 
Duration/
a 
Key to Species Frequency 
Figure (Strain) (Route) 
24 Dog	 90 d 
24 hr/d(Beagle) 
Immuno/ Lymphoret 
25 Rat 90 d 
24 hr/d(Fischer- 344) 
26 Mouse	 90 d 
24 hr/d(C57BL/6N) 
System 
Resp 
Cardio 
Gastro 
Hemato 
Musc/skel 
Hepatic 
Renal 
Endocr 
Dermal 
Bd Wt 
Metab 
Other 
LOAEL 
NOAEL 
(mg/m³) 
Less Serious 
(mg/m³) 
Serious 
(mg/m³) 
Reference 
Chemical Form Comments 
750 
750 
750 
750 
750 
150 750 (diffuse hepatocellular 
swelling) 
Gaworski et al. 1984, 1985 
JP-5 
Vapor exposure 
750 
750 
750 
750 
750 
750 
750 Gaworski et al. 1984, 1985 
JP-5 
Vapor exposure 
Histology of 
lymphoreticular organs. 
750 F Gaworski et al. 1984, 1985 
JP-5 
Vapor exposure 
Histology of 
lymphoreticular organs 
34
   
1016
750
919
1500
1021
750
1061
1000
915
500
1000
916
1000
917
1200
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/m³) 
Less Serious 
(mg/m³) 
LOAEL 
Serious 
(mg/m³) 
Reference 
Chemical Form 
27 Dog 
(Beagle) 
90 d 
24 hr/d 750 Gaworski et al. 1984, 1985 
FO1JP5 
Neurological 
28 Rat 
(Fischer- 344) 
4 wk 
5 d/wk 
6 hr/d 
1500 Fechter et al. 2012 
JP-8 
29 Rat 
(Fischer- 344) 
90 d 
24 hr/d 750 Gaworski et al. 1984, 1985 
JP-5 
30 Rat 
(Long- Evans) 
6 hr/d 
5 d/wk 
4 wk 
1000 (central auditory 
processing dysfunction) 
Guthrie et al. 2014 
JP-8 
31 Rat 
(Sprague-
Dawley) 
6 wk 
5 d/wk 
6 hr/d 
c 
500 M 1000 M (impaired learning in 
moderately difficult tasks) 
Ritchie et al. 2001 
JP-8 
32 Rat 
(Sprague-
Dawley) 
6 wk 
5 d/wk 
6 hr/d 
1000 M (altered appetite 
reinforcement approach 
sensitization) 
Rossi et al. 2001 
JP-8 
33 Rat 
(Sprague-
Dawley) 
6 wk 
5 d/wk 
6 hr/d 
1200 M (increased forelimb grip 
strength) 
Rossi et al. 2001 
JP-5 
Comments 
Vapor exposure 
Histopathology of 
lymphoreticular organs. 
Mostly vapor exposure 
NOAEL for auditory 
function 
Vapor exposure 
Histology of the brain 
and sciatic nerve. 
mostly vapor exposure 
Vapor exposure 
Vapor exposure 
Vapor exposure 
35
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Table 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (continued) 
Exposure/ LOAEL 
Duration/
a FrequencyKey to Species NOAEL Less Serious Serious(Route)Figure (Strain) System (mg/m³) (mg/m³) (mg/m³) 
34 Mouse 90 d 750 F24 hr/d(C57BL/6N) 
35 Dog 90 d 75024 hr/d(Beagle) 
Reproductive 
36 Rat 90 d 75024 hr/d(Fischer- 344) 
37 Mouse 90 d 750 F24 hr/d(C57BL/6N) 
38 Dog 90 d 75024 hr/d(Beagle) 
Reference 
Chemical Form 
Gaworski et al. 1984, 1985 
JP-5 
Gaworski et al. 1984, 1985 
JP-5 
Gaworski et al. 1984, 1985 
JP-5 
Gaworski et al. 1984, 1985 
JP-5 
Gaworski et al. 1984, 1985 
JP-5 
Comments 
Vapor exposure 
Histology of the brain 
and sciatic nerve. 
Vapor exposure 
Histopathology of the 
brain and sciatic nerve. 
Vapor exposure 
Histology of 
reproductive organs. 
Vapor exposure 
Histology of the 
reproductive organs. 
Vapor exposure 
Histopathology of the 
reproductive organs. 
a The number corresponds to entries in Figure 3-1. 
b Used to derive an intermediate-duration Minimal Risk Level (MRL) of 2 mg/m3 for JP-5 vapor. The LOAEL was multiplied by the ratio of the animal-to-human blood:gas partition 
coefficients to calculate a human equivalent concentration (HEC). The LOAELHEC was divided by an uncertainty factor of 90 (3 for the use of a minimal LOAEL, 3 for extrapolation 
from animals to humans with dosimetric adjustment and 10 for human variability). 
c Used to derive an intermediate-duration MRL of 3 mg/m3 for JP-8 vapor. The NOAEL was adjusted for intermittent exposure and multiplied by the ratio of the animal-to-human 
blood:gas partition coefficients to calculate a human equivalent concentration (HEC). The NOAELHEC was divided by an uncertainty factor of 30 (3 for extrapolation from animals to 
humans with dosimetric adjustment and 10 for human variability). 
Bd Wt = body weight; Cardio = cardiovascular; d = day(s); Endocr = endocrine; F = Female; Gastro = gastrointestinal; Hemato = hematological; hr = hour(s); Immuno/Lymphoret = 
immunological/lymphoreticular; LOAEL = lowest-observed-adverse-effect level; M = male; min = minute(s); Metab = metabolism; Musc/skel = musculoskeletal; NOAEL = 
no-observed-adverse-effect level; RD50 = exposure concentration producing a 50% decrease in respiratory rate; Resp = respiratory; x = time(s); wk = week(s) 
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Figure 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation 
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Figure 3-1 Levels of Significant Exposure to Jp-5, Jp-8, And Jet A Fuels - Inhalation (Continued)
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Figure 3-1 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Inhalation (Continued)
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vapor (Carpenter et al. 1976). The study authors used a hot nichrome wire for the volatilization of the test
material and reported that the concentration was probably the “highest attainable concentration at which 
vapor analysis is representative of liquid analysis.” At a concentration of approximately 100 mg/m3 
(25°C) air is substantially saturated with kerosene vapor, although this is dependent upon the constituents
of the mixture (Carpenter et al. 1976).
Limited epidemiological data suggest that chronic human inhalation exposure to kerosene vapor and/or
combustion products from cooking with kerosene stoves does not induce respiratory illness.  The
presence of kerosene stoves in the homes of Malaysian children was not associated with chronic cough,
persistent wheeze, asthma, or chest illness (Azizi and Henry 1991).  Asthmatic bronchitis and frequent
common colds in 3-year-old Japanese children were not associated with the presence of kerosene stoves 
in their homes (Tominaga and Itoh 1985).  The latter study corrected for exposure to passive smoke.  
These data are of limited usefulness because the duration of exposure was not reported and the levels of
kerosene exposure could not be quantified.  Finally, it is unclear whether kerosene exposure occurred in
these individuals because it was used during cooking or because a kerosene stove was present in the 
home.
Studies in rats and mice provide suggestive evidence that JP-8, at high concentrations, is a respiratory 
irritant. In a study conducted by Whitman and Hinz (2001), RD50 (concentration resulting in a 50%
decrease in respiratory rate) values of 2,876 mg/m3 (95% confidence interval of 2,107–3,925 mg/m3) and 
1,629 mg/m3 (95% confidence interval of 1,418–1,871 mg/m3) were calculated for aerosolized JP-8 and 
JP-8+100 (mostly vapors) (JP-8+100 is JP-8 fuel with additives to increase the thermal stability by
100°F), respectively, following a 30-minute head-only exposure in male Swiss-Webster mice. The 
investigators noted that there were no signs of narcosis or pulmonary irritation for either substance.  In a 
similar study, an RD50 of 3,338 mg/m3 (95% confidence interval of 1,759–6,332 mg/m3) was calculated
for aerosolized JP-5 (concentrations are for aerosol and vapor components) (Whitman and Hinz 2001). 
Signs of upper respiratory irritation were observed in rats exposed to 3,430 mg/m3 JP-8 vapor or
3,570 mg/m3 JP-8+100 vapor (Wolfe et al. 1996).  However, exposure to 4,440 mg/m3 JP-8 or
4,540 mg/m3 JP-8+100 as a vapor/aerosol mixture did not result in signs of respiratory irritation (Wolfe et 
al. 1996).
Several studies have examined the possible toxicity of JP-8 and Jet A to the respiratory tract following
acute exposure. Herrin et al. (2006) and Wong et al. (2008) found that nose-only exposure of mice to 45 
or 53 mg/m3 aerosolized JP-8 (vapor and aerosol components) 1 hour/day for 7 days resulted in 
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ultrastructural changes in the alveolar type II cells, particularly an increase in volume density of lamellar
bodies; this change was not considered an adverse effect.  Wong et al. (2008) found increases in 
inspiratory and expiratory lung resistance, but no effect on total lung compliance at 53 mg/m3. 
Respiratory permeability was increased by 31.2% by JP-8 exposure, but this was not significantly
different compared to controls. However, Herrin et al. (2006) found a significant decrease in inspiratory
dynamic lung compliance at 406 mg/m3 (aerosol and vapor components) and no change in lung resistance
or respiratory permeability at concentrations as high as 406 mg/m3 (aerosol and vapor components).  It is
unclear why the results of the Herrin et al. (2006) and Wong et al. (2008) differ.
Two studies conducted by Sweeney et al. (2013) found no histological alterations in the respiratory tract
following a 4-hour/day, 5-day/week exposure to Jet A vapors and aerosols for 14 days.  The highest tested
concentrations were 1,662 mg/m3 in the first study with Sprague-Dawley rats and 1,980 mg/m3 in the
second study with Sprague-Dawley rats and F344 rats.  Some alterations in lung lavage fluid parameters,
which may be indicative of inflammation were observed in the second study.  The alterations include
increases in monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein 2 
(MIP-2) in F344 rats exposed to 869 or 1,980 mg/m3 Jet A and increases in MCP-1 in Sprague-Dawley
rats exposed to 1,980 mg/m3.  The biological relevance of these alterations in the absence of
morphological alterations is not known.
Several studies in rats, mice, and dogs have examined the respiratory tract following intermediate-
duration exposure JP-5 or JP-8 vapor.  No histological alterations were observed in the respiratory tract of
rats, mice, or dogs exposed continuously to up to 750 mg/m3 JP-5 vapor (the highest concentration tested)
for 90 days (Gaworski et al. 1984).  Similarly, no respiratory tract lesions were observed in rats
continuously exposed to up to 1,000 mg/m3 JP-8 vapor for 90 days (Mattie et al. 1991). Alveolar
capillary distention was observed in male Sprague-Dawley rats exposed to 500 or 1,000 mg/m3 JP-8 
vapor 6 hours/day for 91 days (Hanas et al. 2010); no effects were observed at 250 mg/m3. It should be
noted that this study only examined three rats per group.
A series of studies were conducted at the University of Arizona to evaluate the potential respiratory
toxicity of JP-8 (Hays et al. 1995; Pfaff et al. 1995, 1996; Robledo and Witten 1998, 1999; Robledo et al. 
2000; Wang et al. 2001; Wong et al. 2004).  As noted in the discussion in Section 3.2.1, these studies only
measured the aerosol component of the test atmosphere; thus, the concentrations reported by the
investigators underestimate the actual JP-8 exposure (vapor and aerosol phases). These studies provide
information on the toxicity of JP-8, but do not provide reliable concentration-response data. The studies 
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used similar experimental designs in which small groups of rats or mice were nose-only exposed to 
several concentrations of JP-8 for 1 hour or for 1 hour/day for 7 days; studies in rats also involved 
exposures for 1 hour/day for 28 or 56 days.  A 7-day exposure resulted in pulmonary congestion with 
hemorrhaging in the distal lung with breaks in the alveolar capillary membranes (Hays et al. 1995; Pfaff
et al. 1996).  Electron microscopy showed degeneration of alveolar type II cells (Pfaff et al. 1995).  
Interstitial perivascular edema and thickening of the bronchiolar epithelium were observed after a 56-day 
exposure (Hays et al. 1995).  Other respiratory effects observed in rats at similar concentrations include
an increase in respiratory permeability following ≥7 days of exposure (Hayes et al. 1995; Pfaff et al. 
1995), increases in inspiratory resistance and inspiratory dynamic compliance (Pfaff et al. 1995), and a 
decrease in substance P and corresponding increase in neutral endopeptidase (NEP) concentration in the 
bronchoalveolar lavage fluid (BALF) samples (Pfaff et al. 1995, 1996).  NEP is the primary tachykinin
degradative enzyme in the lung and its origin is primarily epithelial; substance P is thought to play a role
in airway reactivity and pulmonary epithelial integrity. Similar effects have been observed in mouse 
studies conducted at the University of Arizona; however, comparing the results of the rat studies to the 
mouse studies suggests that mice may be more sensitive than rats since effects are observed at lower
concentrations.  The morphological effects observed in mice include peribronchiolar edema and 
deterioration of the alveolar-capillary barrier (Robledo and Witten 1998; Robledo et al. 2000) and ectasia 
of respiratory bronchioles and alveoli at higher concentrations (Wong et al. 2004).  BALF analysis
showed increased total protein levels, total cell counts, neutrophil levels, decreased macrophage levels,
increased lactate dehydrogenase, and/or N-acetyl-β-D-glucosaminidase activities (Robledo and Witten
1998; Robledo et al. 2000; Wang et al. 2001).  In addition to these morphological alterations, increases in 
dynamic compliance (Wang et al. 2001) and increases in respiratory permeability (Robledo and Witten 
1998; Robledo et al. 2000; Wang et al. 2001) were observed.  A study investigating the molecular
mechanism of the lung effects found alterations in the levels of proteins suggestive of impaired protein 
synthethic/processing machinery, ultrastructural damage, toxic/metabolic stress and detoxification
systems, and functional responses to carbon dioxide handling, acid-base homeostasis, and fluid secretion
(Witzmann et al. 1999). A subsequent study by this group found decreases in α1-anti-trypsin levels in
JP-8 exposed mice (Drake et al. 2003); α-1-anti-trypsin deficiency has been show to play a role in the 
development of pulmonary emphysema. The Wang et al. (2001) study examined possible age-related
differences in the respiratory toxicity of JP-8 in 3.5- and 12-month-old mice.  Alterations in lung function 
and respiratory permeability appeared to be similar in the two groups, but some differences in BALF
analysis were detected. The levels of tumor necrosis factor-α (TNF-α) in the BALF were significantly
increased in the adult-exposed group and significantly decreased in the young-exposed groups, as
compared to their respective controls. Macrophage inflammatory protein-2 levels in the BALF were
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significantly increased in the adult and young mice; the levels in the adult-exposed group were
significantly higher than the young-exposed group, but no differences were found between the two 
control groups.  Prostaglandin E2 (PGE2) release was significantly lower in both exposed groups, as 
compared to the respective control groups; the levels in the adults were higher than the young-exposed 
groups, but the adult controls also had higher levels than the young controls.  The investigators concluded 
that the young and adult mice had similar toxicities to JP-8, although the inflammatory mechanisms may
be different.
Cardiovascular Effects. Mild hypertension was noted for 4 days in one of two individuals following
a 1-hour exposure to JP-5 vapor that occurred while flying a small airplane, although the concentration 
was not established and it is not known if JP-5 was the causative agent (Porter 1990).  No relevant data 
were located for JP-8 and Jet A.
Multifocal damage, consisting of myocardial scarring and inflammatory cell infiltration, was observed in 
male Sprague-Dawley rats exposed to 500 or 1,000 mg/m3 JP-8 vapor 6 hours/day for 91 days (Hanas et
al. 2010). The extent of the damage increased with the exposure concentration, and no effects were
observed at 250 mg/m3. Continuous exposure of rats, mice, or dogs to up to 750 mg/m3 JP-5 vapor for
90 days did not induce gross or microscopic alterations in the heart (Gaworski et al. 1984). Inhalation of
kerosene aerosol by guinea pigs for 15 minutes/day for 21 days induced aortic plaques that resembled 
those seen in atherosclerosis in that species (Noa and Illnait 1987a, 1987b).  Significant increases in total
serum cholesterol and decreases in high-density lipoprotein (HDL) were also noted.  In these studies, only
one concentration of kerosene aerosol, within a range of 20,400–34,000 mg/m3, was tested.  
A significant decrease in absolute heart weight was observed in Sprague-Dawley rats exposed to
1,622 mg/m3 Jet A vapors and aerosols 4 hours/day, 5 days/week for 14 days; however, no histological
alterations were observed in the heart (Sweeeney et al. 2013).  No significant or treatment-related
histopathological changes were noted in the heart tissue of rats or dogs exposed to up to 100 mg/m3 
deodorized kerosene (saturation concentration) for 6 hours/day, 5 days/week for 13 weeks (Carpenter et
al. 1976).
Gastrointestinal Effects. One of two individuals who were exposed to JP-5 vapor for approximately
1 hour while flying a small airplane experienced nausea after landing (Porter 1990).  The nausea subsided
within 24 hours.  Whether or not the nausea was related to the JP-5 exposure could not be determined.  
No relevant data were located for JP-8 or Jet A.
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Continuous exposure of rats, mice, or dogs to up to 750 mg/m3 JP-5 vapors for 90 days did not induce
gross or microscopic alterations in the gastrointestinal tract (Gaworski et al. 1984). A significant decrease 
in absolute gastrointestinal weight was observed in rats exposed to 1,622 mg/m3 Jet A vapors and aerosols
4 hours/day, 5 days/week for 14 days (Sweeeney et al. 2013); this alteration was observed 14 days post-
exposure, but was not observed 24 hours or 7 days after exposure termination.  No histological alterations
were observed in the gastrointestinal tract, and alterations in gastrointestinal weight were not observed in 
a subsequent study in which rats were exposed to 1,980 mg/m3 4 hours/day, 5 days/week for 14 days
(Sweeney et al. 2013).  No histopathological changes were noted in the gastrointestinal system of rats or
dogs exposed to up to 100 mg/m3 deodorized kerosene vapor for 6 hours/day, 5 days/week for 13 weeks
(Carpenter et al. 1976).
Hematological Effects. Complete blood counts performed on two individuals exposed to unknown 
concentrations of JP-5 vapor for approximately 1 hour while flying a small airplane were normal (Porter
1990). A study of active duty military personnel performing fuel system maintenance found significant
increases in white blood cell counts, neutrophil levels, and monocyte levels among 45 workers with high
exposure to JP-8 fuel, as compared to 78 workers with low or no exposure to jet fuels; no significant
alterations in lymphocyte subpopulations were observed (Rhodes et al. 2003). Exposure was monitored 
by measuring levels of naphthalene in environmental air and in breath.  The mean concentration of
naphthalene in air was 583 µg/m3 for the high-exposure group and 2.47 µg/m3 for the low-exposure
group.  The respective post-exposure breath concentrations of naphthalene were 3.80 and 0.80 µg/m3. 
There were no differences in pre-exposure breath concentrations of naphthalene between the two groups, 
(0.71 vs. 0.75 µg/m3).
Exposure to JP-8 vapor 6 hours/day for 91 days resulted in a reduction in fat cells/globules and cell
proliferation in bone marrow from male Sprague-Dawley rats; the extent of the fat cell reduction was 
concentration-related (Hanas et al. 2010). There was a 10% reduction in fat cells at 250 mg/m3, a 50%
reduction at 500 mg/m3, and a scarce number remained at 1,000 mg/m3. Continuous exposure of rats to 
150 or 750 mg/m3 JP-5 vapors for 90 days induced significant changes in hematology including decreased 
red blood cells in mid- and high-exposure males, decreased hemoglobin in high-exposure males,
increased red blood cells in mid- and high-exposure females, and increased white blood cells in mid- and 
high-exposure females (Gaworski et al. 1984).  However, all of these parameters were within normal
limits. In similarly exposed dogs, hematology parameters were within normal limits, although there were
slight decreases in red blood cell counts, hematocrit, and hemoglobin in high-exposure dogs (Gaworski et
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al. 1984). No hematological alterations were observed 24 hours after termination of a 14-day exposure to 
Jet A vapors and aerosols (4 hours/day, 5 days/week) (Sweeney et al. 2013).  Seven days post-exposure, a
decrease in the percentage of lymphocytes and a decrease in the total number of lymphocytes were
observed in Sprague-Dawley rats exposed to 1,021 and 1,662 mg/m3; no alterations were observed
14 days post-exposure.  The biological significance of this effect is not known. No exposure-related
hematological effects were noted in rats or dogs exposed to up to 100 mg/m3 deodorized kerosene vapor
for 6 hours/day, 5 days/week for 13 weeks (Carpenter et al. 1976).
Musculoskeletal Effects. No studies were located regarding musculoskeletal effects in humans after
inhalation exposure to JP-5, JP-8, or Jet A fuels.
Continuous exposure of rats, mice, or dogs to up to 750 mg/m3 JP-5 vapors for 90 days did not induce
gross or microscopic alterations in bone or skeletal muscle (Gaworski et al. 1984).
Hepatic Effects. No studies were located regarding hepatic effects in humans after inhalation
exposure to JP-5, JP-8, or Jet A fuels.
Several histological alterations were observed in the livers of male Sprague-Dawley rats exposed to
500 or 1,000 mg/m3 JP-8 vapor 6 hours/day for 91 days (Hanas et al. 2010); no liver effects were 
observed at 250 mg/m3. The hepatic effects included dilated sinusoids, cytoplasmic clumping, and fatty
hepatocytes. No histological alterations were noted in the livers of rats continuously exposed to JP-8 
vapor concentrations as high as 1,000 mg/m3 for 90 days (Mattie et al. 1991). Rats exposed to JP-5
vapor, 6 hours/day, 5 days/week for approximately 30 days, did not exhibit any significant changes in 
hepatic tissue morphology or serum alanine aminotransferase (ALT) or aspartate aminotransferase (AST)
levels; the concentration was reported at 1,100 mg/m3 as decane (Bogo et al. 1983).  Continuous exposure
of rats to up to 750 mg/m3 JP-5 vapor for 90 days did not induce gross or microscopic alterations in the
liver (Gaworski et al. 1984).  However, mice similarly exposed to 150 or 750 mg/m3 JP-5 vapor showed 
significantly increased incidences of hepatocellular fatty change and vacuolization (Gaworski et al. 1984).
The incidences were 8/37 (22%), 29/33 (88%), and 23/34 (68%) in the control, mid- and high-exposure
groups, respectively. In the same study, dogs exposed to 750 mg/m3JP-5, but not 150 mg/m3, showed 
mild, diffuse hepatocellular swelling.  Electron microscopy revealed this to be excessive glycogen
accumulation. No alterations in serum alanine aminotransferase levels or histological alterations were 
observed in Sprague-Dawley rats or F344 rats exposed to 1,980 mg/m3 Jet A vapors and aerosols 
4 hours/day, 5 days/week for 14 days (Sweeney et al. 2013).  Following exposure to up to 100 mg/m3 
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deodorized kerosene vapor for 6 hours/day, 5 days/week for 13 weeks, no histopathological changes in
the liver were noted in rats or dogs, and no liver weight changes were noted in dogs (Carpenter et al.
1976).
Renal Effects. Urinalyses values were within normal limits in two aviators who were exposed to JP-5 
vapor for approximately 1 hour while flying a small airplane (Porter 1990). No relevant information was
located for JP-8 or Jet A fuels.
Several studies have identified a nephropathy in male rats that is associated with exposure to some 
organic chemicals, including some jet fuels (Gaworski et al. 1984; Hanas et al. 2010; Mattie et al. 1991).  
Male rats exposed continuously to ≥150 mg/m3 JP-5 vapor (Gaworski et al. 1984) or ≥500 mg/m3 JP-8 
vapor for 90 days (Mattie et al. 1991) showed hyaline droplets in the tubular epithelium; proximal tubule
damage was also observed in rats exposed to 250 mg/m3 JP-8 vapors, 6 hours/day for 91 days (Hanas et
al. 2010).  This hydrocarbon-induced nephropathy has only been demonstrated in adult male rats and has
been linked to a specific protein, alpha2u-globulin, which is produced under hormonal control by the liver
(Alden 1986; Swenberg 1993); concentration-related increases in alpha2u-globulin levels were measured
in rats exposed to 250–1,000 mg/m3 JP-8 vapors (Hanas et al. 2010).  Alpha2u-globulin accumulates in
hyaline droplets and the buildup of alpha2u-globulin-containing hyaline droplets is thought to lead to cell
necrosis; the cellular debris accumulates at the corticomedullary junction, causing tubule dilation and
mineralization of the tubules. However, alpha2u-globulin is unique to male rats and is not present in 
human kidneys; hence the renal effects observed in male rats exposed to JP-8 are not relevant to humans
(EPA 1991c; Flamm and Lehman-McKeeman 1991; Hard et al. 1993; Swenberg 1993).  
Female rats exposed to up to 1,980 mg/m3 Jet A vapors and aerosols 4 hours/day, 5 days/week for 14 days
(Sweeney et al. 2013) or continuously to up to 1,000 mg/m3 JP-8 vapors for 90 days (Mattie et al. 1991)
did not show histological alterations in the kidneys.  Similarly, no renal lesions have been observed in 
female mice continuously exposed to 750 mg/m3 JP-5 vapors (Gaworski et al. 1984), male and female 
dogs continuously exposed to 750 mg/m3 JP-8 vapor (Gaworski et al. 1984), or male dogs exposed to 
100 mg/m3 deodorized kerosene vapor 6 hours/day, 5 days/week for 13 weeks (Carpenter et al. 1976).
Male rats exposed to JP-5 vapor (concentration reported as 1100 mg/m3 decane), 6 hours/day, 
5 days/week for approximately 30 days did not exhibit any significant changes in renal tissue 
morphology, but did report increased water consumption which may be indicative of renal damage (Bogo 
et al. 1983).
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Endocrine Effects. No histopathological changes were noted in the adrenal or thyroid glands of rats
or dogs exposed to up to 100 mg/m3 deodorized kerosene vapor 6 hours/day, 5 days/week for 13 weeks
(Carpenter et al. 1976) or rats, mice, or dogs continuously exposed to 750 mg/m3 JP-5 vapors for 90 days
(Gaworski et al. 1984).
Ocular Effects. One case study describes eye irritation in two individuals exposed to unknown 
concentrations of JP-5 vapor for approximately 1 hour while flying a small airplane (Porter 1990); it is
not known if JP-5 was the causative agent.  No relevant data were located for JP-8 or Jet A.  Although the
exposure concentrations were not stated, the study author indicates that near the end of the flight, the
“cockpit became overwhelmed with the odor of JP-5 fuel.” Both individuals experienced a burning
sensation in their eyes, and one had itchy, watery eyes 1 day after the exposure.  Hyperemic conjunctiva 
was also reported for one of the individuals; this effect subsided after 4 days.  All effects appear to have 
been local in nature.  No eye irritation was reported in six volunteers exposed to 140 mg/m3 deodorized 
kerosene vapor for 15 minutes (Carpenter et al. 1976).
Nose-only exposure of male Swiss Webster mice to 1,000 or 2,500 mg/m3 (aerosol component only)
aerosolized JP-8+100 1 hour/day for 7 days did not result in gliosis or histopathological alterations in the
retina (McGuire et al. 2000).  However, increased immunoreactivity of anti-GSTM antibodies in the 
retinal Müller cells, which may be indicative of oxidative stress, was found at both concentrations.
Signs of eye irritation were reported in F-344 rats exposed whole-body to 3,430 mg/m3 JP-8 vapor or
3570 mg/m3 JP-8+100 vapor for 4 hours, but no such effects were reported during exposures to 
4,440 mg/m3 that included a combination of vapor and aerosolized JP-8 fuel or 4,540 mg/m3 
JP-8+100 vapor/aerosol (Wolfe et al. 1996).
Body Weight Effects. No studies were located regarding body weight effects in humans after
inhalation exposure to JP-5, JP-8, or Jet A fuels.
No biologically relevant alterations in body weight gain were observed in Sprague-Dawley and F344 rats
exposed to up to 1,980 mg/m3 Jet A vapor and aerosol 4 hours/day, 5 days/week for 14 days (Sweeney et
al. 2013). There was no significant change in body weight gain in mice, dogs, or female rats following
90-day continuous inhalation exposure to up to 750 mg/m3 JP-5 vapor (Gaworski et al. 1984).  However,
final body weight of male rats exposed to 150 or 750 mg/m3 JP-5 vapor was reduced 15–19% (Gaworski
et al. 1984). Intermittent whole-body exposure of male Sprague-Dawley rats to 1,000 mg/m3 JP-8 vapors
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for 6 weeks resulted in body weights lower than controls during the exposure period, but the difference
between the groups was not statistically significant (Witzmann et al. 2000). Male F344 rats continuously
exposed to airborne JP-8 vapor (500 or 1,000 mg/m3) for 90 days followed by a 21-month recovery period 
showed a 5–8% reduction in body weight relative to controls during the exposure period (Mattie et al. 
1991). However, at the end of the 21-month recovery period, body weights were reduced 14–16% in both 
exposed groups relative to controls.  Female body weights were not significantly affected by exposure to 
JP-8 (Mattie et al. 1991). There was no change in body weight gain in rats or dogs exposed to up to 
100 mg/m3 deodorized kerosene vapor 6 hours/day, 5 days/week for 13 weeks (Carpenter et al. 1976).
Metabolic Effects. There were no alterations in blood glucose in either of two individuals following a
1-hour exposure to unknown concentrations of JP-5 vapor while flying a small airplane (Porter 1990). No
relevant information was located for JP-8 or Jet A fuels.
Serum levels of glucose and electrolytes were not significantly altered in rats or dogs exposed
continuously to up to 750 mg/m3 JP-5 vapor for 90 days (Gaworski et al. 1984).
3.2.1.3  Immunological and Lymphoreticular Effects 
No studies were located regarding immunological and lymphoreticular effects in humans exposed to JP-5, 
JP-8, or Jet A fuels.
Harris and associates at the University of Arizona conducted a number of studies designed to assess the 
immunotoxic potential of JP-8 (Harris et al. 1997a, 1997b, 1997c, 2000a, 2000b, 2000c, 2007a, 2007c, 
2008).  As discussed in Section 3.2.1, there are a number of limitations to these studies; the primary 
limitation was the inaccurate measurement of the test atmosphere because only the aerosol component of
the aerosolized JP-8 was measured.  Thus, the reported concentrations underestimated the JP-8 exposure
levels and the data are not considered suitable for concentration-response analysis. Additionally, the
animals may have been exposed to plasticizing chemicals from the breakdown of the plastic cups used to
hold the JP-8 during aerosolization (Mattie 2013).  The results of the University of Arizona studies 
discussed in this paragraph are considered supporting studies and are not presented in Table 3-1 or
Figure 3-1.  Most of the immunotoxicity studies conducted by this group involved nose-only exposure of
male and female C57Bl/6 mice to aerosolized JP-8 1 hour/day for 7 days.  The studies consistently found 
decreases in spleen and thymus weights and decreases in the number of viable immune cells in these
organs (Harris et al. 1997a, 1997b, 1997c); the effects on thymus immune cell numbers were observed at
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the lowest concentrations tested.  Multiphasic alterations in the number of viable immune cells were 
observed in other tissues.  In the lymph nodes and peripheral blood, low concentrations of aerosolized 
JP-8 resulted in decreases in cell numbers, mid-range concentrations increased cell numbers, and high
concentrations decreased cell numbers (Harris et al. 1997a, 1997b).  In the bone marrow, increases in cell
numbers were observed at low concentrations and decreases were observed at a mid-range concentration.  
A number of alterations in immunocompetence were also observed.  Impaired immune responses were 
found in mice exposed to aerosolized JP-8 following stimulation with the T-cell mitogen concanavalin A
or the T-cell growth factor interleukin-2 (IL-2) (Harris et al. 1997a). Exposure to aerosolized JP-8+100 
also resulted in a suppressed response to concanavalin A (Harris et al. 2000b).  Harris et al. (2008)
showed that a 7-day exposure to aerosolized JP-8 could reduce immunocompetence, evidenced by
decreased immune cell viability, decreased immune proliferative responses to mitogens, and the loss of
CD3+, CD4+, and CD8+ T cells from the lymph nodes, but not from the spleen.  Exposure of mice to 
aerosolized JP-8 for 7 days before intravenous injection of B16 tumor cells induced an approximately
8.7-fold increase in tumor formation in the lungs, whereas mice exposed to JP-8 at the time of tumor
induction showed a 5.6-fold increase in the number of tumors (Harris et al. 2007c).  Although the results
were not statistically analyzed, the findings were interpreted as a suppressive effect of JP-8 exposure on 
the immune system, leading to increased tumor formation and metastases. A 7-day exposure to 
aerosolized JP-8 also increased the severity of a viral infection (mice were exposed to A/Hong Kong/8/68 
influenza virus 1 day post-JP-8 exposure) (Harris et al. 2008).  A study of the time course of JP-8-induced 
effects showed that a 1-hour exposure caused significant spleen and thymus weight loss and loss on viable
cells in the spleen within 2 hours of the exposure (Harris et al. 2002).  It was also shown that immune
function, as assessed by the response to mitogens, was impaired 1 hour after exposure and did not recover
within 24 hours.  Harris et al. (1997c) found that the decreases in immune organ weights and decreased
immune function persisted for 4 weeks post-exposure to aerosolized JP-8.  Harris and associates also
examined the possible mechanisms of immunotoxicity in mice exposed to aerosolized JP-8.  The studies
showed that substance P, a small peptide thought to be involved in airway reactivity and in maintaining
pulmonary epithelial integrity, could protect the immune system from JP-8-induced damage and also 
reverse the damage if administered at appropriate times before and/or after JP-8 exposure (Harris et al.
1997b, 2000c). They also showed that exposure to JP-8 rapidly increased serum levels of two
immunosuppressive agents, interleukin-10 (IL-10) and prostaglandin E2 (PGE2) (Harris et al. 2007a).
Since treatment with a PGE2 inhibitor did not completely reverse the effects of JP-8, the increased levels 
of IL-10 and PGE2 could only partially explain all of the effects of JP-8 exposure on immune function.  
Another study showed that exposure to aerosolized JP-8 almost completely inhibited natural killer (NK) 
cell activity, significantly suppressed the generation of lymphokine-activated killer (LAK) cell activity,
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suppressed the generation of cytotoxic T lymphocyte cells from precursor T cells, and inhibited helper
T cell activity (Harris et al. 2000a).  
A more recent study conducted at the University of Arizona by Hilgaertner et al. (2011) used a different
system for generating aerosolized JP-8, and both the aerosol and vapor components of the test atmosphere
were measured. This study found significant decreases in spleen and thymus weights in C57BL/6 mice
exposed to 1,000, 4,000, or 8,000 mg/m3 (aerosol and vapor components) aerosolized JP-8 1 hour/day for
7 days; there were no changes in spleen weights at 2,000 mg/m3.  Thymus weights were significantly 
decreased at ≥1,000 mg/m3; slight but statistically significant decreases in body weight were also
observed at ≥1,000 mg/m3. However, the body weights at all concentrations were within 10% of controls.  
Viable cell levels were significantly decreased in the bone marrow at 8,000 mg/m3, in the spleen and 
peripheral blood at 4,000 mg/m3, and in the thymus at ≥2,000 mg/m3; significant increases in bone
marrow and peripheral blood viable cell levels were observed at 4,000 and 1,000 mg/m3, respectively.
Assessment of immune function by proliferative responses to mitogens showed significant suppression by 
exposure to JP-8 fuel (about 70% at 1,000 mg/m3).
Two 14-day studies in rats did not find concentration-related alterations in splenic lymphocyte
phenotypes at Jet A vapor and aerosol levels up to 1,980 mg/m3 (Sweeney et al. 2013). Harris et al.
(2000b) also conducted a study in mice exposed to Jet A-1 fuel 1 hour/day for 7 days; similar to the JP-8 
studies conducted by this group, only the aerosol component of the test atmosphere was measured.  The
study found no alteration in splenic lymphocyte populations, but did find significant increases in double 
negative thymocytes and a concominant decrease in double positive thymocytes.  A significant 
suppression of the response to concanavalin A was also observed in this study.
A study of unadditized jet fuel kerosene vapor (a composite blend of unadditized Jet A fuel) (500 mg/m3 
exposure level) or aerosol/vapor (1,000 or 2,000 mg/m3 exposure levels) in which female B6C3F1 mice 
and female Crl:CD rats were exposed nose-only 6 hours/day, 7 days/week for 28 days did not find 
significant alterations in spleen or thymus weight, the T-dependent antibody-forming cell response, or the
delay-type hypersensitivity response at exposure levels as high as 2,000 mg/m3 (White et al. 2013). For
the most part, spleen cell numbers and phenotypes were unaffected by exposure to kerosene; however, 
some non-concentration-related alterations were observed, including increased number of absolute NK
cells in mice exposed to 500 or 1,000 mg/m3, increased percentage of helper T-cells in mice exposed to 
1,000 or 2,000 mg.m3, reduced spleen cell number in rats exposed to 1,000 mg/m3, and reduced absolute
number of splenic B cells in rats exposed to 1,000 mg/m3.  NK cell activity was not affected in mice, and 
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no assessment could be done in rats due to an unusually low response in all groups. The results of this 
study suggested that, at least in part, the performance additives in JP-8 fuel could be responsible for the
effects observed on cell-mediated immunity following exposure to JP-8.
No gross or microscopic alterations in the thymus, spleen, and/or lymph nodes were induced after
continuous exposure of rats, mice, or dogs to ≤750 mg/m3 JP-5 vapor for 90 days (Gaworski et al. 1984), 
continuous exposure of rats to ≤1,000 mg/m3 JP-8 vapor (Mattie et al. 1991), exposure of rats to 
≤1,980 mg/m3 Jet A aerosols and vapors 4 hours/day, 5 days/week for 14 days (Sweeney et al. 2013), or
exposures of rats or dogs to 100 mg/m3 deodorized kerosene vapor for 6 hours/day, 5 days/week
(Carpenter et al. 1976).  Immune function was not assessed in these studies.
The highest NOAEL values and all LOAEL values from each reliable study for immunological effects in
each species and duration category are recorded in Table 3-1 and plotted in Figure 3-1.
3.2.1.4  Neurological Effects 
Limited information was located regarding neurological effects in humans resulting from acute exposure 
to jet fuels. Coordination and concentration difficulties and fatigue were noted in two individuals
following exposure to JP-5 in the cockpit of an unpressurized aircraft for one hour (Porter 1990).  The
odor of JP-5 in the cockpit at the end of the flight was described as overwhelming; however, it is not 
known whether JP-5 was the causative agent.  Other effects included headache, apparent intoxication, and 
anorexia.  Neither experienced any sensory impairment.  The effects subsided within 24 hours in one of
the exposed individuals and within 4 days in the other.
A study of 27 U.S. Air Force employees examined the association between exposure to JP-8 and postural
balance (Smith et al. 1997).  The subjects had been exposed to JP-8 for at least 6 months.  Although 
exposure concentrations could not be calculated in mg/m3 because of insufficient data, mean 8-hour
breathing zone samples for employees in all job categories exposed to JP-8 fuel were: benzene
(5.03±1.4 ppm); toluene (6.11±1.5 ppm); xylenes (6.04±1.4 ppm); and naphthas (419.6±108.9 ppm).  The
study authors noted a statistical association between sway length and cumulative JP-8 benzene, which 
implied a subtle influence on vestibular/proprioception functionalities.  However, a recent study of
37 active duty Air Force personnel found that workday exposure to JP-8 was not significantly associated
with postural sway (Maule et al. 2013).  Instead, increases in workday postural sway were associated with
demographic variables including younger age, being a current smoker, and higher body mass index.  In 
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this study, exposure was assessed by personal breathing zone levels of naphthalene and total
hydrocarbons and urinary levels of 1- and 2-naphthol.  A study of 63 Air National Guard personnel found 
that subjects exposed to JP-8 performed significantly poorer than a sample of unexposed (n=50) age- and 
education-matched individuals in 20 out of 47 measures of information processing and other
neurocognitive tests (Tu et al. 2004).  Exposure was assessed by daily breath analyses.  Total JP-8 
concentrations among the exposed workers before work ranged from 0 to 7.6 mg/m3, whereas at the end
of the workday, exposures ranged from 0.2 to 11.5 mg/m3. In the unexposed subjects, total hydrocarbon 
concentrations at the beginning of the day ranged from 0.3 to 2.1 mg/m3 and did not change significantly
during the course of the day. A neurobehavioral assessment of 117 Air Force personnel exposed to JP-8 
(primarily fuel cell maintenance workers) found significantly lower performance on digit span, symbol
digit latency, and tapping tests that were conducted prior to the day’s exposure; a group of 165 Air Force
personnel with minimal exposure to JP-8 served as the control group (Air Force 2001).  The investigators
suggested that this was indicative of a carry-over or non-resolving effect associated with JP-8 exposure.  
A more recent study examined the potential neurotoxicity of JP-8 in 38 active duty Air Force personnel
who performed job tasks that involved regular and routine individual personal exposure to JP-8 (high 
exposure group) and 36 Air Force personnel with low or no exposure to JP-8 (Proctor et al. 2011).  The
8-hour geometric mean time-weighted average total hydrocarbon concentrations were 0.53 mg/m3 (range 
of 0.24–22.01 mg/m3) and 2.65 mg/m3 (range of 0.24–73.93 mg/m3) in the low- and high-exposure
groups, respectively.  Neuropsychological battery testing performed on days 1, 2, 4, and 6 were designed 
to assess attention, reaction time, psychomotor speed and efficiency, memory, and balance.  When 
compared to normative, reference group data from groups of healthy adults (obtained from clinical test
manuals or published studies), there were no significant alterations in performance on neuropsychological
tests in the study participants (all groups combined), with the exception of lower performance scores on 
the Total Recall, Delayed Recall, and retention task tests among 20–29-year-old study participants.  
Interpretation of the results of this study is limited by the lack of comparison between the two exposure 
groups. Bell et al. (2005) exposed several groups of veterans to clean air or 0.00057 ppm JP-8 vapor for
7 minutes once a week for 3 weeks.  Faster central reaction and peripheral reaction times were observed
on a test of visual divided attention in the JP-8-exposed veterans compared to the air exposed veterans.
Studies in laboratory animals provide information regarding neurobehavioral and neurochemical effects
as well as on effects on hearing. Exposure of male Long-Evans rats exposed nose-only to 1,000 mg/m3 
JP-8, which was mostly in the vapor phase (1–5% aerosol) (only concentration tested), for 4 hours did not
result in auditory impairment as assessed by decreased hair cell function, as measured by distortion 
product otoacoustic emissions (DPOAE), or loss of outer hair cells (Fechter et al. 2007).  A subsequent
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4-hour exposure to noise with a 105 dBlin sound intensity in the octave band of 8 Hz resulted in a
depression of DPOAE amplitude, which was greater than in rats exposed only to noise.  A subsequent
4-hour exposure to 97 dB or 1-hour exposure to 102 dB noise (8 Hz) resulted in further decreases in 
DPOAE amplitude, as compared to noise-only or JP-8-only exposed rats (Fechter et al. 2007).  A
significant increase in the auditory threshold, as measured by recording compound action potentials
(CAPs) from the round window, was observed in rats exposed to JP-8 once, followed by a 4-hour
exposure to noise at 105 dB; no alterations in auditory threshold were observed in the rats repeatedly
exposed to JP-8 and noise (Fechter et al. 2007). In a subsequent study, no alterations in DPOAE were 
observed in rats exposed to up to 1,000 mg/m3 JP-8 vapor 4 hours/day for 5 days (Fechter et al. 2010).  At
2,000 mg/m3, an initial loss in DPOAE amplitude at test frequencies above those predicted to be affected
from noise-only exposure was observed 4 days after exposure termination; however, 4 weeks post-
exposure, the DPOAE amplitude was similar to controls. When the rats were exposed to noise with a 97– 
99 dBA intensity in the 8-Hz octave range for 1 hour immediately after each JP-8 exposure, there were
significant decreases in DPOAE amplitude in the 1,000 and 2,000 mg/m3 groups.  No alterations in pure
tone auditory threshold were observed in the JP-8 or JP-8 plus noise groups.
Fechter et al. (2012) found similar results in rats exposed to JP-8 (mostly vapor) 6 hours/day, 5 days/week
for 4 weeks. No significant alterations in DPOAE amplitude, pure tone auditory threshold, or the number
of cochlear outer hair cells were observed in rats exposed only to up to 1,500 mg/m3 JP-8.  In rats
simultaneously exposed to 1,500 mg/m3 JP-8 and noise with a 85 dB intensity (a noise intensity that is 
considered non-damaging) and octave band centered on 8 Hz, there were marked decreases in DPOAE
amplitude measured 10 days and 4 weeks post-exposure and increases in pure tone auditory threshold; no 
alterations were observed at the two lower JP-8 concentrations. A decrease in DPOAE amplitude was 
also observed in rats exposed to JP-8 and intermittent noise (102 dB intensity for 15 minutes/hour), as
compared to controls; however, there was no difference when compared to rats only exposed to 
intermittent noise.  Some losses of cochlear outer hair cells were observed in rats exposed to 1,500 mg/m3 
JP-8 and continuous or intermittent noise were observed; however, the total loss was <1%. In contrast to
these findings, Guthrie et al. (2014) found significant central auditory processing dysfunction in rats
exposed to 1,000 mg/m3 JP-8 (mostly vapor) 6 hours/day, 5 days/week for 4 weeks.  The dysfunction was
manifested as impaired brainstem encoding of stimulus intensity and was observed in rats exposed to JP-8 
and JP-8 with noise (85 dB intensity 6 hours/day, 5 days/week for 4 weeks).  No alterations in peripheral
auditory function or loss of hair cochlear outer cells were found.
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A study that tested both JP-5 and JP-8 reported slightly different results for the two fuels (Rossi et al.
2001).  Male Sprague-Dawley rats were exposed to 1,200 mg/m3 JP-5 vapor or 1,000 mg/m3 JP-8 vapor
6 hours/day, 5 days/week for 6 weeks.  Neurobehavioral toxicity assessment battery tests were 
conducted 65 days post-exposure.  At termination, levels of neurotransmitters and their metabolites were
determined in serum and in five brain regions.  In rats exposed to JP-5, significant alterations in
performance on battery tests were limited to an increase in forelimb grip strength.  The only significant
alteration in serum neurotransmitter levels was an increase in 5-hydroxyindoleacetic acid, a serotonin 
metabolite.  Significant decreases in dihydroxyphenylacetic acid (DOPAC, a major metabolite of
dopamine) levels in the cortex, increases in dopamine levels in the hippocampus, and decreases in
homovanillic acid in the hippocampus were also observed. In rats exposed to JP-8, a significant
alteration in performance on the novel appetitive stimulus test (hypothesized to quantify dopamine
system sensitization) was observed.  Evaluation of serum neurotransmitter levels showed a significant
decrease in the serotonin metabolite 5-hydroxyindoleacetic acid levels.  DOPAC levels were 
significantly decreased in the cerebellum and brainstem.  Using the same exposure protocol, the same 
group of investigators showed that exposure to 1,000 mg/m3 JP-8 had no significant effect on the
performance of simple operant tasks (Ritchie et al. 2001).  Although no significant differences in 
performance on the more difficult tasks between the controls and exposed groups were observed, 
significant decreases in performance were observed between the low- and high-exposure groups in the
two most difficult tasks.  Levels of dopamine in the cerebral cortex and DOPAC levels in the brain were
significantly higher in both exposure groups, as compared to controls.
Studies in male F-344 rats conducted at the University of Arizona (see Section 3.2.1 for a discussion of
study limitations) also examined the neurotoxicity of aerosolized JP-8.  Intermittent nose-only exposure
to aerosolized JP-8 for 4 weeks did not affect learning and memory for spatial location in a swim task in 
rats, nor did it influence visual discrimination learning (Baldwin et al. 2001).  However, increased central
nervous system excitability was observed.  Greater hyperlocomotive behavior and increased arousal
levels were observed in functional observational battery tests and faster swim speeds during spatial testing
in the Morris swim task were observed (Baldwin et al. 2001).  According to the investigators, the effects 
on arousal levels and locomotor activity are consistent with stimulation of the mesolimbic dopaminergic
system. Evaluation of levels of neurotransmitters and their metabolites in various brain areas showed a 
significant increase in DOPAC levels in the hippocampal region in exposed rats relative to controls,
which was more pronounced as the duration of exposure increased. This suggested increase in dopamine
release and metabolism (Baldwin et al. 2007).
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Continuous exposure of rats, mice, or dogs to up to 750 mg/m3 JP-5 vapor for 90 days (Gaworski et al.
1984) or intermittent exposure of rats or dogs to ≥100 mg/m3 deodorized kerosene vapor 6 hours/day, 
5 days/week for 13 weeks (Carpenter et al. 1975, 1976) did not induce gross or microscopic alterations in 
the brain or sciatic nerve.
The highest NOAEL values and all LOAEL values from each reliable study for neurological effects in
each species and duration category are recorded in Table 3-1 and plotted in Figure 3-1.
3.2.1.5  Reproductive Effects
A study of 170 military and civilian women recruited from 10 U.S. Air Force bases found that women 
working in occupations involving fuel handling did not have significantly higher odds of menstrual
disorders in adjusted analyses (Army 2001; Reutman et al. 2002).  In the study, exposure was
characterized by measuring aliphatic hydrocarbons (total C6–C16) and total benzene, toluene, 
ethylbenzene, and xylene in exhaled breath.  However, the study did find a significant (p=0.007) reverse
association between preovulatory luteinizing hormone (LH) and breath aliphatic hydrocarbons. The 
mechanism by which aliphatic hydrocarbons could lower LH is unknown, but the investigators suggested
that LH levels could potentially be lowered by effects on the pituitary gland, hypothalamus, or
extrahypothalamic central nervous system inputs.  Although not clearly stated, the assumption appeared 
to be that exposure was mainly to JP-8, but exposure to other products such as a gasoline, diesel fuels, 
and the products of their complete and incomplete combustion was not totally ruled out.
3.2.1.6  Developmental Effects
No studies were located regarding developmental effects in humans after inhalation exposure to JP-5, 
JP-8, or Jet A fuels.
Continuous exposure of rats, mice, or dogs to up to 750 mg/m3 JP-5 vapors for 90 days did not induce
gross or microscopic alterations in the reproductive organs (Gaworski et al. 1984). Similarly, no
histological alterations were observed in reproductive organs of female rats exposed to up to 1,980 mg/m3 
Jet A vapor and aerosol 4 hours/day, 5 days/week for 14 days (Sweeney et al. 2013).  No other
reproductive end point was assessed in these studies.
Information on the developmental toxicity of JP-5, JP-8, or Jet A fuels in laboratory animals is limited
to a study conducted by the University of Arizona (Harris et al. 2007b).  As noted previously (see
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Section 3.2.1 for discussion of the University of Arizona studies), interpretation of these studies is
limited by an underestimation of the exposure concentration and possible exposure to plasticizers.
Nose-only exposure of pregnant C57Bl/6 mice to aerosolized JP-8 (1 hour/day on GDs 7–21 or 15–21)
resulted in significant decreases in thymus and spleen weight, viable immune cells from these organs,
and suppressed immune function at 6–8 weeks old, regardless of the duration of maternal exposure
(Harris et al. 2007b).  It appeared that male pups were more severely affected than female pups. Since 
mothers displaying the most severe effect gave birth to pups that were the most affected by JP-8 
exposure, the investigators suggested that susceptibility to the effects of JP-8 might be, at least in part,
genetically determined.  Average litter size was also significantly reduced in the exposed groups.
3.2.1.7  Cancer
There are limited data on the carcinogenicity of JP-5, JP-8, and Jet A fuels.  A few studies have examined
cancer incidence and/or mortality among workers exposed to jet fuels; however, in all of the studies, the
workers were exposed to a number of types of jet fuels including JP-4.  A large study by D’Este et al. 
(2008) found significantly higher incidences of cancer diagnoses among the 873 aircraft maintenance
workers examined than in two large (>7,500 people) comparisons groups.  As noted by the investigators, 
these maintenance workers were exposed to a number of compounds in addition to the jet fuels including
hexavalent chromium, carbon black, ethylbenzene, and petroleum solvents; additionally, the workers
were exposed to JP-4 fuel. A historical prospective cohort study of >2,000 men in the Swedish Air Force
with exposure to aircraft fuel did not find an association between jet fuel exposure and the lymphatic
malignancies (Seldén and Ahlborg 1991).  The workers in this study were exposed to several types of jet
fuels including JP-4 and Jet A-1.  A population-based, case-referent study using a cohort of 3,726 cancer
patients, of whom 43 individuals were exposed to jet fuel and 234 individuals were exposed to kerosene 
found a significant association between jet fuel exposure and kidney cancer (odds ratio [OR] 3.1; 90%
confidence interval [CI] 1.5–6.6).  However, some of the patients with kidney cancer who were exposed 
to jet fuel had also been exposed to aviation gasoline, which may have been responsible for the
development of renal tumors (Siemiatycki et al. 1987).  Limitations of this study included multiple
chemical exposures and inadequate description of the jet fuels and exposure concentrations.  A follow-up 
of this study (Parent et al. 2000) examined the ORs between renal cell cancers and selected substances 
and found that of the 142 cases of renal cell cancer examined, 6 individuals were exposed to jet fuel and 
4 were exposed to jet fuel engine emissions. The ORs (adjusted for age, smoking, and body mass index)
were 3.9 (95% CI 1.6–9.8) and 2.7 (05% CI 0.9–8.1), respectively.  Although a statistical significant 
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association between renal cell cancer and jet fuel exposure was found, the study does not prove causality
and the type of jet fuel was not specified.
Several studies have also examined the carcinogenicity of kerosene in humans. No association between 
the use of kerosene stoves for cooking and bronchial cancer was found among nonsmoking women (Chan
et al. 1979).  The concentrations and durations of exposures were not reported, and it could not be
ascertained whether exposures were to kerosene vapor or kerosene aerosol.  Zheng et al. (1992) examined 
the possible association between the use of kerosene stoves and exposure to “petroleum products,” and 
oral or pharyngeal cancer.  Significantly more male cancer cases (27%) used kerosene stoves than
controls (14.1%).  A similar effect was not observed for females.  This study is limited in that a wide
range of fuels were used, the fuels were not adequately described, and no differentiation was made 
between effects potentially associated with kerosene vapor and effects possibly associated with the 
products of combustion. In a matched case-control study examining risk factors for two common types of
brain tumors in children, astrocytic glioma and primitive neuroectodermal tumor (PNET), a significant 
association (OR 8.9; 95% CI 1.l–71.1) was found between astrocytoma and the use of kerosene during
pregnancy by income-adjusted mothers (Bunin et al. 1994).  The study used 321 control group individuals
and monitored 321 cases, of which 155 were astrocytic glioma cases and 166 were PNET cases.  
Limitations in this study included possible selection bias, lack of information regarding exposure duration 
and concentrations, and exposure to other agents, such as alcohol, N-nitroso compounds, and possibly
pesticides.
No studies were located regarding carcinogenicity in laboratory animals following inhalation exposure to 
JP-5, JP-8, or Jet A fuels. 
3.2.2 Oral Exposure
3.2.2.1  Death 
No reports of deaths in humans due to ingestion of JP-5, JP-8, or Jet A fuels were located. Numerous
case studies have described death following the accidental ingestion of kerosene, particularly by children 
(usually under the age of 5, but as old as 15 years).  Kerosene ingestion is one of the most common forms
of acute childhood poisoning in many developing countries.  Kerosene is used for cooking, heating, and 
lighting and is typically stored in containers and places easily accessible to children. Deaths following
ingestion of kerosene were usually attributed to lipoid pneumonia (Morrison and Sprague 1976;
Santhanakrishnan and Chithra 1978; Zucker et al. 1986) that was probably induced by the aspiration of
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the kerosene.  Specific respiratory effects associated with death from kerosene ingestion include 
pneumothorax (Lucas 1994; Mahdi 1988; Zucker et al. 1986), emphysema (Mahdi 1988), respiratory
failure (Abu-Ekteish 2002), and pneumonitis (Balme et al. 2012; Singh et al. 1981).  Cardiac arrhythmia 
was reported as the cause of death in one child; however, it was suspected that myocarditis and
pulmonary edema may have been the cause of the rapid deterioration and death of the child (Dudin et al.
1991).  Many other studies have reported deaths due to ingestion of kerosene without providing a specific
cause of death (i.e., Chun 1998; Gupta et al. 1998; Lang et al. 2008; Simmank et al. 1998).  Estimated
ingested doses of kerosene associated with death are approximately 1,900 mg/kg based on the ingestion of
30 mL of kerosene by a 2-year-old child, and approximately 16,800 mg/kg based on the ingestion of
200 mL of kerosene by a 1-year-old child (Santhanakrishnan and Chithra 1978).  An estimated oral dose 
of <5,300 mg/kg kerosene resulted in the death of a 10-month-old girl (Zucker et al. 1986).  No lethality
was reported for children from 10 months to 5 years old following ingestion of estimated doses ranging
from 120 to 870 mg/kg and, in one instance, a dose as high as 1,700 mg/kg of kerosene (Dudin et al.
1991).  Although kerosene ingestion is the second leading cause of poisoning in rural Sri Lanka, 
accounting for 9.5% of the total cases, no deaths due to ingestion were reported (Hettiarachchi and
Kodithuwakku 1989).
A single oral dose of 22,400 mg/kg kerosene killed 4/5 adult rats, 10/15 5-week-old rats, and
15/15 10-day-old rats in 1–3 days, suggesting increased susceptibility in younger animals (Deichmann et
al. 1944).  Death occurred in two out of six rats subsequent to a single gavage dose of 47,280 mg/kg JP-5, 
but none died after receiving a single dose of ≤29,944 mg/kg JP-5 (Parker et al. 1981). An LD50 of 
>48,000 mg/kg was noted in rats receiving a single oral dose by gavage of JP-5 (Bogo et al. 1983).  
However, it should be noted that the volumes of the doses by gavage used here were extremely large and
that any amount above 20 mL (lowest dose used in this study was 24 mL/kg) is probably too high a dose
for rats. No deaths were observed in groups of male and female Fischer 344 rats administered a single 
gavage dose of 5,000 mg/kg JP-8 or JP-8+100 (Wolfe et al. 1996) or in male and female Sprague-Dawley
rats administered a single gavage dose of 25,000 mg/kg Jet A fuel (Vernot et al. 1990b).
The acute oral LD50 values for kerosene in guinea pigs and rabbits have been reported to be 16,320 and 
22,720 mg/kg, respectively (Deichmann et al. 1944).  In guinea pigs, 1 of 10 died at a single oral dose of
3,760 mg/kg, and 7 of 10 died at a single oral dose of 19,200 mg/kg.  Death in rabbits did not occur after
a single oral dose of 8,000 mg/kg, with 3 of 10 and 6 of 10 rabbits dying at single oral doses of
12,800 and 28,800 mg/kg, respectively.  In guinea pigs, death occurred following a single oral dose of
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3,760–19,200 mg/kg kerosene.  Gavage administration of 6,400 mg/kg/day kerosene for 7–10 days was 
lethal to four of five male calves; only one dose was tested in this study (Rowe et al. 1973).
Mortality in rats was induced by aspiration of 0.05–0.25 mL of kerosene; there was a dose-response
relationship for death in this study (Gerarde 1963).  Aspiration was induced by placing the test material 
into the back of the throat, causing the animal to choke, which forced the test compound into the
respiratory tract.  The purpose of using aspiration as a route of exposure in animals was to mimic human 
respiratory exposure occurring during vomiting after ingestion of kerosene.  Mortality in mice was noted
following a single exposure to 20 μL kerosene by aspiration (Nouri et al. 1983).  This latter study is
limited because only one dose was tested.
Lethal dose in rats from the Parker et al. (1981) study and for rats, rabbits and guinea pigs from the 
Deichmann et al. (1994) study are recorded in Table 3-2 and plotted in Figure 3-2.
3.2.2.2  Systemic Effects
No studies were located regarding ocular or metabolic effects in humans or laboratory animals after oral
exposure to JP-5, JP-8, or Jet A fuels.  The highest NOAEL and all LOAEL values from each reliable 
study for systemic effects in each species and duration category are recorded in Table 3-2 and plotted in 
Figure 3-2.
Respiratory Effects. No studies were located regarding respiratory effects in humans following oral
exposure to JP-5, JP-8, or Jet A fuels.
A number of studies have reported respiratory effects in humans ingesting kerosene. Even if kerosene is 
initially ingested, the respiratory toxicity is usually attributable to the aspiration of kerosene into the lungs
during vomiting (Coruh and Inal 1966; Majeed et al. 1981; Nomi and Al-Rahim 1970).  Based on reports
that examined at least 50 cases of kerosene ingestion by children, the respiratory effects that primarily
occur from kerosene ingestion are bronchopneumonia, bronchitis, pneumonitis, lung infiltrates and 
effusions, cough, dyspnea, and tachypnea (Abu-Ekteish 2002; Akamaguna and Odita 1983; Aldy et al.
1978; Annobil 1983; Annobil and Ogunbiyi 1991; Balme et al. 2012; Benois et al. 2009; Chun 1998;
Lang et al. 2008; Lucas 1994; Mahdi 1988; Santhanakrishnan and Chithra 1978; Shotar 2005; Simmank
et al. 1998; St. John 1982).  Pneumonitis, pulmonary edema, and/or pneumonia were reported for children 
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Table 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels  - Oral 
Exposure/ 
Duration/
a 
Key to Species Frequency 
Figure (Strain) (Route) System 
Bd Wt 
Hemato 
Hepatic 
Bd Wt 
Metab 
Hepatic 
Renal 
Dermal 
Bd Wt 
NOAEL 
(mg/kg/day) 
500 F 
18912 M 
37824 M 
37824 M 
5000 
LOAEL 
Less Serious 
(mg/kg/day) 
18912 M (2-3-fold increase in 
white cell count) 
18912 M (hepatocyte 
vacuolization) 
18912 M (10-16% weight loss) 
47280 M (cytoplasmic 
vacuolization of 
hepatocytes) 
47280 M (hyaline droplets in 
tubular epithelial cells) 
18912 M (ventral alopecia) 
Serious 
(mg/kg/day) 
47280 M (2/6 rats died during the 
study) 
1000 F	 (31% reduced weight
 
gain on Gd 5-20)
 
Reference 
Chemical Form 
Parker et al. 1981 
JP-5 
Cooper and Mattie 1996 
JP-8 
Parker et al. 1981 
JP-5 
Parker et al. 1981 
JP-5 
Wolfe et al. 1996 
JP-8 
Comments 
Observed renal effects 
are not relevant to 
humans 
ACUTE EXPOSURE
 
Death 
1 Rat 
(Sprague-
Dawley) 
Systemic 
2 Rat 
(Sprague-
Dawley) 
3	 Rat 
(Sprague-
Dawley) 
4	 Rat 
(Sprague-
Dawley) 
5 Rat
 
(Fischer- 344)
 
once 
(G) 
10 d 
Gd 6-15 
1 x/d 
(G) 
once 
(G) 
once 
(G) 
once 
(G) 
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Table 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Oral	 (continued) 
Exposure/ 
Duration/
a 
Key to Species Frequency 
Figure (Strain) (Route) 
6	 Rat once 
(Fischer- 344) (G) 
7 Mouse	 7 d 
1 x/d(B6C3F1) 
(GO) 
8 Mouse	 14 d 
1 x/d(B6C3F1) 
(GO) 
9 Mouse 14 d 
(B6C3F1) 1 x/d 
(GO) 
Immuno/ Lymphoret 
10 Mouse 7 d 
(B6C3F1) 1 x/d 
(GO) 
System 
Bd Wt 
Hepatic 
Hemato 
Hepatic 
Renal 
Bd Wt 
Hemato 
Hepatic 
Renal 
Bd Wt 
NOAEL 
(mg/kg/day) 
5000 
2500 F 
750 F 
2500 F 
2500 F 
1000 F 
500 F 
1000 F 
1000 F 
Less Serious 
(mg/kg/day) 
1000 F	 (increased relative liver 
weight) 
1000 F	 (increased relative liver 
weight) 
1000 F	 (significantly increased 
relative liver weight) 
1000 F	 (suppressed humoral 
immunity) 
LOAEL 
Serious 
(mg/kg/day) 
Reference 
Chemical Form 
Wolfe et al. 1996 
JP-8+100 
Dudley et al. 2001 
JP-8 
Keil et al. 2004 
JP-8 
Peden-Adams et al. 2001 
JP-8 
Dudley et al. 2001 
JP-8 
Comments 
No histological 
examination. 
No histological 
examination. 
Similar effects seen in 
AhR-nonresponsive 
mice. 
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Table 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Oral	 (continued) 
a 
Key to Species 
Figure (Strain) 
11	 Mouse 
(B6C3F1) 
12	 Mouse 
(B6C3F1) 
Developmental 
13 Rat 
(Sprague-
Dawley) 
14	 Mouse 
(C57BL/6N) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/kg/day) 
Less Serious 
(mg/kg/day) 
LOAEL 
Serious 
(mg/kg/day) 
Reference 
Chemical Form Comments 
14 d 
1 x/d 
(GO) 
b 
250 F 500 F (decreased humoral 
immunity) 
Keil et al. 2004 
JP-8 
14 d 
1 x/d 
(GO) 
500 F (suppressed 
plaque-forming cell 
response) 
Peden-Adams et al. 2001 
JP-8 
10 d 
Gd 6-15 
1 x/d 
(G) 
500 1000 (4-6% decreased fetal 
weight) 
Cooper and Mattie 1996 
JP-8 
Maternal weight was 
decreased 31%. 
Gd 6-15 
1 x/d 
(GO) 
1000 (decrease IgM PFC 
response to SRBC in 
offspring) 
Keil et al. 2003 
JP-8 
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Table 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Oral (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
INTERMEDIATE EXPOSURE 
Systemic 
15 Rat 
(Sprague-
Dawley) 
90 d 
1 x/d 
(GO) 
System 
Resp 
NOAEL 
(mg/kg/day) 
3000 M 
Less Serious 
(mg/kg/day) 
LOAEL 
Serious 
(mg/kg/day) 
Reference 
Chemical Form 
Mattie et al. 1995 
JP-8 
Comments 
Observed renal effects 
are not relevant to 
humans 
Cardio 3000 M 
Gastro 750 M (stomach hyperplasia) 
Hemato 750 M (decreased lymphocytes; 
increased neutrophils) 
Musc/skel 3000 M 
Hepatic 750 M (about 2-fold increase in 
ALT and AST activities) 
Renal 750 M (hyaline droplet 
formation) 
Endocr 3000 M 
Dermal 750 M (perianal dermatitis) 
Bd Wt 750 M 1500 M (15% reduction in final 
body weight) 
3000 M (34% reduced final body 
weight) 
Metab 750 M (hypoglycemia) 
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Table 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Oral (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/kg/day) 
Less Serious 
(mg/kg/day) 
LOAEL 
Serious 
(mg/kg/day) 
Reference 
Chemical Form Comments 
16 Rat 
(Sprague-
Dawley) 
21 wk 
1 x/d 
(G) 
Gastro 325 F 750 F (stomach hyperplasia) Mattie et al. 2000 
JP-8 
Hemato 1500 F 
Dermal 
Bd Wt 
750 F 
750 F 
1500 F (perianal dermatitis) 
1500 F (10-20% reduced body 
weight) 
Metab 1500 F 
17 Rat 
(Sprague-
Dawley) 
90 d 
1 x/d 
(G) 
Bd Wt 750 M 1500 M (15% reduction in final 
body weight) 
3000 M (significant body weight 
loss) 
Mattie et al. 2000 
JP-8 
18 Rat 
(Sprague-
Dawley) 
90 d 
(GO) 
Resp 500 F Smith et al. 1999 
Jet A 
Cardio 500 F 
Gastro 20 F 100 F (increased salivation and 
shoveling behavior which 
may be indicative of 
mouth irritation) 
Hemato 500 F 
Hepatic 100 F 500 F (increased liver weight 
and enlarged livers) 
Renal 500 F 
Endocr 500 F 
Bd Wt 500 F 
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Table 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Oral (continued) 
a 
Key to 
Figure 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/kg/day) 
Less Serious 
(mg/kg/day) 
LOAEL 
Serious 
(mg/kg/day) 
Reference 
Chemical Form Comments 
19 Mouse 
(C57BL/6N) 
90 d 
(GO) 
Resp 
Cardio 
500 M 
500 M 
Smith et al. 1999 
Jet A 
Gastro 500 M 
Hemato 500 M 
Renal 500 M 
Endocr 500 M 
Immuno/ Lymphoret 
20 Rat 
(Sprague-
Dawley) 
Neurological 
21 Rat 
(Sprague-
Dawley) 
90 d 
1 x/d 
(GO) 
90 d 
1 x/d 
(GO) 
Bd Wt 500 M 
3000 M 
3000 M 
Mattie et al. 1995 
JP-8 
Mattie et al. 1995 
JP-8 
NOAEL is for histology 
of lymphreticular 
organs. 
NOAEL is for histology 
of the brain and sciatic 
nerve. 
22 Rat 
(Sprague-
Dawley) 
90 d 
(GO) 
100 F 500 F (lethargy) Smith et al. 1999 
Jet A 
23 Mouse 
(C57BL/6N) 
90 d 
(GO) 
20 M 100 M (lethargy and hunched 
posture) 
Smith et al. 1999 
Jet A 
Reproductive 
24 Rat 
(Sprague-
Dawley) 
90 d 
1 x/d 
(GO) 
3000 M Mattie et al. 1995 
JP-8 
NOAEL is for histology 
of the testes. 
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Table 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Oral	 (continued) 
a 
Key to Species 
Figure (Strain) 
25	 Rat 
(Sprague-
Dawley) 
26	 Rat 
(Sprague-
Dawley) 
Developmental 
27 Rat 
(Sprague-
Dawley) 
28	 Rat 
(Sprague-
Dawley) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
System 
NOAEL 
(mg/kg/day) 
Less Serious 
(mg/kg/day) 
LOAEL 
Serious 
(mg/kg/day) 
Reference 
Chemical Form Comments 
21 wk 
1 x/d 
(G) 
1500 F Mattie et al. 2000 
JP-8 
NOAEL is for female 
fertility. 
90 d 
1 x/d 
(G) 
3000 M Mattie et al. 2000 
JP-8 
NOAEL is for male 
fertility and sperm 
parameters. 
21 wk 
1 x/d 
(G) 
750 1500 (11% decrease pup's 
weight on PND 4) 
Mattie et al. 2000 
JP-8 
21 wk 
1 x/d 
(G) 
c 
325 (decreased scores in a 
swimming test) 
Mattie et al. 2001 
JP-8 
a The number corresponds to entries in Figure 3-2. 
b Used to derive an acute-duration MRL of 3 mg/kg/day for JP-8. The NOAEL was divided by an uncertainty factor of 100 (10 for extrapolation from animals to humans and 10 for 
human variability). 
c Used to derive an intermediate-duration MRL of 0.3 mg/kg/day for JP-8. The LOAEL was divided by an uncertainty factor of 1000 (10 for use of a LOAEL, 10 for extrapolation from 
animals to humans, and 10 for human variability). 
ALT = alanine aminotransferase; AST = asparate aminotransferase; Bd Wt = body weight; Cardio = cardiovascular; d = day(s); Endocr = endocrine; F = Female; (G) = gavage; 
Gastro = gastrointestinal; Gd = gestational day; (GO) = gavage in oil; Hemato = hematological; IgM = immunoglobulin M; Immuno/Lymphoret = immunological/lymphoreticular; 
LOAEL = lowest-observed-adverse-effect level; M = male; Metab = metabolism; Musc/skel = musculoskeletal; NOAEL = no-observed-adverse-effect level; PFC = plaque forming 
cells; PND = post-natal day; Resp = respiratory; SRBC = sheep red blood cell; x = time(s); wk = week(s) 
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Figure 3-2 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Oral
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and adults who had ingested kerosene (Subcommittee on Accidental Poisoning 1962).  A follow-up study
conducted on children who had been diagnosed with pneumonitis due to kerosene ingestion 10 years 
earlier and who had abnormal chest radiographs at the time of diagnosis found an increase in volume of
isoflow, a decrease in change in flow while breathing helium compared to air at 50% vital capacity, and
the continued presence of abnormal chest radiographs. The study suggests that there may be long-term 
respiratory effects following aspiration of ingested kerosene (Tal et al. 1984). Simmank et al. (1998)
conducted a similar, although much shorter, follow-up on a group of 57 children with clinical signs of
pneumonitis.  The exposed children and 41 controls were evaluated every 2 weeks for 3 months after the
accident. The results showed that kerosene ingestion was not associated with increased respiratory 
morbidity in the 3 months following the accident, regardless of the child’s nutritional status or the
severity of the initial kerosene pneumonitis.
Several studies have reported estimated doses, usually based on the finding of an empty container near the
poisoned child (Agarwal and Gupta 1974; Akamaguna and Odita 1983; Aldy et al. 1978; Coruh and Inal
1966; Dudin et al. 1991; Nouri and Al-Rahim 1970; Saksena 1969; Santhanakrishnan and Chithra 1978).  
Although the effects associated with specific doses were not stated, kerosene was associated with
pulmonary complications in 11 of the 422 cases studied (the incidence of the effects, ages associated with 
the effects, and doses were not reported).  Pneumothorax, pneumomediastinum, and death were most
frequently reported.  The Subcommittee on Accidental Poisoning (1962) estimated that ingestion of 10– 
30 mL results in respiratory distress from aspiration of kerosene (Zucker et al. 1986).  Respiratory distress 
was reported to have resulted in the deaths of a 2-year-old child and a l-year-old child after ingestion of
30 mL (1,900–2,000 mg/kg) and 200 mL (15,300–16,800 mg/kg) of kerosene, respectively
(Santhanakrishnan and Chithra 1978).
Not all cases of kerosene ingestion result in toxicity.  For instance, in two study populations, as many as 
56% of the cases studied were asymptomatic (Mahdi 1988; Santhanakrishnan and Chithra 1978).  Also, 
39% of one population of children had normal lung x-rays following kerosene ingestion (Annobil and 
Ogunbiyi 1991).  No doses were reported in these cases, although the study authors estimated them as 
small.  This reinforces the position that aspiration is the route of exposure when respiratory signs or
symptoms of toxicity are seen following ingestion.
No treatment-related histopathological changes in the lung or nasal turbinates were reported in a study in 
which male Sprague-Dawley rats were administered up to 3,000 mg/kg neat JP-8 by gavage once a day 
for 90 days (Mattie et al. 1995) or in a study in which female Sprague-Dawley rats or male C57BL/6 mice 
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were administered via gavage up to 500 mg/kg/day Jet A fuel in corn oil for 90 days (Smith et al. 1999).  
Mononuclear and polymorphonuclear cell infiltration and unspecified pathological lesions were noted in 
the lungs of guinea pigs after gavage administration of 3,200–8,000 mg/kg kerosene (Brown et al. 1974).  
In mice, aspiration of 20 μL of kerosene induced pulmonary consolidation and hemorrhage, pneumonitis, 
a decrease in pulmonary clearance of Staphylococcus aureus, and an increase in relative lung weight
(Nouri et al. 1983).  Dogs exposed to 0.5 mL/kg kerosene by aspiration exhibited increases in oxygen 
utilization, intrapulmonary physiologic shunt fraction, respiratory rate, and decreases in arterial oxygen 
tension (Goodwin et al. 1988).  In the aspiration studies, the actual dose entering the lungs could not be
determined.
Cardiovascular Effects. No studies were located regarding cardiovascular effects in humans 
following oral exposure to JP-5, JP-8, or Jet A fuels. Tachycardia was noted in children following acute
ingestion of kerosene (Akamaguna and Odita 1983; Coruh and Inal 1966).  In one case study,
cardiomegaly, but not heart failure, occurred in 20% of the cases of kerosene poisoning (Akamaguna and
Odita 1983).
No treatment-related histopathological effects on the heart were observed when male Sprague-Dawley
rats were treated with neat JP-8 at doses of up to 3,000 mg/kg once a day for 90 days (Mattie et al. 1995)
or female Sprague-Dawley rats and male C57BL/6 mice were administered up to 500 mg/kg/day Jet A 
fuel for 90 days (Smith et al. 1999). Decreases in heart rate and mean arterial blood pressure occurred in
dogs following aspiration of 0.5 mL/kg kerosene, but these values returned to the control values within
60 minutes (Goodwin et al. 1988).  The actual dose entering the lungs by aspiration cannot be determined.  
This study is limited, however, because only one dose was tested.
Gastrointestinal Effects. No information was located regarding gastrointestinal effects in humans 
following oral exposure to JP-5, JP-8, or Jet A fuels. The most commonly reported gastrointestinal effect
in children following acute ingestion of kerosene is vomiting (Akamaguna and Odita 1983; Aldy et al.
1978; Benois et al. 2009; Chun 1998; Lucas 1994; Mahdi 1988; Majeed et al. 1981; Nouri and Al-Rahim 
1970; Saksena 1969; Shotar 2005; St. John 1982), including bloody vomit (Nomi and Al-Rahmin 1970).  
Other effects noted have been abdominal pain and/or distension (Akamaguna and Odita 1983; Mahdi
1988; Majeed et al. 1981; Nouri and Al-Rahim 1970; Saksena 1969), gastroenteritis (Saksena 1969), and 
diarrhea (Majeed et al. 1981). Reliable doses are not available in these reports.
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Stomach irritation and hyperplasia were observed in male Sprague-Dawley rats treated with ≥750 mg/kg 
JP-8 by gavage once a day for 90 days (Mattie et al. 1995).  The incidence and severity of the gastritis and
hyperplasia were increased at all doses compared to controls. Gastritis may have resulted from contact
irritation of the JP-8, since it was administered to the animals without a vehicle. A NOAEL for these
effects was not established in the study. Squamous hyperplasia in the stomach was also reported in 
female Sprague-Dawley rats administered 750 mg/kg JP8-8 fuel daily by gavage for 21 weeks (Mattie et
al. 2000); the NOAEL was 325 mg/kg/day.
Increased salivation was observed in female Sprague-Dawley rats administered via gavage 100 or
500 mg/kg/day Jet A fuel in corn oil for 90 days; shoveling behavior was also observed at these dose 
levels (Smith et al. 1999). Neither effect was observed in rats administered 20 mg/kg/day.  The 
investigators suggested that the salivation and shoveling behavior were consistent with an irritation
response in the mouth.  These signs of irritation were not observed in similarly exposed male C57BL/6 
mice (Smith et al. 1999).
Hematological Effects. No information was located regarding hematological effects in humans 
following oral exposure to JP-5, JP-8, or Jet A fuels. Several case studies reported hematological effects 
in children following acute ingestion of kerosene.  The increased incidence of leukocytosis ranged from
8.6% to 80% of the respective study populations (Abu-Ekteisch 2002; Chun 1998; Dudin et al. 1991;
Majeed et al. 1981; Nouri and Al-Rahim 1970).  These studies do not state how long after exposure this
effect was observed or provide reliable dosing information.
Administration of a single gavage dose of 18,912 mg/kg (only dose tested) petroleum-derived JP-5 fuel
to male Sprague-Dawley rats resulted in a statistically significant reduction in the hematocrit 48 hours
after dosing, although it was still within normal limits (Parker et al. 1981).  Red blood cell count was
also significantly reduced in rats killed 24 hours after dosing, but still was within normal limits. White 
cell count was significantly increased (2–3-fold) in rats sacrificed 24 and 48 hours after dosing relative 
to controls. There were no significant alterations in other hematological parameters. Administration of
up to 1,000 mg/kg/day of JP-8 to female B6C3F1 mice by gavage in olive oil for 14 days did not
significantly alter erythrocyte or leukocyte number (total and differential counts), hemoglobin, or
hematocrit (Peden-Adams et al. 2001).  In a similar study, treatment of female B6C3F1 mice with doses 
between 250 and 2,500 mg/kg/day JP-8 fuel by gavage for 14 days reduced mean hemoglobin levels, 
hematocrit levels, and red blood cell counts and increased mean corpuscular volume at 2,500 mg/kg/day;
mean corpuscular volume was also increased at 1,500 and 2,000 mg/kg/day (Keil et al. 2004).  
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Considering that the mean values differed ≤7% from control values and that each dose group consisted 
of only 4–6 mice, these hematological changes are probably of little or no toxicological significance.
In male Sprague-Dawley rats administered neat JP-8 by gavage for 90 days, there were no significant
changes in red blood cell count at doses as high as 3,000 mg/kg/day, but there was a significant increase 
in neutrophils and a significant decrease in lymphocytes at ≥750 mg/kg/day, as compared to controls
(Mattie et al. 1995).  The increase in neutrophils could have been a response to the renal nephropathy
observed in this study, but the cause of the decrease in lymphocytes was unclear and may be related to the 
body weight effects.  Platelets were increased at 3,000 mg/kg/day compared to controls. In contrast, 
administration of up to 1,500 mg/kg/day to female Sprague-Dawley rats by gavage for 21 weeks (90 days 
followed by cohabitation, gestation, delivery, and lactation) did not significantly alter a comprehensive
number of hematological parameters, including those examined in the male study (Mattie et al. 2000).
Significant decreases in red blood cell levels were observed in female Sprague-Dawley rat administered
via gavage Jet A fuel in corn oil for 90 days (Smith et al. 1999).  Decreases in hemoglobin and hematocrit 
levels were also observed at 100 and 500 mg/kg/day.  Although the hematological alterations are
considered to be treatment-related, the magnitudes of the changes were minimal and were not considered 
biologically relevant.  No treatment-related alterations in hematological parameters were observed in
similarly exposed male C57BL/6 mice (Smith et al. 1999).
Musculoskeletal Effects. No studies were located regarding musculoskeletal effects in humans after
oral exposure to JP-5, JP-8, or Jet A fuels.
No histological alterations were observed in skeletal muscle or bone of male Sprague-Dawley rats treated
with up to 3,000 mg/kg neat JP-8 for 90 days (Mattie et al. 1995) or female Sprague-Dawley rats and
male C57BL/6 mice treated with up to 500 mg/kg/day Jet A fuel in corn oil for 90 days (Smith et al. 
1999).
Hepatic Effects. No studies were located regarding hepatic effects in humans after oral exposure to
JP-5, JP-8, or Jet A fuels.
Administration of a single gavage dose of 18,912 mg/kg JP-5 fuel (only dose tested) to male Sprague-
Dawley rats resulted in increases in serum lactate dehydrogenase, AST, and ALT within 3 days after
dosing (Parker et al. 1981).  Microscopic examination of the liver showed vacuolization of periportal
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hepatocytes in rats killed on day 2.  Liver lesions were also described in male Sprague-Dawley rats 

14 days after receiving single doses of JP-5 ranging from 18,912 to 47,280 mg/kg (Parker et al. 1981).

However, it is not clear at what dose level the lesions appeared; therefore, this effect is not listed in
 
Table 3-2. Rats receiving a single dose of 24 mL JP-5/kg by gavage (approximately 19.2 mg/kg/)
 
exhibited a transient increase in serum levels of ALT and AST (Bogo et al. 1983; Mehm and Feser 1984).  

It was noted that the elevated levels of ALT and AST occurred as early as 6 hours post-treatment and 

lasted up to 5 days post-treatment (Mehm and Feser 1984).  Liver sections revealed mitotic figures and
 
increased numbers of binucleated cells.  Normal tissue was observed after 5 days (Bogo et al. 1983;
 
Mehm and Feser 1984).
 
Three acute studies in B6C3F1 mice reported significant increases in relative liver weight (23–29%) 

following gavage administration of 1,000 mg/kg/day JP-8 fuel for 7–14 days (Dudley et al. 2001; Keil et
 
al. 2004; Peden-Adams et al. 2001).  However, none of these studies conducted tests for liver function or
 
examined the liver microscopically.
 
Male Sprague-Dawley rats that received 750, 1,500, or 3,000 mg/kg neat JP-8 by gavage once a day for
 
90 days had significant increases in serum ALT and AST activities in all treated groups (about 2-fold, but
 
not dose-related), decreased triglycerides in high-dose rats, and increased total bilirubin in all treated
 
groups (Mattie et al. 1995).  Microscopic examination of the liver did not show treatment-related
 
alterations.
 
Significant increases in absolute and relative liver weight were observed in female Sprague-Dawley rats 

administered via gavage 500 mg/kg/day Jet A fuel in corn oil for 90 days (Smith et al. 1999); enlarged 

livers were also observed during the gross necropsy examine in the 500 mg/kg/day group.  No alterations
 
in liver weight or appearance were observed at 100 mg/kg/day, and no histological alterations were
 
observed at 500 mg/kg/day.  No hepatic effects were observed in similarly exposed male C57BL/6 mice 

exposed to up to 500 mg/kg/day for 90 days (Smith et al. 1999).
 
Renal Effects. No information was located regarding renal effects in humans following oral exposure
 
to JP-5,JP-8, Jet A fuels. Urinalysis tests in children were generally reported to be normal following
 
acute ingestion of kerosene (Dudin et al. 1991; Mahdi 1988; Nouri and Al-Rahim 1970), although 

albuminuria was occasionally noted (Dudin et al. 1991; Nouri and Al-Rahim 1970); the studies did not 

provide reliable information on the amount of kerosene ingested.
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Acute- and intermediate-duration studies that tested male rats described the formation of hyaline droplets
in the cytoplasm of epithelial cells in the proximal tubules in the kidneys.  Parker et al. (1981) observed 
this in male rats after a single dose of 18,912 mg/kg JP-5 fuel (only dose level tested).  Similar
observations were made by in male rats administered single doses ≥19,200 mg/kg JP-5 fuel (Bogo et al. 
1983) and a 90-day study in rats administered doses ≥750 mg/kg/day JP-8 fuel (Mattie et al. 1995).  As
indicated in Section 3.2.1.2 (renal effects by inhalation exposure), the nephropathy characterized by the
buildup of alpha2u-globulin-containing hyaline droplets is unique to mature male rats and has no
toxicological relevance for humans. A significant increase in relative kidney weight was observed in
female Sprague-Dawley rats following gavage administration of 500 mg/kg/day Jet A fuel for 90 days; no 
histological alterations were observed (Smith et al. 1999).
Relative kidney weight was not significantly affected in female B6C3F1 mice dosed by gavage with up to 
2,500 mg/kg JP-8 fuel for 14 consecutive days; no other renal end points were assessed (Keil et al. 2004;
Peden-Adams et al. 2001). No alterations in kidney weight or morphology were observed in male
C57BL/6 mice administered via gavage 500 mg/kg/day Jet A fuel in corn oil for 90 days (Smith et al. 
1999).
Endocrine Effects.  No studies were located regarding endocrine effects in humans after oral
exposure to JP-5, JP-8, or Jet A fuels.
No histopathological changes were observed in the adrenal glands or pancreas of male Sprague-Dawley
rats treated by gavage with up to 3,000 mg/kg JP-8 for 90 days (Mattie et al. 1995) or in female Sprague-
Dawley rats and male C57BL/6 mice administered up to 500 mg/kg/day Jet A fuel for 90 days.
Dermal Effects. No studies were located regarding dermal effects in humans following oral exposure
to JP-5, JP-8, or Jet A fuels.
Ventral alopecia was consistently seen in Sprague-Dawley rats following gavage administration of single 
doses ≥19,200 mg/kg JP-5 and observed for 14 days (Parker et al. 1981).  Perianal dermatitis was reported
in male Sprague-Dawley rats dosed daily by gavage with ≥750 1,500, or 3,000 mg/kg neat JP-8 (Mattie et 
al. 1995).  The incidence of the lesion was similar in all the treated groups. The same type of lesion was
reported in female Sprague-Dawley rats dosed with 1,500 mg/kg/day JP-8 fuel for 21 weeks, but not in
rats dosed with 750 mg/kg/day (Mattie et al. 2000).
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Body Weight Effects. No studies were located regarding body weight effects in humans after oral
exposure to JP-5, JP-8, or Jet A fuels.
Several studies provide information regarding body weight in laboratory animals exposed to jet fuels, but
data on food consumption were generally not available.  A single dose of 18,912 mg/kg JP-5 induced 
weight losses of 10–16% in Sprague-Dawley rats within 3 days of dosing (Parker et al. 1981).  Single
doses of up to 5,000 mg/kg JP-8 or JP-8+100 did not significantly affect body weight of male or female
F-344 rats during a 14-day observation period (Wolfe et al. 1996).  However, treatment of pregnant rats 
with 1,000 mg/kg JP-8 fuel on GDs 6–15 reduced body weight gain by 31% during GDs 5–20; the
NOAEL was 500 mg/kg/day (Cooper and Mattie 1996).  Adjusted maternal body weight (the maternal
body weight minus the gravid uterine weight) was significantly decreased compared to controls at
1,500 and 2,000 mg/kg. In 14-day gavage studies in female B6C3F1 mice, a dose of up to 
2,500 mg/kg/day JP-8 (highest dose tested) did not significantly affect body weight (Keil et al. 2004; 
Peden-Adams et al. 2001).
In intermediate-duration gavage studies with JP-8 in male and female Sprague-Dawley rats, the NOAEL
for body weight effects was 500 mg/kg/day (Mattie et al. 1995, 2000).  In these studies, doses of
1,500 mg/kg/day JP-8 reduced final body weight 10–20% relative to controls. No alterations in body
weight gain were observed in female Sprague-Dawley rats or male C57BL/6 mice receiving gavage doses 
of 500 mg/kg/day Jet A fuel in corn oil for 90 days (Smith et al. 1999).
Metabolic Effects. No studies were located regarding metabolic effects in humans following oral
exposure to JP-5, JP-8, or Jet A fuels.
In an acute study of male Sprague-Dawley rats, a single dose of 18,912 mg/kg JP-5 did not significantly
affect serum levels of sodium or potassium (Parker et al. 1981).  In a 90-day gavage study of male 
Sprague-Dawley rats administered 750, 1,500, or 3,000 mg/kg/day JP-8, significant metabolic alterations
included increased serum sodium (2.8%) and chlorine (4.8%) in high-dose rats and decreased glucose in
all treated groups (26% in low-dose rats) (Mattie et al. 1995).  However, administration of up to 
1,500 mg/kg/day neat JP-8 (highest dose tested) by gavage to female Sprague-Dawley rats for 90 days 
before mating and continuing through gestation and lactation did not induce significant alterations in 
serum levels of glucose or electrolytes (Mattie et al. 2000).
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Other Effects. Fever was commonly reported in children following ingestion of kerosene (Abu-
Ekteisch 2002; Akamaguna and Odita 1983; Aldy et al. 1978; Benois et al. 2009; Chun 1998; Dudin et al.
1991; Lang et al. 2008; Lucas 1994; Mahdi 1988; Majeed et al. 1981; Nouri and Al-Rahim 1970; Saksena
1969; Shotar 2005; Simmank et al. 1998; St. John 1982).
3.2.2.3  Immunological and Lymphoreticular Effects 
No studies were located regarding immunological or lymphoreticular effects in humans after oral
exposure to JP-5, JP-8, or Jet A fuels or in animals following exposure to JP-5 or Jet A.
Three acute-duration studies of female B6C3F1 mice provide information regarding immune competence 
following gavage exposure to JP-8 fuel.  Peden-Adams et al. (2001) administered 0, 500, or
1,000 mg/kg/day JP-8 by gavage in olive oil to the mice for 14 days before immunosuppression was
assessed.  End points examined included spleen and thymus weight and organ cellularity, NK cell
activity, cytotoxic T-cell activity, mitogen-induced lymphocyte proliferation, nitrogen production by
peritoneal macrophages, plaque-forming cell response to SRBCs, delayed type hypersensitivity, and 
susceptibility to tumor B16F10 or Listeria monocytogenes challenges.  Of all of the end points measured,
only the plaque-forming cell response was significantly reduced at both JP-8 dose levels; the decrease 
was dose-related.  Dudley et al. (2001) tested the hypothesis that JP-8 may exert immunosuppression by
acting through the aryl hydrocarbon receptor (AhR). Tests conducted in the wild B6C3F1 strain of mice 
and the Ah-nonresponsive DBA/2 mouse strain showed that both strains were equally sensitive to JP-8’s
toxicity.  In both mouse strains, administration via gavage of 2,000 mg/kg/day JP-8 for 7 days resulted in 
decreases in thymus weight and cellularity; administration of 1,000 or 2,000 mg/kg/day resulted in 
decreases in plaque-forming cell response to SRBCs.  JP-8 did not induce CYP1A1 or promote down-
regulation of the AhR, suggesting that JP-8 may exert immunotoxicity via an AhR-independent
mechanism.  In the third study, administration of JP-8 resulted in decreases in thymic cellularity at 
≥2,000 mg/kg/day and decreases in thymic CD8+, CD4+, and CD4+/CD8+ T-cell subpopulations at
2,000 mg/kg/day; no changes in the CD4/CD8 ratios or the relative percentages of T-cell subpopulations
were observed (Keil et al. 2004).  In the spleen, cellularity and absolute values of T-cell phenotypes were 
not affected; an increase in the percentage of CD4+ cells was observed at 1,000 and 2,000 mg/kg/day.  In 
the bone marrow, there was a 47% increase in colony-forming units at 2,000 mg/kg/day, but no alteration 
in total bone marrow cellularity.  Alterations in immune function were also observed; suppression of the
antibody plaque-forming cell response to SRBCs was observed at ≥500 mg/kg/day.  However, serum
levels of anti-SRBC IgM were not altered when measured by either the enzyme-linked immuosorbent
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assay (ELISA) or hemagglutination (Keil et al. 2004).  The NOAEL for immunological effects in the
study was 250 mg/kg/day.
Gavage administration of up to 3,000 mg/kg of neat JP-8 to Sprague-Dawley rats once/day for 90 days 
did not cause histopathological changes in the spleen, thymus, or lymph nodes (Mattie et al. 1995).
3.2.2.4  Neurological Effects 
No information was located regarding neurological effects in humans following ingestion of JP-5, JP-8, 
or Jet A fuels.
Lethargy, semicoma, and/or coma were reported in children and adults who had ingested kerosene.  
Estimated exposure levels of 10–30 mL kerosene were associated with complications of the central
nervous system in 18 of 422 study participants (Subcommittee on Accidental Poisoning 1962).  These 
effects also occurred at doses beyond this range, but the exact exposure levels are not known.  Incidences 
of the effects, the ages associated with the effects, and the ingested doses were not reported.
Several case studies have reported neurological effects in children following acute ingestion of kerosene.  
In studies that examined 50–205 kerosene poisoning cases, the neurological effects noted most frequently
were unconsciousness or semiconsciousness, drowsiness, restlessness, and irritability (Abu-Ekteisch
2002; Akamaguna and Odita 1983; Aldy et al. 1978; Benois et al. 2009; Chun 1998; Coruh and Inal 1966;
Dudin et al. 1991; Lang et al. 2008; Lucas 1994; Mahdi 1988; Majeed et al. 1981; Nouri and Al-Rahim 
1970; Saksena 1969; Santhanakrishnan and Chithra 1978; Shotar 2005; St. John 1982).  Coma and 
convulsions were also noted in numerous studies, but were usually evident in only one or two individuals
per study population (Coruh and Inal 1966; Dudin et al. 1991; Majeed et al. 1981; Nouri and Al-Rahim 
1970; Saksena 1969; Santhanakrishnan and Chithra 1978).  Of 78 children (aged 11–48 months) known 
to have ingested kerosene, 2 developed coma, convulsions, and then died after ingesting a quantity of
kerosene estimated to be between 30 mL (1,890 mg/kg) and 50 mL (4,255 mg/kg) (Dudin et al. 1991).  
The cause of death was not neurological for these children; death was attributable in one case to severe 
metabolic acidosis associated with hypoxia and in the second case to arrhythmia as well as myocarditis 
and pulmonary edema.  Neither coma nor convulsions occurred in 76 children aged 10 months to 5 years
after ingesting 3–20 mL of kerosene (equivalent to 126–1,754 mg/kg).  However, in the majority of the
cases of kerosene ingestion, neurological effects were not associated with specific reported quantities.  
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3. HEALTH EFFECTS
There are limited data that suggest that the central nervous system effects following ingestion of kerosene 
are due to hypoxia from kerosene-induced respiratory impairment (Majeed et al. 1981; Shotar 2005).
No clinical signs of neurotoxicity and no treatment-related histopathological changes were found in the
brain or sciatic nerve of male Sprague-Dawley rats administered up to 3,000 mg/kg neat JP-8 by gavage
for 90 days (Mattie et al. 1995). This NOAEL is recorded in Table 3-2 and plotted in Figure 3-2.
Lethargy was observed in approximately 50% of the female Sprague-Dawley rats receiving gavage doses 
of 500 mg/kg/day Jet A fuel in corn oil for 90 days, but was not observed at the lower doses (20 and 
100 mg/kg/day). It was observed on exposure days 5–7 and there were nine incidences among the seven
affected rats. Lethargy was also observed in 33, 80, and 100% of male C57BL/6 mice administered 20, 
100, or 500 mg/kg/day Jet A fuel for 90 days (Smith et al. 1999). In the mice exposed to 20 mg/kg/day, 
lethargy was only observed on exposure day 23.  At 100 mg/kg/day, lethargy was observed on days 21– 
43 and there were 44 incidences.  At 500 mg/kg/day, there were 417 incidences of lethargy among the
15 mice and they occurred on days 6–62. Hunched posture was also observed in 80, 80, and 100% of the
mice in the 20, 100 and 500 mg/kg/day groups; as compared to 27% in the controls.
3.2.2.5  Reproductive Effects
No studies were located regarding reproductive effects in humans after oral exposure to JP-5, JP-8, or
Jet A fuels.
Very limited information was located regarding reproductive effects in laboratory animals.  Gavage 
administration of up to 3,000 neat JP-8 to male Sprague-Dawley rats for 90 days did not induce
histological alterations in the testes (Mattie et al. 1995).  The same group of investigators also reported 
that administration of up to 3,000 mg/kg/day neat JP-8 by gavage to male Sprague-Dawley rats for
70 days before mating with untreated females had no significant effect on fertility or sperm parameters 
measured in epididymal sperm samples (sperm concentration, motile sperm concentration, percent
motility, velocity, linearity, maximum amplitude of lateral head displacement [ALH], mean ALH, and 
beat/cross frequency) (Mattie et al. 2000).
Administration of up to 1,500 mg/kg/day neat JP-8 by gavage to female Sprague-Dawley rats for 90-day 
before mating and continuing throughout gestation did not significantly affect pregnancy rate, gestation 
length, or litter size (Mattie et al. 2000).
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3. HEALTH EFFECTS
NOAELs for reproductive effects from the Mattie et al. (1995, 2000) studies are recorded in Table 3-2 
and plotted in Figure 3-2.
3.2.2.6  Developmental Effects 
No studies were located regarding developmental effects in humans after oral exposure to JP-5, JP-8, or
Jet A fuels.
In a gestational exposure study, pregnant Sprague-Dawley rats were treated by gavage with 0, 500, 1,000, 
1,500, or 2,000 mg/kg JP-8 during GDs 6–15 and were sacrificed on GD 20 (Cooper and Mattie 1996).  
Maternal weight gain on GDs 5–20 was significantly reduced in all treated groups (31% at 
1,000 mg/kg/day).  Maternal deaths occurred during the study in groups dosed with ≥1,000 mg/kg/day,
and the cause was found to be related to the presence of JP-8 in the lungs.  Fetal weight was significantly
reduced in a dose-related manner (about 4–6% at 1,000 mg/kg/day).  There were no significant alterations
in other developmental parameters examined, including incidences of fetal malformations and variations.
The developmental NOAEL was 500 mg/kg/day and the LOAEL was 1,000 mg/kg/day.
Developmental effects were also examined in a study in which female Sprague-Dawley rats were 
administered 325, 750, and 1,500 mg/kg/day JP-8 for 90 days before mating and continuing throughout
gestation and lactation (Mattie et al. 2000).  There were no significant effects on pregnancy rate, gestation
length, litter size, or percent live pups.  However, pup weights were significantly lower in the high-dose
group on PNDs 4 and 14 (11 and 10%, respectively).  Neurodevelopmental testing of these pups showed a
significant alteration in the total score for the swimming development test at ≥325 mg/kg/day on PND 8 
and ≥750 mg/kg/day on PND 14; however, no significant alterations in total score were observed on
PNDs 10, 12, 16, 18, or 20 (Mattie et al. 2001).  The alterations in the total scores were primarily due to
swimming direction scores; significant decreases in direction scores were observed on PND 6 
(≥750 mg/kg/day), PND 8 (≥325 mg/kg/day), and PND 14 (≥750 mg/kg/day); no alterations in angle of
head or limb usage scores were observed at any time point.  No significant alterations in surface righting
(tested on PND 4), negative geotaxis (tested on PND 5), or water maze performance (tested on PNDs 70 
and 77) were observed. The investigators suggested that the results in the swimming development test
were indicative of a possible developmental delay in motor coordination; however, the delay did not
affect motor ability at later ages. The developmental LOAEL was 325 mg/kg/day for alterations in 
swimming behavior; a developmental NOAEL was not defined.
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Keil et al. (2003) studied immune parameters, host resistance, body and organ weights (spleen, thymus, 
and liver), hematology parameters, and thyroid hormones in C57BL/6 mice offspring from dams
administered 0, 1,000, or 2,000 mg/kg JP-8 fuel by gavage in olive oil on GDs 6–15.  Evaluations were 
conducted at 3 and 8 weeks of age.  Exposure to JP-8 fuel resulted in a significant decrease in thymic 
cellularity and an increase in spleen weight at 8 weeks of age.  Hematological parameters were not
significantly affected by gestational exposure to JP-8.  There were no dose-related alterations in thymic or
splenic lymphocytic subpopulations at weaning or in adult offspring.  A significant decrease in B-cell
lymphocyte proliferation was reported in high-dose offspring at weaning; T-lymphocyte proliferation was
not affected at weaning or in adult offspring.  Exposure to JP-8 did not induce compound-related
alterations in macrophage parameters.  Significant dose-related decreases in the IgM plaque-forming cell 
response to SRBCs occurred in adult offspring from both dose groups (46 and 81% decreases with the
respective dosages). Exposure to JP-8 did not significantly affect bone marrow cellularity, stem cell
proliferation, or splenic NK cell function.  Adult offspring exposed to JP-8 showed no significant change
in susceptibility to infection with L. monocytogenes, but susceptibility to B16F10 tumor challenge was
decreased in both dose groups.  Finally, serum T4 levels were significantly reduced (38%) in high-dose
adult offspring.
The highest NOAEL values and all LOAEL values from each reliable study for developmental effects in
each species and duration category are recorded in Table 3-2 and plotted in Figure 3-2.
3.2.2.7  Cancer
No studies were located regarding cancer in humans or laboratory animals after oral exposure to JP-5, 
JP-8, or Jet A fuels. However, a single study provided information regarding cancer of kerosene in
animals. Male and female Sprague-Dawley rats (50/sex/group) were exposed to 0, 500, or 800 mg/kg
kerosene by gavage in olive oil 4 days/week for 104 weeks (Maltoni et al. 1997).  The study was 
terminated after 123 weeks, at which time survivors underwent complete necropsy and all major organs 
and tissues were prepared for microscopic examination.  It should be noted that no statistical analyses of
the results were performed.  It appeared that the percent of animals bearing malignant tumors may have 
been increased in the high-dose group; a Fisher Exact test conducted by ATSDR showed that the increase
in malignant tumors in the high-dose group was not statistically significant (p=0.0623).  Exposure to 
kerosene did not seem to increase the percent of females bearing mammary cancers (6, 6, and 10% in the 
control, low-, and high-dose groups, respectively).  In addition, kerosene did not seem to increase the
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3. HEALTH EFFECTS
percent of animals bearing various head cancers (Zymbal gland, ear duct, nasal cavity, oral cavity, and 
head).  Finally, the percent of females bearing malignant tumors of the uterus and vagina appeared
elevated in the exposed groups, but there was no dose-response relationship (2, 14, and 10% in the
control, low-, and high-dose groups, respectively).
3.2.3 Dermal Exposure 
3.2.3.1  Death 
No studies were located regarding death in humans after dermal exposure to JP-5, JP-8, or Jet A fuels.
No deaths were observed in groups of male and female New Zealand White rabbits following a 4-hour
application of 2,000 mg/kg JP-8 or JP-8+100 under occluded conditions (Wolfe et al. 1996).  A 24-hour
exposure to 5,000 mg/kg Jet A under occluded conditions also did not result in deaths in male and female 
New Zealand White rabbits (Vernot et al. 1990b).  Daily dermal exposures to 0.1 mL kerosene for 1 week
were not lethal to male mice (Upreti et al. 1989).  Death in mice occurred after dermal administration of
30,000– 40,000 mg/kg JP-5 daily for 14 consecutive days, but not after daily dermal application of 5,000– 
20,000 mg/kg JP-5 for 14 days (NTP/NIH 1986).  Dermal application of 2,000–8,000 mg/kg JP-5 
5 days/week for 13 weeks (NTP/NIH 1986) or 42.2 mg JP-5 3 times/week for 40 weeks or twice weekly
for 60 weeks (Schultz et al. 1981) was also lethal to mice.  Conversely, dermal application of 500 or
1,000 mg/kg JP-5 5 days/week for 13 weeks (NTP/NIH 1986) or 21.1 mg JP-5 2 or 3 times/week for
40 or 60 weeks (Schultz et al. 1981) was not lethal to mice.  Statistically significant increases in mortality
were noted in female mice following chronic exposure (five dermal applications per week for 103 weeks)
to JP-5 at doses of 250 and 500 mg/kg when compared to controls.  Incidence of death in females due to
treatment was 15/50 at 250 mg/kg and 33/50 at 500 mg/kg, compared to deaths in 4/50 controls.  
Excessive dermatitis and ulceration were seen at the site of the application (NTP/NIH 1986).  Although 
the number of deaths in males under these conditions was increased over that of the controls, the increase 
in mortality was not statistically significant.  This suggests that female mice may be more susceptible to
exposure by this route.  At 500 mg/kg, deaths were observed as early as week 2 of exposure to JP-5.  It is
possible that oral exposure may have contributed to the observed effects; NTP/NIH (1986) did not specify
whether the animals were protected against oral exposure through grooming/fur licking behavior.  In
addition, the toxicity caused by the loss of skin integrity due to application of petroleum products at this
level in mice could have substantially affected the study results.
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LOAEL values for lethality from each reliable study for death in each species and duration category are 
recorded in Table 3-3.
3.2.3.2  Systemic Effects
The highest NOAEL and all LOAEL values from each reliable study for systemic effects in each species 
and duration category are recorded in Table 3-3.
Respiratory Effects. No studies were located regarding respiratory effects in humans following
dermal exposure to JP-5, JP-8, or Jet A fuels.
No histopathological or organ weight changes were noted in the respiratory system of male mice
following daily dermal exposures to 0.1 mL kerosene for 1 week (Upreti et al. 1989), 13-week exposures 
to 2,000–8,000 mg/kg JP-5 (five applications per week), or chronic exposures (five dermal applications 
per week for 103 weeks) to 250 or 500 mg/kg JP-5 (NTP/NIH 1986).
Cardiovascular Effects. No studies were located regarding cardiovascular effects in humans 
following dermal exposure to JP-5, JP-8, or Jet A fuels.
Application of 300 μL of JP-8 to a clipped area of the neck of male Long-Evans rats 7 days/week resulted
in slight and predominantly perivascular lymphocyte infiltration in the heart (Larabee et al. 2005).  
Approximately 80% of the myocardial fibers showed fat infiltration, and edema or swelling was observed
in 80–90% of the heart section.  It should be noted that the study did not provide incidence data.  In 
addition to the morphological changes, an increase in the levels of inducible heat shock protein 70 was
observed in the heart.  No histopathological changes were noted in the cardiovascular system of mice 
dermally exposed to 2,000–8,000 mg/kg JP-5 for 13 weeks (five applications per week) or mice 
chronically exposed (five applications per week for 103 weeks) to 250 or 500 mg/kg JP-5 (NTP/NIH 
1986).
Gastrointestinal Effects. No studies were located regarding gastrointestinal effects in humans after
dermal exposure to JP-5, JP-8, or Jet A fuels.
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels  - Dermal 
Species 
(Strain) 
Exposure/ 
Duration/ 
Frequency 
(Route) 
ACUTE EXPOSURE 
Death 
B6C3F1 
Mouse 2 wk 
7 d/wk 
System NOAEL Less Serious 
LOAEL 
30000 M 
mg/kg/day 
Serious 
(100% mortality) 
Reference 
Chemical Form 
NTP/NIH 1986 
JP-5 
Comments 
Systemic 
(Fischer- 344) 
Rat 7 d 
1 x/d Dermal 0.156 mL (gross and microscopic 
M alterations of the skin) 
Baker et al. 1999 
JP-8 
Bd Wt 0.156 mL
 M 
(Fischer- 344) 
Rat 7 d 
1 x/d Dermal 0.156 mL (gross and microscopic 
M alterations of the skin) 
Baker et al. 1999 
JP-8+100 
Bd Wt 0.156 mL 
M 
(Sprague-
Dawley) 
Rat 1 hr Dermal 0.23 mL (increased 
transepidermal water 
loss and skin 
inflammation) 
Chatterjee et al. 2006 
JP-8 
(Long- Evans) 
Rat 7 d 
1 x/d Dermal 0.3 mL (thickened epidermis an 
inflammatory infiltration)M 
Gallucci et al. 2004 
JP-8 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal	 (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious	 Serious Chemical Form Comments 
Rat
 
(Fischer- 344)
 
Rat
 
SD hairless
 
Rat
 
SD hairless
 
Rat
 
SD hairless
 
Rat
 
(Long- Evans)
 
1 hr 
5 d 
4 x/d 
5 d 
4 x/d 
5 d 
4 x/d 
7 d 
1 x/d 
Dermal 
Dermal 
Dermal 
Dermal 
Cardio 
Hepatic 
Renal 
0.25 mL (morphological and 
M	 biochemical alterations i 
the skin) 
0.014 mL (Moderate-to-severe 
M erythema and moderate
edema under occluded 
conditions) 
0.014 mL (altered skin morphology 
M and function) 
0.014 mL (altered skin morphology 
M and function) 
0.3 mL (alteration of myocardial
M fibers) 
0.3 mL (isolated hepatic cell
 
M death)
 
0.3 mL (some renal tubular cell
M death) 
Kabbur et al. 2001 
JP-8 
Kanikkannan et al. 2002 
Jet A 
Kanikkannan et al. 2002 
JP-8 
Kanikkannan et al. 2002 
JP-8+100 
Larabee et al. 2005 
JP-8 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
B6C3F1 
Mouse 2 wk 
7 d/wk Bd Wt 5000 
mg/kg/day 
10000 (17% decrease in body 
weight gain)mg/kg/day 
(New 
Zealand) 
Rabbit 4 hr Dermal 0.5 mL (moderately irritating 
under occluded 
conditions) 
Bd Wt 0.5 mL 
(New 
Zealand) 
Rabbit 24 hr Dermal 0.05 mL (altered stratum corneum 
M barrier function) 
New Zealand 
Rabbit 24 hr Ocular 0.1 mL (minimal eye irritation) 
New Zealand 
Rabbit 24 hr Dermal 0.5 mL (miild dermal irritation) 
(New 
Zealand) 
Rabbit 4 hr Dermal 0.5 mL 
M 
NTP/NIH 1986 
JP-5 
Hurley et al. 2011 
JP-8 
Singh and Singh 2004 
JP-8 
Vernot et al. 1990b 
Jet A 
Vernot et al. 1990b 
Jet A 
Wolfe et al. 1996 
JP-8 
Slightly irritating under 
semi-occluded 
exposure. 
NOAEL is for skin 
irritation. 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
(New 
Zealand) 
Rabbit 24 hr Dermal 2000 mg/kg (mild erythema)
 B 
Wolfe et al. 1996 
JP-8 
Bd Wt 2000 mg/kg
 B 
(New 
Zealand) 
Rabbit 4 hr Dermal 0.5 mL
 M 
Wolfe et al. 1996 
JP-8+100 
NOAEL is for skin 
irritation. 
(New 
Zealand) 
Rabbit 24 hr Dermal 2000 mg/kg (mild erythema)
 B 
Wolfe et al. 1996 
JP-8+100 
Bd Wt 2000 mg/kg
 B 
Yucatan 
Pig 24 hr Dermal 0.25 mL (disruption of barrier
M function of the skin) 
Kanikkannan et al. 2001 
JP-8 
Yorkshire 
Pig 4 d 
1 x/d Dermal 0.025 mL 
F 
0.335 mL (slight to moderate 
F erythema and slight
edema under occluded 
Monteiro-Riviere et al. 2001 
Jet A 
test conditions) 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
Pig 4 d Dermal Monteiro-Riviere et al. 2001 Chemical was applied1 x/d 0.025 mL 0.335 mL (erythema, edema,Yorkshire via a fuel-soaked
F F epidermal hyperplasia) JP-8 fabric. 
Pig 4 d Dermal Monteiro-Riviere et al. 2001 Chemical was applied1 x/d 0.025 mL 0.335 mL (erythema, edema,Yorkshire via a fuel-soakedJP-8+100F epidermal hyperplasia) fabric. 
Yorkshire 
Pig 4 d 
1 x/d Dermal 0.335 mL (morphological 
alterations in the skin) 
Monteiro-Riviere et al. 2004 
Jet A 
Yorkshire 
Pig 4 d 
1 x/d Dermal 0.335 mL (morphological 
alterations to the skin) 
Monteiro-Riviere et al. 2004 
JP-8 
Fuel was applied in a 
fuel-soaked cotton 
fabric. 
Yorkshire 
Pig 4 d 
1 x/d 
Immuno/ Lymphoret 
CBA/Ca 
Mouse once 
Dermal 
0.025 mL 
F 
0.335 mL (morphological 
alterations in the skin) 
Monteiro-Riviere et al. 2004 
JP-8+100 
Kanikkannan et al. 2000 
Jet A 
Fuel was applied in a 
fuel-soaked cotton 
fabric. 
CBA/Ca 
Mouse once 
0.025 mL (weak skin sensitization) 
F 
Kanikkannan et al. 2000 
JP-8 
CBA/Ca 
Mouse once 
0.025 mL 
F 
Kanikkannan et al. 2000 
JP-8+100 
NOAEL is for skin 
sensitization. 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
Mouse once 
(C57BL/6N) 0.3 mL (suppressed contact hypersensitivity) 
Mouse 4 d 
C3H/HeNCr 1 x/d 0.025 mL (suppressed immune 
F memory) 
Mouse once 
C3H/HeNCr 0.075 mL (immune suppression) 
F 
C3H/HeNCr 
Mouse 4 d 
1 x/d 0.01 mL 
F 
0.025 mL (suppressed 
F immunological memory) 
Mouse once 
C3H/HeNCr 0.3 mL (suppressed
F delayed-type
hypersensitivity 
response) 
Mouse 1-5 d 
CH3/HeNCr 1 x/d 0.05 mL (suppressed contact 
F hypersensitivity) 
CH3/HeNCr 
Mouse once 
0.05 mL 
F 
0.1 mL (suppressed contact
F hypersensitivity) 
Limon-Flores et al. 2009 
JP-8 
Ramos et al. 2002 
Jet A 
Ramos et al. 2002 
Jet A 
Ramos et al. 2002 
JP-8 
Ramos et al. 2007 
JP-8 
Ullrich 1999 
JP-8 
Ullrich and Lyons 2000 
JP-8 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
(New 
Zealand) 
Gn Pig 4 d 
1 x/d 0.1 mL 
M 
Wolfe et al. 1996 
JP-8 
NOAEL is for lack of 
sensitization. 
(New 
Zealand) 
Gn Pig 4 d 
1 x/d 
INTERMEDIATE EXPOSURE 
Death 
B6C3F1 
Mouse 13 wk 
7 d/wk 
0.1 mL 
M 
2000 F 
mg/kg/day 
(60% mortality) 
Wolfe et al. 1996 
JP-8+100 
NTP/NIH 1986 
JP-5 
NOAEL is for lack of 
sensitization. 
BALB/C 
Mouse 40 wk 
3 x/wk 42.2 F 
mg/kg/day 
(40% mortality) 
Schultz et al. 1981 
JP-5 
BALB/C 
Mouse 40 wk 
3 x/wk 41.5 F 
mg/kg/day 
(27% mortality) 
Schultz et al. 1981 
JP-8 
Systemic 
(Fischer- 344) 
Rat 28 d 
1 x/d Dermal 0.156 mL (gross and microscopic 
M alterations of the skin) 
Baker et al. 1999 
JP-8 
Bd Wt 0.156 mL 
M 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
Rat
 
(Fischer- 344)
 
Rat
 
(Sprague-

Dawley)
 
Rat
 
(Sprague-

Dawley)
 
Mouse
 
(C3H)
 
Mouse
 
(CD-1)
 
Mouse
 
(CD-1)
 
28 d 
1 x/d Dermal 0.156 mL (gross and microscopic 
M alterations of the skin) 
Baker et al. 1999 
JP-8+100 
Bd Wt 0.156 mL 
M 
28 d Dermal 500 F 
mg/kg/day 
(severe skin irritation) 
Mann et al. 2008 
Jet A 
28 d Dermal 165 F 
mg/kg/day
(transient skin irritation) 
Mann et al. 2008 
Jet A 
2 x/wk 
13 wk Dermal 10 M 
%volume 
50 M 
%volume 
(skin irritation) 
Freeman et al. 1990 
Jet A 
2 x/wk 
52 wk Dermal 100 M 
%volume 
(moderate irritation) 
Nessel et al. 1999 
Jet A 
7 x/wk 
52 wk Dermal 28.6 M 
%volume 
Nessel et al. 1999 
Jet A 
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mg/kg/day
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
B6C3F1 
Mouse 13 wk 
7 d/wk Resp 8000 
mg/kg/day 
NTP/NIH 1986 
JP-5 
Cardio 8000 
mg/kg/day 
Gastro 8000 
mg/kg/day 
Hemato 500 
mg/kg/day 
(splenic hematopoiesis) 
Hepatic 500 
mg/kg/day 
(karyomegaly) 
Renal 8000 
mg/kg/day 
Dermal 500 
mg/kg/day 
(slight to moderate 
dermatosis) 
Bd Wt 2000 
mg/kg/day 
4000 
mg/kg/day 
(decrease in body weigh 
gain) 
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352
mg/kg/day
352
mg/kg/day
mg/kg/day
mg/kg/day
907
mg/kg/day
907
mg/kg/day
mg/kg/day
mg/kg/day
1041 mg/kg/day
1041
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
BALC/C 
Mouse 40 wk 
3 x/wk Hepatic 42.2 
mg/kg/day 
Renal 
Bd Wt 
BALC/C 
Mouse 40 wk 
3 x/wk Hepatic 41.5 
mg/kg/day 
Renal 
Bd Wt 
Immuno/ Lymphoret 
(Sprague-
Dawley) 
Rat 28 d 
495 F 
mg/kg/day 
21.1 M 
mg/kg/day 
21.1 F 
mg/kg/day 
21.1 
mg/kg/day 
21.1 M 
mg/kg/day 
21.1 F 
mg/kg/day 
21.1 
mg/kg/day 
(increased kidney 
weight) 
(decreased kidney 
weight) 
(7-11% decrease in bod 
weight) 
(decreased kidney 
weight) 
(increased kidney 
weight) 
(7-11% decrease in bod 
weight) 
Schultz et al. 1981 
JP-5 
Schultz et al. 1981 
JP-8 
Mann et al. 2008 
Jet A 
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29
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264
265
mg/kg/day
265
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%volume
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mg/app
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
Hartley 
Gn Pig 3 wk 
1 d/wk 
6 hr/d 
Dermal 0.5 mL Vernot et al. 1990b 
Jet A 
Neurological 
B6C3F1 
Mouse 13 wk 
7 d/wk 8000 M 
mg/kg/day 
NTP/NIH 1986 
JP-5 
Reproductive 
B6C3F1 
Mouse 13 wk 
7 d/wk 8000 
mg/kg/day 
NTP/NIH 1986 
JP-5 
Cancer 
(CD-1) 
Mouse 2 x/wk 
52 wk 100 M 
%volume 
(increased tumor 
incidence) 
Nessel et al. 1999 
Jet A 
CHRONIC EXPOSURE 
Death 
C3H/HeN 
Mouse 3 x/wk 
62 wk 25 B 
mg/app 
(50% mortality) 
Clark et al. 1988 
Jet A 
B6C3F1 
Mouse 90-103 wk 
5 d/wk 250 M 
mg/kg/day 
(34% mortality) 
NTP/NIH 1986 
JP-5 
250 F 
mg/kg/day 
(30% mortality) 
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal	 (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious	 Serious Chemical Form Comments 
Systemic 
Mouse 3 x/wk Dermal	 Clark et al. 198825 B (skin irritation,C3H/HeN 62 wk 
mg/app	 inflammation, and Jet A 
necrosis) 
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278
mg/kg/day
278
mg/kg/day
mg/kg/day
mg/kg/day mg/kg/day
mg/kg/day
mg/kg/day mg/kg/day
mg/kg/day mg/kg/day
mg/kg/day
mg/kg/day mg/kg/day
JP
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D
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
B6C3F1 
Mouse 90-103 wk 
5 d/wk Resp 500 
mg/kg/day 
Cardio 500 
mg/kg/day 
Gastro 500 
mg/kg/day 
Hemato 250 500 
mg/kg/day mg/kg/day 
Musc/skel 500 
mg/kg/day 
Hepatic 250 500 
mg/kg/day mg/kg/day 
Renal 250 500 
mg/kg/day mg/kg/day 
Dermal 
Bd Wt 250 500 
mg/kg/day mg/kg/day 
NTP/NIH 1986 
JP-5 
(amyloid deposits in 
spleen) 
(amyloid deposits in live 
(amyloid deposits in 
kidney) 
250 
mg/kg/day 
(12-25% decrease in 
body weight gain) 
(ulcers; dermatitis) 
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274
mg/kg/day
mg/kg/day
274
275
mg/kg/day
275
276
mg/kg/day
276
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mg/app
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Table 3-3 Levels of Significant Exposure to JP-5, JP-8, And Jet A Fuels - Dermal (continued) 
Exposure/ LOAEL
 
Duration/
 
Frequency Reference
Species 
(Route)(Strain) System NOAEL Less Serious Serious Chemical Form Comments 
Immuno/ Lymphoret 
B6C3F1 
Mouse 90-103 wk 
5 d/wk 250 
mg/kg/day 
500 
mg/kg/day 
(granulocyte hyperplasia 
in the bone marrow; 
hyperplasia in the lymph 
nodes) 
NTP/NIH 1986 
JP-5 
Neurological 
B6C3F1 
Mouse 90-103 wk 
5 d/wk 500 
mg/kg/day 
NTP/NIH 1986 
JP-5 
Reproductive 
B6C3F1 
Mouse 90-103 wk 
5 d/wk 500 
mg/kg/day 
NTP/NIH 1986 
JP-5 
Cancer 
C3H/HeN 
Mouse 3 x/wk 
56-62 wk 25 B 
mg/app 
(fibromas, sarcomas) 
Clark et al. 1988 
Jet A 
B = both sexes; Bd Wt = body weight; Cardio = cardiovascular; d = day(s); F = Female; Gastro = gastrointestinal; Gn pig = guinea pig;  Hemato = hematological; hr = hour(s); 
Immuno/Lymphoret = immunological/lymphoreticular; LOAEL = lowest-observed-adverse-effect level; M = male; Musc/skel = musculoskeletal; NOAEL = no-observed-adverse-effect 
level; Resp = respiratory; x = time(s); wk = week(s) 
98
    
 
    
 
 
    
   
 
 
      
 
 
 
   
    
 
      
 
 
   
   
 
     
  
 
     
   
    
   
      
     
 
 
       
  
 
   
      
   
 
 
 
 
  
99JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
No histopathological changes were noted in the gastrointestinal tract of mice subsequent to five dermal
applications of JP-5 for 13 weeks (2,000–8,000 mg/kg) or in mice chronically exposed (five applications
per week for 103 weeks) to 250 or 500 mg/kg JP-5 (NTP/NIH 1986).
Hematological Effects. No studies were located regarding hematological effects in humans after
dermal exposure to JP-5, JP-8, or Jet A fuels.
Hematopoiesis by the spleen (extramedullary hematopoiesis) was noted in mice receiving 8,000 mg/kg 
JP-5 by dermal administration 5 days/week for 13 weeks or 500 mg/kg JP-5 for 103 weeks (NTP/NIH 
1986).  Extramedullary hematopoiesis may be indicative of a 1% hematological effect.
Musculoskeletal Effects. No studies were located regarding musculoskeletal effects in humans after
dermal exposure to JP-5, JP-8, or Jet A fuels.
No histopathological changes were noted in the musculoskeletal system of mice following dermal
application of 250 or 500 mg/kg JP-5 5 days/week for 103 weeks (NTP/NIH 1986).
Hepatic Effects. No studies were located regarding hepatic effects in humans after dermal exposure
to JP-5, JP-8, or Jet A fuels.
Application of 300 μL of JP-8 to a clipped area of the neck of male Long-Evans rats 7 days/week resulted
in spotty, isolated hepatic cell death and loss of cytoplasm with shrinking nuclei in 1% of hepatic cells 
(Larabee et al. 2005).  It should be noted that only a qualitative description of the results was provided.  
Slight hepatic karyomegaly was noted in mice receiving 500–8,000 mg/kg JP-5 dermally 5 times/week
for 13 weeks (NTP/NIH 1986). Amyloidosis of the liver occurred in mice following the dermal
administration of 500 mg/kg JP-5, 5 times/week for 103 weeks, but not in those treated with 250 mg/kg 
(NTP/NIH 1986).
Renal Effects. No studies were located regarding renal effects in humans after dermal exposure to
JP-5, JP-8, or Jet A fuels.
No histopathological or organ weight changes were noted in the kidneys of male mice following daily
dermal exposures to 0.1 mL kerosene for 1 week (Upreti et al. 1989) or following exposure to 2,000– 
8,000 mg/kg JP-5 5 times/week for 13 weeks (NTP/NIH 1986).  Repeated application of 300 μL of JP-8 
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100JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
to a clipped area of the neck of male Long-Evans rats 7 days/week induced renal tubular cell death in
approximately 10% of the proximal tubules (Larabee et al. 2005).  This was not observed in control
preparations, but quantitative data were not provided.  Amyloidosis of the kidney was found to be
secondary to dermatitis in mice chronically exposed (five dermal applications per week for 103 weeks) to
500 mg/kg JP-5 (NTP/NIH 1986).
Endocrine Effects. No studies were located regarding endocrine effects in humans after dermal
exposure to either JP-5, JP-8, or Jet A fuels.
There were no histopathological changes, or changes in the weights of adrenal glands, of male mice 
following daily dermal exposure to 0.1 mL kerosene for 1 week (Upreti et al. 1989).
Dermal Effects. No studies were located regarding dermal effects in humans following dermal
exposure to JP-5, JP-8, and Jet A fuels.
Information is available regarding dermal exposure of humans to kerosene.  In one study, there was a 
dose-dependent increase in dermatitis from acute exposures to 55–85% solutions of kerosene (1.5 mL of a
solution applied to “midback” for 24 hours) (Tagami and Ogino 1973).  No effects were noted in these 
subjects from exposure to the 40% solution of kerosene.  This study is limited because no vehicle controls 
were used.  Also, each subject was exposed to all test solutions (i.e., four different concentrations of
kerosene), but the chronological spacing of the four treatments is not known.  Therefore, it is not known if
some of the observed effects were a result of sensitization, rather than a direct effect of the kerosene.  
Topical application of 1.0 mL of kerosene impaired protein synthesis, but not deoxyribonucleic acid 
(DNA) replication or collagen synthesis in the epidermis (Lupulescu and Birmingham 1975).  Hyperemia,
cellular damage of the epidermis, and mild edema also occurred following a single 90-minute exposure to 
1 mL kerosene (Lupulescu and Birmingham 1976; Lupulescu et al. 1973).  Histological changes included
disorganization of the cells, cytolysis, and enlarged intercellular spaces in the stratum corneum and 
spinous cells of the epidermis (Lupulescu and Birmingham 1976).  Effects had subsided within 72 hours
in some individuals (Lupulescu et al. 1973).  These studies are limited because each tested only one dose.
Dermal effects of kerosene from known or suspected short-term dermal exposures are described in several
case studies.  Erythema, bullae, burning, and itching were reported in a 45-year-old man following a
20-minute dermal exposure to kerosene (Mosconi et al. 1988).  Three males (2–15 years old) and one
female (2 years old) exhibited blisters, reddening, flaccid bullae, pustules, soreness, burning, swelling, 
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101JP-5, JP-8, AND JET A FUELS
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and denudation of the skin following dermal exposures to unknown volumes of kerosene (Tagami and 
Ogino 1973).  Large blisters, erythema, and peeling skin were reported in two cases of apparent oral
exposure to kerosene (Annobil 1988); however, the strong odor of kerosene on one of the individuals and
the kerosene-stained clothing of the other strongly indicate that dermal exposure may have also occurred 
in these cases.  Exposure levels were not specified.  Dermatosis and erythema were evident in factory
workers who were exposed to kerosene for up to 5 hours daily by handling kerosene-soaked steel parts;
exposure levels were not reported (Jee et al. 1985).
Numerous studies have examined the effect of jet fuels on the skin of animals, as dermal exposure is a 
relevant occupational route of exposure.  Application of 250 μL of JP-8 fuel to the clipped skin of male
Fischer-344 rats for 1 hour under occluded conditions resulted in evidence of dermal inflammation
(Kabbur et al. 2001).  Morphological changes (increase in extravascular dermal granulocytes) were
observed as early as 2 hours after exposure started and were more prominent 6 hours after exposure
started. The morphological changes were preceded by an increase in biomarkers of inflammation, such
as interleukin (IL)-1α and inducible nitric oxide synthase protein and nitrite levels in the skin.  Exposure
to a lower concentration (156 µL/cm2) JP-8 for 1 hour did not result in visible damage to the skin of rats
(McDougal et al. 2007).  However, alterations in gene expression in the epidermis showed that shortly
after exposure, there was activation of several signaling pathways related to inflammation, apoptosis,
cell growth, and proliferation. Similar results were reported by Gallucci et al. (2004), who noted that
unoccluded application of 300 μL JP-8 to the clipped area of the skin of male Long-Evans rats for 7 days 
induced thickened epidermis and profound inflammatory infiltration.  This was associated with changes
in the expression of numerous proinflammatory cytokines.  Occluded application of 230 μL JP-8 to the
skin of hairless rats for 1 hour significantly increased the cytokine IL-1α in blood and TNFα in the skin 
24 hours after dosing (Chatterjee et al. 2006). Once daily unoccluded application of 0.156 mL JP-8 or
JP-8+100 to the skin of Fischer rats under non-occluded conditions for 7–28 days resulted in erythema 
and edema, characterized as very slight during the first few days of exposure and well-defined by the
end of the first week of exposure (Baker et al. 1999).  Histopathological alterations observed in the skin 
included spongiosis, orthokeratosis, parakeratosis, hyperplasia, hypergranulosis, dyskeratosis, 
inflammatory infiltrates, edema, and vasodilation.  In animals exposed for 28 days and allowed to 
recover for 7–28 days, the histopathological alterations were limited to hypergranulosis. Studies in rats 
also showed significant increases in transepidermal water loss (TEWL, a measure of stratum corneum
barrier function) as a result of nonocclusive application of 14 μL JP-8, JP-8+100, or Jet A fuels
4 times/day for 5 days (Kanikkannan et al. 2002). Dermal exposure to these fuels also resulted in slight
erythema under non-occluded conditions and moderate-to-severe erythema and moderate edema under
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
   
      
     
   
   
     
       
   
 
 
    
  
 
  
     
       
   
         
     
  
 
   
  
    
  
     
    
   
   
   
     
    
    
   
 
 
 
 
  
102JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
occluded conditions (Kanikkannan et al. 2002). An intermediate-duration study with Jet A showed that
the concentration and/or vehicle strongly influence the extent of skin damage (Mann et al. 2008).
Unoccluded application of 500 mg/kg/day of neat Jet A resulted in severe irritation in Sprague-Dawley
rats; the study was terminated after 5 days due to morbidity.  Application of 500 mg/kg/day as 50% Jet
A in mineral oil resulted in mild-to-moderate erythema and desquamation after 28 days of exposure.  
More severe irritation was observed when the Jet A was diluted to 50% using a 4:1 acetone:olive oil 
vehicle. Another study by Mann et al. (2008) reported transient skin irritation in Sprague-Dawley rats 
dermally exposed to 165 or 330 mg/kg/day Jet A in mineral oil for 28 days; at 495 mg/kg/day, erythema, 
edema, and eschar were observed.
In New Zealand White rabbits, application of 500 µL JP-8 to clipped skin for 4 hours resulted in moderate
irritation when tested under occluded conditions and slight irritation when tested under semi-occluded 
conditions (Hurley et al. 2011).  Another study found mild erythema in New Zealand White rabbits 
administered 500 µL JP-8 under semi-occluded conditions for 4 hours (Wolfe et al. 1996).  Mild
erythema was also found following administration of one of two formulations of JP-8+100 (Wolfe et al.
1996). The primary skin index for all three fuels was less than 1, indicating that it is not a skin irritant.
Another study reported that application of 500 µL undiluted JP-5 or JP-8 to a clipped and occluded area 
of the skin of rabbits for 4 hours did not induce skin irritation (Schultz et al. 1981). Mild dermal irritation
was reported in New Zealand White rabbits exposed to 500 µL Jet A for 24 hours under occluded 
conditions (Vernot et al. 1990b).
Repeated application of 335 μL of JP-8 fuel to the clipped skin of female weanling Yorkshire pigs by
means of a fuel-soaked fabric induced slight erythema at 5 hours and increased erythema at 5 days 
(Monteiro-Riviere et al. 2001).  Jet A fuel was slightly more irritating than JP-8; slight to moderate
erythema and slight edema were observed (Monteiro-Riviere et al. 2001).  Light microscopy showed 
slight intracellular epidermal edema at 5 and 24 hours and at 5 days post-dosing with JP-8 or Jet A fuels.  
Application sites also had intra-corneal micro-abscesses filled with inflammatory cells, and epidermal
thickening was evident.  Further studies using electron microscopy showed that the primary ultrastructural
changes after JP-8 or Jet A fuel exposure involve alterations in the lipid bilayers of the skin that would 
likely affect the epidermal-dermal barrier in a manner that would allow further fuel absorption (Monteiro-
Riviere et al. 2004). The results from an additional study from this group of investigators indicated that
individual aliphatic hydrocarbons, such as tridecane, tetradecane, and pentadecane, are the principal 
source of JP-8-induced irritation (Muhammad et al. 2005b). Kanikkannan et al. (2001) showed that a
24-hour skin treatment with 250 μL JP-8 in male Yucatan minipigs significantly increased TEWL at
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2 and 24 hours after exposure and caused moderate erythema and moderate to severe edema 1 hour after
exposure.  Singh and Singh (2004) reported an increase in TEWL in male New Zealand White rabbits
after application of 50 μL JP-8 to the shaved back and left covered for 1 hour; this was due to the rupture
of the skin barrier and an increase in temperature.  Chatterjee et al. (2006) also reported an increase in
TEWL in hairless rats applied 230 μL JP-8 for 1 hour.
Acute dermal exposures (14 days) to unspecified concentrations of JP-5 induced dermatitis (acanthosis, 
scaly skin, hair loss, inflammation, parakeratosis, and/or hyperkeratosis of the skin) in mice (NTP/NIH 
1986).  Intermediate exposure (five dermal applications per week for 14 weeks) to 500–8,000 mg/kg JP-5
induced slight-to-moderate dermatosis, which increased with dose in mice (NTP/NIH 1986). Chronic
dermal application of 250 or 500 mg/kg JP-5 5 times/week for 103 weeks induced dermatitis and 
ulcerations of the skin of mice (NTP/NIH 1986).  The severity, but not the incidence, of dermatitis
induced by JP-5 was dose dependent; the doses were possibly too high and may have caused a chemical
burn.  Similarly, the incidence of ulcers induced by the chronic application of JP-5 was dose-dependent.
Repeated exposure studies in mice exposed to Jet A also reported dermal irritation.  Minimal skin 
irritation was observed following application of 50% Jet A mineral oil 2 times/week for 13 weeks
(Freeman et al. 1990).  Moderate irritation was observed following application of 100% Jet A applied 
2 times/week for 52 weeks (Nessel et al. 1999).  No irritation was observed when 28.6% Jet A in mineral
oil was applied 7 times/week for 52 weeks (Nessel et al. 1999). A 62-week exposure (3 times/week) of
mice to 25 mg neat Jet A resulted in skin irritation, inflammation, and necrosis (Clark et al. 1988);
inflammation was observed in the female mice 2 months prior to the appearance in males.
Ocular Effects. No studies were located regarding ocular effects in humans following dermal
exposure to JP-5, JP-8, or Jet A fuels.
No signs of ocular irritation were noted in rabbits exposed to JP-5 or JP-8 in several studies (Cowan and
Jenkins 1981; Schultz et al. 1981), although Draize scores were not reported by some of the investigators 
(Cowan and Jenkins 1981). Minimal eye irritation was observed in rabbits following application of 0.1 
mL Jet A (Vernot et al. 1990b).
Body Weight Effects. No studies were located regarding body weight effects in humans after dermal
exposure to JP-5, JP-8, or Jet A fuels.
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Application of 0.156 mL of JP-8 or JP-8+100 fuels onto the skin of F-344 rats for up to 28 days did not
affect body weight (Baker et al. 1999). In rabbits, a single 4-hour topical exposure to 2,000 mg/kg JP-8 
or JP-8+100 did not significantly affect body weight during a subsequent 14-day period (Wolfe et al.
1996).  There was no change in body weight of male mice following daily dermal exposures to 0.1 mL
kerosene for 1 week (Upreti et al. 1989).  However, exposure to at least 10,000, but not 5,000 mg/kg JP-5, 
7 days per week for 2 weeks induced a 17% decrease in body weight gain in mice (NTP/NIH 1986).
Mice treated dermally with JP-5 (at 500, 1,000, 2,000, 4,000, or 8,000 mg/kg) 5 times/week for 13 weeks 
exhibited relatively small changes in weight gain.  Male mice treated with 8,000 mg/kg displayed a 7%
decrease in body weight, while a 3% increase was observed in females treated with 8,000 mg/kg
(NTP/NIH 1986).  Although an analysis of the weight data was not included, the data suggest that weight
was not significantly affected by the dermal treatment with JP-5 in this study.  Dermal application of JP-5 
three times per week for 40 weeks produced significant weight reduction in mice (Schultz et al. 1981);
total weekly doses were 126.6 and 63.3 mg of JP-5.  Chronic dermal exposures (dermal application
3 times/week for 103 weeks) to 500 mg/kg JP-5 induced decreases in body weight relative to controls
(NTP/NIH 1986).
3.2.3.3  Immunological and Lymphoreticular Effects 
No studies were located regarding immunological or lymphoreticular effects in humans after dermal
exposure to JP-5, JP-8, or Jet A fuels.
Acute dermal treatment (“patch test”) with 1% JP-5 induced mild dermal sensitization in guinea pigs
(Cowan and Jenkins 1981).  Dermal sensitization did not occur in guinea pigs that were dermally treated 
with nine doses of 0.1% JP-5 in propylene glycol over a 3-week period (Schultz et al. 1981). Negative 
results were observed in a skin sensitization test of JP-8 and JP-8+100 in male Hartley guinea pigs that
exhibited edema (Wolfe et al. 1996).  Similarly, skin sensitization was not observed in male Hartley
guinea pigs following application of 0.5 mL Jet A (Vernot et al. 1990b).
Other studies have also shown that JP-8 and Jet A are not skin sensitizers. Application of 25 μL of JP-8 
on the back of the ear of female CBA/Ca mice for 3 consecutive days induced local lymph node 
proliferative activity; a stimulation index of 3.17 was determined, indicating that JP-8 was a weak skin
sensitizer (Kanikkannan et al. 2000); the threshold definition for a skin sensitizer in this assay is a
stimulation index of 3.  Adding butylated hydroxytoluene (BHT, an antioxidant additive) to the JP-8 
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resulted in a lower stimulation index (2.83), although the difference was not statistically significant.  The
investigators speculated that BHT may inhibit the formation of oxidative products and free radicals from
JP-8.  Kanikkannan et al. (2000) also tested JP-8+100 and Jet A in using the mouse local lymph node
assay; the stimulation indices were 2.38 and 2.44, respectively, indicating that neither fuel was a skin
sensitizer.
Application of 50 μL JP-8 to the shaved back of adult female C3H/HeN mice for 4–5 days resulted in 
significant inhibition of contact and delayed-type hypersensitivity, but application for ≤3 days was
without significant effect (Ullrich 1999). This occurred regardless of whether the contact allergen was 
applied directly to the JP-8 treated site or at a distant untreated site.  A single exposure to 150, 240, or
300 µL JP-8 resulted in suppressed delayed-type hypersensitivity to Candida albicans in female 
C3H/HeN mice (Ramos et al. 2002, 2004, 2007, 2009); repeated exposure to 25 µL JP-8 over
4 consecutive days also resulted in suppression of delayed-type hypersensitivity (Ramos et al. 2002).  
Similarly, a single exposure to ≥75 µL Jet A or repeated exposure to ≥25 µL Jet A over 4 days resulted in 
suppression of delayed-type hypersensitivity in mice (Ramos et al. 2002, 2004). Exposure to 300 μL JP-8 
significantly depressed the ability of splenic T lymphocytes to proliferate in response to plate-bound 
monoclonal antiCD3 (Ullrich 1999).  JP-8 (300 μL) also significantly increased serum levels of the 
cytokine IL-10.  Ullrich and Lyons (2000) showed that immune suppressive cytokines, presumably
produced by JP-8-treated epidermal cells, are responsible for the immune suppression seen in JP-8-treated
mice, and that blocking and/or neutralizing their production in vivo overcomes the immunotoxic effects of
JP-8. In a more recent study, application of 300 μL of JP-8 to the skin of C57BL/6 mice resulted in 
significant suppression of contact hypersensitivity (Limón-Flores et al. 2009).  However, no immune
suppression was observed in treated mice that were mast cell deficient, suggesting that mast cells mediate
immune suppression.  Additional experiments showed that PGE2 is the critical mast cell product
activating immune suppression and suggested that mast cells migrate from the skin to draining lymph 
nodes, thereby transmitting the immunosuppressive signal from the skin to the immune system (Limón-
Flores et al. 2009).  Ramos et al. (2009) showed that JP-8 activated reactive oxygen species and nuclear
factor kappa B (NF-κB), which resulted in an upregulation of cyclooxygenase (COX)-2, an enzyme that
regulates prostaglandin synthesis. Ramos et al. (2007) suggested that the aromatic hydrocarbons present
in JP-8 were the immunosuppressive agents.  S-8 synthetic fuel, which is devoid of aromatic 
hydrocarbons, did not result in suppression of delayed-type hypersensitivity; however,
immunosuppression was observed when a mixture of hydrocarbons (benzene, toluene, ethylbenzene, 
xylene, 1,2,4-trimethylbenzene, cyclohexylbenzene, and dimethylnaphthalene) was added to the S-8.
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Intermediate-duration exposure of Sprague-Dawley rats to 495 mg/kg/day Jet A (60% dilution in mineral 
oil) did not result in alterations in spleen or thymus weights, spleen lymphocyte population, splenic B-cell
or T-cell phenotypes, splenic IgM antibody response to SRBCs or anti CD3 antibody, stimulated T-cell
proliferation, or NK cell activity (Mann et al. 2008).  Chronic dermal application of 500 mg/kg JP-5 five
times per week for 103 weeks induced granulocytic hyperplasia in the bone marrow in male and female 
mice and hyperplasia in the lymph nodes of female mice (NTP/NIH 1986).  Amyloidosis of the spleen 
was found secondary to dermatitis in mice dermally treated with 500 mg/kg JP-5 five times per week for
103 weeks; this effect was not noted following dermal application of 250 mg/kg JP-5 (NTP/NIH 1986).  
This was most likely a result of chronic ulceration at the site of application.
The highest NOAEL and all LOAEL values from each reliable study for immunological effects in each
species and duration category are recorded in Table 3-3.
3.2.3.4  Neurological Effects 
No studies were located regarding neurological effects in humans following dermal exposure to JP-5, 
JP-8, or Jet A fuels.
3.2.3.5  Reproductive Effects
No studies were located regarding reproductive effects in humans after dermal exposure to JP-5, JP-8, or
Jet A fuels.
Increased response to tactile stimuli and hyperactivity occurred in male mice at initiation of daily dermal
exposures to 0.1 mL kerosene for 1 week (Upreti et al. 1989).  Females were not tested in this study.  No
histopathological changes were noted in the nervous system of mice following dermal application of up to 
8,000 mg/kg JP-5 5 times/week for 13 weeks or mice chronically exposed (five applications per week for
103 weeks) to up to 500 mg/kg JP-5 (NTP/NIH 1986).
The highest NOAEL values for neurological effects in each species and duration category are recorded in 
Table 3-3.
No histological changes were noted in the reproductive system of mice dermally treated 5 times/week for
13 weeks with up to 8,000 mg/kg JP-5 or in mice chronically exposed to up to 500 mg/kg JP-5 five times 
per week for 103 weeks (NTP/NIH 1986).
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These NOAEL values for reproductive effects in each species and duration category are recorded in
Table 3-3.
3.2.3.6  Developmental Effects 
No studies were located regarding developmental effects in humans or laboratory animals after dermal
exposure to JP-5, JP-8, or Jet A fuels.
3.2.3.7  Cancer
No studies were located regarding cancer in humans after dermal exposure to JP-5, JP-8, or Jet A fuels.
An increase in skin tumors (squamous cell carcinoma and fibrosarcomas) was observed in C3H/HeN mice
following dermal application of 25 mg neat Jet A 3 times/week for 62 weeks (Clark et al. 1988). This 
concentration was also associated with significant skin damage including inflammation and necrosis. A 
tumor promotion study demonstrated that damage to the skin was necessary for the induction of tumors
(Nessel et al. 1999).  In this study, CD-1 mice were exposed dimethylbenzanthracene (DMBA), which is 
a tumor initiator, prior to exposure to Jet A.  Application of neat Jet A 2 times/week for 52 weeks resulted
in a significant increase in skin tumors in CD-1 mice (Nessel et al. 1999); the tumor incidence was 11/30, 
as compared to 1/30 in the controls.  Moderate dermal irritation was also observed at this concentration.  
However, no skin tumors were observed following the application of 28.6% Jet A in mineral oil
7 times/week for 52 weeks; this concentration did not result in skin irritation. The weekly Jet A doses 
were the same in both studies (25 µL) and the investigators suggested that the fuel did not induce tumors
in the absence of skin irritation.  
Unspecified skin tumors were induced in C3HF/Bd mice following a 40-week exposure to 22.9 mg (but
not 42.2 mg) JP-5 or a 60-week exposure to 5.7–42.2 mg JP-5 (the highest incidence was at 11.4 mg)
(Schultz et al. 1981).  Tumors were more prevalent in females than in males.  None of the control animals 
developed skin tumors, and statistical analysis was not conducted.  The tumor incidence was not dose-
dependent, and historical control data for this strain of mouse were not provided. No skin cancer was 
reported in B6C3F1 mice treated dermally with 250 or 500 mg/kg JP-5 five times/week for 103 weeks 
(NTP/NIH 1986).  Malignant lymphomas were noted in 39% of females treated with 250 mg/kg JP-5, 
11% of females at 500 mg/kg JP-5, and 15% of females in the control group.  No dose-response
relationship was apparent for this effect.  A significant negative trend in the incidence of malignant 
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lymphomas was noted in males of the high-dose group; rates dropped from 16% in the control group to
6% at 250 mg/kg JP-5 and 2% at 500 mg/kg JP-5. Significant dermal damage (ulceration and dermatitis)
was observed at both JP-5 concentrations.  
3.3  GENOTOXICITY
Limited information is available regarding genotoxicity in humans due to exposure to jet fuels.  A
study of Turkey Air Force personnel exposed to JP-8 found significant increases in the occurrence of
sister chromatid exchanges in peripheral lymphocytes; when the personnel were divided by smoking 
status, only the occurrence in smokers was statistically significant (Erdem et al. 2012).  No significant
alterations in occurrence of high frequency of sister chromatid exchange cells or in micronuclei
frequency were observed.  In a study of DNA damage among U.S. Air Force personnel, no significant
differences in mean comet assay measurements in leukocytes between different JP-8 exposure
categories (high, medium, or low potential exposure) were observed (Krieg et al. 2012).  Because the
high-exposure workers wore respirators, it is presumed that dermal contact was the primary route of
exposure.  No associations were found for benzene or naphthalene work shift air levels and DNA
damage.  However, significant associations were found between pre-shift breath benzene levels and
mean tail DNA damage and mean tail (Olive) moment; but the number of cells with highly damaged
DNA was statistically decreased as pre-shift benzene breath level increased.  In contrast, mean tail
DNA and mean tail (Olive) moment decreased as post-shift breath benzene levels increased.  Pre- and 
post-shift naphthalene breath levels were not significantly associated with DNA damage.  The post-
shift number of cells with highly damaged DNA was significantly associated with urinary levels of
(2-methoxyethoxy) acetic acid (MEAA), a metabolite of 2-(2-methoxyethoxy) ethanol; however, the
association was no longer statistically significant when MEAA levels were adjusted for creatinine 
levels.
Significant increases in the frequency of micronuclei were observed in peripheral blood polychromatic
erythrocytes following application of 240 mg JP-8 or Jet A to the shaved backs of female C3H/HeNCr
(MTV-) mice (Vijayalaxmi et al. 2004).  Although an increase in micronuclei frequency was also
observed in bone marrow cells for both fuels, the difference over controls was not statistically significant.
However, when the experiment was repeated with JP-8 and Jet A, no statistically significant alterations in
micronuclei frequency were observed in the peripheral blood or bone marrow (Vijayalaxmi et al. 2006).  
Additionally, a 3-day repeated dermal exposure to 240 mg/day JP-8 or Jet A did not result in increases in
micronuclei formation. Kerosene administered intraperitoneally did not increase the frequency of
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
   
    
       
      
   
 
       
   
       
  
      
   
  
        
   
   
  
    
   
  
    
    
  
   
    
 
     
   
  
  
  
 
  
 
 
 
 
  
109JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
chromosomal aberrations in bone marrow cells harvested from male or female Sprague-Dawley rats 
following a one-time exposure to 0.04, 0.13, or 0.4 mL or a 5-day exposure to 0.02, 0.06, or 0.18 mL/day 
(Conaway et al. 1984).  JP-8 did not induce significant dominant lethal effects either in mice at dietary
doses of 0.13, 0.4, or 1.3 mL/kg or in rats at gavage doses of 0.1, 0.3, or 1.0 mL/kg (Air Force 1978a).
Table 3-4 summarizes the results of in vivo genotoxicity studies.
Several studies have examined the genotoxicity of jet fuels using in vitro assays. JP-5 was not mutagenic
in the Ames assay in Salmonella typhimurium TA98 when incubated with or without metabolic activation
(Schultz et al. 1981).  Similarly, JP-5 was not mutagenic in various strains of S. typhimurium
preincubation assays with or without metabolic activation (NTP/NIH 1986).  Negative results were also
reported for JP-8 in several Salmonella strains and the yeast Saccharomyces cerevisiae D4 (Air Force
1978a). Hydrotreated kerosene was not mutagenic in S. typhimurium TA98 with or without activation in 
a study conducted by Blackburn et al. (1986).  Similar results were reported for kerosene in various
Salmonella strains incubated with or without metabolic activation (Conaway et al. 1984). In in vitro
studies with mammalian cells, neither JP-8 nor kerosene was mutagenic in the L5178Y mouse lymphoma
assay with or without activation (Air Force 1978a; Conaway et al. 1984).  DNA damage assessed by
increased unscheduled DNA synthesis was reported in WI-38 cells derived from human embryonic lung
following incubation with JP-8 (Air Force 1978a).  Two more recent studies of jet fuels also yielded
positive results.  Using the Comet Assay, Grant et al. (2001) showed that JP-8 induced DNA damage in 
H4IIE rat hepatoma cells when incubated for 4–8 hours with JP-8 in concentrations ranging from 3 to 
20 µg/mL.  In this concentration range, JP-8 did not induce cytotoxicity or significant apoptosis.  Using
the same assay, Jackman et al. (2002) reported that JP-8, JP-5, and JP8+100 induced significant DNA
damage in human peripheral blood lymphocytes.  JP-8+100 was the most potent, inducing DNA damage
at the lowest concentration tested (1/500 dilution).  JP-8+100 and JP-8 were considerably more potent
than JP-5.  Table 3-5 summarizes the genotoxicity of jet fuels in in vitro assays.
Overall, the studies of genotoxicity of JP-5, JP-8, and kerosene yielded mixed results. The only two 
occupational studies located did not provide evidence of genotoxicity, but additional studies are necessary
to draw firm conclusions regarding occupational exposures.  Examination of mammalian cells from
animals exposed to JP-8 or kerosene provided negative results, as did studies of mutagenicity in
prokaryotic organisms.  However, two more recent studies with mammalian cells in vitro showed that
JP-5, JP-8, and JP-8+100 can cause DNA damage.
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Table 3-4.  Genotoxicity of JP-8, Jet A, and Kerosene In Vivo
Species
(exposure route) End point Results Reference
JP-8 fuel
Human (inhalation)
Human (inhalation)
Human (dermal)
Mice (dermal)
Mice (dermal)
Mice (dermal)
Mice (dermal)
Mice (oral)
Rats (oral)
Jet A fuel
Mice (dermal)
Mice (dermal)
Mice (dermal)
Mice (dermal)
Kerosene
Rat (intraperitoneal)
Sister chromatid exchange (peripheral
 
lymphocytes)
 
Micronuclei (peripheral lymphocytes)
 
DNA damage
 
Micronuclei (polychromatic erythrocytes)
 
Micronuclei (bone marrow)
 
Micronuclei (polychromatic erythrocytes)
 
Micronuclei (bone marrow)
 
Dominant lethal (germ cells) 

Dominant lethal (germ cells) 

Micronuclei (polychromatic erythrocytes)
 
Micronuclei (bone marrow)
 
Micronuclei (polychromatic erythrocytes)
 
Micronuclei (bone marrow)
 
Chromosomal aberrations (bone marrow)
 
+ Erdem et al. 2012
 
– Erdem et al. 2012
 
– Krieg et al. 2012
 
+ Vijayalaxmi et al. 2004
 
– Vijayalaxmi et al. 2004
 
– Vijayalaxmi et al. 2006
 
– Vijayalaxmi et al. 2006
 
– Air Force 1978a 
– Air Force 1978a 
+ Vijayalaxmi et al. 2004
 
– Vijayalaxmi et al. 2004
 
– Vijayalaxmi et al. 2006
 
– Vijayalaxmi et al. 2006
 
– Conaway et al. 1984
 
– = negative result; + = positive result 
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Table 3-5.  Genotoxicity of JP-5, JP-8 and Kerosene In Vitro
Results
With Without
Species (test system) End point activation activation Reference
JP-5 fuel
Prokaryotic organisms
Salmonella typhimurium (TA1535, Gene mutation – – NTP/NIH 1986
TA97, TA98, TA100)
S. typhimurium (TA98) Gene mutation – – Schultz et al. 1981
Mammalian cells
Human lymphocytes DNA damage No data + Jackman et al. 2002 
JP-8 fuel
Prokaryotic organisms
S. typhimurium (TA98, TA100, Gene mutation – – Air Force 1978a
TA1535, TA1537, TA1538
Saccharomyces cerevisiae D4 Gene mutation – – Air Force 1978a
Mammalian cells
Mouse lymphoma (L5178Y) Gene mutation – – Air Force 1978a
WI-38 cells (derived from human DNA damage + + Air Force 1978a
embryonic lung)
Human lymphocytes DNA damage No data + Jackman et al. 2002 
H4IIE rat hepatoma cells DNA damage No data + Grant et al. 2001 
JP-8+100 fuel
Mammalian cells
Human lymphocytes DNA damage No data + Jackman et al. 2002 
Kerosene
Prokaryotic organisms
S. typhimurium (TA98) Gene mutation – – Blackburn et al. 1986
S. typhimurium (TA1535, TA1537, Gene mutation – – Conaway et al. 1984
TA1538, TA98, TA100) 
Mammalian cells
Mouse lymphoma (L5178Y) Gene mutation – – Conaway et al. 1984
C = negative result; + = positive result; DNA = deoxyribonucleic acid 
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3.4  TOXICOKINETICS
Few data were available concerning the absorption, distribution, metabolism, and excretion of JP-5, JP-8, 
or Jet A fuels.  Information on the toxicokinetics of some components of jet fuel is available (see 
toxicological profiles for benzene [Agency for Toxic Substances and Disease Registry 2007a]; toluene
[Agency for Toxic Substances and Disease Registry 2015]; total xylenes [Agency for Toxic Substances 
and Disease Registry 2007b]; ethylbenzene [Agency for Toxic Substances and Disease Registry 2010);
and naphthalene, 1-methylnaphthalene, and 2-methylnaphthalene [Agency for Toxic Substances and 
Disease Registry 2005]); it should be noted, however, that the interaction of these compounds may
influence their individual toxicokinetic properties. Indirect evidence suggests that JP-5, JP-8, and Jet A
fuel components may be absorbed through the respiratory tract and the gastrointestinal tract in humans
and laboratory animals (see Section 3.4.1).  Experimental studies in humans and animals, as well as in 
vitro studies using human or animal skin models, have demonstrated the dermal absorption of JP-8 
components.  No data were located concerning the metabolism of JP-5, JP-8, or Jet A fuel in humans or
laboratory animals.  No quantitative data were found regarding the excretion of JP-5, JP-8, or Jet A fuel.
3.4.1 Absorption 
3.4.1.1  Inhalation Exposure 
No studies were located specifically regarding the absorption of JP-5, JP-8, or Jet A fuel components in 
humans or laboratory animals after inhalation exposure.  However, adverse health effects including
systemic toxicity and neurotoxicity observed in humans (Air Force 2001; Proctor et al. 2011; Tu et al. 
2004) or laboratory animals (Gaworski et al. 1984; Hanas et al. 2010; Mattie et al. 1991; Ritchie et al.
2001; Rossi et al. 2001) exposed to jet fuels by inhalation provide indirect evidence for inhalation 
absorption.
3.4.1.2  Oral Exposure
No studies were located specifically regarding the absorption of JP-5, JP-8, or Jet A fuel components in 
humans after oral exposure.  Indirect evidence of oral absorption of jet fuel components comes from
studies reporting non-portal of entry effects in animals exposed to JP-5 (Bogo et al. 1983; Parker et al.
1981), JP-8 (Cooper and Mattie 1996; Dudley et al. 2001; Keil et al. 2004; Mattie et al. 1995, 2000;
Peden-Adams et al. 2001), or Jet A (Smith et al. 1999).  
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3.4.1.3  Dermal Exposure 
Information on the absorption of JP-8 components through the skin comes from an occupational exposure
study (Chao et al. 2005), short-duration experimental studies in humans (Chao and Nylander-French 
2004; Mattorano et al. 2004), modeling studies (Kim et al. 2006a, 2006b, 2007), and in vitro studies using
human or animal skin models (Baynes et al. 2001; Kanikkannan et al. 2001; McDougal et al. 2000;
Muhammad et al. 2005a; Riviere et al. 1999).  Using a tape-stripping method that used naphthalene as a 
marker of JP-8 exposure, Nylander-French and associates (Chao and Nylander-French 2004; Mattorano et
al. 2004) demonstrated the dermal absorption of JP-8 through human skin following exposure to liquid jet
fuel for ≤30 minutes.  The amount of naphthalene removed in the tape strips was inversely related to the
post-exposure time.  Mattorano et al. (2004) estimated that 5 minutes after exposure, 70% of the
naphthalene remained on the skin of fuel cell maintenance workers; after 10 minutes, only 33% remained 
on the skin and after 20 minutes, approximately 1% remained.  A study of Air Force fuel-cell
maintenance workers routinely working with JP-8 found a significant relationship between exposure
category (high, moderate, or low exposure based on job titles) and naphthalene levels detected via tape 
stripping in various areas of the body (Chao et al. 2005).  Multivariate linear regression models also
showed that skin irritation and increasing duration of exposure increased JP-8 component dermal
absorption.
Subsequent studies attempted to quantify the absorption and penetration of several aromatic and aliphatic
components of JP-8. Kim et al. (2006b) estimated that the aromatic components penetrated faster than the
aliphatic components after a single 30-minute dermal-only exposure to JP-8.  The rank order of the
apparent permeability coefficients (KP) of aromatic and aliphatic components of JP-8 was naphthalene
> 1-methyl naphthalene = 2-methyl naphthalene > decane > dodecane > undecane.  Kim et al. (2006a)
calculated apparent permeability coefficients of 5.3x10-5, 2.9x10-5, 3.2x10-5, 6.5x10-6, 4.5x10-7, and 
1.6x10-6 cm/hour for naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and 
dodecane, respectively.
A data-based, four-compartment model developed by Kim et al. (2006a) accurately predicted the time-
course of absorption and appearance in the blood of six components of JP-8 (naphthalene, 1-methyl 
naphthalene, 2-methyl naphthalene, n-decane, n-undecane, and n-dodecane) in humans following
administration of JP-8 to the forearm.  The four compartments were the stratum corneum, viable
epidermis, blood, and a fat storage compartment. The diffusion rate constant across the stratum corneum
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was predicted to be about 4 orders of magnitude less than diffusion across the viable epidermis. The 
model was used to estimate the cumulative internal dose of naphthalene resulting from dermal exposure
to JP-8 at three different concentrations:  344, 483, and 4,188 ng/m2 for 4 hours; the cumulative doses
were 1.61, 2.26, and 19.56 ng-minute/mL, respectively.  A subsequent study used a mathematical model
and tape-stripping data in humans to calculate diffusion coefficients for five JP-8 components (Kim et al.
2008).  The diffusion coefficients were 4.2, 4.6, 4.5, 4.2, and 5.0 cm2/minute x10-8 for naphthalene,
1-methylnaphthalene, 2-methylnaphthalene, undecane, and dodecane, respectively.
In vitro studies using human (Kanikkannan et al. 2001), pig (Kanikkannan et al. 2001; Riviere et al. 
1999), or rat (McDougal et al. 2000) skin have demonstrated the penetration and absorption of JP-8 
components.  Using rat skin, McDougal et al. (2000) showed that 13 components of JP-8 penetrated the
skin after a 3.5-hour exposure; the components included diethylene glycol monomethyl ether, decane, 
methyl naphthalenes, trimethyl benzenes, undecane, naphthalene, xylene, dimethyl naphthalenes, toluene, 
dodecane, nonane, ethylbenzene, and tridecane.  The aromatic hydrocarbon components penetrated the
skin better than the aliphatic components. The permeability coefficients ranged from 8.0x10-2 for 
diethylene glycol monomethyl ether to 1.4x10-5 for dodecane.  The components with lower octanol/water
partition coefficients were found to have the larger permeability coefficients. The permeability
coefficients of tridecane, nonane, naphthalene, and toluene from JP-8 across human skin (6.699x10-5 , 
7.239x10-5, 2.170x10-4, 1.968x10-4, respectively) were similar to the values calculated using pig ear skin
(6.982x10-5, 5.410x10-5, 1.808x10-4, 2.470x10-4, respectively) (Kanikkannan et al. 2001).  Riviere et al.
(1999), using pig skin, estimated that 1.17, 0.63, and 0.18% (measured as the percentage of the dose) of
radiolabelled naphthalene, dodecane, and hexadecane from JP-8 were absorbed. Similarly, Baynes et al.
(2001) found that approximately 1% of naphthalene and 0.6% of dodecane dose was absorbed through 
porcine skin flaps.  In an in vivo study in weanling pigs, a 30-minute exposure to radiolabelled 
hexadecane, heptane, and xylene in a JP-8 vehicle resulted in 0.34, 0.18, and 0.12% of the dose being
detected at the application site (Singh et al. 2003).  Previous in vivo exposure to JP-8 for 1 or 4 days
resulted in an increased absorption of aromatic hydrocarbons such as naphthalene, ethylbenzene, 
o-xylene, and trimethylbenzene following in vitro pig skin exposure (Muhammad et al. 2005a).  For some
aliphatic compounds (undecane, dodecane, and tridecane), a 1-day in vivo exposure did not affect the 
absorption following a subsequent in vitro exposure; however, a 4-day exposure did result in significant
increase in absorption in the in vitro exposure phase of the study. The investigators suggested that the 
increased absorption was due to lipid extraction from the stratum corneum by the JP-8 components.
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At the end of a 3.5-hour in vitro exposure of rat skin, only six JP-8 components were detected in the skin;
all were aliphatic compounds with high octanol/water partition coefficients: nonane, decane, undecane, 
dodecane, tridecane, and tetradecane (McDougal et al. 2000). An in vivo study in rats also showed that
the amount of aliphatic compounds absorbed was influenced by the concentration of kerosene per unit
area of skin exposed rather than the amount of skin that was exposed (Tsujino et al. 2003).
3.4.2 Distribution 
3.4.2.1  Inhalation Exposure 
No studies were located regarding the distribution of JP-5, JP-8, or Jet A fuel in humans after inhalation 
exposure. A study by Martin et al. (2012) demonstrated that one component of JP-8 (toluene) was
detected in the blood, fat, brain, lung, and liver following a 4-hour exposure to 2,700 mg/m3 JP-8 aerosols 
or 900 mg/m3 JP-8 vapor.
3.4.2.2  Oral Exposure
No studies were located regarding the distribution of JP-5, JP-8, or Jet A fuel in humans after oral
exposure.
3.4.2.3  Dermal Exposure 
No studies were located regarding the distribution of JP-5, JP-8, or Jet A fuel in humans or laboratory
animals after dermal exposure.
3.4.3 Metabolism
No studies were located regarding the metabolic pathway of JP-5, JP-8, or Jet A fuel in humans or
laboratory animals subsequent to inhalation, oral, or dermal exposure.
Limited animal data indicate that kerosene is absorbed and the components are distributed to various
tissues (Mann et al. 1977).  Kerosene, labelled with 3H-toluene or 14C-hexadecane, was given to
tracheotomized baboons (15 mL/kg) by nasogastric tube (Mann et al. 1977).  Radioactivity was recovered
from the brain, lung, liver, spleen, heart, and kidney after 6 hours.  3H-Toluene was absorbed and taken up 
by most tissues to a greater extent than was 14C-hexadecane; however, the amounts absorbed and 
distributed were minimal (Mann et al. 1977).
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3.4.4 Elimination and Excretion 
There are limited data on the excretion of JP-5, JP-8, or Jet A fuels following inhalation, oral, or dermal
exposure in humans or laboratory animals. A study of workers exposed to JP-8, found higher post-shift 
1-naphthol and 2-naphthol urinary levels, as compared to pre-shift levels (Maule et al. 2013).
3.4.5 Physiologically Based Pharmacokinetic (PBPK)/Pharmacodynamic (PD) Models 
Physiologically based pharmacokinetic (PBPK) models use mathematical descriptions of the uptake and
disposition of chemical substances to quantitatively describe the relationships among critical biological
processes (Krishnan et al. 1994).  PBPK models are also called biologically based tissue dosimetry
models.  PBPK models are increasingly used in risk assessments, primarily to predict the concentration of
potentially toxic moieties of a chemical that will be delivered to any given target tissue following various
combinations of route, dose level, and test species (Clewell and Andersen 1985).  Physiologically based 
pharmacodynamic (PBPD) models use mathematical descriptions of the dose-response function to 
quantitatively describe the relationship between target tissue dose and toxic end points.
PBPK/PD models refine our understanding of complex quantitative dose behaviors by helping to 
delineate and characterize the relationships between: (1) the external/exposure concentration and target
tissue dose of the toxic moiety, and (2) the target tissue dose and observed responses (Andersen and 
Krishnan 1994; Andersen et al. 1987).  These models are biologically and mechanistically based and can 
be used to extrapolate the pharmacokinetic behavior of chemical substances from high to low dose, from
route to route, between species, and between subpopulations within a species.  The biological basis of
PBPK models results in more meaningful extrapolations than those generated with the more conventional
use of uncertainty factors.
The PBPK model for a chemical substance is developed in four interconnected steps: (1) model
representation, (2) model parameterization, (3) model simulation, and (4) model validation (Krishnan and
Andersen 1994).  In the early 1990s, validated PBPK models were developed for a number of
toxicologically important chemical substances, both volatile and nonvolatile (Krishnan and Andersen 
1994; Leung 1993).  PBPK models for a particular substance require estimates of the chemical substance-
specific physicochemical parameters, and species-specific physiological and biological parameters. The 
numerical estimates of these model parameters are incorporated within a set of differential and algebraic 
equations that describe the pharmacokinetic processes.  Solving these differential and algebraic equations 
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provides the predictions of tissue dose.  Computers then provide process simulations based on these
solutions.  
The structure and mathematical expressions used in PBPK models significantly simplify the true 
complexities of biological systems. If the uptake and disposition of the chemical substance(s) are 
adequately described, however, this simplification is desirable because data are often unavailable for
many biological processes.  A simplified scheme reduces the magnitude of cumulative uncertainty.  The
adequacy of the model is, therefore, of great importance, and model validation is essential to the use of
PBPK models in risk assessment.
PBPK models improve the pharmacokinetic extrapolations used in risk assessments that identify the
maximal (i.e., the safe) levels for human exposure to chemical substances (Andersen and Krishnan 1994).
PBPK models provide a scientifically sound means to predict the target tissue dose of chemicals in
humans who are exposed to environmental levels (for example, levels that might occur at hazardous waste 
sites) based on the results of studies where doses were higher or were administered in different species.
Figure 3-3 shows a conceptualized representation of a PBPK model.
If PBPK models for JP-5, JP-8, and Jet A fuels exist, the overall results and individual models are 
discussed in this section in terms of their use in risk assessment, tissue dosimetry, and dose, route, and
species extrapolations.
Kim et al. (2006a) developed a four-compartment dermatotoxicokinetic model that accurately predicted 
the time-course of absorption and appearance in the blood of six components of JP-8 (naphthalene, 
1-methyl naphthalene, 2-methyl naphthalene, n-decane, n-undecane, and n-dodecane) in humans
following administration of JP-8 to the forearm.  The mean apparent permeability coefficients for the six
components are 5.3x0-5, 3.2x10-5, 2.9x10-5, 6.5x10-6, 1.6x10-6, and 4.5x10-7 for naphthalene, 
2-methylnaphthalene, 1-methylnaphthalene, decane, dodecane, and undecane, respectively.
With the goal of developing a PBPK model for inhaled JP-8, Campbell and Fisher (2007) examined the
metabolic interactions of two JP-8 components, m-xylene and ethylbenzene.  At low JP-8 concentrations
(<400 mg/m3), minimal or no metabolic interactions were found.  At the highest concentration 
(2,700 mg/m3), a 40 and 46% increase in the area-under-the-concentration curve values for blood xylene
and ethylbenzene, respectively, was found.  Martin et al. (2012) developed a PBPK model for JP-8 that
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Figure 3-3.  Conceptual Representation of a Physiologically Based
 
Pharmacokinetic (PBPK) Model for a 

Hypothetical Chemical Substance
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Note:  This is a conceptual representation of a physiologically based pharmacokinetic (PBPK) model for a 
hypothetical chemical substance.  The chemical substance is shown to be absorbed via the skin, by inhalation, or by
ingestion, metabolized in the liver, and excreted in the urine or by exhalation.
Source:  adapted from Krishnan and Andersen 1994
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could predict the dosimetry following inhalation of aerosol and vapor jet fuel. The model was developed 
using submodels for six aliphatic and aromatic hydrocarbon markers (n-octane, n-decane, n-tetradecane,
toluene, ethylbenzene, and m-xylene), plus three submodels that represent the lumped fractions in fuel
based on physical property similarities (aromatic hydrocarbons, 8–10-carbon hydrocarbon aliphatics, and 
heavier aliphatic hydrocarbons). The investigators noted that additional refinements of this model will
include submodels for other jet fuel components.
3.5  MECHANISMS OF ACTION 
3.5.1 Pharmacokinetic Mechanisms
No studies were identified concerning the pharmacokinetic mechanisms of JP-5, JP-8, or Jet A fuels.
3.5.2 Mechanisms of Toxicity
A number of acute inhalation studies involving mixed exposure to JP-8 aerosols and vapors have 
identified the respiratory tract as a target of toxicity. The observed effects include increased respiratory
permeability, increases in inspiratory resistance and dynamic compliance, interstitial edema and 
thickening of the bronchiolar epithelium, and deterioration of the alveolar-capillary barrier (Hays et al.
1995; Herrin et al. 2006; Pfaff et al. 1995, 1996; Robledo and Witten 1998, 1999; Robledo et al. 2000;
Wang et al. 2001; Wong et al. 2004, 2008).  The molecular mechanisms responsible for these effects have 
not been established.
In vivo and in vitro studies have found that alveolar type II cells and alveolar macrophages are targets of
JP-8 toxicity.  In the alveolar type II cells, exposure to lower JP-8 concentrations results in an increase in
the density of lamellar bodies (Espinoza et al. 2007; Hays et al. 1995, 2003; Herrin et al. 2006; Wong et
al. 2008), which is indicative of an increase in the production and secretion of surfactant (Hays et al.
2003).  At higher JP-8 concentrations, lysis of alveolar type II cells has been observed (Hays et al. 2003;
Pfaff et al. 1995).  Robb et al. (2010) demonstrated a gradual decline in cultured alveolar type II cell
viability with increasing JP-8 concentrations.  It is likely that the cell death is due to apoptosis rather than 
necrosis (Boulares et al. 2002; Stoica et al. 2001); this is supported by the finding of DNA fragmentation 
and increased cystolic cytochrome C levels, which is indicative of mitochondrial damage (Stoica et al.
2001).
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The damage to respiratory cells may be related to increased levels of reactive oxygen species (ROS)
generated during phase 1 metabolism of JP-8 components and the subsequent depletion of glutathione
(Hays et al. 2003).  Glutathione depletion could result in airway cell necrosis and dilation of bronchial
airway junctions and ultimately to increased respiratory permeability via exfoliation of the airways. This 
theory is supported by the finding of increased ROS generation (Espinoza et al. 2007) and decreased 
glutathione levels in alveolar macrophages exposed to high JP-8 concentrations (Boulares et al. 2002).  At
lower JP-8 concentrations, intracellular glutathione levels were not affected; however, there was a 
decrease in manganese superoxide dismutase levels, which may result in increases in nitric oxide and
peroxynitrite formation (Espinoza et al. 2007).  The generation of these reactive nitrogen species induced 
the expression of a number of proinflammatory mediators in alveolar macrophages including
interleukin-1 (IL-1), COX-2, inducible nitric oxide synthase (iNOS), and poly(ADP-ribose) polymerase 
(PARP-1) (Espinoza et al. 2006, 2007; Sun et al. 2007).
3.5.3 Animal-to-Human Extrapolations 
The available toxicological studies do not allow determining which species would be a suitable model to
predict health outcomes in humans exposed to JP-5, JP-8, or Jet A fuels.
3.6  TOXICITIES MEDIATED THROUGH THE NEUROENDOCRINE AXIS
Recently, attention has focused on the potential hazardous effects of certain chemicals on the endocrine
system because of the ability of these chemicals to mimic or block endogenous hormones.  Chemicals 
with this type of activity are most commonly referred to as endocrine disruptors. However, appropriate
terminology to describe such effects remains controversial.  The terminology endocrine disruptors, 
initially used by Thomas and Colborn (1992), was also used in 1996 when Congress mandated the EPA to 
develop a screening program for “...certain substances [which] may have an effect produced by a 
naturally occurring estrogen, or other such endocrine effect[s]...”. To meet this mandate, EPA convened a 
panel called the Endocrine Disruptors Screening and Testing Advisory Committee (EDSTAC), and in 
1998, the EDSTAC completed its deliberations and made recommendations to EPA concerning endocrine
disruptors.  In 1999, the National Academy of Sciences released a report that referred to these same types 
of chemicals as hormonally active agents. The terminology endocrine modulators has also been used to
convey the fact that effects caused by such chemicals may not necessarily be adverse.  Many scientists 
agree that chemicals with the ability to disrupt or modulate the endocrine system are a potential threat to
the health of humans, aquatic animals, and wildlife.  However, others think that endocrine-active 
chemicals do not pose a significant health risk, particularly in view of the fact that hormone mimics exist
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
    
   
   
  
     
 
   
    
 
     
     
 
    
    
     
 
   
 
  
        
 
   
    
 
     
   
  
 
   
     
     
  
   
 
 
 
 
  
121JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
in the natural environment.  Examples of natural hormone mimics are the isoflavinoid phytoestrogens
(Adlercreutz 1995; Livingston 1978; Mayr et al. 1992).  These chemicals are derived from plants and are 
similar in structure and action to endogenous estrogen.  Although the public health significance and 
descriptive terminology of substances capable of affecting the endocrine system remains controversial,
scientists agree that these chemicals may affect the synthesis, secretion, transport, binding, action, or
elimination of natural hormones in the body responsible for maintaining homeostasis, reproduction, 
development, and/or behavior (EPA 1997).  Stated differently, such compounds may cause toxicities that
are mediated through the neuroendocrine axis.  As a result, these chemicals may play a role in altering,
for example, metabolic, sexual, immune, and neurobehavioral function.  Such chemicals are also thought
to be involved in inducing breast, testicular, and prostate cancers, as well as endometriosis (Berger 1994;
Giwercman et al. 1993; Hoel et al. 1992).
There is no evidence from human or animal studies suggesting that JP-5, JP-8, or Jet A fuels might be
endocrine disruptors following inhalation, oral, or dermal exposure. In addition, no in vitro studies were 
located regarding endocrine disruption of JP-5, JP-8, or Jet A fuels.
3.7  CHILDREN’S SUSCEPTIBILITY
This section discusses potential health effects from exposures during the period from conception to 
maturity at 18 years of age in humans, when all biological systems will have fully developed.  Potential
effects on offspring resulting from exposures of parental germ cells are considered, as well as any indirect
effects on the fetus and neonate resulting from maternal exposure during gestation and lactation.  
Relevant animal and in vitro models are also discussed.
Children are not small adults.  They differ from adults in their exposures and may differ in their
susceptibility to hazardous chemicals.  Children’s unique physiology and behavior can influence the
extent of their exposure.  Exposures of children are discussed in Section 6.6, Exposures of Children.
Children sometimes differ from adults in their susceptibility to hazardous chemicals, but whether there is 
a difference depends on the chemical (Guzelian et al. 1992; NRC 1993).  Children may be more or less
susceptible than adults to health effects, and the relationship may change with developmental age 
(Guzelian et al. 1992; NRC 1993).  Vulnerability often depends on developmental stage.  There are
critical periods of structural and functional development during both prenatal and postnatal life, and a
particular structure or function will be most sensitive to disruption during its critical period(s).  Damage
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may not be evident until a later stage of development.  There are often differences in pharmacokinetics
and metabolism between children and adults.  For example, absorption may be different in neonates
because of the immaturity of their gastrointestinal tract and their larger skin surface area in proportion to 
body weight (Morselli et al. 1980; NRC 1993); the gastrointestinal absorption of lead is greatest in infants
and young children (Ziegler et al. 1978).  Distribution of xenobiotics may be different; for example, 
infants have a larger proportion of their bodies as extracellular water, and their brains and livers are 
proportionately larger (Altman and Dittmer 1974; Fomon 1966; Fomon et al. 1982; Owen and Brozek
1966; Widdowson and Dickerson 1964).  The fetus/infant has an immature (developing) blood-brain 
barrier that past literature has often described as being leaky and poorly intact (Costa et al. 2004).  
However, current evidence suggests that the blood-brain barrier is anatomically and physically intact at 
this stage of development, and the restrictive intracellular junctions that exist at the blood-CNS interface 
are fully formed, intact, and functionally effective (Saunders et al. 2008, 2012).
However, during development of the blood-brain barrier, there are differences between fetuses/infants and
adults which are toxicologically important. These differences mainly involve variations in physiological
transport systems that form during development (Ek et al. 2012).  These transport mechanisms (influx and 
efflux) play an important role in the movement of amino acids and other vital substances across the
blood-brain barrier in the developing brain; these transport mechanisms are far more active in the
developing brain than in the adult.  Because many drugs or potential toxins may be transported into the
brain using these same transport mechanisms—the developing brain may be rendered more vulnerable
than the adult.  Thus, concern regarding possible involvement of the blood-brain barrier with enhanced 
susceptibility of the developing brain to toxins is valid. It is important to note however, that this potential
selective vulnerability of the developing brain is associated with essential normal physiological
mechanisms; and not because of an absence or deficiency of anatomical/physical barrier mechanisms.
The presence of these unique transport systems in the developing brain of the fetus/infant is intriguing; as 
it raises a very important toxicological question as to whether these mechanisms provide protection for
the developing brain or do they render it more vulnerable to toxic injury.  Each case of chemical exposure
should be assessed on a case-by-case basis.  Research continues into the function and structure of the 
blood-brain barrier in early life (Kearns et al. 2003; Saunders et al. 2012; Scheuplein et al. 2002).
Many xenobiotic metabolizing enzymes have distinctive developmental patterns. At various stages of
growth and development, levels of particular enzymes may be higher or lower than those of adults, and 
sometimes unique enzymes may exist at particular developmental stages (Komori et al. 1990; Leeder and
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Kearns 1997; NRC 1993; Vieira et al. 1996).  Whether differences in xenobiotic metabolism make the
child more or less susceptible also depends on whether the relevant enzymes are involved in activation of
the parent compound to its toxic form or in detoxification.  There may also be differences in excretion, 
particularly in newborns who all have a low glomerular filtration rate and have not developed efficient
tubular secretion and resorption capacities (Altman and Dittmer 1974; NRC 1993; West et al. 1948).  
Children and adults may differ in their capacity to repair damage from chemical insults.  Children also
have a longer remaining lifetime in which to express damage from chemicals; this potential is particularly
relevant to cancer.
Certain characteristics of the developing human may increase exposure or susceptibility, whereas others 
may decrease susceptibility to the same chemical.  For example, although infants breathe more air per
kilogram of body weight than adults breathe, this difference might be somewhat counterbalanced by their
alveoli being less developed, which results in a disproportionately smaller surface area for alveolar
absorption (NRC 1993).
There are no studies of children exposed to JP-5, JP-8, or Jet A fuels, which reflects the fact that exposure 
to these fuels occurs almost exclusively at work during their manufacture or use. However, exposure to
kerosene via ingestion is one of the most common forms of acute childhood poisoning in many 
developing countries, since kerosene is used for cooking, heating and lightning and is usually stored in 
containers and places easily accessible to children. Detailed information regarding effects reported in
children following ingestion of kerosene as well as original references have been presented in
Section 3.2.2, Oral Exposure, and will not be repeated here. Instead, an overview is presented below.
Ingestion of kerosene caused death in children attributed to lipoid pneumonia, caused in turn, by
aspiration of kerosene into the lungs during vomiting.  One report estimated a lethal dose of
approximately 1,900 mg/kg based on the ingestion of 30 mL of kerosene by a 2-year-old child.  Based on 
reports that examined at least 50 cases of kerosene ingestion by children, the respiratory effects that
primarily occur from kerosene ingestion are bronchopneumonia, bronchitis, pneumonitis, lung infiltrates
and effusions, cough, dyspnea, and tachypnea.  Some studies reported long-lasting respiratory effects 
following acute poisoning, but others have not.  The amount ingested and the promptitude and quality of
the initial care probably play a role on whether acute poisoning causes long-lasting effects. Vomiting, 
possibly due to gastric irritation, is frequently reported in acute poisoning.  Leukocytosis and fever are
also commonly seen.  In reports of multiple cases, the neurological effects noted most frequently were 
unconsciousness or semiconsciousness, drowsiness, restlessness, and irritability. Coma and convulsions 
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
  
    
   
 
       
     
     
  
   
    
   
 
 
   
     
   
   
    
   
    
    
 
   
 
    
   
 
 
     
    
  
 
  
   
 
 
 
 
  
124JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
were also noted in numerous studies, but were usually evident in only one or two individuals per study
population. There are limited data that suggest that the central nervous system effects following ingestion
of kerosene are due to hypoxia from kerosene-induced respiratory impairment.
Developmental studies in animals have shown that inhalation or oral exposure of pregnant mice to JP-8
can result in altered immune competence in the pups (Harris et al. 2007b; Keil et al. 2003).  Oral exposure
of pregnant rats to JP-8 resulted in alterations in a swimming test in the pups that were indicative of a 
possible developmental delay in motor coordination; however, the delay did not affect motor ability at
later ages (Mattie et al. 2001).  Reduced fetal and pup weights were reported in developmental studies in 
rats exposed to JP-8 (Cooper and Mattie 1996; Mattie et al. 2001); however, no teratogenicity has been
reported in developmental studies in animals exposed to JP-5, JP-8, or Jet A fuels.
An early study in rats reported that a single dose of 22,400 mg/kg of kerosene killed 4/15 adults, 
10/15 juveniles, and 15/15 neonates in 3 days, suggesting increased susceptibility in younger animals
compared to adults (Deichmann et al. 1944).  A more recent study examined age-related differences in the 
toxicity JP-8 on various parameters of respiratory function (pulmonary mechanics, respiratory
permeability, lavaged cell profile, and chemical mediators in BALF) in mice aged 3.5 or 12 months
(Wang et al. 2001).  The mice were exposed nose-only to aerosolized JP-8 1 hour/day for 7 days. The
results showed similar responses in both groups of mice; however, it appeared that the inflammatory
mechanisms might have been different. No further information was located to determine whether there
are age-related susceptibilities to jet fuels in humans or in animals.
3.8  BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They have 
been classified as markers of exposure, markers of effect, and markers of susceptibility (NAS/NRC
1989).
A biomarker of exposure is a xenobiotic substance or its metabolite(s) or the product of an interaction
between a xenobiotic agent and some target molecule(s) or cell(s) that is measured within a compartment
of an organism (NAS/NRC 1989). The preferred biomarkers of exposure are generally the substance 
itself, substance-specific metabolites in readily obtainable body fluid(s), or excreta.  However, several
factors can confound the use and interpretation of biomarkers of exposure.  The body burden of a
substance may be the result of exposures from more than one source. The substance being measured may
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be a metabolite of another xenobiotic substance (e.g., high urinary levels of phenol can result from
exposure to several different aromatic compounds).  Depending on the properties of the substance (e.g., 
biologic half-life) and environmental conditions (e.g., duration and route of exposure), the substance and 
all of its metabolites may have left the body by the time samples can be taken.  It may be difficult to
identify individuals exposed to hazardous substances that are commonly found in body tissues and fluids
(e.g., essential mineral nutrients such as copper, zinc, and selenium).  Biomarkers of exposure to JP-5,
JP-8, and Jet A fuels are discussed in Section 3.8.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an
organism that, depending on magnitude, can be recognized as an established or potential health
impairment or disease (NAS/NRC 1989). This definition encompasses biochemical or cellular signals of
tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital epithelial
cells), as well as physiologic signs of dysfunction such as increased blood pressure or decreased lung
capacity.  Note that these markers are not often substance specific. They also may not be directly
adverse, but can indicate potential health impairment (e.g., DNA adducts).  Biomarkers of effects caused
by JP-5, JP-8, and Jet A fuels are discussed in Section 3.8.2.
A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism's ability
to respond to the challenge of exposure to a specific xenobiotic substance.  It can be an intrinsic genetic or
other characteristic or a preexisting disease that results in an increase in absorbed dose, a decrease in the 
biologically effective dose, or a target tissue response. If biomarkers of susceptibility exist, they are 
discussed in Section 3.10, Populations That Are Unusually Susceptible.
3.8.1 Biomarkers Used to Identify or Quantify Exposure to JP-5, JP-8, and Jet A Fuels
A study of Air Force personnel exposed to high (fuel cell maintenance workers), moderate (regular
contact with jet fuel via fuel handling, distribution, recovery, and testing), and low (subjects without
direct contact) levels of JP-8 found exposure-related increases in benzene and naphthalene levels in
expired air (Egeghy et al. 2003).  Multivariate analysis found a high correlation between airborne
naphthalene and a priori JP-8 exposure categories and was not highly influenced by background sources
and cigarette smoking. It contrast, benzene levels in post-exposure breath were significantly related to
pre-exposure breath benzene levels and recent smoking, suggesting that breath benzene levels may not be 
a good biomarker of JP-8 exposure.  Pleil et al. (2000) found increases in breath levels of “JP-8 
fingerprint compounds” (nonane, decane, undecane, and dodecane) in after-work breath samples of fuel
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maintenance workers, as compared to before-work samples.  Similar to the Egeghy et al. (2003) study, 
Pleil et al. (2000) found that benzene in expired air was not a good biomarker of exposure to JP-8 because 
smoking can result in a 400% increase in the benzene mean body burden.
Several studies have examined the possible association between exposure to JP-8 in Air Force fuel cell
maintenance workers and urinary excretion of several potential biomarkers, particularly 1- and 
2-naphthol.  Urinary levels of naphthalene, 1-naphthol, and/or 2-naphthol were higher in workers with 
high levels of JP-8 exposure as compared to workers with low levels of exposure (Serdar et al. 2003;
Smith et al. 2012) and the levels of 1- and 2-naphthol in urine were correlated with naphthalene air levels
(Serdar et al. 2004; Smith et al. 2012).  Other studies of Air Force fuel cell maintenance workers found a
statistical association between urinary 2-naphthol levels and dermal exposure to JP-8; however, no 
association was found for urinary 1-naphthol levels (Chao and Nylander-French 2004; Chao et al. 2006).  
However, exhaled breath naphthalene and breathing zone naphthalene levels significantly predicted 
urinary 1-naphthol and 2-naphthol levels (Chao et al. 2006). Regression analysis showed that breathing
zone naphthalene levels was a significant predictor of urinary 1-naphthol levels (after controlling for
smoking status, pre-shift 1- and 2-naphthol levels, and post-shift creatinine levels), but did not predict 
urinary 2-naphthol levels; time spent in the fuel tank was a significant predictor of 1- and 2-naphthol
levels (Smith et al. 2012).  High levels of urinary benzene were also found in the high-exposure workers;
however, the levels were similar to levels found in smokers (Serdar et al. 2003).
Urinary level of MEAA, a metabolite of 2-(2-methoxyethoxy)ethanol, which is added to JP-8, was shown 
to be a suitable biomarker of JP-8 exposure in oral and dermal exposure studies in mice (B’Hymer et al. 
2005).  In Air Force personnel, MEAA was detected in 94% of the urine samples of personnel in the high-
exposure group, 34% in the medium-exposure group, and 3% in the low-exposure group (B’Hymer et al. 
2012b). The mean urinary MEAA level (both unadjusted and adjusted for creatinine) in the high-
exposure group was significantly higher than the medium- and low-exposure groups and the mean of the
medium-exposure group was significantly higher than the low-exposure group.  B’Hymer et al. (2012a)
compared two other potential biomarkers of JP-8 exposure in Air Force personnel: S-benzylmercapturic 
acid (BMA), a metabolite of toluene, and S-phenylmercapturic acid (PMA), a metabolite of benzene, to 
the results from the B’Hymer et al. (2012b) study of MEAA.  BMA was detected in almost all urine
samples from personnel in the high- (98%), medium- (97%), and low- (95%) exposure categories, and the
mean levels were significantly higher in the high-exposure group, as compared to the low-exposure
group, but no difference was found between the high- and medium-exposure groups.  When BMA levels 
were adjusted for creatinine levels, no significant differences were found between the groups.  PMA was 
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detected in 34, 24, and 20% of the personnel in the high-, medium-, and low-exposure groups, 
respectively.  Mean levels of PMA were significantly higher in the high-exposure group, as compared to
the medium- and low-exposure groups; however, when the PMA levels were adjusted for creatinine 
levels, no significant differences were found between the three exposure categories.  Based on these 
results, B’Hymer et al. (2012a) concluded that MEAA is a suitable biomarker of JP-8 exposure because it
appears to be relatively specific for JP-8 exposure and it is easily detected at levels that allow for
distinguishing differences in exposure levels.
Kang-Sickel et al. (2011) examined the potential use of naphthyl-keratin adduct levels in the skin as a 
potential biomarker of dermal exposure to JP-8 among Air Force fuel maintenance workers.  Naphthyl­
keratin adduct levels correlated with urine naphthalene levels, but did not correlate with dermal, breath, or
breathing zone naphthalene levels or with urinary 1-naphthol, 2-naphthol, or total naphthol levels.  
However, regression analyses showed that log-transformed dermal naphthalene levels and age were 
inversely associated with skin naphthyl-keratin adduct levels and that naphthyl levels increased with
exposure duration (on sampling day). The investigators noted that as more naphthalene was absorbed into
the stratum corneum and metabolized by keratinocytes to form keratin adducts, less would remain on the
surface of the stratum corneum for sampling by tape-stripping, which may explain the inverse association
between dermal naphthalene levels and adduct levels.
3.8.2 Biomarkers Used to Characterize Effects Caused by JP-5, JP-8, and Jet A Fuels
No specific, quantitative biomarkers of effect for jet fuels were identified.
3.9  INTERACTIONS WITH OTHER CHEMICALS
The only information regarding interaction of jet fuels with other chemicals is from a study examining
immunotoxicity induced in female mice by single and concurrent exposure to N,N-diethyl-m-toluamide
(DEET), pyridostigmine bromide (PYR), and JP-8 (Peden-Adams et al. 2001).  Co-exposure to these 
chemicals was common among U.S. service personnel in the Persian Gulf War. JP-8 and PYR were
administered orally to mice, whereas DEET was administered by subcutaneous injection singly or as a
tertiary mixture for 14 days.  Most of a comprehensive number of immune end points examined were not
altered by the single or tertiary mixture of compounds (500 or 1,000 mg/kg JP-8; 15.5 or 31 mg/kg
DEET; 2 or 5 mg/kg PYR).  However, there was synergism with PYR, DEET, and JP-8, resulting in 
immune suppression of delayed-type hypersensitivity. While all individual agents suppressed humoral
immunity, the effect was not exacerbated by the simultaneous exposure to PYR, DEET, and JP-8.
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Kerosene vapor has been shown to increase hexobarbital-induced sleeping time in rats following acute 
exposure, and to alter the antipyretic action of phenacetin (an antipyretic) following subchronic exposure
(Starek and Vojtisek 1986).  In comparison to rats treated only with kerosene, intratracheal exposure of
rats to chrysotile asbestos (5 mg) and kerosene (0.05 mL) resulted in a decrease in cytochrome P-450 and 
decreases in the activities of benzo(a)pyrene hydroxylase, epoxide hydrase, and glutathione-S-transferase 
(Arif et al. 1992).  The investigators suggested that asbestos may increase the toxic potential of kerosene.
It should be kept in mind that any effect of JP-5, JP-8, or kerosene is the result of unknown interactions
between the individual components in these fuels.
3.10  POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 
A susceptible population will exhibit a different or enhanced response to JP-5, JP-8, and Jet A fuels than 
will most persons exposed to the same level of JP-5, JP-8, and Jet A fuels in the environment. Reasons
may include genetic makeup, age, health and nutritional status, and exposure to other toxic substances
(e.g., cigarette smoke).  These parameters may result in reduced detoxification or excretion of JP-5, JP-8, 
and Jet A fuels, or compromised function of organs affected by JP-5, JP-8, and Jet A fuels.  Populations
who may be at greater risk due to their unusually high exposure to JP-5, JP-8, and Jet A fuels are
discussed in Section 6.7, Populations with Potentially High Exposures.
No information was located regarding the toxicity of JP-5, JP-8, and Jet A fuels in susceptible
populations.  Available human data, in general, were based upon case studies that reported ingestion of
kerosene by children.  Children were not shown to be particularly susceptible to kerosene in the data
reviewed; however, children appear to be more likely to be accidentally orally exposed to kerosene than 
adults.  In particular, children who were ≤5 years old often mistakenly drank kerosene because it was 
accessible.
Data from a single animal study suggest that children may be more sensitive than adults to at least some 
of the effects of jet fuels, because younger rats were found to be more susceptible to acute oral exposure
to kerosene than older rats.  A single oral dose of 22,400 mg/kg kerosene killed 27% of the adult rats, 
66% of the 5-week-old rats, and 100% of the 10-day-old rats (Deichmann et al. 1944).  It is not known, 
however, whether kerosene would also be more toxic in younger humans than in older humans.
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
   
 
 
     
   
   
  
     
 
   
   
 
   
  
 
     
  
 
    
 
 
 
   
  
      
     
 
 
   
      
 
 
 
 
    
     
       
 
 
 
 
  
129JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
3.11  METHODS FOR REDUCING TOXIC EFFECTS
This section will describe clinical practice and research concerning methods for reducing toxic effects of
exposure to JP-5, JP-8, and Jet A fuels.  However, because some of the treatments discussed may be 
experimental and unproven, this section should not be used as a guide for treatment of exposures to JP-5,
JP-8, and Jet A fuels.  When specific exposures have occurred, poison control centers and medical
toxicologists should be consulted for medical advice.  The following texts provide information about
treatment following exposures hydrocarbon products, the main components of JP-5, JP-8, and Jet A fuels:  
Gummin DD.  2015. Hydrocarbons.  In: Hoffman RS, Howland MA, Lewin NA, et al., eds.  Goldfrank's
toxicologic emergencies. 10th ed.  New York, NY:  McGraw Hill Education, 1334-1345.  
Shannon MW, Borron SW, Burns MJ, eds.  2007.  Haddad and Winchester’s clinical management of
poisoning and drug overdose.  4th ed.  Philadelphia, PA:  WB Saunders Company, 1343-1346.
Wang RY.  2004.  Hydrocarbon products.  In: Dart RC, ed.  Medical toxicology.  3rd ed.  Philadelphia,
PA:  Lipincott Williams & Wilkins, 1328-1351.  
3.11.1 Reducing Peak Absorption Following Exposure 
The following information was extracted from the books listed above. 
The mitigation procedures for jet fuels parallel those for hydrocarbon poisoning in general.  Inhalation 
and ingestion appear to be the most serious routes of exposure.  In the case of overexposure by inhalation, 
it is suggested that the patient be moved to an area of fresh air and given basic supportive treatment,
including 100% humidified supplemental oxygen as required. Contaminated clothing should be removed 
to avoid further exposure.
For poisoning by ingestion, the treatment protocol is more complex.  As with inhalation, it is
recommended that the patient receive prompt supportive medical care. The primary concern for the
person who has ingested hydrocarbons such as kerosene is hydrocarbon aspiration either during ingestion 
or during gastric evacuation.  Aspiration of the hydrocarbon into the lungs can cause hydrocarbon 
pneumonitis and secondary infections, including pneumonia.
Because of the aspiration risk, a controversy has developed over which (if either) of two gastric 
evacuation treatments is better: induced vomiting or gastric lavage.  In general, the recommendation is
that no form of gastric emptying be used if the amount of hydrocarbon ingestion is small.  If unknown or
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large amounts (volumes >100 mL) have been ingested, then the decision as to how or if there is a need to 
evacuate the stomach should be based on the state of the patient, the hydrocarbon’s viscosity, and the
involvement of other more dangerous chemicals.  The viscosity of the fuel is extremely important and
may determine the extent of the lung damage following aspiration.  For conscious patients with 
operational intact gag reflexes and without spontaneous emesis, induced vomiting seems to be the
preferred method of gastric emptying; otherwise, endotracheal intubation followed by gastric lavage can
be employed.
Controversy also exists over whether or not to administer activated charcoal (to bind the hydrocarbon) or
cathartics.  Some people question the overall effectiveness of activated charcoal and cathartics.  In
addition, activated charcoal may cause vomiting, which may or may not be desired.  Most agree,
however, that if cathartics are administered, they should be saline cathartics, such as magnesium or
sodium sulfate or citrate, and not oil-based cathartics, such as mineral oil.
In general, the prophylactic administration of antibiotics or corticosteroids does not appear useful in 
treating hydrocarbon pneumonitis.  The use of antibiotics is recommended only to only treat secondary
lung infections.
If the skin is exposed to jet fuels, washing the area of contact with large amounts of soapy water is
recommended.  If blistering or skin loss occurs, then the use of sterile water alone is suggested.  For
ocular exposure, flushing the eyes liberally with water and, if necessary, using proparacaine
hydrochloride to assist the irrigation, are the recommended treatment protocols.
A study was conducted to determine whether protection through the use skin creams or lotions was
feasible, and whether a single application would provide sufficient and consistent protection before
exposure to JP-8 (Wagner et al. 2009). The investigators tested a wide variety of over-the-counter (OTC)
creams as well as some formulated creams in vitro using a Silastic® barrier or harvested pig skin and in 
vivo in rabbit skin.  In the in vivo experiments, the barrier creams were scored in three ways: by visual
scoring described by the Draize method, by colorimetry, and by histopathology.  JP-8 was applied 
undiluted in amounts of 0.5 mL to shaved areas of the backs of rabbits by means of Hill Top Chambers
for 4 hours.  Application sites were scored 40 minutes after the chambers were removed and 24, 48, and 
72 hours after exposure. While some OTC creams showed some effectiveness in preventing JP-8 
absorption in the cell diffusion chambers, they did not prevent absorption and skin irritation in the live
rabbits’ skin.  Some formulated creams worked better than OTC creams in the diffusion chamber, yet they
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did not perform when tested on the animal model.  The investigators concluded that the best protection
against dermal exposure to JP-8 is the use of personal protection equipment.
3.11.2 Reducing Body Burden
Little is known about the toxicokinetics of jet fuels, and there are no accepted methods for the reduction 
of body burden.
3.11.3 Interfering with the Mechanism of Action for Toxic Effects
Although the pulmonary response to aerosolized kerosene and the effect of kerosene on heme 
biosynthesis have been partially investigated, the toxicities of jet fuels as well as their mechanisms are not
well defined.  As such, no known therapies are available to disrupt the mechanisms of action.
3.12  ADEQUACY OF THE DATABASE 
Section 104(I)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of JP-5, JP-8, and Jet A fuels is available. Where adequate 
information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is
required to assure the initiation of a program of research designed to determine the health effects (and
techniques for developing methods to determine such health effects) of JP-5, JP-8, and Jet A fuels.
3.12.1 Existing Information on Health Effects of JP-5, JP-8, and Jet A fuels
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to
JP-5, JP-8, and Jet A fuels are summarized in Figure 3-4.  The purpose of this figure is to illustrate the
existing information concerning the health effects of JP-5, JP-8, and Jet A fuels. Each dot in the figure
indicates that one or more studies provide information associated with that particular effect.  The dot does
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be
evaluated and prioritized, and a substance-specific research agenda will be proposed.
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not necessarily imply anything about the quality of the study or studies, nor should missing information in 
this figure be interpreted as a “data need”.  A data need, as defined in ATSDR’s Decision Guide for
Identifying Substance-Specific Data Needs Related to Toxicological Profiles (Agency for Toxic
Substances and Disease Registry 1989), is substance-specific information necessary to conduct
comprehensive public health assessments.  Generally, ATSDR defines a data gap more broadly as any
substance-specific information missing from the scientific literature.
There are limited data on the toxicity of JP-5, JP-8, or Jet A fuels in humans; the available studies have 
evaluated neurologic, reproductive, genotoxic, or carcinogenic end points following inhalation exposure.  
However, there are a number of studies and case-reports of humans exposed to kerosene, which has a
similar composition to jet fuels. These kerosene studies have reported systemic effects following
inhalation exposure, death, systemic, and neurological effects following oral exposure, and systemic
effects following dermal exposure.  Information is also available in laboratory animals on death and acute 
and intermediate systemic effects as well as on immunological, neurological, developmental, and
carcinogenic effects following inhalation exposure to jet fuels; on death, acute and intermediate systemic 
effects, immunological, neurological, reproductive, developmental, and genotoxic effects following
ingestion; and on death, acute, intermediate, and chronic systemic effects, immunological, neurological, 
and carcinogenic effects following dermal exposure.
Therefore, as Figure 3-4 shows, the majority of the data on health effects of jet fuels comes from animal
studies with some limited data in humans exposed via inhalation exposure.
3.12.2 Identification of Data Needs 
The following are topical sections that identify gaps in the present state of knowledge concerning the 
toxicology of JP-5, JP-8, and Jet A fuels.  Each of the sections identifies specific areas in which additional
data are needed to gain a greater understanding of the toxicity of jet fuels as well as of the biochemical 
mechanisms of their toxicity.
Acute-Duration Exposure. The only information available regarding effects in humans following
acute inhalation exposure to the jet fuels subject of this profile is that from a report of accidental exposure
to unknown concentrations of JP-5 vapors by two pilots flying a small airplane (Porter 1990). This report
provided some information on systemic and neurological effects; limited conclusions can be drawn from 
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Figure 3-4.  Existing Information on Health Effects of JP-5, JP-8, and Jet A Fuels
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data on two individuals.  A study in six volunteers exposed to 140 mg/m3 deodorized kerosene vapors for
15 minutes provided data on throat and eye irritation for this fuel (Carpenter et al. 1976).  This
information is insufficient to derive an acute inhalation MRL for JP-5, JP-8, or Jet A fuels based on
human data.  Studies in animals provided information on respiratory and ocular effects of JP-8 and 
JP-8+100 in rats (Wolfe et al. 1996), respiratory effects of JP-8 in mice (Herrin et al. 2006; Robledo and 
Witten 1998, 1999; Robledo et al. 2000; Wang et al. 2001; Wong et al. 2004, 2008), immunological
effects of JP-8 in mice (Harris et al. 1997a, 1997b, 1997c, 2000a, 2000b, 2000c, 2007a, 2007c, 2008;
Hilgaertner et al. 2011), and neurological effects in rats (Fechter et al. 2007, 2012). Of the studies in
mice, only Herrin et al. (2006), Hilgaertner et al. (2011), and Wong et al. (2008) measured both aerosol
and vapor components of the airborne JP-8.  These studies were not considered suitable for development
of an acute inhalation MRL for JP-8 because the daily exposure duration (1 hour) was short and there
would be considerable uncertainty in extracting these data for continuous exposure.  Additional studies
are needed in which a variety of end points, including respiratory effects and immunotoxicity, are
examined following exposure for at least 6 hours/day. No human acute-duration oral data were located
for JP-5, JP-8, or Jet A fuels.  However, there are numerous case reports of accidental oral exposure to 
kerosene, particularly in children (Abu-Ekteish 2002; Akamaguna and Odita 1983; Aldy et al. 1978;
Annobil 1983; Annobil and Ogunbiyi 1991; Balme et al. 2012; Benois et al. 2009; Chun 1998; Dudin et
al. 1991; Lang et al. 2008; Lucas 1994; Mahdi 1988; Santhanakrishnan and Chithra 1978; Shotar 2005;
Simmank et al. 1998; St. John 1982).  These and many additional reports provide information regarding 
death and systemic and neurological effects, but few provided estimates of the amounts ingested.  The
animal data provided information regarding death in various species (Deichmann et al. 1944; Parker et
al.1981), immunological effects (Dudley et al. 2001; Keil et al. 2004; Peden-Adams et al. 2001), and 
developmental effects (Cooper and Mattie 1996; Keil et al. 2003). The database is lacking an adequate 
study examining systemic toxicity, which precludes identifying the most sensitive target of toxicity and 
derivation of an acute-duration oral MRL.  A repeated-dose study in rats and mice that includes 
examination of major tissues and organs would be useful for determining the critical targets of toxicity.
No acute-duration dermal studies in humans exposed to JP-5, JP-8, or Jet A fuels were found.  However,
a few studies showed that dermal exposure to kerosene can cause dermatitis and erythema in humans
(Mosconi et al. 1988; Tagami and Ogino 1973).  Numerous studies in animals provide information 
regarding dermal effects in various animal species (Baker et al. 1999; Chatterjee et al. 2006; Deichmann 
et al. 1944; Gallucci et al. 2004; Hurley et al. 2011; Kabbur et al. 2001; Kanikkannan et al. 2002;
Monteiro-Riviere et al. 2001, 2004; Singh and Singh 2001; Wolfe et al. 1996).  Many of these studies
described morphological and functional alterations of the skin.  Additional studies describing skin
alterations do not appear necessary, but further research on the mechanisms involved would provide
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valuable information.  Acute dermal studies that described alterations in immune function in mice
exposed to JP-8 are also available (Kanikkannan et al. 2000; Limón-Flores et al. 2009; Ramos et al. 2002, 
2007; Ullrich 1999; Ullrich and Lyons 2000).  Studies that examined the issue of skin sensitization in
mice are also available (Kanikkannan et al. 2000; Wolfe et al. 1996).
Intermediate-Duration Exposure. No studies were located of humans exposed to JP-5, JP-8, or Jet
A fuels for intermediate durations.  Animal data are available for intermediate duration by the inhalation,
oral, and dermal routes of exposure.  Ninety-day studies are available for JP-8 in rats (Hanas et al. 2010;
Mattie et al. 1991), JP-5 in rats, mice, and dogs (Gaworski et al. 1984), and kerosene in rats and dogs
(Carpenter et al. 1976). These studies provided information mainly on systemic effects, specifically on
histopathology of major organs and tissues.  Other intermediate-duration inhalation studies provided data
on neurological effects of JP-8 and JP-5 in rats (Ritchie et al. 2001; Rossi et al. 2001) and immunological
effects of jet fuel kerosene in rats and mice (White et al. 2013). The lowest LOAEL identified was 
150 mg/m3 and it was for liver histopathology in mice exposed to JP-5 vapors (the lowest exposure 
concentration tested) (Gaworski et al. 1984).  The lowest LOAEL for JP-8 was 500 mg/m3 (aerosol and 
vapor components) and it was for morphological alterations in the lungs, heart, liver, and bone marrow of
rats; the NOAEL was 250 mg/m3.  As it appears that acute-duration inhalation studies (Herrin et al. 2006;
Wong et al. 2008) identified ultrastructural alterations in the lungs of mice exposed to significantly lower
exposure concentrations of JP-8 (45–53 mg/m3), it would be appropriate to conduct intermediate-duration
inhalation studies that examine the lungs of mice and rats with transmission electron microscopy and 
perform lung function tests in the animals.  Intermediate-duration oral studies provided data on a wide 
range of systemic end points in rats exposed to JP-8 (Mattie et al. 1995, 2000).  These studies also 
provided information on fertility in male and female rats.  An additional study conducted neurobehavioral
tests on the offspring of female rats that were exposed to JP-8 during cohabitation, gestation, delivery,
and lactation (Mattie et al. 2001). The intermediate-duration oral database was considered inadequate for
derivation of an MRL.  Intermediate-duration inhalation studies have identified the liver as the most
sensitive target of toxicity in mice and dogs; the LOAEL in mice is lower than the highest NOAEL in
rats.  An oral study in mice in which the major tissues and organs are examined would allow greater
confidence in identifying the most sensitive target of toxicity. Intermediate-duration dermal studies 
reported lethal doses for JP-5 and JP-8 in mice (NTP/NIH 1986; Schulz et al. 1991) and provided 
information on systemic effects in mice following repeated dermal application of JP-5 for 13 weeks
(NTP/NIH 1986).  The latter study examined a wide range of systemic end points and reported 
hematological, hepatic, and dermal effects at the lowest dose tested, 500 mg/kg/day.  No reliable
intermediate-duration dermal studies with JP-8 were located.  Since skin contact is an important route of
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
     
  
 
       
  
     
       
   
     
     
  
 
    
  
 
 
    
      
    
     
   
   
   
  
       
    
    
  
 
     
 
 
        
   
 
 
 
 
  
136JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
occupational exposure to jet fuels, an intermediate-duration study with JP-8 that examines a wide range of
end points seems warranted.
Chronic-Duration Exposure and Cancer. No studies were located regarding health effects in
humans following chronic-duration exposure to JP-5 by any route of exposure.  Very limited information 
is available for JP-8.  Suggestive evidence of neurological alterations was presented in three studies of
military personnel exposed to JP-8 (Proctor et al. 2011; Smith et al. 1997; Tu et al. 2004), but not in a 
more recent study (Maule et al. 2013).  Another study of military personnel reported an association 
between JP-8 exposure and leukocytosis (Rhodes et al. 2003). No chronic-duration studies in animals
were available for JP-8 by any route of exposure or for JP-5 by the inhalation and oral routes of exposure.  
Inhalation and dermal studies with JP-8 would be valuable since these are relevant routes of occupational
exposure to JP-8.  Results from the inhalation study could be used to derive a chronic-duration inhalation
MRL for JP-8.  A 103-week dermal bioassay for JP-5 in mice reported dermatitis at the lowest dose 
tested, 250 mg/kg/day, and amyloid deposits in the spleen, liver and kidneys at 500 mg/kg/day (NTP/NIH
1986).
No studies were located regarding cancer in humans exposed to JP-5, JP-8, or Jet A fuels.  Health
screening of military personnel with past or current exposure to these fuels that included monitoring for 
cancer, particularly of the respiratory tract and the skin would be useful, as these are the sites with the 
most contact with the fuels in occupational settings, could provide useful information on the carcinogenic
potential of jet fuel exposure.  A few studies reported an association between kerosene and oral and 
pharyngeal cancer (Zheng et al. 1992), brain tumors (Bunin et al. 1994), and kidney cancer (Siemiatycki
et al. 1987).  The result of these studies should be interpreted with caution because, often, potential 
confounders were not well controlled, exposure concentrations were not available, and the possibility of
simultaneous exposure to other chemicals could not be ruled out.  There are no studies of cancer in 
animals exposed to JP-8 by any route of exposure or to JP-5 by inhalation or orally.  Inhalation and
dermal studies with JP-8 would be appropriate since these are relevant routes of occupational exposure.
A dermal bioassay for JP-5 in mice did not find evidence of carcinogenicity (NTP/NIH 1986).  However, 
dermal exposure of mice to undiluted kerosene resulted in an increased number of skin tumors (Nessel et
al. 1998).  In the latter study, it appeared that tumors developed only in the presence of skin irritation;
further research into the possible mechanisms involved in dermal carcinogenicity would be valuable.
Genotoxicity. Studies of workers exposed to JP-8 did not provide evidence of in vivo genotoxicity
(Erdem et al. 2012; Krieg et al. 2012).  In vivo studies in animal also yielded negative results (Air Force
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1978a; Conaway et al. 1984; Vijayalaxmi et al. 2006). In vitro studies in Salmonella or in mammalian 
cells incubated with JP-5, JP-8, or kerosene with or without metabolic activation yielded negative results 
(Blackburn et al. 1986; NTP/NIH 1986).  However, three studies with mammalian cells in vitro reported 
that JP-8 induced DNA damage (Air Force 1978a; Grant et al. 2001; Jackman et al. 2002).  One of these
studies also showed that JP-5 and JP-8+100 could induce DNA damage (Jackman et al. 2002).  Further
occupational studies with enough statistical power and appropriate control of potential confounders are
necessary to draw stronger conclusions.
Reproductive Toxicity. The only relevant information located is that from a study of military and
civilian women from 10 U.S. Air Force bases who reported a significant inverse association between
exposure to JP-8 and serum levels of LH (Army 2001; Reutman et al. 2002).  No significant association
was found between exposure to JP-8 and higher odds of menstrual disorders.  Further studies of
reproductive end points in women exposed to jet fuels would be valuable.  Conduction of fertility surveys
among populations (males and females) with past or current occupational exposure to JP-8 or JP-5 to 
determine potential abnormalities would be useful. JP-8 did not affect fertility in male or female rats in
intermediate-duration oral studies (Mattie et al. 2000).  Other long-term studies with oral JP-8 exposure to 
rats (Mattie et al. 1995), JP-5 dermal exposure to mice (NTP/NIH 1986), or JP-5 vapor exposure to rats,
mice, or dogs (Gaworski et al. 1984) did not report morphological alterations in the reproductive organs
of the animals.  It appears that although additional oral studies in animals are not necessary at this time,
information is lacking from inhalation and dermal exposure, the two relevant routes of occupational
exposure. It may be useful to conduct fertility surveys among populations (males and females) with past
or current occupational exposure to JP-8 or JP-5 to determine potential abnormalities.
Developmental Toxicity. No information was found regarding developmental toxicity in humans
from inhalation, oral, or dermal exposures to jet fuels.  Significant decreases in fetal body weight were 
found after pregnant rats were treated orally with doses of JP-8 that also significantly reduced maternal 
weight gain (Cooper and Mattie 1996). No teratogenicity was observed in that study.  Immune
suppression was reported in offspring from mice exposed to airborne (Harris et al. 2007b) or oral JP-8 
during gestation (Keil et al. 2003).  In addition, transient neurobehavioral alterations were reported in 
offspring of rats exposed orally with JP-8 during pregnancy (Mattie et al. 2001). Results from the
inhalation study suggested that there might be a genetic component involved in determining the immune
response in the offspring exposed in utero; this possibility should be explored further. Standard 
developmental end points have not been examined following inhalation or dermal exposures, the two
relevant routes of occupational exposure; therefore, studies by these routes may be warranted. It would 
***DRAFT FOR PUBLIC COMMENT***
    
 
    
 
 
    
     
   
 
      
   
  
     
    
      
     
     
  
 
     
   
  
         
     
   
   
    
  
    
     
  
   
    
    
    
 
     
 
   
 
 
 
 
  
138JP-5, JP-8, AND JET A FUELS
3. HEALTH EFFECTS
be interesting to determine whether maternal immunotoxicity is necessary to observe immunotoxicity in
the offspring.  Monitoring women who were or are exposed to JP-5, JP-8, or Jet A fuels during pregnancy 
could provide valuable information regarding birth parameters. 
Immunotoxicity. No information was found regarding immunotoxicity in humans exposed to JP-5, 
JP-8, or Jet A fuels.  A series of studies examined immune function in mice acutely exposed to airborne
JP-8 (Harris et al. 1997a, 1997b, 1997c, 2000a, 2000b, 2000c, 2007a, 2007c, 2008).  However, in these
studies, only the aerosol component (not the vapor component) was measured; therefore, the total
exposure concentration of JP-8 was underestimated. It would be useful to replicate these studies to 
determine the true exposure level at which the various immune alterations occur.  Several studies have 
tried to determine which component or components of the fuels are responsible for the immune effects
(Hilgaertner et al. 2011; Ramos et al. 2007; White et al. 2013).  The results were not consistent between
studies and further exploration of this line of research may be warranted.
Neurotoxicity. A few studies examined possible associations between occupational exposure to JP-8 
and neurological effects. These studies reported an association between cumulative, but not daily,
exposure to JP-8 and altered balance (Maule et al. 2013; Smith et al. 1997), and between exposure to JP-8 
and alterations in neuropsychological tests (Proctor et al. 2011; Tu et al. 2004). Continued monitoring of
these cohorts seems appropriate. Accidental ingestion of kerosene has resulted in neurological effects,
including unconsciousness or semiconsciousness, drowsiness, restlessness, and irritability (Abu-Ekteisch
2002; Akamaguna and Odita 1983; Aldy et al. 1978; Benois et al. 2009; Chun 1998; Coruh and Inal 1966;
Dudin et al. 1991; Lang et al. 2008; Lucas 1994; Mahdi 1988; Majeed et al. 1981; Nouri and Al-Rahim 
1970; Saksena 1969; Santhanakrishnan and Chithra 1978; Shotar 2005; St. John 1982). Many of these 
cases occurred in other countries and may be difficult to follow-up.  However, cases identified in the
Unites States, where kerosene can be purchased for use, for example, in portable heaters, could be
followed to determine whether acute exposure to a high amount of kerosene results in long-lasting
neurological effects.  This could also be studied in animal models.  Intermediate-duration studies in rats
showed that exposure to JP-5 or JP-8 vapors can induce neurobehavioral alterations and changes in the
levels of neurotransmitter in brain areas (Ritchie et al. 2001; Rossi et al. 2001).  However, this has not
been examined in long-term, low-exposure studies that simulate occupational settings.
Epidemiological and Human Dosimetry Studies. A few studies have examined the effects of
exposure to JP-8 on human health.  These studies examined occupationally exposed subjects and provided 
some evidence suggesting that long-term exposure to JP-8 may be associated with adverse neurological
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effects (Proctor et al. 2011; Smith et al. 1997; Tu et al. 2004). An additional study reported that daily
exposure to JP-8 was not associated with alterations in balance (Maule et al. 2013). Since those exposed 
at work may be subjected to the highest levels of exposure, continued monitoring of these groups is
important to detect any emerging health condition associated with exposure to jet fuels. Studies in
animals indicate that the respiratory tract may be a sensitive target for JP-8 toxicity; therefore,
occupational studies should monitor respiratory function with appropriate tests.  Exposure of the general
population to JP-5 and JP-8 is likely to be limited to populations living on or near military installations
where JP-5 and/or JP-8 are utilized. However, should unintentional exposure to JP-5 and JP-8 occur as a 
result of groundwater contamination from spilled jet fuels or contact with soils that have been 
contaminated with jet fuels, those exposed should be monitored for potential adverse health effects.  
Biomarkers of Exposure and Effect.
Exposure. A number of studies examining biomarkers that could be used to identify and/or quantify
exposure to JP-8 have focused on measuring the levels of specific components of JP-8 in expired air or
metabolites of components in urine. Levels of naphthalene, nonane, decane, undecane, and dodecane in 
expired air have been shown to be elevated in fuel maintenance workers exposed to JP-8 (Egeghy et al.
2003; Pleil et al. 2000); however, the benzene level in expired air was heavily influenced by pre-exposure
levels and smoking and was not a good biomarker (Egeghy et al. 2003; Pleil et al. 2000).  Similarly,
urinary levels of naphthalene, 1-naphthol, 2-naphthol, and MEAA have been shown to be elevated in
workers exposed to JP-8 (B’Hymer et al. 2012a; Chao and Nylander-French 2004; Chao et al. 2006;
Serdar et al. 2003; Smith et al. 2012).  Levels of naphthalene, 1-naphthol, and 2-naphthol in urine were
higher in workers with high exposure to JP-8, and the 1- and 2-naphthol levels were correlated with the 
naphthalene levels in air (Serdar et al. 2004; Smith et al. 2012).  B’Hymer et al. (2012a) found significant
differences in urinary levels of MEAA, a metabolite of a JP-8 additive, between workers with high, 
medium, and low JP-8 exposure levels; since it is relatively specific for JP-8 exposure and urinary levels 
appear to be related to air concentrations, MEAA appears to be a suitable biomarker of exposure.  
Additional research is needed to establish a quantitative relationship between urinary levels and air
concentrations.
Effect. No specific biomarkers of effect were identified for JP-5, JP-8, or Jet A fuels.  Additional studies
of acute, intermediate, and chronic exposure are needed to identify biomarkers of effects for specific 
target organs following exposure to jet fuels.
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Absorption, Distribution, Metabolism, and Excretion. With the exception of dermal absorption 
data, no quantitative data were located regarding the absorption, distribution, metabolism, or excretion of
jet fuels following inhalation, oral, or dermal exposure in humans.  Observation of systemic effects 
following inhalation and oral exposure provide indirect evidence for the absorption of jet fuels.  The
dermal absorption of JP-8 has been demonstrated in humans and animals (Baynes et al. 2001; Chao and 
Nylander-French 2004; Kanikkannan et al. 2001; Kim et al. 2006a, 2006b, 2007; Mattorano et al. 2004;
McDougal et al. 2000; Muhammad et al. 2005a; Riviere et al. 1999). As would be expected, the studies 
found large differences in the absorption of different JP-8 components, with the aromatics penetrating the
skin faster than the aliphatic compounds (Kim et al. 2006b; McDougal et al. 2000); thus, the composition 
of the dermally absorbed components will vary greatly from the composition of JP-8 (McDougal and 
Robinson 2002).  Additional studies are needed to further examine the time course of dermal absorption
of different jet fuel components and to determine other factors that could influence dermal absorption, 
such as prior exposure.  Acute, intermediate, and chronic data are needed to assess the relative rates and
extent of absorption, distribution, and excretion of jet fuels with respect to all three routes of exposure as
well as with respect to time and dose.
Comparative Toxicokinetics. Limited data are available regarding comparative toxicokinetics.  The
acute oral LD50 values in guinea pigs and rabbits for kerosene have been reported to be 16,320 and 
22,720 mg/kg, respectively (Deichmann et al. 1944).  These data suggest that there may be species 
differences in the oral toxicity of kerosene (suggesting a species difference for JP-5); however, more data
would be needed to thoroughly examine species variation in toxicokinetics.  This information would be
useful for identifying similar target organs and for adequately assessing which animals can serve as the 
best models for humans as well as defining mechanisms of action.
Methods for Reducing Toxic Effects. The mitigation procedures for both JP-5 and JP-8 parallel 
those for hydrocarbon poisoning.  Several treatments for hydrocarbon poisoning have been considered 
controversial: gastric decontamination, induced emesis versus gastric lavage, and administration of
activated charcoal, cathartics, antibiotics, and corticosteroids.  Most studies indicate that antibiotics and
corticosteroids are not effective treatments for hydrocarbon-induced pneumonitis (Brown et al. 1974;
Gummin 2015; Shannon et al. 2007; Steele et al. 1972; Wolfsdorf and Kundig 1974).  However, more
research regarding the usefulness of cathartics and activated charcoal is needed.  In addition, elucidating
the toxicokinetics of absorption of jet fuels in the gastrointestinal tract would help determine whether
gastric decontamination is worth the risk of pulmonary aspiration.  Related to gastric decontamination is
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the question of whether induced emesis is safer than gastric lavage.  Since there are presently no known 
antidotes for hydrocarbon poisoning, research in this area would be beneficial as well.
Children’s Susceptibility. Data needs relating to both prenatal and childhood exposures, and
developmental effects expressed either prenatally or during childhood, are discussed in detail in the
Developmental Toxicity subsection above.
There are no studies of children exposed to JP-5, JP-8, or Jet A fuels, which is not unexpected since
exposure to these fuels is likely to occur mainly in occupational settings.  However, as previously
mentioned, exposure to kerosene via ingestion is one of the most common forms of acute childhood 
poisoning in many developing countries since kerosene is used for cooking, heating and lighting and is
usually stored in containers and places easily accessible to children.  Accidental poisoning has resulted in 
respiratory, gastrointestinal, neurological, and hematological effects; fever has also been reported, and in
some cases, death occurred (Abu-Ekteish 2002; Akamaguna and Odita 1983; Aldy et al. 1978; Annobil
1983; Annobil and Ogunbiyi 1991; Balme et al. 2012; Benois et al. 2009; Chun 1998; Dudin et al. 1991;
Lang et al. 2008; Lucas 1994; Mahdi 1988; Santhanakrishnan and Chithra 1978; Shotar 2005; Simmank
et al. 1998; St. John 1982).  These and many other case reports do not provide enough information to 
determine whether or not children are more susceptible to kerosene than adults. It would be useful to 
follow-up children who have suffered poisoning with kerosene to determine whether high acute exposure
results in long-term effects.
A study in animals showed that young rats are more susceptible to the effects of acute oral exposure to
high doses of kerosene than adult rats (Deichmann et al. 1944). However, it would be inappropriate to 
predict what would occur in humans based on the results of a single study. 
Child health data needs relating to exposure are discussed in Section 6.8.1, Identification of Data Needs:
Exposures of Children.
3.12.3 Ongoing Studies 
No ongoing studies pertaining to JP-5 and JP-8 were identified in RePORTER (2014).
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4. CHEMICAL AND PHYSICAL INFORMATION
4.1  CHEMICAL IDENTITY
Information regarding the chemical identities of JP-5, JP-8, and Jet A fuels is located in Table 4-1.  
Nearly all jet fuel is made from kerosene derived from petroleum; however, a small percentage is made 
from oil sands (Chevron 2006).  Kerosene is manufactured from the distillation of crude oil at
atmospheric pressure (straight-run) or from catalytic, thermal, or steam cracking of heavier petroleum
streams (cracked kerosene).  Figure 4-1 depicts a general schematic of a refinery capable of producing jet
fuels along with other light, middle, and heavy distillates of crude oil.  The exact composition of any
particular batch of jet fuels is dependent upon the crude oil from which it was derived and on the refinery
processes used for its production.  Regardless of the source and production process, kerosenes and jet
fuels primarily consist of C9 to C16 hydrocarbons that boil in the range of 145–300°C (API 2010a).  
Analytical techniques are not capable of separating and characterizing each molecular species of these 
complex mixtures (likely >1,000 individual components); however, the predominant components of jet
fuels are branched and linear paraffins and naphthenes (cycloalkanes) which usually account for over
70% of the components by volume (API 2010a; Chevron 2006).  Aromatic hydrocarbons such as
alkylbenzenes and naphthalenes do not exceed 25% of the total.  Olefins represent an insignificant
fraction of the total composition of JP-5, JP-8, and Jet A fuels.  The final product must meet all of the
performance and regulatory requirements of the specific fuel.  ASTM International (formerly known as 
the American Society for Testing and Materials) and the U.K. Ministry of Defense publish specifications
and test methods for commercial jet fuels and more information regarding these standards may be 
obtained from these organizations. These requirements, including a description on the different additives
used in aviation fuels have been summarized in an ExxonMobil report on world jet fuel specifications
(ExxonMobil 2005).  The U.S. government and other nations’ governments maintain specifications for jet
fuels for military use (Chevron 2006).
Two important types of jet fuels exist for commercial aviation, Jet A and Jet A-1.  Jet A is predominantly
used in the continental United States while Jet A-1 is used throughout the rest of the world (ExxonMobile
2005). These fuels are nearly identical; however the most important difference between them is that
Jet A-1 is refined to have a lower maximum freezing point (-47°C) than Jet A (-40°C).  The lower
freezing point makes Jet A-1 a better choice for international flights, especially on polar routes during the
winter season (Chevron 2006).  In addition, Jet A typically does not contain a static dissipator additive
that may be required for Jet A-1 fuels (ExxonMobil 2005).  Table 4-2 lists some compositional data for
14 different Jet A fuel samples provided by the American Petroleum Institute (API). 
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Table 4-1.  Chemical Identity of JP-5, JP-8, and Jet A Fuels
Characteristic Information
Chemical name JP-5 JP-8 Jet A
Synonym(s) NATO F-44; AVCAT; NATO F-34; AVTUR; MIL- No data
aviation kerosene; DTL-83133H; aviation 
kerosene; fuel oil no. 1; kerosene; kerosene; fuel
jet kerosene; turbo fuel A; oil no. 1; jet kerosene;
straight run kerosene; turbo fuel A; straight run
distillate fuel oils, kerosene; distillate fuel
lighta,b,c,d oils, lighta,b,c,d,e 
Registered trade No data No data No data
name(s)
Chemical formulaf No data No data No data
Chemical structuref No data No data No data
Identification 
numbers:
CAS registry 8008-20-6g/70892-10-3h 8008-20-6g/70892-10-3h 8008-20-6g/70892-10-3h 
NIOSH RTECS OA5500000b (kerosene) OA5500000b (kerosene) OA5500000b (kerosene)
EPA hazardous No data No data No data
waste
OHM/TADS 7217063g (kerosene) 7217063g (kerosene) 7217063g (kerosene)
DOT/UN/NA/IMDG UN 1223; IMO 3.3b UN 1223; IMO 3.3b UN 1223; IMO 3.3b 
shipping (kerosene) (kerosene) (kerosene)
HSDB 632b (kerosene) 632b (kerosene) 632b (kerosene)
NCI No data No data No data
aRTECS 1998
bHSDB 2012
cIARC 1989
dArmy 1988
eDOD 2013
fFuel oils are mixtures of various hydrocarbons designed to meet specifications set forth by the American Society for
Testing and Materials (DOD 1992); therefore, chemical structure and chemical formula cannot be determined.
gNTP/NIH 1986
hOHM/TADS 1985
CAS = Chemical Abstracts Service; DOT/UN/NA/IMDG = Department of Transportation/United Nations/North 
America/International Maritime Dangerous Goods Code; EPA = Environmental Protection Agency;
HSDB = Hazardous Substances Data Bank; NCI = National Cancer Institute; NIOSH = National Institute for
Occupational Safety and Health; OHM/TADS = Oil and Hazardous Materials/Technical Assistance Data System;
RTECS = Registry of Toxic Effects of Chemical Substances
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Figure 4-1.  Kerosene/Jet Fuel Processing
Adapted from API 2010a; Chevron 2006
***DRAFT FOR PUBLIC COMMENT***
    
 
  
 
 
   
 
 
 
 
 
 
 
 
 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
     
    
    
    
    
    
    
    
 
 
 
 
  
146JP-5, JP-8, AND JET A FUELS
4.  CHEMICAL AND PHYSICAL INFORMATION
Table 4-2.  Compositional Analysis of 14 Samples of Jet A Fuel
Average weight Minimum weight Maximum weight
Component percentage percentage percentage
Hydrocarbon types by mass spectrometry ASTM Method D2425
Paraffins 46.66 32.60 59.10
Monocycloparaffins 26.19 13.80 34.20
Dicycloparaffins 5.89 4.10 8.50
Tricycloparaffins 0.77 0.40 1.40
Benzenes 12.99 9.50 16.50
Indanes/tetralins 4.05 2.50 6.60
CnH2n–10 0.96 0.60 1.80
Naphthalene 0.44 0.00 1.10
Naphthalenes 1.46 0.90 2.00
CnH2n–14 0.34 0.20 0.50
CnH2n–16 0.23 0.00 0.50
CnH2n–18 0.00 0.00 0.00
Total aromatics 21.18 17.90 27.20
Total olefins 0.00 0.00 0.00
Total paraffins + napthenes 78.82 72.80 82.10
Total aromatics by gas chromatography/mass spectrometry ASTM Method D5769
Benzene 0.01 0.00 0.02
Toluene 0.14 0.06 0.50
Ethylbenzene 0.15 0.08 0.26
m.p-xylene 0.54 0.24 1.25
1,2-Dimethylbenzene 0.27 0.11 0.51
Isopropylbenzene 0.07 0.05 0.11
Propylbenzene 0.14 0.06 0.25
1-Methyl-3-ethylbenzne 0.50 0.21 1.02
1-Methyl-4-ethylbenzne 0.13 0.04 0.24
1,3,5-Trimethylbenzene 0.25 0.11 0.65
1-Methyl-2-ethylbenzene 0.18 0.02 0.30
1,2,4-Trimethylbenzene 0.94 0.50 1.78
1,2,3-Trimethylbenzene 0.33 0.20 0.43
Indane 0.06 0.00 0.12
Alkyl Indanes 0.61 0.06 1.13
1,4-Diethyl + butylbenzene 0.32 0.11 0.50
1,2-Diethylbenzene 0.18 0.02 0.41
1,2,4,5-Trimethyl benzene 0.11 0.09 0.20
1,2,3,5-Tetramethylbenzene 0.46 0.08 0.72
Total C10 benzenes 1.34 0.08 2.76
Total C11 benzenes 2.88 0.10 4.53
Total C12 benzenes 0.18 0.69 0.34
Naphthalene 0.18 0.07 0.30
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Table 4-2.  Compositional Analysis of 14 Samples of Jet A Fuel
Average weight Minimum weight Maximum weight
Component percentage percentage percentage
2-Methylnaphthalene 0.38 0.18 0.57
1-Methylnaphthalene 0.28 0.13 0.37
Source:  API (2010b)
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The U.S. military uses two kerosene-based aircraft fuels, JP-5 and JP-8.  JP-8 is the military equivalent of
Jet A-1; however, it contains a corrosion inhibitor and anti-icing additive that is not required in the ASTM
specification of Jet A-1.  The primary difference between the two military fuels is that the flash point 
temperature for JP-5 is higher (60°C) as compared to JP-8 (38°C).  The higher flash point for JP-5 is more
suitable for safe handling and fueling practices aboard aircraft carriers and this is the primary fuel used by
the U.S. Navy (Chevron 2006).  An important additive for military fuels is enhanced thermal stability
additives. Jet fuels act as a heat sink for modern aircraft engines. They absorb heat from engine oil,
hydraulic fluid and air conditioning apparatus (Chevron 2006). Jet fuels used for high performance
military aircraft engines have even greater need of thermal stability as compared to commercial aviation
fuels.  In the late 1990s, the U.S. Air Force began development of an additive to increase the thermal
stability of jet fuels. JP-8 fuel containing this additive package is usually referred to as JP-8+100 because
this additive increased the thermal stability of the fuel by 100°F; however, this particular additive is not
currently approved for use in commercial aircraft fuels (Chevron 2006).  Beginning in 2013, the U.S. Air
Force began using Jet A (plus additives) rather than JP-8 for continental flight usage in order to save on 
fuel costs (Air Force 2013).
Potter and Simmons provided general compositional data for JP-5 and JP-8 fuels and these data are 
provided in Tables 4-3 and 4-4, respectively.
4.2  PHYSICAL AND CHEMICAL PROPERTIES 
Information regarding the physical and chemical properties of Jet A, JP-5, and JP-8 is located in
Table 4-5.
In summary, the composition of Jet A/A-1, JP-5, and JP-8 are very similar.  They consist predominantly
of C9–C16 hydrocarbons that are a combination of n-paraffins, isoparaffins, naphthenes, and aromatics.  
The paraffin and napthene fraction typically compose over 70% of the fuels by weight, while the aromatic
fraction is ≤25%.  Olefins typically comprise <1% of the total.  The important differences in the fuels
relates to certain physical properties and the inclusion of particular additives to enhance performance.
Jet A-1 has a lower maximum freezing point (-47°C) than Jet A (-40°C); JP-8 is the military equivalent to
Jet A-1, but contains certain additives that are not required in Jet A-1; and JP-5 is formulated to have a
higher flash point temperature (60°C) than JP-8 (38°C).
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Table 4-3.  Compositional Data for JP-5a
Compound Weight percentage
Alkenes
Tridecene 0.45
Alkyl aromatic
m-xylene 0.13
o-xylene 0.090
1,2,4-Trimethylbenzene 0.37
1,2,3,4-Tetramethylbenzene 1.5
1,3-Diethylbenzene 0.61
1,4-Diethylbenzene 0.77
1,2,4-Triethylbenzene 0.72
1-tert-Butyl-3,4,5-trimethylbenzene 0.24
n-Heptylbenzene 0.27
n-Octylbenzene 0.78
1-Ethylpropylbenzene 1.2
Branched paraffins
3-Methyloctane 0.070
2,4,6-Trimethylheptane 0.070
2-Methyldecane 0.61
4-Methyldecane 0.78
2,6-Dimethyldecane 0.72
2-Methylundecane 1.4
2,6-Dimethylundecane 2.0
Naphthenes
1,1,3-Trimethylcyclohexane 0.050
1,3,5-Trimethylcyclohexane 0.090
n-Butylcyclohexane 0.90
Phenylcyclohexane 0.82
Heptylcyclohexane 0.99
Diaromatics excluding naphthalenes
Biphenyl 0.70
n-Paraffins
n-Octane 0.12
n-Nonane 0.38
n-Decane 1.8
n-Undecane 4.0
n-Dodecane 3.9
n-Tridecane 3.5
n-Tetradecane 2.7
n-Pentadecane 1.7
n-Hexadecane 1.1
n-Heptadecane 0.12
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Table 4-3.  Compositional Data for JP-5a
Compound Weight percentage
Napthalenes
Napthalene 0.57
1-Methylnapthalene 1.4
2-Methylnapthalene 1.4
1-Ethylnaphthalene 0.32
2,3-Dimethylnaphthalene 0.46
2,6-Dimethylnaphthalene 1.1
aDoes not include all JP-5 fuel components.
Source:  Potter and Simmons (1998)
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Table 4-4.  Compositional Data for JP-8a 
Compound Weight percentage
Alkenes
Tridecene 0.73
Alkyl aromatic
m-Xylene 0.060
o-Xylene 0.060
1,2,3-Trimethylbenzene 0.27
1,2,3,4-Tetramethylbenzene 1.1
1,3-Dimethyl-5-ethylbenzene 0.62
1-Methyl-2-isopropylbenzene 0.56
1,2,4-Triethylbenzene 0.99
1,3,5-Triethylbenzene 0.60
n-Heptylbenzene 0.25
n-Octylbenzene 0.61
1-Ethylpropylbenzene 0.99
Branched paraffins
3-Methyloctane 0.040
2,4,6-Trimethylheptane 0.070
2-Methyldecane 0.41
2,6-Dimethyldecane 0.66
2-Methylundecane 1.2
2,6-Dimethylundecane 2.1
Naphthenes
1,1,3-Trimethylcyclohexane 0.060
1,3,5-Trimethylcyclohexane 0.060
1-Methyl-4-ethylcyclohexane 0.10
Propylcyclohexane 0.14
n-Butylcyclohexane 0.74
Hexylxyxlohexane 0.93
Phenylcyclohexane 0.87
Heptylcyclohexane 1.0
Diaromatics excluding naphthalenes
Biphenyl 0.63
n-Paraffins
n-Heptane 0.030
n-Octane 0.090
n-Nonane 0.31
n-Decane 1.3
n-Undecane 4.1
n-Dodecane 4.7
n-Tridecane 4.4
n-Tetradecane 3.0
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Table 4-4.  Compositional Data for JP-8a 
Compound Weight percentage
n-Pentadecane 1.6
n-Hexadecane 0.45
n-Heptadecane 0.080
n-Octadecane 0.020
Napthalenes
Napthalene 1.1
1-Methylnapthalene 1.8
2-Methylnapthalene 1.5
1-Ethylnaphthalene 0.33
2,3-Dimethylnaphthalene 0.36
2,6-Dimethylnaphthalene 1.3
aDoes not include all JP-8 fuel components.
Source:  Potter and Simmons (1998)
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Table 4-5.  Physical and Chemical Properties of Jet Fuelsa 
Property JP-5 JP-8	 Jet Ab
Molecular weightc No data No data No data
Color Clear and brightd Clear and brightd Clear
Physical state Liquide Liquide Liquid
Melting point -46°Cd -52°Cd -40°C (Jet A); -47°C (Jet A­
1)
Boiling point 170°Cf; 150–290°Cg 170°Cf; 150–290°Cg 145–300°C
Density at 15 °C 0.788–0.845 kg/Lf 0.775–0.840 kg/Lf 0.775–0.840 kg/Lh
Odor Kerosene-likei (kerosene) Kerosene-likei (kerosene) Kerosene-likei (kerosene)
Odor threshold (ppm): 1j; 0.082k (kerosene) 1j; 0.082k (kerosene) 0.082k (kerosene)
Solubility:
Water at 20°C ~5 mg/Le (kerosene)	 12.44 mg/L (unspecified 10.4 mg/L
 
temperature)b ~5 mg/Le (kerosene)
 
~5 mg/Le (kerosene)
 
Organic solvents Miscible with other Miscible with other Miscible with other
petroleum solventsk petroleum solventsk petroleum solventsk 
Partition coefficients:
Log Kow 3.3–7.06e (kerosene) 3.3–7.06e (kerosene) 3.3–7.06e (kerosene)
Log Koc 9.6x102–5.5x106e	 9.6x102–5.5x106e 9.6x102–5.5x106e (kerosene)
(kerosene) (kerosene)
Vapor pressure at 2.25–25.1 mm Hg at 2.25–25.1 mm Hg at >7.5 mm Hg at 37.8°C
21°C 21°Cb 21°Cb
1.12–26.4 mmHge 1.12– 
(kerosene) 26.4 mmHge(kerosene)
Henry's law constant 5.9x10-5–7.4 atm- 5.9x10-5–7.4 atm-m3/mole 5.9x10-5–7.4 atm-m3/mole
at 20°C m3/mole (kerosene) (kerosene) (kerosene)
Autoignition 229°Cj (kerosene) 229°Cj (kerosene) 229°Cj (kerosene)
temperature
Flashpoint (minimum) 60°Cd,i 38°Cd,i	 38°Cg 
Flammability limits (% 0.7–5%j (kerosene) 0.7–5%j (kerosene) 0.7–5%j (kerosene)
 
volume in air)
 
Conversion factors No data No data No data
 
Explosive limits 0.7–5%l (kerosene) 0.7–5%l (kerosene) 0.7–5%l (kerosene)
 
aValues listed are specifications required or general characteristics of each class of jet fuels.
bAPI 2010a
cFuel oils are mixtures of various hydrocarbons designed to meet specifications set forth by the American Society for
Testing and Materials (DOD 1992); therefore, molecular weight cannot be determined.
dDOD 1992
eAir Force 1989b
fArmy 1988
gIARC 1989
hChevron 2006
iAir Force 1989a
jCoast Guard 1985
kOHM/TADS 1985
lHSDB 2012
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155JP-5, JP-8, AND JET A FUELS
5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
5.1  PRODUCTION
No information is available in the TRI database on facilities that manufacture or process JP-5, JP-8, and 
Jet A fuels because these chemicals are not required to be reported under Section 313 of the Emergency
Planning and Community Right-to-Know Act (Title III of the Superfund Amendments and 
Reauthorization Act of 1986) (EPA 2005).
As discussed in Chapter 4, most jet fuels are derived from petroleum.  During the 1970s and 1980s, shale
oil had been used to manufacture jet fuels, but this is no longer economically feasible (Chevron 2006).  
Figure 4-1 provides a general schematic for the straight-run production of jet fuels from crude oil.  Heated 
crude oil is introduced into an atmospheric pressure distillation unit and the liquefied petroleum gasses
(propane and butane) are boiled off from the top of the distillation column and eventually recondensed by
a condenser unit.  Middle distillates such as kerosene and diesel are drawn off the distillation column and 
treated by various processes that remove or reduce undesirable components before becoming jet fuels
(API 2010b; Chevron 2006).  The sweetening process removes corrosive mercaptans from the kerosene
fraction by the mercapton oxidation (Merox) process in which mercaptans are converted to disulfides 
using a catalyst and an alkaline solution.  The disulfides are noncorrosive and may be left in the final
product or removed by additional treatment to lower the sulfur content of the resultant jet fuel.  
Hydroprocessing employs hydrogen and an appropriate catalyst to remove olefins, sulfur, and nitrogen-
containing compounds from the distilled kerosene. Jet fuel manufactured by a particular refinery may be 
derived exclusively from straight-run processing or it may be a blend of straight-run, hydroprocessed, 
and/or hydrocracked product (as depicted in Figure 4-1); however, the finished product must meet all of
the performance and regulatory requirements of the specific fuel as discussed in Chapter 4.
Concern that diminishing oil supplies could disrupt production of jet fuels from traditional petroleum
sources has prompted research into alternative production methods.  The Fischer-Tropsch process has
been used to develop synthetic jet fuels from feedstocks other than petroleum (Chevron 2006; FAA
2009).  In this process, Syngas (synthesis gas), a mixture of carbon monoxide and hydrogen, is reacted 
with catalysts to produce a variety of hydrocarbons. These hydrocarbons are then blended to produce a
highly parafinnic synthetic jet fuel that contains virtually no sulfur, nitrogen, or aromatic compounds.  
The benefits and disadvantages of producing jet fuels using the Fischer-Tropsch process and other
methods compared to traditional manufacturing methods using petroleum feedstock have been reviewed 
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in a technical report produced by the Rand Corporation and the Massachusetts Institute of Technology
(MIT) (FAA 2009).
Domestic production, import, and export data for kerosene is summarized in Tables 5-1 and 5-2.  These
data were derived from the EPA Inventory Update Reporting (IUR) system (EPA 2010) and the newly
developed Chemical Data Reporting (CDR) database (EPA 2012a).  According to the CDR website
(http://www.epa.gov/oppt/cdr/), approximately 2.07x1011 pounds (93,725,241 tonnes) of kerosene was
manufactured in 2012; however, several companies claimed this information as confidential business 
information (CBI) and therefore, the actual production volume is expected to be greater than what is
indicated in Table 5-1 (EPA 2012a).
While the demand for kerosene has gradually declined over the previous 4 decades, demand for jet fuels
has steadily increased.  As a result, many refiners have chosen to produce Jet A-1 as their basic product
and to simply divert a portion of the product for marketing as kerosene (IARC 1989).  In the United 
States, production of jet fuels, including both kerosene-type (JP-5 and JP-8) and wide-cut fuels, increased
from 37,636,000 tonnes (293,560,800 barrels) in 1970 to 56,939,000 tonnes (444,124,200 barrels) in 1985 
(IARC 1989).  In the countries of the Organisation for Economic Cooperation and Development (OECD), 
production increased from 57,659,000 tonnes (449,740,200 barrels) to 90,280,000 tonnes (704,184,000 
barrels) during the same time period (IARC 1989).  According to the Department of Energy, the
consumption of jet fuels in the United States in 2010 and 2011 was 1.43 and 1.42 million barrels per day, 
respectively, for an annual consumption rate of 521,950,000 barrels consumed in 2010 and 518,300,000 
barrels consumed in 2011 (EIA 2013c).  The consumption rate is projected to increase to 1.52 million 
barrels per day (554,800,000 barrels annually) by 2020, 1.60 million barrels per day (584,000,000 barrels
annually) by 2030, and 1.66 million barrels per day (605,900,000 barrels annually) by 2040 (EIA 2013c).
Data regarding the weekly production of jet fuels by U.S. refineries since 2010 are provided in Tables 5-3 
(commercial jet fuels) and 5-4 (military jet fuels) from the U.S. Energy Information Administration (EIA
2014a).
5.2  IMPORT/EXPORT
Imports of distillate fuels have varied from year to year since the 1970s.  Since 1975, imports of distillate
jet fuels such as jet fuel no. 1 into the United States have been low compared to the amount of distillate jet
fuels produced in the United States (API 1991).  Imports of kerosene fluctuated between 1975 and 1984 
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Table 5-1.  Domestic Production, Import, and Export Volumes of Kerosene in 
2012a
Domestic
manufacturing Imported Volume Parent
(pounds) (pounds) Volume used exported Parent company name company city
2,400,000,000 0 0 Sunoco, Inc. Philadelphia
109,000,000,000 109,000,000,000 0 Sunoco, Inc. Philadelphia
2,530,000,000 0 0 ConocoPhillips Co. Linden
3,739,372,000 0 0 Motiva Enterprises LLC Houston
1,055,839,514 1,055,839,514 0 Equilon Enterprises LLC Houston
2,946,370,260 2,946,370,260 0 Shell Deer Park Refining Deer Park
Limited Partnership
6,442,919,000 0 0 Motiva Enterprises LLC Houston
2,945,948,325 N/A 0 Shell Trading US Co. Houston
1,185,666,446 1,185,666,446 0 Shell Chemical Company LP Houston
5,537,432,425 0 0 Motiva Enterprise LLC Houston
389,977,246 389,977,246 0 Hunt Consolidated, Inc. Dallas
CBI CBI CBI CBI CBI CBI
1,600,000,000 400,000,000 0 Western Refining El Paso
Southwest, Inc.
490,030,931 N/A 0 Citgo Petroleum Corporation Houston
141,484 N/A 0 Equilon Enterprises LLC Houston
DBA Shell Oil
66,697,537 0 0 Calumet Specialty Products Princeton
Partners LP
405,477,132 0 0 Calumet Specialty Products Shreveport
Partners LP
25,920,768 0 0 Calumet Specialty Products Indianapolis
Partners LP
66,000,000 62,000,000 0 Citgo Petroleum Corporation Lemont
2,691,000,000 2,691,000,000 0 Marathon Oil Corporation Findlay
620,000,000 0 0 ConocoPhillips Co. Houston
42,000,000 42,000,000 0 Calumet Specialty Products Indianapolis
Partners LP
857,000,000 0 0 Alon USA LP Dallas
105,362 105,362 0 United Refining Co. Warren
CBI CBI CBI CBI Lyondell Chemical Co. Houston
2,213,000,000 1,223,000,000 0 Marathon Oil Corporation Findlay
126,000,000 126,000,000 0 Murphy Oil USA, Inc. El Dorado
696,175,997 696,175,997 0 PPB Energy Parsippany
1,511,255,360 1,511,255,360 0 Total Petrochemicals and Houston
Refining USA, Inc.
CBI CBI CBI Exxon Mobil Corporation Irving
2,698,292 2,698,292 0 Solvchem, Inc. Pearland
CBI CBI CBI BASF Corporation Florham Park
2,830,000,000 2,830,000,000 0 Marathon Oil Corporation Findlay
97,754,939 97,754,939 0 ConocoPhillips Co. Anchorage
2,000,000,000 2,000,000,000 0 ConocoPhillips Co. Ferndale
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Table 5-1.  Domestic Production, Import, and Export Volumes of Kerosene in 
2012a
Domestic
manufacturing Imported Volume Parent
(pounds) (pounds) Volume used exported Parent company name company city
CBI CBI CBI Koch Industries, Inc. Wichita
1,500,000,000 0 0 Tesoro Corporation Kapolei
CBI CBI CBI Exxon Mobil Corporation Irving
CBI CBI CBI Chalmette Refining LLC Chalmette
200,000,000 N/A 0 Chevron Corporation Houston
CBI CBI CBI Exxon Mobil Corporation Irving
2,400,000,000 2,400,000,000 0 Chevron Corporation San Ramon
71,298,667 0 0 Nustar Energy LP Brooks City-
Base
1,359,000,000 1,359,000,000 0 Marathon Oil Corporation Findlay
410,000,000 77,000,000 0 Tesoro Corporation Mandan
1,500,000,000 590,000,000 910,000,000 Petrobras America, Inc. Pasadena
1,313,155,341 1,313,155,341 0 Valero Services, Inc. San Antonio
549,000,000 549,000,000 0 Marathon Oil Corporation Findlay
CBI CBI CBI CBI Innospec, Inc. Littleton
1 N/A 0 ConocoPhillips Co. Houston
CBI N/A 0 Ethyl Corporation Richmond
940,000,000 0 0 Tesoro Corporation Wilmington
330,000,000 N/A 0 Tesoro Corporation San Antonio
CBI CBI 0 Exxon Mobil Corporation Irving
2,809,664,659 2,809,664,659 0 Citgo Petroleum Corporation Corpus Christi
540,000,000 540,000,000 0 Hollyfrontier Corporation Dallas
CBI CBI CBI CBI Valero Energy Corporation San Antonio
1,600,000,000 1,600,000,000 0 Hollyfrontier Corporation Dallas
CBI CBI CBI CBI Valero Energy Corporation San Antonio
CBI CBI 0 Alon USA LP Paramount
CBI CBI CBI CBI Valero Energy Corporation Texas City
40,000,000 0 0 Marathon Oil Corporation Findlay
1,300,000,000 1,300,000,000 0 ConocoPhillips Co. Houston
CBI CBI CBI CBI BP Products North America, Naperville
Inc.
1,200,000,000 1,200,000,000 0 Tesoro Corporation San Antonio
575,862,000 0 72,413,000 Astra West Coast Refining, Huntington 
Inc. Beach
1,300,000,000 129,930,445 0 Tesoro Corporation Kenai
870,000,000 660,000,000 0 Tesoro Corporation San Antonio
CBI CBI CBI Koch Industries Inc. Wichita
2,539,212,856 2,539,212,856 0 PBF Energy Paulsboro
CBI N/A CBI Dorf Ketal Chemicals LLC Stafford
1,700,000,000 1,700,000,000 0 ConocoPhillips Co. Houston
720,000,000 718,496,972 0 Delek Us Holdings Inc. Brentwood
1,356,000,000 1,356,000,000 0 Husky Energy, Inc. Wilmington
CBI CBI CBI 0 Ocean Investments Corp. Portsmouth
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Table 5-1.  Domestic Production, Import, and Export Volumes of Kerosene in 
2012a
Domestic
manufacturing Imported Volume Parent
(pounds) (pounds) Volume used exported Parent company name company city
CBI CBI CBI CBI Premcor Refining Group San Antonio
130,000,000 130,000,000 0 Hollyfrontier Corporation Dallas
CBI CBI CBI CBI Valero Services, Inc. San Antonio
998,799,401 0 0 Suncor Energy USA, Inc. Commerce City
5,100,000,000 0 0 ConocoPhillips Co. Houston
500,000,000 500,000,000 0 Countrymark Indianapolis
220,000,000 0 0 Gary-Williams Energy Wynnewood
Corporation
CBI CBI CBI CBI Hovensa LLC Christiansted
CBI N/A 0 3M Co. St. Paul
267,994,032 267,994,032 0 Alon USA LP Dallas
1,100,000,000 0 0 Hollyfrontier Corporation Dallas
320,000,000 220,000,000 0 Hollyfrontier Corporation Dallas
CBI CBI CBI CBI Casey Co. Long Beach
770,000,000 9,500,000 0 Tesoro Corporation Salt Lake City
45,420,783 N/A 0 Lukoil Pan Americas LLC New York
CBI CBI CBI CBI The Premcor Refining Memphis
Group, Inc.
2,464,937,141 2,464,937,141 0 PBF Energy Oregon
6,332,180,492 1,440,978 6,333,621,470 0 Citgo Petroleum Corporation Houston
1,925,000,000 1,925,000,000 0 Murphy Oil USA, Inc. El Dorado
66,000,000 36,000,000 0 Hollyfrontier Corporation Dallas
930,000,000 930,000,000 0 ConocoPhillips Co. Houston
19,000,000 18,000,000 0 American Refining Group Bradford
CBI CBI CBI CBI Valero Services, Inc. Corpus Christi
CBI CBI CBI CBI Sinclair Oil Corporation Salt Lake City
CBI CBI CBI CBI CBI CBI
100,000,000 100,000,000 0 Montana Refining Co. Great Falls
927,477,168 0 0 Transworld Oil Lake Charles
CBI CBI CBI CBI CBI CBI
3,082,443,279 805,012,637 2,277,430,642 ConocoPhillips Co. Houston
145,475,223 0 0 CVR  Refining, LLC Coffeyville
390,000,000 390,000,000 0 Western Refining Gallup
Southwest, Inc.
120,000,000 120,000,000 0 WRB Refining LP Houston
162,100,000 0 162,100,000 Black Elk Refining, LLC Houston
CBI CBI CBI CBI Valero Ultramar Holdings, Ardmore
Inc.
841,000,000 841,000,000 0 Northern Tier Energy LLC Ridgefield
CBI CBI CBI CBI Valero Energy Corporation San Antonio
1,600,000,000 1600,000,000 0 National Cooperative McPherson
Refinery Association
CBI CBI CBI Exxon Mobil Corporation Irving
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Table 5-1.  Domestic Production, Import, and Export Volumes of Kerosene in 
2012a
Domestic
manufacturing 
(pounds)
Imported 
(pounds) Volume used
Volume 
exported Parent company name
Parent
company city
CBI CBI CBI CBI CBI CBI
CBI CBI CBI CBI Valero Energy Corporation San Antonio
480,000,000 240,000,000 0 CHS, Inc. Inver Grove 
Heights
aData obtained from the EPA Chemical Data Reporting database (EPA 2012a).
CBI = confidential business information
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Table 5-2.  Non-confidential 2006 Inventory Update Reporting Records by
 
Chemical, Including Manufacturing, Processing, and Use Information for
 
Kerosene (Petroleum); CAS Registry No. 8008-20-6; Aggregated 

National Production Volume: ≥1 Billion Pounds
 
Company and site information
Company Site City Statea Manufacture Import Site limited
AGE Refining, Inc. San Antonio San Antonio TX Yes No Yes
Alon USA LP Big Spring Big Spring TX Yes No Yes
Refinery
American Refining American Refining Bradford PA Yes No No
Group, Inc. Group, Inc.
BP America, Inc. BP, Prudhoe Bay Prudhoe Bay AK Yes No No
Crude Oil Topping 
Plant
BP America, Inc. Los Angeles Carson CA Yes No No
(Carson) Refinery
BP America, Inc. Texas City Texas City TX Yes No No
Refinery
BP America, Inc. BP Products Warrenville IL No Yes N/A
North America 
Inc., IST
BP America, Inc. Whiting Refinery Whiting IN Yes No No
BP America, Inc. Toledo Refinery Oregon OH Yes No No
Big West Oil, LLC North Salt Lake North Salt Lake UT
Refinery
CHS, Inc. Laurel Refinery Laurel MT Yes No No
CITGO Petroleum Corporate Office Houston TX No Yes N/A
Corporation
CITGO Petroleum CITGO Refining Corpus Christi TX Yes No No
Corporation and Chemicals
Company East
Plant
CITGO Petroleum PDV Midwest Lemont IL Yes No No
Corporation Refining, L.L.C.,
Lemont Refinery
(operated by
CITGO Petroleum
Corporation)
CITGO Petroleum Port Everglades Fort FL No Yes N/A
Corporation Terminal Lauderdale
CITGO Petroleum Tampa Terminal Tampa FL No Yes N/A
Corporation
CITGO Petroleum Lake Charles Lake Charles LA Yes No Yes
Corporation Manufacturing 
Complex
CITGO Petroleum Linden Terminal Linden NJ No Yes N/A
Corporation
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Table 5-2.  Non-confidential 2006 Inventory Update Reporting Records by
 
Chemical, Including Manufacturing, Processing, and Use Information for
 
Kerosene (Petroleum); CAS Registry No. 8008-20-6; Aggregated 

National Production Volume: ≥1 Billion Pounds
 
Company and site information
Company Site City Statea Manufacture Import Site limited
Calumet Lubricants Shreveport Shreveport LA Yes No No
Co., L.P. Refinery
Calumet Lubricants Princeton Refinery Princeton LA Yes No Yes
Co., L.P.
Calumet Lubricants Cotton Valley Cotton Valley LA Yes No Yes
Co., L.P. Refinery
Chalmette Refining Chalmette Chalmette LA Yes No No
LLC Refining LLC
Chevron U.S.A., Inc. Global Supply and Houston TX No Yes N/A
Trading
Chevron U.S.A., Inc. El Segundo El Segundo CA Yes No Yes
Coffeyville Coffeyville Coffeyville KS Yes No No
Resources Refining Resources
and Marketing, LLC Refining and 
Marketing, LLC
ConocoPhillips Ferndale Refinery Ferndale WA Yes No Yes
Company
ConocoPhillips Kaparuk River Anchorage AK Yes No No
Company Unit
ConocoPhillips Kaparuk River Anchorage AK Yes No Yes
Company Unit
ConocoPhillips Los Angeles Carson CA Yes No No
Company Refinery Carson 
Plant
ConocoPhillips Ponca City Ponca City OK Yes No No
Company Refinery
ConocoPhillips Sweeny Refinery Old Ocean TX Yes No No
Company
ConocoPhillips Lake Charles Westlake LA Yes No No
Company Refinery
ConocoPhillips Ferndale Refinery Ferndale WA Yes No No
Company
ConocoPhillips Borger Refinery Borger TX Yes No No
Company
ConocoPhillips Bayway Refinery Linden NJ Yes No No
Company
ConocoPhillips Alliance Refinery Belle Chasse LA Yes No No
Company
Countrymark Refinery Mt. Vernon IN Yes No Yes
Cooperative, LLP
Diamond Shamrock Valero Three Three Rivers TX Yes No No
Refining Co., L.P. Rivers Refinery
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Table 5-2.  Non-confidential 2006 Inventory Update Reporting Records by
 
Chemical, Including Manufacturing, Processing, and Use Information for
 
Kerosene (Petroleum); CAS Registry No. 8008-20-6; Aggregated 

National Production Volume: ≥1 Billion Pounds
 
Company and site information
Company Site City Statea Manufacture Import Site limited
Ethyl Corporation Houston Plant Pasadena TX
Exxon Mobil Baton Rouge Baton Rouge LA Yes No No
Corporation Refinery
Exxon Mobil Baytown Refinery Baytown TX Yes No No
Corporation
Exxon Mobil Billings Refinery Billings MT Yes No Yes
Corporation
ExxonMobil Oil Fairfax Fairfax VA No Yes N/A
Corporation
ExxonMobil Oil Torrance Refinery Torrance CA Yes No No
Corporation
ExxonMobil Oil Beaumont Beaumont TX Yes No No
Corporation Refinery
ExxonMobil Oil Joliet Refinery Channahon IL Yes No Yes
Corporation
Flint Hills North Pole North Pole AK Yes No No
Resources, Alaska Refinery
LLC
Flint Hills East Plant Corpus Christi TX Yes No No
Resources, LP
Flint Hills West Plant Corpus Christi TX Yes No No
Resources, LP
Frontier El Dorado Frontier El Dorado El Dorado KS Yes No No
Refining Company Refining Company
Giant Refining Ciniza Jamestown NM Yes No No
Company
Giant Yorktown, Inc. Refinery Grafton VA Yes No No
Glencore Ltd. Glencore Ltd. Stamford CT
Holly Refining & Woods Cross Woods Cross UT Yes No No
Marketing Company Refinery
Hunt Refining Tuscaloosa Tuscaloosa AL Yes No Yes
Company Refinery
Irving Oil, Inc. Irving Oil Portsmouth NH
Terminals Inc. ­
PADD 1
Marathon Oil Catlettsburg Catlettsburg KY Yes No No
Corporation Refining, LLC
Marathon Oil Garyville Garyville LA Yes No No
Corporation
Marathon Petroleum Minnesota St. Paul Park MN Yes No No
Company LLC Refining Division
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Table 5-2.  Non-confidential 2006 Inventory Update Reporting Records by
 
Chemical, Including Manufacturing, Processing, and Use Information for
 
Kerosene (Petroleum); CAS Registry No. 8008-20-6; Aggregated 

National Production Volume: ≥1 Billion Pounds
 
Company and site information
Company Site City Statea Manufacture Import Site limited
Marathon Petroleum Michigan Refining Detroit MI Yes No Yes
Company LLC Division
Marathon Petroleum Texas Refining Texas City TX Yes No No
Company LLC Division
Midland Asphalt Tonawanda Tonawanda NY Yes No No
Materials Inc.
Motiva Enterprises, Port Arthur Port Arthur TX Yes No No
LLC Refinery
Motiva Enterprises, Convent Refinery Convent LA Yes No No
LLC
Motiva Enterprises, Norco Refinery Norco LA Yes No No
LLC
Murphy Oil Meraux Refinery Meraux LA Yes No No
Corporation
Murphy Oil USA, Superior Refinery Superior WI Yes No No
Inc.
Navajo Refining Lovington Lovington NM Yes No No
Company, L.P. Refinery
Navajo Refining Artesia Refinery Artesia NM Yes No No
Company, L.P.
Paramount Paramount Paramount CA Yes No No
Petroleum
Corporation
Paramount Wilibridge Asphalt Portland OR Yes No No
Petroleum Facility
Corporation
Penreco Karns City Karns City PA Yes No No
Premcor USA Inc. The Premcor Memphis TN Yes No No
Refining Group 
Inc. DBA Valero 
Memphis Refinery
Premcor USA Inc. Port Arthur Port Arthur TX Yes No No
Refinery
Safety-Kleen Safety-Kleen Oil East Chicago IN Yes No No
Systems, Inc. Recovery Co.
San Juan Refining Giant Refining, Bloomfield NM Yes No No
Company Bloomfield
Shell Chemical LP Mobile Site Saraland AL Yes No No
Shell Chemical LP St. Rose Site St. Rose LA Yes No No
Shell Chemical LP Yabucoa, Inc. Yabucoa PR Yes No No
Shell Deer Park Shell Deer Park Deer Park TX Yes No No
Refining Company Refining Company
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Table 5-2.  Non-confidential 2006 Inventory Update Reporting Records by
 
Chemical, Including Manufacturing, Processing, and Use Information for
 
Kerosene (Petroleum); CAS Registry No. 8008-20-6; Aggregated 

National Production Volume: ≥1 Billion Pounds
 
Company and site information
Company Site City Statea Manufacture Import Site limited
Shell Oil Products Los Angeles Los Angeles CA Yes No No
US Refinery
Shell Oil Products Puget Sound Anacortes WA Yes No No
US Refinery
Shell Trading (US) Main office Houston TX No Yes N/A
Company
Sigmor Corporation Diamond Sunray TX Yes No No
Shamrock
Refining, L.P.,
Valero McKee
Refinery
Sinclair Refining Casper Refinery Casper WY Yes No Yes
Company
Sinclair Refining Tulsa Refining Tulsa OK Yes No No
Company Company
Sinclair Wyoming Sinclair Wyoming Sinclair WY Yes No No
Refining Company Refining Company
Suncor Energy Commerce City Commerce City CO Yes No No
(U.S.A.) Inc. Refinery
Sunoco, Inc. Tulsa Refinery Tulsa OK Yes No No
Tesoro Corporation Tesoro Alaska Kenai AK Yes No No
Company - Kenai
Refinery
Tesoro Petroleum Hawaii Refinery Kapolei HI Yes No No
Corporation
Tesoro Refining and Anacortes Anacortes WA Yes No No
Marketing Company
Tesoro Refining and Golden Eagle Martinez CA Yes No Yes
Marketing Company Refinery
Tesoro Refining and Mandan Refinery Mandan ND Yes No No
Marketing Company
Tesoro Refining and Salt Lake City Salt Lake City UT Yes No No
Marketing Company Refinery
Texaco Fuel and Marine San Ramon CA No Yes N/A
Downstream LLC Marketing LLC
The Dow Chemical Headquarters Midland MI No Yes N/A
Company
Tremco Beachwood Beachwood OH No Yes N/A
Incorporated
U.S. Oil and Tacoma Tacoma WA Yes No No
Refining Co.
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Table 5-2.  Non-confidential 2006 Inventory Update Reporting Records by
 
Chemical, Including Manufacturing, Processing, and Use Information for
 
Kerosene (Petroleum); CAS Registry No. 8008-20-6; Aggregated 

National Production Volume: ≥1 Billion Pounds
 
Company and site information
Company Site City Statea Manufacture Import Site limited
Valero Energy Premcor Refining Delaware City DE Yes No Yes
Corporation Group Inc.
Valero Refining Valero Marketing San Antonio TX No Yes N/A
Company and Supply
Company
Valero Refining Paulsboro Paulsboro NJ Yes No No
Company Refinery
Valero Refining Benicia Refinery Benicia CA Yes No Yes
Company and Asphalt Plant
Valero Refining Wilmington Wilmington CA Yes No Yes
Company
Valero Refining St. Charles Norco LA Yes No No
Company Refinery
Valero Unit Houston Refinery Houston TX Yes No No
Investments, LLC
Valero Unit Texas City Texas City TX Yes No No
Investments, LLC Refinery
Western Refining Western Refining El Paso TX Yes No No
Company Company
Wynnewood Wynnewood Wynnewood OK Yes No No
Refining Company Refining Company
Wyoming Refining Newcastle Newcastle WY Yes No Yes
Company Refinery
aPost Office abbreviations used.
CAS = Chemical Abstracts Service; N/A = not applicable
Source:  EPA 2010
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Table 5-3. Weekly U.S. Production of Commercial Kerosene-Type Jet Fuel
(Thousand Barrels per Day) Since 2010a 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2010-January 01/01 1,335 01/08 1,354 01/15 1,334 01/22 1,264 01/29 1,215
2010-February 02/05 1,157 02/12 1,134 02/19 1,159 02/26 1,141
2010-March 03/05 1,160 03/12 1,171 03/19 1,147 03/26 1,170
2010-April 04/02 1,190 04/09 1,209 04/16 1,244 04/23 1,289 04/30 1,319
2010-May 05/07 1,328 05/14 1,342 05/21 1,323 05/28 1,296
2010-June 06/04 1,290 06/11 1,280 06/18 1,279 06/25 1,291
2010-July 07/02 1,329 07/09 1,353 07/16 1,381 07/23 1,399 07/30 1,382
2010-August 08/06 1,357 08/13 1,339 08/20 1,308 08/27 1,287
2010-September 09/03 1,285 09/10 1,281 09/17 1,299 09/24 1,282
2010-October 10/01 1,269 10/08 1,251 10/15 1,223 10/22 1,219 10/29 1,216
2010-November 11/05 1,199 11/12 1,217 11/19 1,249 11/26 1,248
2010-December 12/03 1,280 12/10 1,270 12/17 1,266 12/24 1,278 12/31 1,287
2011-January 01/07 1,313 01/14 1,297 01/21 1,288 01/28 1,270
2011-February 02/04 1,243 02/11 1,215 02/18 1,225 02/25 1,217
2011-March 03/04 1,223 03/11 1,255 03/18 1,243 03/25 1,262
2011-April 04/01 1,272 04/08 1,277 04/15 1,293 04/22 1,270 04/29 1,272
2011-May 05/06 1,253 05/13 1,250 05/20 1,278 05/27 1,288
2011-June 06/03 1,331 06/10 1,347 06/17 1,363 06/24 1,396
2011-July 07/01 1,381 07/08 1,400 07/15 1,415 07/22 1,394 07/29 1,413
2011-August 08/05 1,389 08/12 1,363 08/19 1,346 08/26 1,362
2011-September 09/02 1,381 09/09 1,389 09/16 1,415 09/23 1,401 09/30 1,419
2011-October 10/07 1,417 10/14 1,372 10/21 1,342 10/28 1,282
2011-November 11/04 1,238 11/11 1,228 11/18 1,223 11/25 1,217
2011-December 12/02 1,250 12/09 1,276 12/16 1,290 12/23 1,309 12/30 1,293
2012-January 01/06 1,310 01/13 1,311 01/20 1,324 01/27 1,319
2012-February 02/03 1,302 02/10 1,292 02/17 1,296 02/24 1,307
2012-March 03/02 1,293 03/09 1,279 03/16 1,265 03/23 1,247 03/30 1,257
2012-April 04/06 1,271 04/13 1,263 04/20 1,292 04/27 1,291
2012-May 05/04 1,280 05/11 1,280 05/18 1,270 05/25 1,280
2012-June 06/01 1,339 06/08 1,378 06/15 1,425 06/22 1,456 06/29 1,456
2012-July 07/06 1,485 07/13 1,460 07/20 1,447 07/27 1,471
2012-August 08/03 1,486 08/10 1,502 08/17 1,528 08/24 1,504 08/31 1,448
2012-September 09/07 1,404 09/14 1,367 09/21 1,339 09/28 1,357
2012-October 10/05 1,358 10/12 1,340 10/19 1,326 10/26 1,313
2012-November 11/02 1,319 11/09 1,302 11/16 1,297 11/23 1,260 11/30 1,244
2012-December 12/07 1,290 12/14 1,308 12/21 1,339 12/28 1,378
2013-January 01/04 1,374 01/11 1,381 01/18 1,357 01/25 1,318
2013-February 02/01 1,299 02/08 1,290 02/15 1,302 02/22 1,305
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5.  PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
Table 5-3. Weekly U.S. Production of Commercial Kerosene-Type Jet Fuel
(Thousand Barrels per Day) Since 2010a 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2013-March 03/01 1,312 03/08 1,293 03/15 1,300 03/22 1,347 03/29 1,387
2013-April 04/05 1,423 04/12 1,443 04/19 1,429 04/26 1,389
2013-May 05/03 1,405 05/10 1,408 05/17 1,373 05/24 1,370 05/31 1,350
2013-June 06/07 1,344 06/14 1,385 06/21 1,416 06/28 1,437
2013-July 07/05 1,461 07/12 1,460 07/19 1,470 07/26 1,479
2013-August 08/02 1,482 08/09 1,475 08/16 1,478 08/23 1,475 08/30 1,483
2013-September 09/06 1,516 09/13 1,512 09/20 1,489 09/27 1,451
2013-October 10/04 1,405 10/11 1,371 10/18 1,364 10/25 1,362
2013-November 11/01 1,368 11/08 1,380 11/15 1,374 11/22 1,385 11/29 1,401
2013-December 12/06 1,436 12/13 1,475 12/20 1,501 12/27 1,527
2014-January 01/03 1,543 01/10 1,527 01/17 1,495 01/24 1,444 01/31 1,384
2014-February 02/07 1,375 02/14 1,360 02/21 1,369 02/28 1,384
2014-March 03/07 1,375 03/14 1,365 03/21 1,362 03/28 1,361
2014-April 04/04 1,378 04/11 1,395 04/18 1,404 04/25 1,418
2014-May 05/02 1,416 05/09 1,430 05/16 1,429 05/23 1,413 05/30 1,419
2014-June 06/06 1,417 06/13 1,440 06/20 1,433 06/27 1,419
2014-July 07/04 1,440 07/11 1,457 07/18 1,510 1,548
aData obtained from EIA (2014a).
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Table 5-4. Weekly U.S. Production of Military Kerosene-Type Jet Fuel (Thousand 

Barrels per Day) Since 2010a
 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2010-January 01/01 128 01/08 105 01/15 109 01/22 134 01/29 148
2010-February 02/05 154 02/12 153 02/19 128 02/26 137
2010-March 03/05 127 03/12 139 03/19 161 03/26 157
2010-April 04/02 175 04/09 162 04/16 152 04/23 148 04/30 142
2010-May 05/07 144 05/14 136 05/21 143 05/28 147
2010-June 06/04 142 06/11 147 06/18 143 06/25 142
2010-July 07/02 149 07/09 143 07/16 151 07/23 153 07/30 153
2010-August 08/06 153 08/13 138 08/20 140 08/27 141
2010-September 09/03 147 09/10 161 09/17 144 09/24 132
2010-October 10/01 124 10/08 108 10/15 105 10/22 118 10/29 109
2010-November 11/05 123 11/12 125 11/19 111 11/26 116
2010-December 12/03 100 12/10 112 12/17 116 12/24 126 12/31 121
2011-January 01/07 117 01/14 107 01/21 102 01/28 114
2011-February 02/04 113 02/11 122 02/18 116 02/25 110
2011-March 03/04 118 03/11 121 03/18 139 03/25 154
2011-April 04/01 147 04/08 159 04/15 147 04/22 135 04/29 146
2011-May 05/06 144 05/13 140 05/20 138 05/27 131
2011-June 06/03 126 06/10 137 06/17 142 06/24 135
2011-July 07/01 148 07/08 143 07/15 149 07/22 160 07/29 137
2011-August 08/05 147 08/12 149 08/19 163 08/26 165
2011-September 09/02 165 09/09 151 09/16 135 09/23 139 09/30 134
2011-October 10/07 136 10/14 132 10/21 134 10/28 136
2011-November 11/04 136 11/11 135 11/18 132 11/25 133
2011-December 12/02 129 12/09 128 12/16 127 12/23 122 12/30 134
2012-January 01/06 130 01/13 129 01/20 125 01/27 118
2012-February 02/03 110 02/10 110 02/17 103 02/24 98
2012-March 03/02 103 03/09 106 03/16 102 03/23 118 03/30 129
2012-April 04/06 125 04/13 139 04/20 122 04/27 123
2012-May 05/04 133 05/11 119 05/18 128 05/25 128
2012-June 06/01 128 06/08 149 06/15 141 06/22 137 06/29 124
2012-July 07/06 121 07/13 139 07/20 132 07/27 140
2012-August 08/03 127 08/10 126 08/17 126 08/24 115 08/31 113
2012-September 09/07 110 09/14 120 09/21 130 09/28 131
2012-October 10/05 131 10/12 132 10/19 142 10/26 142
2012-November 11/02 134 11/09 135 11/16 117 11/23 117 11/30 134
2012-December 12/07 123 12/14 134 12/21 134 12/28 117
2013-January 01/04 125 01/11 125 01/18 130 01/25 134
2013-February 02/01 123 02/08 112 02/15 115 02/22 112
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Table 5-4. Weekly U.S. Production of Military Kerosene-Type Jet Fuel (Thousand 

Barrels per Day) Since 2010a
 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2013-March 03/01 108 03/08 110 03/15 92 03/22 81 03/29 82
2013-April 04/05 86 04/12 87 04/19 93 04/26 112
2013-May 05/03 113 05/10 118 05/17 139 05/24 136 05/31 134
2013-June 06/07 138 06/14 117 06/21 103 06/28 105
2013-July 07/05 108 07/12 109 07/19 109 07/26 98
2013-August 08/02 89 08/09 99 08/16 101 08/23 104 08/30 116
2013-September 09/06 104 09/13 105 09/20 108 09/27 103
2013-October 10/04 106 10/11 102 10/18 93 10/25 81
2013-November 11/01 81 11/08 89 11/15 94 11/22 98 11/29 102
2013-December 12/06 98 12/13 96 12/20 98 12/27 93
2014-January 01/03 89 01/10 89 01/17 91 01/24 99 01/31 97
2014-February 02/07 96 02/14 92 02/21 85 02/28 89
2014-March 03/07 97 03/14 100 03/21 98 03/28 95
2014-April 04/04 89 04/11 90 04/18 88 04/25 86
2014-May 05/02 87 05/09 88 05/16 90 05/23 98 05/30 94
2014-June 06/06 82 06/13 82 06/20 81 06/27 91
2014-July 07/04 100 07/11 99 07/18 94 99
aData obtained from EIA (2014b).
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5.  PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
and then showed a steady increase from 1985 to 1987, attaining an annual maximum of 6,935,000 barrels
in 1987.  Between 1988 and 1990, imports of kerosene decreased to a low of 1,825,000 barrels (API
1991).  Table 5-1 shows that approximately 2,399,093 tonnes of kerosene (18,712,925 barrels) were
imported into the United States in 2012; however, several companies claimed these data as CBI and did 
not report any import volumes publically.  Table 5-5 shows the weekly import volume of kerosene-type
jet fuels since 2000 as reported by the U.S. Energy Information Administration (EIA 2014b).
Kerosene exportation between 1987 and 1989 remained relatively constant with a yearly export average of
approximately 547,500 barrels.  However, by 1990, the annual export of kerosene was 2,190,000 barrels
(API 1991), an increase of approximately 400%.  Table 5-1 shows that approximately 1,609,977 tonnes
(12,557,821 barrels) of kerosene were exported from the United States in 2012; however, several companies 
claimed these data as CBI and did not report any export volumes publically.  Table 5-6 provides the U.S. 
exports of kerosene-type jet fuels since 1981 as reported by EIA (2014c).
5.3  USE 
Aviation turbine fuels were not used until the 1930s when the first turbojet engine was developed. Jet-
powered aircraft had only limited use in World War II, but further military and commercial developments
allowed jet engines to dominate as power sources for aircraft by the 1960s.  JP-1 was the first U.S.
specification for jet fuel (AN-F-32A, 1944).  JP-1 was a kerosene fuel with a maximum freeze point
of -60°C and a minimum flash point of 43°C established for operability and safety (Air Force 1987).  The
flash and freeze points establish boundaries on the minimum and maximum size, respectively, of the
hydrocarbon molecules in jet fuel.  As fuel specifications evolved, trading off producibility and cost
versus performance and safety, the U.S. Air Force settled on JP-4 (MIL-F-5624A, a gasoline-kerosene 
mix) in the 1950s–1970s, the Navy has used JP-5 (a minimum 60°C flash point kerosene also listed in 
MIL-F-5624) shipboard since the 1950s, and commercial aviation has used Jet A/Jet A-1 (ASTM D1655, 
minimum 38°C flash point) since its rapid growth in the 1960s (Air Force 1987b; Dukek and Winans 
1969; Edwards 2003).  Heavier losses in JP-4 fueled aircraft in Vietnam (versus JP-5) caused the U.S. Air
Force to convert to JP-8 in 1980s.  As discussed in Chapter 4, JP-8 is the military equivalent to Jet A-1, 
but contains additive packages that may not be required for commercial jet fuels.  Recent studies in the 
United States have indicated that use of Jet A with its -40°C maximum freeze point was an acceptable and
cost-effective alternative to JP-8, so the Air Force is scheduled to complete the conversion to F-24 
(Jet A + the additive package) in 2014 for use in the continental United States (Air Force 2013).  Thus, 
setting aside the military additive package, jet fuels world-wide consist almost entirely of the very similar
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Table 5-5.  Weekly U.S. Imports of Kerosene-Type Jet Fuel (Thousand Barrels per
 
Day) Since 2000
 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2000-January 01/07 53 01/14 68 01/21 95 01/28 189 
2000-February 02/04 120 02/11 162 02/18 109 02/25 100 
2000-March 03/03 165 03/10 127 03/17 126 03/24 90 03/31 79 
2000-April 04/07 77 04/14 113 04/21 109 04/28 106 
2000-May 05/05 149 05/12 76 05/19 103 05/26 163 
2000-June 06/02 134 06/09 141 06/16 131 06/23 104 06/30 142 
2000-July 07/07 118 07/14 115 07/21 152 07/28 76 
2000-August 08/04 177 08/11 121 08/18 174 08/25 52 
2000-September 09/01 125 09/08 122 09/15 76 09/22 140 09/29 190 
2000-October 10/06 128 10/13 177 10/20 183 10/27 173 
2000-November 11/03 145 11/10 205 11/17 89 11/24 125 
2000-December 12/01 100 12/08 162 12/15 82 12/22 225 12/29 181 
2001-January 01/05 250 01/12 133 01/19 250 01/26 220 
2001-February 02/02 238 02/09 192 02/16 231 02/23 221 
2001-March 03/02 116 03/09 237 03/16 188 03/23 155 03/30 91 
2001-April 04/06 148 04/13 156 04/20 148 04/27 165 
2001-May 05/04 175 05/11 318 05/18 97 05/25 167 
2001-June 06/01 144 06/08 151 06/15 137 06/22 94 06/29 147 
2001-July 07/06 168 07/13 50 07/20 240 07/27 241 
2001-August 08/03 133 08/10 176 08/17 111 08/24 168 08/31 120 
2001-September 09/07 117 09/14 212 09/21 69 09/28 120 
2001-October 10/05 42 10/12 155 10/19 130 10/26 49 
2001-November 11/02 36 11/09 174 11/16 88 11/23 71 11/30 57 
2001-December 12/07 85 12/14 104 12/21 131 12/28 68 
2002-January 01/04 88 01/11 105 01/18 39 01/25 193 
2002-February 02/01 113 02/08 77 02/15 146 02/22 76 
2002-March 03/01 105 03/08 28 03/15 48 03/22 135 03/29 116 
2002-April 04/05 106 04/12 192 04/19 105 04/26 87 
2002-May 05/03 144 05/10 78 05/17 99 05/24 89 05/31 59 
2002-June 06/07 153 06/14 127 06/21 105 06/28 104 
2002-July 07/05 73 07/12 89 07/19 53 07/26 104 
2002-August 08/02 69 08/09 124 08/16 29 08/23 166 08/30 59 
2002-September 09/06 145 09/13 93 09/20 166 09/27 86 
2002-October 10/04 156 10/11 143 10/18 160 10/25 243 
2002-November 11/01 192 11/08 86 11/15 123 11/22 101 11/29 218 
2002-December 12/06 188 12/13 108 12/20 68 12/27 84 
2003-January 01/03 192 01/10 115 01/17 224 01/24 75 01/31 111 
2003-February 02/07 82 02/14 48 02/21 110 02/28 107 
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Table 5-5.  Weekly U.S. Imports of Kerosene-Type Jet Fuel (Thousand Barrels per
 
Day) Since 2000
 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2003-March 03/07 67 03/14 164 03/21 118 03/28 35 
2003-April 04/04 100 04/11 70 04/18 97 04/25 105 
2003-May 05/02 143 05/09 118 05/16 154 05/23 99 05/30 128 
2003-June 06/06 165 06/13 53 06/20 128 06/27 216 
2003-July 07/04 174 07/11 168 07/18 175 07/25 187 
2003-August 08/01 156 08/08 216 08/15 118 08/22 68 08/29 153 
2003-September 09/05 122 09/12 122 09/19 149 09/26 48 
2003-October 10/03 108 10/10 298 10/17 49 10/24 90 10/31 91 
2003-November 11/07 86 11/14 54 11/21 57 11/28 69 
2003-December 12/05 82 12/12 128 12/19 53 12/26 146 
2004-January 01/02 139 01/09 100 01/16 108 01/23 86 01/30 77 
2004-February 02/06 65 02/13 136 02/20 86 02/27 57 
2004-March 03/05 101 03/12 131 03/19 37 03/26 68 
2004-April 04/02 30 04/09 59 04/16 81 04/23 121 04/30 59 
2004-May 05/07 102 05/14 173 05/21 159 05/28 166 
2004-June 06/04 172 06/11 211 06/18 80 06/25 234 
2004-July 07/02 160 07/09 86 07/16 81 07/23 67 07/30 136 
2004-August 08/06 179 08/13 98 08/20 257 08/27 103 
2004-September 09/03 76 09/10 95 09/17 60 09/24 77 
2004-October 10/01 56 10/08 157 10/15 153 10/22 94 10/29 164 
2004-November 11/05 51 11/12 235 11/19 163 11/26 105 
2004-December 12/03 110 12/10 121 12/17 119 12/24 85 12/31 198 
2005-January 01/07 30 01/14 107 01/21 134 01/28 76 
2005-February 02/04 57 02/11 143 02/18 66 02/25 127 
2005-March 03/04 63 03/11 77 03/18 88 03/25 145 
2005-April 04/01 200 04/08 51 04/15 111 04/22 49 04/29 75 
2005-May 05/06 170 05/13 100 05/20 116 05/27 39 
2005-June 06/03 48 06/10 75 06/17 86 06/24 107 
2005-July 07/01 56 07/08 22 07/15 165 07/22 81 07/29 68 
2005-August 08/05 80 08/12 39 08/19 31 08/26 165 
2005-September 09/02 105 09/09 143 09/16 185 09/23 191 09/30 159 
2005-October 10/07 179 10/14 221 10/21 319 10/28 301 
2005-November 11/04 444 11/11 249 11/18 139 11/25 183 
2005-December 12/02 183 12/09 400 12/16 138 12/23 258 12/30 167 
2006-January 01/06 122 01/13 154 01/20 182 01/27 42 
2006-February 02/03 174 02/10 66 02/17 143 02/24 87 
2006-March 03/03 104 03/10 106 03/17 102 03/24 161 03/31 123 
2006-April 04/07 70 04/14 254 04/21 190 04/28 262 
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Table 5-5.  Weekly U.S. Imports of Kerosene-Type Jet Fuel (Thousand Barrels per
 
Day) Since 2000
 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2006-May 05/05 209 05/12 112 05/19 256 05/26 345 
2006-June 06/02 221 06/09 100 06/16 183 06/23 188 06/30 263 
2006-July 07/07 225 07/14 172 07/21 167 07/28 224 
2006-August 08/04 205 08/11 300 08/18 399 08/25 266 
2006-September 09/01 119 09/08 124 09/15 292 09/22 158 09/29 200 
2006-October 10/06 215 10/13 399 10/20 182 10/27 201 
2006-November 11/03 186 11/10 78 11/17 127 11/24 96 
2006-December 12/01 141 12/08 247 12/15 107 12/22 163 12/29 249 
2007-January 01/05 270 01/12 137 01/19 196 01/26 261 
2007-February 02/02 203 02/09 232 02/16 221 02/23 286 
2007-March 03/02 188 03/09 372 03/16 238 03/23 263 03/30 165 
2007-April 04/06 294 04/13 336 04/20 297 04/27 233 
2007-May 05/04 324 05/11 264 05/18 162 05/25 294 
2007-June 06/01 237 06/08 312 06/15 191 06/22 230 06/29 293 
2007-July 07/06 305 07/13 194 07/20 189 07/27 265 
2007-August 08/03 247 08/10 231 08/17 283 08/24 203 08/31 224 
2007-September 09/07 194 09/14 200 09/21 268 09/28 112 
2007-October 10/05 246 10/12 191 10/19 235 10/26 174 
2007-November 11/02 191 11/09 152 11/16 196 11/23 220 11/30 240 
2007-December 12/07 146 12/14 190 12/21 153 12/28 135 
2008-January 01/04 166 01/11 85 01/18 56 01/25 182 
2008-February 02/01 209 02/08 157 02/15 71 02/22 132 02/29 87 
2008-March 03/07 258 03/14 298 03/21 41 03/28 111 
2008-April 04/04 203 04/11 318 04/18 178 04/25 114 
2008-May 05/02 131 05/09 300 05/16 161 05/23 116 05/30 162 
2008-June 06/06 109 06/13 86 06/20 114 06/27 66 
2008-July 07/04 34 07/11 98 07/18 63 07/25 119 
2008-August 08/01 59 08/08 74 08/15 95 08/22 67 08/29 50 
2008-September 09/05 26 09/12 79 09/19 68 09/26 145 
2008-October 10/03 151 10/10 73 10/17 85 10/24 38 10/31 136 
2008-November 11/07 36 11/14 88 11/21 77 11/28 45 
2008-December 12/05 26 12/12 45 12/19 111 12/26 54 
2009-January 01/02 56 01/09 10 01/16 69 01/23 101 01/30 16 
2009-February 02/06 111 02/13 23 02/20 60 02/27 59 
2009-March 03/06 47 03/13 155 03/20 56 03/27 150 
2009-April 04/03 29 04/10 76 04/17 115 04/24 56 
2009-May 05/01 123 05/08 58 05/15 170 05/22 73 05/29 102 
2009-June 06/05 67 06/12 51 06/19 98 06/26 61 
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Table 5-5.  Weekly U.S. Imports of Kerosene-Type Jet Fuel (Thousand Barrels per
 
Day) Since 2000
 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2009-July 07/03 99 07/10 76 07/17 93 07/24 68 07/31 161 
2009-August 08/07 76 08/14 67 08/21 98 08/28 112 
2009-September 09/04 93 09/11 85 09/18 123 09/25 115 
2009-October 10/02 93 10/09 89 10/16 74 10/23 107 10/30 86 
2009-November 11/06 35 11/13 82 11/20 102 11/27 63 
2009-December 12/04 96 12/11 57 12/18 77 12/25 65 
2010-January 01/01 102 01/08 87 01/15 108 01/22 140 01/29 116 
2010-February 02/05 109 02/12 64 02/19 102 02/26 61 
2010-March 03/05 99 03/12 20 03/19 77 03/26 92 
2010-April 04/02 55 04/09 86 04/16 99 04/23 91 04/30 128 
2010-May 05/07 67 05/14 36 05/21 67 05/28 86 
2010-June 06/04 64 06/11 62 06/18 51 06/25 54 
2010-July 07/02 118 07/09 59 07/16 78 07/23 86 07/30 65 
2010-August 08/06 70 08/13 77 08/20 93 08/27 69 
2010-September 09/03 94 09/10 136 09/17 98 09/24 120 
2010-October 10/01 28 10/08 64 10/15 80 10/22 37 10/29 74 
2010-November 11/05 53 11/12 31 11/19 113 11/26 35 
2010-December 12/03 130 12/10 29 12/17 60 12/24 41 12/31 81 
2011-January 01/07 79 01/14 63 01/21 16 01/28 127 
2011-February 02/04 61 02/11 61 02/18 24 02/25 51 
2011-March 03/04 16 03/11 14 03/18 27 03/25 101 
2011-April 04/01 64 04/08 68 04/15 79 04/22 128 04/29 54 
2011-May 05/06 72 05/13 102 05/20 73 05/27 63 
2011-June 06/03 98 06/10 86 06/17 72 06/24 53 
2011-July 07/01 53 07/08 73 07/15 114 07/22 80 07/29 108 
2011-August 08/05 75 08/12 18 08/19 18 08/26 39 
2011-September 09/02 15 09/09 4 09/16 14 09/23 55 09/30 7 
2011-October 10/07 86 10/14 48 10/21 45 10/28 32 
2011-November 11/04 116 11/11 58 11/18 49 11/25 79 
2011-December 12/02 29 12/09 10 12/16 9 12/23 39 12/30 36 
2012-January 01/06 7 01/13 1 01/20 4 01/27 7 
2012-February 02/03 5 02/10 87 02/17 28 02/24 52 
2012-March 03/02 34 03/09 4 03/16 3 03/23 7 03/30 55 
2012-April 04/06 11 04/13 98 04/20 11 04/27 10 
2012-May 05/04 5 05/11 36 05/18 93 05/25 56 
2012-June 06/01 3 06/08 57 06/15 4 06/22 4 06/29 0 
2012-July 07/06 3 07/13 2 07/20 52 07/27 59 
2012-August 08/03 33 08/10 57 08/17 33 08/24 105 08/31 95 
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Table 5-5.  Weekly U.S. Imports of Kerosene-Type Jet Fuel (Thousand Barrels per
 
Day) Since 2000
 
Week 1 Week 2 Week 3 Week 4 Week 5
End End End End End 
Year-month date Value date Value date Value date Value date Value
2012-September 09/07 73 09/14 142 09/21 35 09/28 113 
2012-October 10/05 16 10/12 111 10/19 153 10/26 136 
2012-November 11/02 16 11/09 51 11/16 5 11/23 25 11/30 26 
2012-December 12/07 53 12/14 25 12/21 0 12/28 0 
2013-January 01/04 63 01/11 0 01/18 2 01/25 96 
2013-February 02/01 54 02/08 47 02/15 45 02/22 77 
2013-March 03/01 23 03/08 34 03/15 44 03/22 4 03/29 0 
2013-April 04/05 0 04/12 83 04/19 37 04/26 0 
2013-May 05/03 21 05/10 35 05/17 35 05/24 46 05/31 136 
2013-June 06/07 76 06/14 70 06/21 108 06/28 73 
2013-July 07/05 47 07/12 99 07/19 46 07/26 6 
2013-August 08/02 63 08/09 193 08/16 55 08/23 117 08/30 148 
2013-September 09/06 85 09/13 67 09/20 96 09/27 73 
2013-October 10/04 45 10/11 50 10/18 52 10/25 80 
2013-November 11/01 53 11/08 55 11/15 77 11/22 123 11/29 18 
2013-December 12/06 25 12/13 63 12/20 46 12/27 31
2014-January 01/03 61 01/10 48 01/17 59 01/24 77 01/31 16
2014-February 02/07 98 02/14 94 02/21 58 02/28 10
2014-March 03/07 84 03/14 8 03/21 96 03/28 107
2014-April 04/04 129 04/11 218 04/18 130 04/25 15
2014-May 05/02 124 05/09 73 05/16 78 05/23 137 05/30 34
2014-June 06/06 92 06/13 28 06/20 196 06/27 154
2014-July 07/04 103 07/11 71 07/18 122
aData obtained from EIA (2014b).
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Table 5-6.  Monthly U.S. Exports of Kerosene-Type Jet Fuel (Thousand Barrels
per Month) Since 1981a
Year January February March April May June July August September October November December
1981 28 21 10 18 16 12 19 22 20 14 23 222
1982 255 245 80 44 27 38 32 32 41 35 269 692
1983 272 223 27 17 40 21 37 193 270 24 373 458
1984 318 68 21 148 22 191 306 52 27 158 329 738
1985 79 624 182 149 147 102 106 660 133 773 848 559
1986 1,188 429 333 371 428 184 300 138 420 778 668 626
1987 1,404 565 214 121 117 146 139 74 1,029 1,086 1,336 2,287
1988 2,524 974 1,624 392 119 463 107 440 265 54 271 2,470
1989 2,297 566 19 477 36 35 287 467 1,018 849 1,183 1,309
1990 668 1,393 515 331 238 207 302 927 1,349 2,246 4,218 1,854
1991 2,265 4,393 1,197 758 1,047 391 840 326 295 1,342 137 1,273
1992 1,375 1,168 194 368 202 583 1,623 500 333 1,266 1,125 3,439
1993 2,976 451 2,575 1,833 1,460 1,035 1,799 1,017 414 396 765 1,063
1994 561 722 445 71 282 305 340 311 784 541 524 1,002
1995 766 545 528 138 221 311 572 535 587 1,774 387 1,940
1996 3,443 1,929 1,543 333 414 325 837 1,040 1,525 821 1,340 3,418
1997 2,407 635 342 621 275 1,146 1,004 819 471 1,214 1,325 2,429
1998 1,137 710 899 957 702 737 796 225 751 663 722 506
1999 785 225 697 736 997 792 1,073 246 995 800 1,825 1,585
2000 408 503 1,030 1,111 1,095 798 641 583 1,008 1,289 1,902 1,221
2001 839 437 1,262 506 513 544 722 743 620 966 1,917 1,426
2002 264 1,130 62 38 94 29 67 50 424 39 351 447
2003 1,125 519 1,067 1,018 603 200 373 214 588 883 295 549
2004 678 556 1,211 571 916 850 318 1,600 2,314 1,566 1,641 2,579
2005 878 1,875 2,235 2,927 3,575 2,040 1,428 1,706 469 351 1,068 651
2006 742 712 1,105 1,263 1,005 1,005 1,050 1,518 1,789 1,724 1,481 1,477
2007 1,213 870 1,631 1,024 602 754 1,641 826 1,257 1,017 2,750 1,427
2008 1,836 1,956 1,984 959 2,346 2,590 2,899 1,910 860 1,876 1,547 1,627
2009 2,379 1,171 1,899 1,981 2,656 1,270 1,505 1,688 1,901 2,949 2,226 3,605
2010 3,514 1,852 2,173 2,281 2,441 1,701 2,539 2,630 2,426 1,973 3,082 4,141
2011 3,906 2,786 2,715 3,059 1,733 2,221 3,390 2,806 3,089 2,419 3,173 4,027
2012 3,562 3,650 3,090 2,697 3,864 4,562 4,390 3,410 3,920 4,637 4,801 5,874
2013 5,014 3,188 4,093 4,129 4,150 5,407 4,938 6,020 4,217 4,304 6,419 6,262
2014 4,268 4,058 4,322 3,414
aData obtained from EIA (2014c).
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Jet A and Jet A-1, which essentially only differ in freeze point.  The composition of these two fuels is
very similar, as can be seen in fuel property collections such as the World Fuel Sampling Program
(Hadaller and Johnson 2006) and the annual Petroleum Quality Information Service (PQIS) reports by
DLA-Energy.  For example, in 2012, the PQIS database reported on thousands of samples of Jet A, JP-8, 
and Jet A-1.  The weighted mean freeze points of Jet A/JP-8/Jet A-1 were -49.8, -51.3, and -52.7°C, 
respectively—much smaller variations than those present within each class of itself. The weighted mean
aromatic content of the three fuels were 17.3, 17.1, and 17.6 vol%, respectively—again, much smaller
variations than seen within each fuel.  Thus, for all intents and purposes, Jet A, JP-8, F-24, and Jet A-1 
can be treated as the same fuel in terms of composition and fuel properties, aside from the presence of the 
military additive package in JP-8 and F-24.
5.4  DISPOSAL
Vapors generated in tank truck loading of jet fuels can be disposed of by the installation of a vapor
recovery system (NIOSH 1989).  Runoff of jet fuels from loading and unloading aircraft operations can 
be separated by an on-site oil/water separation system.
Several methods have been investigated for the disposal of jet fuels spilled onto soil from normal aircraft
operations or from accidental spills.  One method, in situ soil venting, involves using vacuum blowers to 
pull large amounts of air through soil contaminated with jet fuels (Elliot and DePaoli 1990).  The vacuum
pulls out the soil gas, and the jet fuel contaminants volatilize as a result of disrupted equilibrium.  
Incineration of free-product extracted from contaminated media is another method of disposal proposed 
for soils and water contaminated with jet fuels (OHM/TADS 1985).  Incineration of soils contaminated 
with jet fuels has also been investigated (OHM/TADS 1985). Other methods include absorption (straw, 
polyurethane foam, activated carbon, and peat have been used as absorbents), gelling agents, combustion 
promoters, dispersants, and mechanical systems (OHM/TADS 1985).  Biodegradation has also been 
suggested as a means of disposal for spills onto soil (OHM/TADS 1985).  Hydrocarbon-degrading
bacteria have been shown to degrade petroleum products into smaller units and eventually into 
nonseparable particles (Butt et al. 1988).  Soil contaminated with jet fuel no. 1 was found to have a
growth response of 106 colony-forming units per mL in 7 out of 21 types of bacteria isolated for sample 
study (Butt et al. 1988).  For more information on biodegradation, refer to Chapter 5.
Wastes containing Jet A, JP-5, and JP-8 are considered hazardous if they meet certain criteria specified by
law.  Hazardous wastes are subject to the handling, transport, treatment, storage, and disposal regulations
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as promulgated under the Resource Conservation and Recovery Act (IRPTC 1985).  Regulations
governing the treatment and disposal of wastes containing JP-5, JP-8, and Jet A fuels are detailed in
Chapter 7.
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6.1  OVERVIEW
JP-5, JP-8, and Jet A fuels have been identified in at least 23 of the 1,699 hazardous waste sites that have 
been proposed for inclusion on the EPA National Priorities List (NPL) (HazDat 2007).  However, the
number of sites evaluated for JP-5, JP-8, and Jet A fuels is not known.  The frequency of these sites can
be seen in Figure 6-1.
JP-5, JP-8, and Jet A fuels are complex mixtures of aromatic and aliphatic hydrocarbons whose exposure
potentials are based on the mixtures themselves and on the individual components of the mixtures 
(primarily n-alkanes, branched alkanes, benzene and alkylbenzenes, naphthalenes, and PAHs, particularly
in the case of environmental exposures once degradation begins). There are few methods for analyzing
the environmental fate of jet fuels per se; instead, methods are used to analyze the proportions of the
component hydrocarbons of jet fuels.
Jet fuel may be released to the environment by in-flight jettisoning of fuel and from spills or leaks to soil 
or water during use, storage, or transportation.  Jet fuel jettisoned from planes can be transported via
airborne dispersion, and some of it can be transformed photochemically to ozone and other components of
smog.  Jet fuel may form aerosols as a result of reactions with atmospheric chemicals, but the specific
composition of the particulate material is not known.  Most of the jet fuel released to water evaporates
into the air.  The more volatile components of jet fuels (low molecular weight alkanes) evaporate from
soil and water and enter the atmosphere where they are degraded.  Components with higher boiling points
persist longer in soil and water.  Some components of JP-5, JP-8, and Jet A fuels are soluble in water
(e.g., the aromatics—benzene, toluene, and xylene).  Under turbulent water conditions, the more soluble
hydrocarbons remain dissolved longer and may partition to soils and sediments and be biodegraded.  The
rate and extent of biodegradation are dependent on the ambient temperature, the presence of a sufficient
number of microorganisms capable of metabolizing the component hydrocarbons, the amount of aromatic
species in the jet fuel, and the concentration of jet fuel.  Some components also volatilize or migrate 
through the soil to groundwater.
The National Occupational Exposure Survey conducted by NIOSH between 1980 and 1983 estimated that
1,076,518 employees (including 96,255 females) were exposed to kerosene, a primary component of JP-5, 
JP-8, and Jet A fuels, in the workplace.  Worker exposure was most likely in industries associated with
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Figure 6-1.  Frequency of NPL Sites with Jet Fuels Contamination 
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machinery and special trade contractors.  Populations most likely to be exposed to JP-5, JP-8, and Jet A
fuels include those involved in jet fuel manufacturing or refueling operations, aircraft and fuel tank 
maintenance, or using JP-8 in military vehicles or as fuel heating or lighting sources; populations near an 
area where Jet A, JP-5, or JP-8 have been dumped; and populations working or living on military bases
where the fuels are used or stored (and where leaks and spills are likely to occur). The general population
is unlikely to be exposed to jet fuels, and any exposure that does occur is most likely to be limited to
populations living on or near a refinery producing these and other substances, airports, or military
installation where these fuels are utilized.  Unintentional exposure to JP-5, JP-8, and Jet A fuels may
occur as a result of groundwater contamination from accidental spills or contact with soils that have been
contaminated with jet fuels.  Since kerosene is a substance still used as a fuel for cooking and heating, it is
expected that members of the general population who use things such as kerosene heaters or lamps may
be exposed through dermal and inhalation routes. 
6.2  RELEASES TO THE ENVIRONMENT
The Toxics Release Inventory (TRI) data should be used with caution because only certain types of
facilities are required to report (EPA 2005). This is not an exhaustive list.  Manufacturing and processing
facilities are required to report information to the TRI only if they employ 10 or more full-time
employees; if their facility is included in Standard Industrial Classification (SIC) Codes 10 (except 1011, 
1081, and 1094), 12 (except 1241), 20–39, 4911 (limited to facilities that combust coal and/or oil for the
purpose of generating electricity for distribution in commerce), 4931 (limited to facilities that combust
coal and/or oil for the purpose of generating electricity for distribution in commerce), 4939 (limited to
facilities that combust coal and/or oil for the purpose of generating electricity for distribution in
commerce), 4953 (limited to facilities regulated under RCRA Subtitle C, 42 U.S.C. section 6921 et seq.), 
5169, 5171, and 7389 (limited S.C. section 6921 et seq.), 5169, 5171, and 7389 (limited to facilities
primarily engaged in solvents recovery services on a contract or fee basis); and if their facility produces,
imports, or processes ≥25,000 pounds of any TRI chemical or otherwise uses >10,000 pounds of a TRI
chemical in a calendar year (EPA 2005).
JP-5 and JP-8 are fuel mixtures used by the U.S. military and NATO as aviation fuels.  As a result of
normal aircraft operations and fuel storage, JP-5 and JP-8 can be released into the environment.  Under
some conditions, it is common practice for aircraft to jettison excess fuel into the air, releasing it into the 
environment (IARC 1989).  Jet A and Jet A-1 are used as civilian aviation fuels, and therefore, accidental
releases could potentially occur at production (refineries) or storage (e.g., airport) facilities.
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Releases of Jet A, JP-5, and JP-8 are not required to be reported under SARA Section 313; consequently, 
there are no data for these compounds in the 2011 TRI (EPA 2005).
6.2.1 Air
There is no information on releases of JP-5, JP-8, and Jet A fuels to the atmosphere from manufacturing
and processing facilities because these releases are not required to be reported (EPA 2005).
6.2.2 Water
There is no information on releases of JP-5, JP-8, and Jet A fuels to the water from manufacturing and 
processing facilities because these releases are not required to be reported (EPA 2005).
JP-5, JP-8, and Jet A fuels may be released into the air as vapors during aircraft loading and unloading
operations or as a result of their normal use as a jet fuel for civilian or military aircraft (Air Force 1981a;
NIOSH 1989).  Releases into the air may also occur as a result of volatilization of these fuels from
contaminated soils or spill sites (Air Force 1989b).  Atmospheric emissions of jet fuels may be 
determined primarily by detection of their volatile hydrocarbon components.
Jet fuels may be released into surface water or groundwater as a result of leaking storage tanks and
pipelines, surface runoff of unburned fuel residue, airborne jettisoning of fuels, and spills during
dispensing operations and aircraft maintenance (Guiney et al. 1987a; Klein and Jenkins 1983).  Leakage
of jet fuels including JP-5 from storage tanks at the Patuxent Naval Air Test Center (NATC), Patuxent
River, Maryland, has resulted in “severe environmental insult” to a Navy fuel farm and adjacent areas 
(Navy 1988).  During the winter of 1976–1977 a pipeline connecting underground storage tanks ruptured, 
releasing an undetermined amount of JP-5 and other jet fuels into the subsurface system.  The existence 
and possible extent of groundwater contamination are unknown; however, surface waters near the site are
known to be contaminated with jet fuels including JP-5 (Arthur et al. 1992).  Widespread contamination 
of groundwater at the Diego Garcia Navy Support Facility has been reported after several major releases 
of JP-5 fuel from 1991 to 1998 (Hansen 1999).  From 1996 to 1998, over 70,000 gallons of JP-5 fuel were 
recovered from contaminated groundwater using a vacuum-enhanced skimming technique that removes 
fuel floating at the surface of the water table.
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On October 16, 1982, a crack in a petroleum pipeline near Ebensburg, Pennsylvania, released an
estimated 1,310 barrels of “aviation kerosene” into a stream (Guiney et al. 1987a, 1987b).  Kerosene and 
other petroleum products were released by accidental spills and discharges into Newark Bay and its major
tributaries. From 1986 to 1991, about 306 gallons of kerosene were released to Newark Bay or its
tributaries (Crawford et al. 1995).  
6.2.3 Soil 
There is no information on releases of JP-5, JP-8, and Jet A fuels to the soil from manufacturing and 
processing facilities because these releases are not required to be reported (EPA 2005).
6.3  ENVIRONMENTAL FATE
6.3.1 Transport and Partitioning 
The transport and dispersion of JP-5, JP-8, and Jet A fuels are dependent on the water solubility and 
volatility of the component hydrocarbon fractions.  Lower molecular weight hydrocarbons such as n­
alkanes may volatilize relatively quickly from both water and soil, while larger aliphatics may be sorbed
to organic particles in water or soil.  Aromatic hydrocarbons will be dissolved in the aqueous phase in 
both soil and water and may undergo some volatilization.  Information on the specific physical and
chemical properties of several of the component hydrocarbons (e.g., benzene, toluene, xylene, and 
naphthalene) can be found in the ATSDR toxicological profiles for these chemicals.  The many
JP-5, JP-8, and Jet A fuels may be released into soil as a result of accidental spills and leaks in
underground or aboveground storage tank systems.  From March to June 1971, an accidental spill 
released >14 tons of JP-5 jet fuel mixed with jet fuel no. 2 at a storage facility in Searsport, Maine (Dow
et al. 1975).  During the winter of 1976–1977, soils at a fuel farm at Patuxent NATC, Patuxent River, 
Maryland, were contaminated with an unknown quantity of JP-5 when a pipeline connecting underground 
storage tanks ruptured (Arthur et al. 1992).  Since that time, site investigations have revealed that the fuel
has moved through several acres of sandy soil to a depth of 20–30 feet (Arthur et al. 1992).
On November 27, 2001, a pipeline ruptured and released approximately 2,500 barrels of JP-8 into a
drainage system that ultimately leads to a nature preserve near Vidor, Texas (Texas Commission of
Environmental Quality 2004).  The spill resulted in contamination of the Neches River and various
managed pasture lands and hardwood forests.  
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hydrocarbons that compose JP-5, JP-8, and Jet A fuels can be divided into a few groups of hydrocarbon 
classes with similar properties (Air Force 1989b).  These include paraffins (also called alkanes, which are
saturated straight-chain hydrocarbons), cycloparaffins (saturated cyclic hydrocarbons), aromatics (fully
unsaturated cyclic compounds), and olefins (also called alkenes, which are unsaturated straight-chain and 
cyclic hydrocarbons).  Paraffins and cycloparaffins (alkanes and cycloalkanes) are the major hydrocarbon
components of JP-5 and JP-8 and together constitute approximately 80–90% by volume of the fuels
(IARC 1989).  Aromatics constitute approximately 17% of JP-8 and 18% of JP-5 (Army 1988).  It is
important to point out that the specific composition of jet fuels varies among manufacturers and probably
among batches (Air Force 1989a; DOD 1992, 2013).  JP-5 and JP-8 may also contain low levels of
nonhydrocarbon contaminants and additives including sulfur compounds, gums, naphthenic acids,
antioxidants, static inhibitors, icing inhibitors, and corrosion inhibitors (DOD 1992, 2013; IARC 1989).
Transport processes have been shown to be more significant than transformation processes in determining
the initial fate of lower molecular weight petroleum hydrocarbons released to soil and groundwater
systems (Air Force 1989b).  Evaporation from water is the major removal process for low molecular
weight, volatile hydrocarbons, such as those found in JP-5 and JP-8 (EPA 1983).  Loss of JP-8 from water 
was determined to be primarily due to evaporation in a quiescent flask test system study (Dean-Ross et al.
1992).  Loss of individual hydrocarbon components of JP-8 was related to molecular weight and vapor
pressure, with low molecular weight components (toluene and n-octane) being removed within 10 days, 
and high molecular weight components (1-methylnaphthalene and n-dodecane) persisting (Dean-Ross et
al. 1992).  Laboratory experiments have shown that the evaporation rate of jet fuel and its components
increases with wind velocity and, to a lesser extent, with temperature and fuel-layer thickness (Air Force 
1988).  Comparisons of dissolution and evaporation rates under several wind-speed and mixing
conditions showed that evaporation was the dominant fate process for jet fuel components in water.
In a study by Coleman et al. (1984), the partitioning of kerosene (the primary constituent of JP-5 and 
JP-8) into drinking water after 17 hours of incubation resulted in only 0.7% of the kerosene being
dissolved in the water.  Further analysis of the kerosene indicated that although kerosene contains 
approximately 50% aliphatic hydrocarbons (by weight percent), the water-soluble fractions (WSFs)
contained primarily aromatic constituents (>93%) including benzenes and naphthalenes as shown in 
Table 6-1 (Coleman et al. 1984).
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Table 6-1. Analysis of Water-Soluble Fraction of Kerosene 
Water-soluble fractionb 
Kerosene Whole producta 0.5 Hours 17 Hours
Alkanes + cycloalkanes 68.6 4.5 0.5
Benzene + substituted benzenes 13.7 63.5 53.2
Naphthalene+ substituted naphthalenes 5.7 29.6 44.8
aEstimated weight percent
bEstimated weight percent of constituents dissolved in water after 0.5 or 17 hours of incubation
Source:  Coleman et al. 1984
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JP-8 also evaporates from soil, although evaporation in not as important a fate process in soil as it is in 
water.  When water/sediment slurries were treated with JP-8, rates of removal were much slower than
from water alone.  The addition of sediments to water inhibited the evaporative removal of JP-8, 
apparently by adsorbing the components of JP-8 and thus rendering them unavailable for evaporation 
(Dean-Ross et al. 1992).  
Horizontal and vertical migration of JP-5 components has been demonstrated by field observations and 
laboratory experiments.  Model soil core terrestrial ecosystems and outdoor soil cores were treated with
JP-5 to mimic a spill and watered to simulate rainfall (Air Force 1982a).  The individual hydrocarbon 
components of JP-5 were found to vertically migrate to varying depths in quantities independent of one
another, apparently independent of aqueous leachate movement.  Movement of JP-5 in the laboratory
occurred to a depth of 50 cm with the majority of hydrocarbons being transported in the first 10 cm.  Of
the 14 hydrocarbons present, only one component, 1,3,5-trimethylbenzene, was detected below 20 cm.  
Hydrocarbon components did not persist past the 131st day of the experiment.  The outdoor soil core
showed movement of JP-5 to a 30-cm depth.  The majority of hydrocarbons were seen at 10, 20, and 
30 cm.  Hydrocarbon components were detectable in the core until the 173rd day of the experiment (Air
Force 1982a).  Horizontal and vertical migration of jet fuels has also been confirmed by detection of JP-5 
hydrocarbons in soil several meters from the spill site (Arthur et al. 1992).
The movement of a synthetic kerosene through soil was found to be dependent on the moisture content of
the soil.  The greater the moisture content (e.g., 4% compared with 0.8%) of the soil, the less the
adsorption of the more volatile components of the kerosene and the greater and more rapid the penetration
of the liquid component through the soil.  Conversely, the upward mobility of both the liquid and vapor
phases of kerosene through soil decreased with increased moisture content; at field capacity, the upward
capillary movement of the kerosene was completely inhibited (Acher et al. 1989).  Desorption of a
simulated kerosene applied to three types of soil, each with a moisture content at 70% of field capacity,
was found to be complete after 30 days of exposure to the atmosphere with the slowest desorption from
the soil having the greatest organic content (Yaron et al. 1989).  Kerosene loss from a dune sand, a loamy 
sand, and a silty loam soil after 50 days showed that volatilization of all kerosene components was
greatest from the dune sand and loamy sand soils. The larger pore size of these types of soil compared
with the silty loam soil was thought to be the reason for the increased volatilization (Galin et al. 1990).  
Movement of kerosene through three grades of sand was affected mainly by volatilization of the C9–C13 
components; the volatilization of specific kerosene components was generally inversely related to their
carbon number (Galin et al. 1990).
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The movement of kerosene through various types of soil over a 12-hour period was studied.  Upward, 
downward, and lateral movement was greatest in soil of the mica/kaolinite type (11% clay content); 40, 
102, and 45 cm, respectively.  Movement through soils that were primarily kaolinite (clay content of 26– 
52%), regardless of the direction, ranged between 20 and 33 cm (EPA 1986).  Application of herbicides
such as S-ethyl dibutylthiocarbamate to a field using kerosene as a solvent (up to a volume of 40 gallons
per acre) increased the inactivation of the herbicide on soil, whereas acetone, benzene, and xylene did not.  
The accelerated inactivation possibly resulted from a change in surface tension that facilitated the 
volatilization of the herbicide from the soil (Danielson and Gentner 1970).
Studies on the permeability of compacted micaceous soil used as a potential liner for landfills found that
the permeability of the soil to kerosene varied from 3 to 4 orders of magnitude greater compared with 
water (EPA 1984).
Klein and Jenkins (1983) exposed flagfish and rainbow trout to WSF of JP-8 in static acute bioassays and
continuous-flow bioassays.  The mean concentration of JP-8 in whole-body tissue samples increased with 
increasing concentration of the WSF of the fuel.  The bioconcentration factor (BCF), expressed as the
ratio of the concentration in tissue to the concentration of the WSF of JP-8 in the aqueous environment, 
was found to be 159 (log value of 2.2).  Adult flagfish exposed to 2.54 mg/L, for 14 days yielded a BCF
of 130 (log value of 2.1).  Adult flagfish that were placed in uncontaminated water exhibited a depuration 
rate similar to the accumulation rate.  Similar experiments with rainbow trout showed no relationship 
between JP-8 concentrations in surrounding water and whole-body concentrations in the fish. The
relatively low BCF of 63–112 (log value of 1.8–2.1) calculated for rainbow trout indicates that the WSF
of JP-8 does not concentrate as readily in this species.
6.3.2 Transformation and Degradation
6.3.2.1  Air
No studies on the transformation or degradation of JP-5, JP-8, and Jet A fuels in the atmosphere were 
located.  However, volatile components of jet fuels such as benzene, toluene, xylenes, and PAHs may be 
expected to enter the atmosphere where they are subjected to degradation processes.  Further information 
on the atmospheric degradation of selected volatile hydrocarbons is presented in the ATSDR
toxicological profiles for these chemicals (Agency for Toxic Substances and Disease Registry 1995, 
2007a, 2007b, 2015).  The photooxidation half-life range for a group of representative chemicals of
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kerosene, JP-5, and JP-8 was reported as 0.2–1.1 days (API 2010a).  Studies on JP-4, a jet fuel mixture of
gasoline and kerosene, indicate that jet fuels react photochemically in air in the presence of nitrogen oxide
compounds to form ozone, but the effect of temperature on the nitrous oxide oxidation rate is uncertain 
(Air Force 1981b, 1982b).  Reactions of JP-4 produce large amounts of aerosol material (Air Force 
1981b), and it should be noted that JP4 has a considerable gasoline component compared to straight
kerosene.
6.3.2.2  Water
Biodegradation of jet fuels is dependent on the degradation of the various hydrocarbon fractions present
in the oils. The relative order for biodegradation of the hydrocarbon fractions from the most readily
degraded to the least is as follows: n-alkanes, iso-alkanes, olefins, low molecular weight aromatics (at
low, nontoxic concentrations), PAHs, and cycloalkanes (Bartha and Atlas 1977; Edgerton et al. 1987).
Conflicting data exist on the biodegradation of jet fuels and kerosene.  Biodegradation of JP-8 in water
was studied using quiescent flask test systems (Dean-Ross et al. 1992).  Microbial activity in flasks of
water incubated at 30°C on a shaker at 200 revolutions/minute for 4 days was inhibited by all
concentrations of JP-8 tested (0.01, 0.1, 1%), as indicated by a depression of glucose mineralization in 
comparison to a control.  The study authors suggested that one possible explanation for the lack of
biodegradation in water samples is the toxicity of JP-8 to microorganisms at the concentrations tested,
which may severely inhibit microbial activity (Dean-Ross et al. 1992).
Microorganisms readily able to degrade hydrocarbons were isolated from the Neuse River estuary in
North Carolina.  Although the estuary was relatively free of hydrocarbon contamination, 63% of the
bacteria and 71% of the fungi isolated from surface water samples were able to utilize kerosene as the 
sole carbon source (Buckley et al. 1976).  Weathered kerosene (volatile components were allowed to
escape prior to testing) was spiked with four hydrocarbon markers, and the degradation of the markers 
was monitored.  All four markers were degraded by a water-sediment mixture from an “oiled arm” of an
Ohio lake; more rapid-degradation was associated with mixtures taken from relatively polluted areas of
the lake (Cooney et al. 1985), suggesting that biodegradation is enhanced by the presence of acclimated
microorganisms.  Marine bacteria capable of using jet fuel no. 1 were isolated from Narragansett Bay,
Rhode Island.  Most of the bacteria were found to utilize the aliphatic components of the jet fuel,
primarily hexadecane, while only a few of the bacteria were able to degrade the aromatic components.
The bacteria were able to degrade the hexadecane at 0°C, but degradation was significantly improved
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when the incubation temperature was increased to 8 and 16°C; similar but not such dramatic effects were 
seen in the degradation of naphthalene with increased temperature (Cundell and Traxler 1976).
Petroleum residues were measured in the northern Arabian Sea to assess the contamination following the 
oil spills resulting from the Gulf War in 1991.  Little change in variables related to oil pollution took
place in any compartment of the marine environment-water, plankton, fish, or sediments (Sengupta et al. 
1993).
Kerosene achieved 58.6% of its theoretical biochemical oxygen demand (BOD) after 28 days using an 
activated sludge inoculum obtained from a municipal waste water treatment plant and the manometric 
respirometry test (OECD 301F).  It was classified as not readily biodegradable, but was inherently
biodegradable since significant degradation did occur (API 2010a).  Two distillate fuels with similar
composition to JP-5 and JP-8, a low sulfur diesel fuel and a Nigerian diesel fuel, achieved 60 and 57.5%
of their theoretical BOD within 28 days using an activated sludge and the manometric respirometry
(OECD 301F) test, and an aviation turbine fuel (Chemical Abstracts Service Registry Number not stated)
was degraded up to 46% within 10 days in fresh water amended with nutrient salts (nitrogen and 
phosphorous) using a study method that appears to be similar to the closed bottle test (OECD 301D) (API
2010a).  The degradation rates were 53 and 2% after 10 days using seawater with and without the nutrient
amendments, respectively.  Over 99% removal of the hydrocarbon fraction of kerosene type aviation fuels
(Jet A, Jet A-1, and JP-8) in water-soluble fractions were observed using mixed microbial cultures 
isolated from aviation fuel contaminated groundwater in a chemostat culture apparatus over a 113-hour
incubation period (API 2010a). These study results suggest that many of the components of these 
mixtures are quickly degraded and are not expected to be persistent in the environment.
6.3.2.3  Sediment and Soil
Ample evidence exists to indicate that many of the components of kerosene, JP-5, JP-8, and Jet A fuels
are biodegraded in soil.  Microbial degradation in soils is greatest for the aromatic fractions of jet fuels,
while the biodegradation of the aliphatic hydrocarbons decreases with increasing carbon chain length and
the degree of branching.  Evaporation is the primary fate process for these aliphatics (Air Force 1989b).
Application of JP-5 to terrestrial soil core ecosystems and outdoor soil cores resulted in a stressed
condition as indicated by an increased rate of carbon dioxide (CO2) production within 1 day of
application (Air Force 1982a).  The carbon dioxide production of the cores returned to a rate almost
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comparable to that of the controls following the increase.  A possible reason for this increase was 
increased activity of microorganisms that utilize the component hydrocarbons of JP-5.  The study authors
concluded that soil microbes are able to degrade JP-5 in cultures inoculated with soil organisms (Air
Force 1989a).  In a quiescent flask study, JP-8 was found to be nontoxic to sediment microorganisms
(Dean-Ross et al. 1992). The study authors found that removal of some components of JP-8 from active 
soil (soil containing microorganisms) was significantly faster than removal in sterilized soil.  Subsurface
microorganisms present at a fuel spill at Patuxent NATC were able to utilize JP-5 as their sole carbon 
source (Navy 1988).  The study author concluded that potential exists for promoting in situ 
biodegradation of some of the hydrocarbon components by stimulating the growth of indigenous
microflora.  Although most soils contain microorganisms capable of degrading hydrocarbons in situ, the
factors that limit the bioremediation process (e.g., restricted bioavailability of the contaminant, nutrient 
limitations, potential toxicity of fuel hydrocarbons and associated contaminants, inadequate
reduction/oxidation [redox] potential, inadequate or excessive moisture, acidic or basic conditions, and 
oxygen deficiency) need to be overcome in order to stimulate the degradation of jet fuels in soil and
groundwater (Arthur et al. 1992).
The degradation of kerosene in soil was studied when a pipeline ruptured and showered a wheat field with 
kerosene.  After 6 months, the kerosene concentration began to decrease in the upper 30 cm of soil (with 
C13–C17 n-alkanes disappearing more rapidly compared with C10–C12 n-alkanes) and at 21 months, was
reduced to trace amounts; however, kerosene was still detected at soil depths of 30–45+ cm.  The study
authors interpreted this as indicating reduced aerobic biodegradation at this depth, especially since the 
compounds disappeared in the order of their preferential microbial utilization.  Seed germination studies
using the contaminated soil 1 year after the spill (0.34% kerosene concentrations) showed that kerosene
delayed seed germination, but that the percent germination was unaffected (Dibble and Bartha 1979).  
Landfarming techniques (tillage of soil using agricultural implements) developed in The Netherlands to 
enhance biodegradation of contaminants demonstrated that after one growing season, kerosene (initial
concentration of 1,000–10,000 mg/kg dry matter) was significantly degraded (final concentration of
500 mg/kg dry matter) in 40 cm of soil (Soczo and Staps 1988).
The addition of nitrogen (as urea) to soil increases the biodegradation potential of kerosene; however, 
kerosene was found to inhibit the urease activity of soil microbes by up to 35%, suggesting that sources of
nitrogen other than urea should be used (Frankenberger 1988).  The bacterial species in the genera
Achromobacter, Pseudomonas, and Alcaligenes, isolated from the soil of an active oil field in Louisiana, 
were able to aerobically degrade kerosene as determined by oxygen uptake (Cooper and Hedrick 1976).
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Soil Pseudomonas species were able to degrade kerosene to a greater extent than were Enterobacter
species with stationary phases occurring after 10 and 8 days, respectively (Butt et al. 1988).  Seven years 
after the dumping of sludge containing kerosene at two sites, vegetation at each site showed little 
recovery.  Although the bacterial biomass had declined at both sites, microbial activity, as determined by
carbon dioxide evolution, was greater at the site that had received more precipitation and had the more 
aerated soil (Jones 1977). Oxidation of kerosene by soil microbes, as determined by dehydrogenase 
activity, increased with increasing loading rates (up to 60% w/w oil/dry soil) for up to 7 days of
incubation, but decreased thereafter.  Dehydrogenase activity in soil treated with kerosene was 32 μg
formazan/g soil/24 hours (Frankenberger and Johanson 1982).
A study was conducted to investigate the loss of JP-8 in soil with the presence of vegetation (Karthikeyan
et al. 1999).  A biodegradation unit consisting of a sandy soil (82–90% sand, 8–16% silt, 2% clay, and 
0.6–1.1 % organic matter) that had previously been contaminated with toluene, phenol, trichloroethylene
(TCE), and trichloroethane (TCA) was used to grow alfalfa plants. JP-8 was added to different parts of
the biodegradation chamber at depths ranging from 10 to 30 cm and the system was irrigated with water.  
The overall average level was about 1,700 mg JP-8 per kg of soil at the start of the experiment.  
Approximately 3 months following the initial application of JP-8 to the system, the total petroleum
hydrocarbon (TPH) levels had decreased to about 215 mg/kg (0–10 cm), 1,249 mg/kg (10–20 cm), and 
405 mg/kg (20–30 cm) at the front location of the test system.  Concentrations at the back location were
significantly lower.  Experiments conducted on air-dried soils used as sterile controls suggested that
volatilization could account for up to about 52% of the losses from these experiments; however, 
biodegradation was also considered a significant environmental fate process.
6.4  LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
Reliable evaluation of the potential for human exposure to JP-5, JP-8, and Jet A fuels depends in part on 
the reliability of supporting analytical data from environmental samples and biological specimens.
Concentrations of JP-5, JP-8, and Jet A fuels in unpolluted atmospheres and in pristine surface waters are 
often so low as to be near the limits of current analytical methods.  In reviewing data on JP-5, JP-8, and 
Jet A fuel levels monitored or estimated in the environment, it should also be noted that the amount of
chemical identified analytically is not necessarily equivalent to the amount that is bioavailable. The 
analytical methods available for monitoring JP-5, JP-8, and Jet A fuels in a variety of environmental
media are detailed in Chapter 7.
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6.4.1 Air
Components of jet fuels can enter the atmosphere through evaporation from spills and leaks, vaporization 
during fueling operations, fuel jettisoning, and burning in engines.  In a “third generation closed aircraft
shelter,” which has approximately 3 times the interior volume of a “first generation closed aircraft
shelter,” the concentration of JP-8 in the air was measured as 12 mg/m3 during refueling operations.  In 
the immediate vicinity of the refueler technician, JP-8 concentrations were determined to be <22 mg/m3 
(Air Force 1981a).  In contrast, concentrations of JP-4 (a more volatile jet fuel than either JP-5 or JP-8)
ranged from 75 to 267 mg/m3 in a similar structure during fueling operations.  Concentrations of JP-4 in a
first-generation shelter ranged from 533 to 1,160 mg/m3 (Air Force 1981a).
6.4.2 Water
No data were located that discussed specific levels of JP-5, JP-8, and Jet A fuels in water.  During
October of 1983, a leaking pipeline south of Ebensburg, Pennsylvania, released approximately
1,310 barrels of “aviation kerosene” into a trout stream (Guiney et al. 1987a, 1987b).  Total organic
carbon (TOC) content in the stream water was approximately 30–60 ppm during the initial few months
following the spill, which is approximately 1.5–2 times greater than background (Guiney et al. 1987b).  
During the winter of 1976–1977, a leak of unknown quantity in a pipeline at Patuxent NATC in Maryland 
resulted in surface water contamination and possible groundwater contamination by JP-5 (Arthur et al. 
1992).
A study by Puhala et al. (1997) examined jet fuel vapor exposures at three U.S. Air Force bases in the
United States.  At the time of sampling, JP-8 was only used at one base, JP-5 and JP-8 at another, and a
third used only JP-4.  Breathing zone samples were collected for workers in aircraft maintenance, fuel
handling, and flight-line positions.
Mean exposure concentrations for all samples collected were 0.01 ppm benzene (SD=0.0l) and 1.33 ppm
naphthas (SD=l.95) for aircraft maintenance positions; 0.01 ppm benzene (SD=0.0l) and 0.61 ppm
naphthas (SD=0.90) for fuel handling positions; and 0.004 ppm benzene (SD=0.005) and 0.33 ppm
naphthas (SD=0.40) for flight-line positions.
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6.4.3 Sediment and Soil
An unknown quantity of JP-5 leaked from a pipeline during the winter of 1976–1977 at Patuxent NATC
in Maryland, resulting in several acres of soil contamination to a depth of 20–30 feet (Arthur et al. 1992).  
Storage and aircraft refueling operations at research facilities such as Scott Base have resulted in jet fuel
contamination of soils in the Ross Dependency, Antarctica (Aislabie et al. 1998).  TPH levels in 
contaminated soils of the Ross Dependency ranged from <2 to 17,488 μg/g, with the highest levels
observed near leaking pipelines carrying JP-8 and other fuel leak locations near storage and re-fueling
areas. The hydrocarbon profile in these contaminated soils consisted of C9–C14 alkanes, C2–C4 benzenes, 
naphthalene, and methyl naphthalene.  Quantitative amounts collected from soil samples at Scott Base are
shown in Table 6-2.  
Concentrations of kerosene-range hydrocarbons in sediment collected one month after an aviation 
kerosene leaked into a trout stream were reported as “saturated” (Guiney et al. 1987b).  Approximately
14 months after the leak, one site still had kerosene-hydrocarbon sediment levels of 18.0±10.8 ppm and a
second site had a mean concentration of 9.3±9.0 ppm, while a control site had levels of <2.0 ppm.  
Kerosene-hydrocarbon sediment levels returned to normal levels in the stream 21 months after the spill.
TPH levels were measured in soil samples located at the Dobbins Air Force Base located in Marietta,
Georgia (Reed and Sterner 2002).  This facility had a fuel farm that contained eight 50,000-gallon above­
ground storage tanks used to store and distribute JP-4, JP-5, and JP-8 from the mid-1950s through 1993.  
TPH levels at depths of 1–2 feet below the surface ranged from 517 to 2,239 mg/kg in four out of eight
grab samples of soil collected in 1997.  Xylene levels ranged from 0.026 to 0.70 mg/kg; however, other
common constituents of JP-5 and JP-8 such as benzene, toluene, and ethylbenzene were not detected in 
the 1997 preliminary sampling.  Sampling conducted in 2001 at soil depths 1–8.5 feet below the surface 
had detectable benzene levels of 1.3–31 mg/kg and TPH-gasoline range organics ranged from 1 to 
3,400 mg/kg, while TPH-diesel range organics ranged from 7.8 to 9,800 mg/kg (Reed and Sterner 2002). 
TPH levels in soil samples collected at the site of a Harrier jet fueled by JP-8 that crashed near Wright-
Patterson Air Force Base, Ohio ranged from 389 to 11,657 mg/kg and from 3,100 to 8,500 mg/kg for
samples collected on two consecutive days and analyzed by two different analytical methods (Merrill
1998).  Soil samples collected at Misawa Air Base, Japan in 1998 had TPH levels (total aliphatics and
aromatics) ranging from 703 to 11,938 mg/kg at three locations where jet fuels had been stored 
(Vermulen et al. 1998). 
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Table 6-2.  Hydrocarbon Levels (μg/g) from Jet Fuels in Soil Samples from Scott
 
Base, Antarctica
 
Hydrocarbon 1 2 3 4 5 6
 
C9 123 <2 <2 486 1,220 50
 
C10 383 623 <2 1,740 3,570 163
 
C11 663 543 263 2,170 4,176 246
 
C12 446 1,570 554 1,780 3,490 250
 
C13 240 1,120 653 1,016 1,763 166
 
C14 <2 900 443 493 920 63
 
C2-benzenes 772 <2 <2 <2 <2 <2
 
C3-benzenes 1,338 1,825 <2 360 <2 <2
 
C4-benzenes 818 2,009 <2 836 <2 <2
 
Naphthalene 190 773 <2 <2 <2 <2
 
C1-Napthalene 196 1,076 <2 <2 <2 <2
 
Source:  Aislabie et al. 1998
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6.4.4 Other Environmental Media 
No data were located that discussed specific levels of JP-5 or JP-8 in other environmental media such as
food or terrestrial or aquatic plants and animals.  Concentrations of kerosene-range hydrocarbons in fish 
collected during the year following an “aviation kerosene” leak into a trout stream ranged from 2.60 to 
14.37 ppm by weight (Guiney et al. 1987b).  Shellfish taken from unpolluted waters have been found to 
contain between 1 and 12 μg/g wet weight of total hydrocarbons, while fish have been found to contain 
between 4 and 14 μg/g total hydrocarbons (steam distillable) (Connell and Miller 1980).
6.5  GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
Exposure of the general population to JP-5,JP-8, and Jet A fuels is most likely to be limited to populations 
living on or near a military installation where JP-5 or JP-8 are utilized or near commercial airports using
Jet A fuel.  Unintentional exposure to JP-5 and JP-8 may occur as a result of groundwater contamination 
from spilled jet fuels or contact with soils that have been contaminated with jet fuels.  Atmospheric
exposure may occur from fuel leakage, spillage, engine cold starts, and high-altitude aircraft fuel 
jettisoning (Ritchie et al. 2003).  Occupational exposure will occur in individuals involved in the
production of JP-5, JP-8, or Jet A fuels; fueling and defueling aircraft; cleaning up spills and leaks of jet
fuel; and aircraft and fuel tank maintenance.  It was reported that over 1 million U.S. military and civilian
personnel are occupationally exposed to JP-8, JP-8 + 100, JP-5, or to the civil aviation equivalents, Jet A
or Jet A-1 annually (Ritchie et al. 2003).  Exposure occurs via four primary scenarios: (1) direct dermal
contact with raw fuel and/or aerosols; (2) secondary dermal contact with clothing or other items such as
gloves that are contaminated by the fuel; (3) inhalation exposure to fuel or exhaust; or (4) oral exposure to 
aerosol or to fuel contaminated food or water.  In addition to aircraft fueling applications, JP-8 is used for
fueling land vehicles and equipment, fueling of heaters and lighting sources, as a coolant in aircraft, 
combat obscurant, to suppress environmental sand or dust, decontaminate military vehicles and
equipment, and as a carrier for herbicide applications (Ritchie et al. 2003).
Because jet fuels such as JP-5, JP-8, and Jet A are complex mixtures of hundreds of aliphatic and 
aromatic hydrocarbons, exposure to JP-5, JP-8, and Jet A is typically monitored by measuring THCs and 
certain aromatic components such as benzene, toluene, ethylbenzene, xylenes, and naphthalene in air or
expired breath with the knowledge that the levels of these substances may also arise from sources other
than jet fuels.  Members of the Air National Guard at the Warfield Air National Guard Base in Essex,
Maryland were monitored for exposure to JP-8 during normal working hours from August to October
2001 (Tu et al. 2004). Pre-work concentrations of JP-8 constituents in exhaled breath ranged from below
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the detection limits to 7.6 mg/m3 and post-work samples ranged from 0.2 to 11.5 mg/m3; an increase in
postwork levels was only found in fuel cell workers and fuel specialists with the greatest change 
occurring in the fuel cell workers. A control group of 18 nonsmoking, unexposed subjects living in an 
urban environment had exhaled breath concentrations of 0.30–2.13 mg/m3 (pre-work) and 0.21– 
2.28 mg/m3 (post-work). Merchant-Borna et al. (2012) examined 73 U.S. Air Force personnel at three
different bases and monitored their exposure to JP-8 constituents.  They categorized the individuals at
these bases into low- and high-exposure groups based upon expected exposure scenarios given their job 
descriptions.  The high-exposure group primarily consisted of fuel system workers involved in the
removal, repair, inspection, and modification of aircraft fuel systems; the low-exposure group primarily
consisted of workers with intermittent or low-no exposure employed in fuel distribution or maintenance, 
aircraft inspection and maintenance, and administrative/clerical office work. The geometric mean 8-hour
time-weighted average (TWA) concentration of JP-8 constituents (THC, benzene, toluene, ethylbenzene, 
xylene, and naphthalene) in personal air samples were significantly higher in the high-exposure group as
compared to the low-exposure group (p<0.0001), with the exception of toluene.  The geometric mean 
8-hour TWAs for THC were 0.52 mg/m3 (range 0.24–22.01 mg/m3) and 2.64 mg/m3 (range 0.24– 
73.93 mg/m3) for the low and high exposure groups, respectively (Merchant-Borna et al. 2012; Proctor et
al. 2011).  The geometric mean 8-hour TWAs for benzene, ethylbenzene, and naphthalene were
0.88 µg/m3 (range 0.2–250 µg/m3), 0.72 µg/m3 (range 0.1–224 µg/m3), and 0.37µg/m3 (range 0.2– 
11 µg/m3), respectively, in the low-exposure group, and 1.98 µg/m3 (range 0.2–99 µg/m3), 5.57 µg/m3 
(range 0.2–390 µg/m3), and 2.25µg/m3 (range 0.2–55 µg/m3), respectively, in the high-exposure group.  
These results are consistent with the findings of Maule et al. (2013) who examined breathing zone levels 
of Air Force personnel similarly assigned to high- and low-exposure groups.  The geometric mean work-
shift THC concentration of high-exposure personnel was reported as 4.4 mg/m3, while that of the low-
exposure group was 0.9 mg/m3. A study of fuel cell maintenance workers reported geometric mean
breathing zone naphthalene levels of 614 mg/m3 (Chao et al. 2006).  The work-shift naphthalene
geometric means were 4.8 and 0.7 µg/m3 for the high- and low-exposure groups, respectively.  Egeghy et 
al. (2003) measured levels of benzene and naphthalene in the air and breath of Air Force personnel
exposed to JP-8.  Based upon job function, personnel were pre-assigned to high- (fuel maintenance), 
moderate- (fuel handling, distribution, recovery, and testing), and low- (jobs with minimal jet fuel
exposure) exposure groups  Levels of naphthalene in both air and breath samples were highest for
personnel assigned to the high-exposure category and there was little overlap in air levels among workers 
assigned to the high-, moderate-, and low-exposure groups.  Benzene levels were also greater in air and
breath samples of workers assigned to the high-exposure category; however, there was substantial overlap
in air levels for each category, suggesting that sources other than JP-8 (e.g., smoking or gasoline exhaust)
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could be accounting for some of the benzene exposure among these personnel (Egeghy et al. 2003).  Even 
so, the authors noted that benzene levels exceeded the American Conference of Governmental Industrial 
Hygienists (ACGIH) threshold limit value (TLV) of 1.6 mg/m3 in 5 and 15% of the air concentrations of
the moderate- and high-exposure groups, respectively.  Benzene and naphthalene levels in personal air
were also considerably greater in this study (485 µg/m3 for naphthalene in the high exposure category and 
252 µg/m3 for benzene in the high-exposure category) as compared to the studies of Merchant-Borna et
al. (2012) and Maule et al. (2013).  The elevated levels in the Egeghy et al. (2003) study may be due to 
the fact that personnel were actively monitored while working in tanks and the use of fire suppression 
foam in this study, which increases exposure (Merchant-Borna et al. 2012).
6.6  EXPOSURES OF CHILDREN 
This section focuses on exposures from conception to maturity at 18 years in humans.  Differences from
adults in susceptibility to hazardous substances are discussed in Section 3.7, Children’s Susceptibility.
Children are not small adults.  A child’s exposure may differ from an adult’s exposure in many ways.  
Children drink more fluids, eat more food, breathe more air per kilogram of body weight, and have a
larger skin surface in proportion to their body volume.  A child’s diet often differs from that of adults.  
The developing human’s source of nutrition changes with age:  from placental nourishment to breast milk
or formula to the diet of older children who eat more of certain types of foods than adults.  A child’s
behavior and lifestyle also influence exposure.  Children crawl on the floor, put things in their mouths, 
sometimes eat inappropriate things (such as dirt or paint chips), and spend more time outdoors.  Children 
also are closer to the ground, and they do not use the judgment of adults to avoid hazards (NRC 1993).
Children are expected to be exposed to JP-5, JP-8, and Jet A fuels by the same routes that affect general
population adults; however, barring an accidental spill near their residence, it is unlikely that children will
be exposed to significant levels of these fuels as they are primarily used in the aviation industry and the
highest exposure levels are expected to occur for workers and military personnel involved in aviation 
fueling procedures or the production of kerosene-based fuels.  Children residing on or near military bases 
where JP-8 and JP-5 are used may experience a slightly higher level of exposure than children of the 
general population. 
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6.7  POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
Military or civilian workers involved in fueling and defueling operations may be exposed to higher levels 
of JP-5, JP-8, and Jet A fuels than members of the general population (Air Force 1981a; Merchant-Borna
et al. 2012; Tu et al. 2004).  Maintenance workers who monitor jet fuel storage tanks may be exposed to 
components of these fuels via inhalation of jet fuel vapors. Maintenance workers may also be dermally
exposed to jet fuels while sampling, gauging, and draining water (condensation) from fuel storage tanks
(Chao et al. 2005; NIOSH 1989).  The military also uses JP-8 in ground vehicles, generators, cooking
stoves, and tent heater; workers involved in fueling maintaining this equipment may also be exposed to 
higher levels. Workers in the petroleum industry may receive intermittent inhalation, oral, and dermal
exposure to kerosene and jet fuels during the refining process.  Exposure is most likely to occur during
the distillation of crude oil, when monitoring and servicing of equipment are carried out, or when 
sampling must be done (Runion 1988).  Use of a respirator, protective clothing, and increased ventilation 
can all reduce worker exposure to jet fuel vapor. The use of JP-8 rather than JP-4 reduces occupational
exposure to jet fuel vapors for maintenance workers and pilots because the vapor pressure of JP-8 is an 
order of magnitude less than JP-4 at 38°C.  This results in less vapor being vented from JP-8-fueled 
aircraft than JP-4-fueled aircraft (Air Force 1981a). The similarly low volatility of JP-5 suggests that
reduced exposure to JP-5 vapors will also occur in aircraft fueled with JP-5.
6.8  ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of JP-5, JP-8, and Jet A fuels is available. Where adequate 
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a
program of research designed to determine the health effects (and techniques for developing methods to 
determine such health effects) of JP-5, JP-8, and Jet A fuels.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be 
evaluated and prioritized, and a substance-specific research agenda will be proposed.
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6.8.1 Identification of Data Needs 
Physical and Chemical Properties. The physical and chemical properties of JP-5 and JP-8 
(kerosene) and their primary component chemicals are well defined and can be used to estimate the fate 
of these jet fuels following release to the environment (Air Force 1989b; IARC 1989).  However, because 
jet fuels are complex mixtures of hydrocarbons, their environmental fate is determined by both the
characteristics of the mixture and the individual components, making modeling based on physical and 
chemical properties difficult. Additional information on the identification of the compounds used as
additives would be useful in assessing the environmental fate of jet fuels. Data needs associated with
specific compounds that are components of JP-5 and JP-8 (e.g., benzene, toluene, xylene, and PAHs) are
presented in the ATSDR toxicological profiles for these chemicals (Agency for Toxic Substances and
Disease Registry 1995, 2007a, 2007b, 2015).
Production, Import/Export, Use, Release, and Disposal. According to the Emergency
Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Section 11023, industries are required 
to submit substance release and off-site transfer information to the EPA.  The TRI, which contains this
information for 2011, became available in November of 2013. This database is updated yearly and should
provide a list of industrial production facilities and emissions.
JP-5 and JP-8 are used primarily as military aviation fuels (Air Force 1989b; IARC 1989). Most releases 
of jet fuels are the result of in-flight jettisoning of fuel and spills either on land or water (Arthur et al.
1992; IARC 1989).  Production, consumption, import, and export volumes are available for kerosene and 
jet fuels (EIA 2013c; EPA 2012a).  Further information on the production volumes for each specific jet
fuel, environmental releases, and disposal of jet fuels would aid in assessing the potential for human 
exposure as a result of accidental or intentional release.
Environmental Fate. The environmental fate of JP-5, JP-8, and Jet A fuels is based on the
environmental partitioning of the major hydrocarbon fractions.  For aliphatic hydrocarbons, volatilization 
of lower molecular weight alkanes and sorption to organic matter for larger aliphatics, followed by
biodegradation, are the primary degradation processes (Air Force 1982a; Cooney et al. 1985; Dean-Ross 
et al. 1992).  Aromatic components are most susceptible to biodegradation in warm water or soil, 
although some volatilization may occur in colder waters (Walker et al. 1976).  Jet fuel contaminants that
migrate through soil may contaminate groundwater.  The deposition of aliphatics from the water column 
may persist for over a year (Oviatt et al. 1982).  Jet fuel that spills or leaks into soil can migrate both 
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vertically and horizontally (Air Force 1982a).  JP-5, JP-8, and Jet A fuels jettisoned into the atmosphere
probably contribute photochemically to the formation of ozone and particulates (Air Force 1981b, 1982b), 
and some of the fuel components and reactant products are probably transported via wind dispersion. 
Environmental fate data needs associated with specific compounds that are components JP-5, JP-8, and 
Jet A fuels (e.g., benzene, toluene, xylene, and PAHs) are presented in the ATSDR toxicological profiles
for these chemicals (Agency for Toxic Substances and Disease Registry 1995, 2007a, 2007b, 2015).  
Information on light- and chemical-mediated reactions of jet fuel components would aid in determining
the fate of JP-5, JP-8, and Jet A fuels in soil and water.  More information on the fate of individual 
components these fuels under varying environmental conditions, including the interaction of JP-5, JP-8, 
and Jet A fuels with different soil types, would be helpful in determining any horizontal and vertical
migration patterns of jet fuels in contaminated groundwater systems.
Bioavailability from Environmental Media. The extent of absorption of JP-5, JP-8, and Jet A
fuels by inhalation, oral, and/or dermal routes is unknown.  However, toxicity data are available for
humans exposed to jet fuels and kerosene by each of these routes (Porter 1990; Subcommittee on 
Accidental Poisoning 1962).  These data indicate that absorption does occur.  The extent of absorption by
these routes depends on the volatility, solubility, lipophilicity, and other properties of the specific jet fuel 
components.  Several of these component compounds have been discussed in their individual ATSDR
toxicological profiles (e.g., benzene, toluene, xylene, and PAHs), which should be consulted for further
information (Agency for Toxic Substances and Disease Registry 1995, 2007a, 2007b, 2015).  More data
linking exposure levels of jet fuels with biological levels of component chemicals would be useful in 
determining which chemicals in the mixture are most likely to be absorbed and by which routes.  This
information would aid in determining daily human exposure levels and more accurately assessing the
risks associated with exposure to jet fuels.
Food Chain Bioaccumulation. Data on the bioaccumulation of JP-8 in flagfish, rainbow trout, and 
golden shiners suggest that bioaccumulation and biomagnification are low (Klein and Jenkins 1983).  
Aquatic organisms are able to bioaccumulate some hydrocarbon fractions; however, depuration occurs if
the source of the contamination is removed (Klein and Jenkins 1983).  JP-5, JP-8, and Jet A fuels are
expected to separate into their individual hydrocarbon components in the environment, and the
bioaccumulation potentials of these components are believed to be independent of each other.  Further 
studies are needed to determine the biomagnification potentials of these components up the food chain
within aquatic and terrestrial ecosystems.  Specific research needs are presented in the individual ATSDR
toxicological profiles on specific hydrocarbon components such as benzene, toluene, xylenes, and PAHs
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(Agency for Toxic Substances and Disease Registry 1995, 2007a, 2007b, 2015). Research on the 
biomagnification of jet fuels as actual mixtures would not be useful because they are not available to the
food chain as mixtures.
Exposure Levels in Environmental Media. Reliable monitoring data for the levels of JP-5, JP-8, 
and Jet A fuels in contaminated media at hazardous waste sites are needed so that the information
obtained on levels of JP-5, JP-8, and Jet A fuels in the environment can be used in combination with the
known body burden of JP-5, JP-8, and Jet A fuels to assess the potential risk of adverse health effects in
populations living in the vicinity of hazardous waste sites.
There is limited information available on the levels of jet fuels found in air, soil, or water where jet fuels
are used or stored.  Some information exists on the levels of JP-8 in the air in closed buildings during
refueling operations (Air Force 1981a).  Very little information is available for JP-5, JP-8, and Jet A fuels
concentrations in soil, water, and other environmental media (Arthur et al. 1992; Guiney et al. 1987a, 
1987b; Navy 1988).  More data on levels of jet fuels or their components in the environmental media 
around facilities where jet fuels are produced, stored, and used would be useful to assess the potential risk
from these likely sources of exposure.
Reliable monitoring data for the levels of JP-5, JP-8, and Jet A fuels in contaminated media at hazardous 
waste sites are needed so that the information obtained on levels of these fuels in the environment can be 
used in combination with the known body burdens of JP-5, JP-8, and Jet A fuels to assess the potential
risk of adverse health effects in populations living in the vicinity of hazardous waste sites.
Exposure Levels in Humans. Populations known to have an increased risk of exposure to JP-5, 
JP-8, and Jet A fuels and their component hydrocarbons include: workers who manufacture or use the
fuels; workers involved with monitoring and servicing jet fuel storage tanks; people living or working on 
military installations where military jet fuels are used or stored; and populations living or working near a
spill, leak, or dump site (Air Force 1981a; NIOSH 1989; Runion 1988).  Although there are studies
assessing the exposure levels of these groups (Maule et al. 2013; Merchant-Borna et al. 2012; Tu et al. 
2004), further information is needed to assess the continuing levels of exposure for these populations.  
This information is necessary for assessing the need to conduct health studies on these populations.
This information is necessary for assessing the need to conduct health studies on these populations.
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Exposures of Children. Unless an accidental spill occurs near their residence, it is unlikely that
children will be exposed to JP-5, JP-8, and Jet A fuels since they are primarily used in the aviation
industry and the highest exposure levels are expected to occur for workers and military personnel
involved in aviation fueling procedures.  Children residing on military bases where JP-8 and JP-5 are used
may experience a slightly higher level of exposure than children of the general population.
Child health data needs relating to susceptibility are discussed in Section 3.12.2, Identification of Data
Needs: Children’s Susceptibility.
Exposure Registries. No exposure registries for JP-5, JP-8, and Jet A fuels were located.  This 
substance is not currently one of the compounds for which a sub-registry has been established in the 
National Exposure Registry.  The substance will be considered in the future when chemical selection is 
made for sub-registries to be established. The information that is amassed in the National Exposure 
Registry facilitates the epidemiological research needed to assess adverse health outcomes that may be 
related to exposure to this substance.
6.8.2 Ongoing Studies 
No ongoing environmental fate studies for JP-5, JP-8, and Jet A fuels were identified using the National
Institutes of Health (NIH) RePORTER version 6.1.0 (NIH Research Portfolio Online Reporting Tools) or
the Defense Technical Information Center (DTIC) online database.
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The purpose of this chapter is to describe the analytical methods that are available for detecting,
measuring, and/or monitoring Jet A, JP-5, and JP-8, their metabolites, and other biomarkers of exposure
and effect to Jet A, JP-5, and JP-8.  The intent is not to provide an exhaustive list of analytical methods.  
Rather, the intention is to identify well-established methods that are used as the standard methods of
analysis.  Many of the analytical methods used for environmental samples are the methods approved by
federal agencies and organizations such as EPA and the National Institute for Occupational Safety and 
Health (NIOSH).  Other methods presented in this chapter are those that are approved by groups such as 
the Association of Official Analytical Chemists (AOAC) and the American Public Health Association
(APHA).  Additionally, analytical methods are included that modify previously used methods to obtain 
lower detection limits and/or to improve accuracy and precision.
7.1  BIOLOGICAL MATERIALS
No analytical methods were located for detecting JP-5, JP-8, and Jet A fuels in biological materials.
However, analytical methods for detection in biological samples do exist for kerosene, which has a 
similar chemical composition as jet fuels (Air Force 1989a; Army 1988; DOD 1992).  See Table 7-1 for a
summary of the analytical methods most commonly used to measure kerosene in biological samples.
Analytical methods are available for a number of the components of jet fuels; the analytical methods for
some of the individual hydrocarbon components of JP-5, JP-8, and Jet A fuels (e.g., benzene, toluene, 
xylenes, and PAHs) are discussed in the toxicological profile for the component (Agency for Toxic
Substances and Disease Registry 1995, 2007a, 2007b, 2015). The toxicological profile for total 
petroleum hydrocarbons (Agency for Toxic Substances and Disease Registry 1999) provides additional
information on analytical methods.
The primary method for detecting kerosene in biological materials such as blood is gas chromatography
(GC).  GC may be combined with mass spectroscopy (MS) for peak identification with the gas 
chromatograph in the electron impact mode (Kimura et al. 1988, 1991).  Quantification methods include
the use of mass fragmentography (Kimura et al. 1988).  Hydrocarbon components of kerosene are
determined based on analysis of headspace gas above the sample (Kimura et al. 1991).  This method is
useful to distinguish between kerosene intoxication and gasoline intoxication since kerosene gives a high
toluene peak and has a pseudocumene-to-toluene ratio only half that of gasoline.  Capillary columns were
used, with either Porapak, ChromosorbB, or ChemipakB, giving acceptable results (Kimura et al. 1988).  
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Table 7-1. Analytical Methods for Determining Kerosene in Biological Materials
Sample matrix Preparation method
Analytical 
method
Sample 
detection 
limit
Percent
recovery Reference
Blood Add internal standard; extract
with n-pentane; centrifuge;
freeze; decant solvent;
GC/MS 50 pg Not
reported
Kimura et al.
1988
concentrate; inject to gas
chromatograph
Blood Mix sample with internal
standard; add salt solution;
equilibrate; aspirate
headspace vapor and inject
to gas chromatograph
GC/MS 50 pg 
(toluene)
Not
reported
Kimura et al.
1991
Stomach 
contents, blood,
urine
Extract sample with ethyl
acetate; condense; inject to
gas chromatograph
GC/FID/MS 0.2 μg/mL 93–100 Hara et al.
1988
FID = flame ionization detection; GC = gas chromatography; MS = mass spectrometry
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The percent recoveries of these methods were not provided.  Wide-bore capillary columns have also been
used (Hara et al. 1988) for GC/MS analysis combined with flame ionization detectors (FID).  This
method determined levels of m- and o-xylene (components of kerosene) in the blood, urine, and stomach 
contents.  The sensitivity and precision of this method was generally good (93–100% recovery).
B’Hymer et al. (2005, 2012b) discussed an analytical method to detect 2-methoxyethoxy acetic acid
(MEAA) in urine samples using GC with a MS detector (detection limit 0.1 μg/mL).  MEAA is a
metabolite of 2-(2-methoxyethoxy) ethanol, a glycol ether that is used as an anti-icing agent in JP-8.  In a
study of Air Force personnel exposed to JP-8, mean post-shift urinary MEAA levels in personnel
assigned to a high exposure group (aircraft fuel system maintenance workers) were approximately
10 times greater than personnel assigned to a low exposure group, and the frequency of detection (n>the
limit of detection) of MEAA in post-shift urine samples was 94% for the high exposure group and only
3% for the low exposure group (B’Hymer et al. 2012b).
No analytical methods studies were located for detecting kerosene in biological samples other than blood, 
urine, or stomach contents.
7.2  ENVIRONMENTAL SAMPLES 
Because JP-5, JP-8, and Jet A fuels are composed of a complex mixture of hydrocarbons, there are few
methods for the environmental analysis of the actual mixtures (IARC 1989).  However, methods are
reported for the analysis of the component hydrocarbons of kerosene.  The methods most commonly used 
to detect the major hydrocarbon components of kerosene in environmental samples are GC/FID and 
GC/MS.  See Table 7-2 for a summary of the analytical methods used to determine hydrocarbon 
components in environmental samples.  Exposure levels to JP-5, JP-8, and Jet A fuels are often
characterized by measuring the total hydrocarbons and other important constituents typically found in the
jet fuels (benzene, toluene, ethylbenzene, xylene, and naphthalene) and reporting these levels.  NIOSH
method 1550 provides a general description of an analytical procedure for characterizing various types of
hydrocarbon mixtures (NIOSH 1994a).  Several of the components of kerosene and jet fuels have been
discussed in detail in their individual toxicological profiles (e.g., benzene, toluene, xylenes, and PAHs), 
which should be consulted for more information on analytical methods (Agency for Toxic Substances and 
Disease Registry 1995, 2007a, 2007b, 2015). The toxicological profile for total petroleum hydrocarbons
(Agency for Toxic Substances and Disease Registry 1999) provides additional information on analytical
methods for environmental samples.
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Table 7-2. Analytical Methods for Determining Kerosene and Hydrocarbons in 

Environmental Samples
 
Sample 
Sample 	 Analytical detection Percent
matrix	 Preparation method method limita recoverya Reference
Air	 Samples are collected by
drawing a known volume 
of air through glass
sampling tubes containing 
coconut shell charcoal;
samples are extracted 
with 99:1 carbon disulfide
(CS2):N,N-dimethyl­
formamide (DMF)
Air	 Adsorb to Florisil filter;
elute with CS2; evaporate 
under vacuum
Water	 Strip sample in sparger
with helium; adsorb 
effluent gas to adsorption 
tube; thermally desorb to 
gas chromatograph
Water	 Acidify sample; extract
with hexane; dry solvent
phase; inject to gas
chromatograph
Water	 Purge sample with inert
(purgeable	 gas; adsorb vapor in trap;
aromatics)	 heat trap; backflush to gas
chromatograph
Water	 Purge sample with helium;
collect vapor on 
adsorption tube; thermally
desorb; concentrate;
backflush to gas
chromatograph
Water	 Purge sample with 
ambient air; adsorb to 
charcoal filter with CS2; 
inject to gas
chromatograph
Water	 Extract aqueous sample 
with pentane; equilibrate;
inject to gas
chromatograph
Water	 Adjust sample pH to >11;
(base/neutral	 extract sample with 
and acids)	 CH2Cl2 solvent; adjust pH
to <2; reextract; dry;
concentrate; inject to gas
chromatograph
GC/FID	 0.1 mg/5– 
10 mL sample
GC	 Not reported
GC/FID/MS	 10 μg/L
GC/FID	 0.25 mcl/L
GC/FID	 0.2 μg/L
GC/FID	 10 μg/L
GC/MS	 5 ng/L
GC/MS	 Not reported
GC/MS	 1.5–7.8 μg/L 
(varies with
actual
compound)
96–106 NIOSH 1994a 
(Method 1550)
Not reported	 Baldwin 1977
89.7–95.7	 Bianchi et al. 1991
Not reported	 Dell’Acqua and 
Bush 1973
92–96	 EPA 1991b 
(Method 602 and 
610)
91–112	 Belkin and 
Esposito 1986
0.4–89 (75% Coleman et al.
average) 1981
Not reported	 Coleman et al.
1984
Not reported	 EPA 1991b 
(Method 602 and 
610)
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Table 7-2. Analytical Methods for Determining Kerosene and Hydrocarbons in 

Environmental Samples
 
Sample 
matrix Preparation method
Analytical 
method
Sample 
detection 
limita
Percent
recoverya Reference
Seawater Extract aqueous phase of
sample with pentane;
evaporate; inject to gas
chromatograph
GC/MS Not reported Not reported Boylan and Tripp 
1971
Soil (other
solid
materials)
Extract sample with CCl4; 
inject extract
GLC Not reported Not reported Midkiff and 
Washington 1972
Solid waste
matrices
Solvent extraction
followed by purge-and­
trap or direct injection
GC/MS 0.01–0.50 μg/L 84–109 EPA 2006 
(Method 8260 C)
Soil Extract sample with CCl4; 
centrifuge; remove water
and humic materials with 
GC/FID Not reported Not reported Galin et al. 1990
NA2SO4 and Al2O3; inject
extract
Soil Purge at elevated 
temperatures; heat trap to 
desorb material into gas
chromatograph column
GC Not reported Not reported Chang and Lopez.
1992
Soil Sample extracted using 
water and cyclohexane
Synchronous
scanning 
fluorescence 
Not reported Not reported Phaff et al. 1992
spectroscopy
Sediment Sample dried, ground, and 
extracted with n-pentane
GC/FID Not reported Not reported Guiney et al.
1987b
Fish tissue Extract with KOH in
methanol; partition into 
GC/FID Not reported 95 Guiney et al.
1987b
n-pentane; concentrate;
analyze using gas
chromatograph
aThe sample detection limit and percent recovery will vary for each of the components of these mixtures.  The 
reported values in these tables are for the specific components analyzed in each method.
Al2O3 = aluminum oxide; CCl4 = carbon tetrachloride; CH2Cl2 = dichloromethane (methylene chloride); FID = flame
ionization detection; GC = gas chromatography; GLC = gas liquid chromatography; KOH = potassium hydroxide;
MS = mass spectrometry; Na2SO4 = sodium sulfate
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GC is the most commonly used method to selectively detect, identify, and quantify the volatile
hydrocarbon components of kerosene in air (Andrasko 1983; Baldwin 1977; NIOSH 1994a).  Air samples
may be collected on adsorbent tubes such as charcoal, Plorisil®, Tenax®, Porapak®, or Chromosorb®. 
Active carbon wires have also been used (Andrasko 1983).  The hydrocarbons are extracted from the
tubes by thermal desorption or with a liquid solvent such as carbon disulfide and analyzed on the gas
chromatograph.  Precision is good (relative SD = 0.052) using the charcoal tubes (NIOSH 1994a);
recovery data were not reported for the other types of adsorption tubes, although desorption from the
active carbon wires ranged between 90 and 99% recovery, with a detection limit in the ppb range.  A
Tenax-TA® sorbent trap has been used with subsequent thermal desorption (Andrasko 1983).  Combining
sample concentration with the headspace method allows for sampling of smaller air volumes and for other
environmental samples, such as kerosene combustion debris, that have undergone significant evaporation.  
The headspace method requires concentrating the sample prior to analysis (Andrasko 1983; Baldwin 
1977).
GC/FID and GC/MS have been used to measure the water-soluble components of kerosene in industrial
effluents and estuarine water (Bianchi et al. 1991), sea water (Boylan and Tripp 1971), drinking water
(Coleman et al. 1984; Dell’Acqua and Bush 1973), and groundwater (Thomas and Delfino 1991).  Purge-
and-trap sample preparation methods have been used to determine purgeable (volatile) aromatic
compounds in stream water contaminated by an “aviation kerosene” spill (Guiney et al. 1987b).  This
method requires a trap with a Tenax®/ChromosorbB absorbent and the use of a gas chromatograph with a
photoionization detector (PID) (EPA 1991b), an ion trap detector (ITD), or FID (Guiney et al. 1987b;
Thomas and Delfino 1991).  A modification of the purge-and-trap method uses ambient temperatures, has 
the advantage of being applicable to a variety of waters, requires virtually no sample preparation (no 
solvents are required), and has an analysis time of approximately 30 minutes (Bianchi et al. 1991).  While
this method may be used for determining the presence of petroleum contaminants in water, it cannot
distinguish between various sources of this contamination.
EPA Method 8260C is a GC/MS method that is used to quantify volatile organic compounds in various
solid waste matrices and is applicable for the components of JP-5, JP-8, and Jet A fuels.  This method is
appropriate for nearly all types of environmental sample matrices, regardless of water content.  Sample 
types that can be analyzed for include air sampling trapping media, groundwater, surface water, aqueous
sludges, caustic liquors, acid liquors, waste solvents, oily wastes, mousses, tars, fibrous wastes, polymeric 
emulsions, filter cakes, spent carbons, spent catalysts, soils, and sediments (EPA 2006).
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Distinctions between WSFs of mixed hydrocarbons may be made by using solvent extraction of the
water-soluble base/neutral and acid fractions with methylene chloride (EPA 1991b; Thomas and Delfino 
1991).  This separation of base/neutral and acid fractions till permit GC resolution of the type of water-
soluble hydrocarbons present in the aqueous phase.  Hexane has also been used as a solvent (Dell’Acqua
and Bush 1973), as has pentane (Coleman et al. 1984).
A dynamic thermal stripper has also been used to detect low levels (ppb range) of kerosene present in
water samples (Belkin and Esposito 1986).  This method traps the fuels on an adsorption tube using
helium gas for purging.  The fuel is then thermally desorbed and backflushed to a gas chromatograph with 
FID.  This method also does not require any solvent and needs only a 15-mL sample.  Recovery for this 
method is good (91–114%) with precision ranging from 6.4 to 14.3% relative standard deviation.  A
modified Grob closed-loop-stripping method, which uses a wall-coated open tubular glass capillary
column combined with GC/MS, has been used to extract and quantify low levels (ppt) of hydrocarbons in 
water samples. The method continually recirculates an ambient air stream through the 3.8-L water
sample for approximately 2 hours and collects the vapor on an activated carbon filter, followed by
extraction with carbon disulfide and analysis (Coleman et al. 1981).
GC/FID (Galin et al. 1990), gas liquid chromatography (GLC) with FID (Midkiff and Washington 1972), 
and elevated temperature purge and trap with GC (Chang et al. 1992) have been used to measure jet fuels 
in soils.  Sediments of a trout stream contaminated with “aviation kerosene” were analyzed for
hydrocarbon residues using GC/FID (Guiney et al. 1987b).  Carbon tetrachloride is the recommended 
solvent because it causes less interference with the chromatographic peaks of the jet fuels (Galin et al.
1990; Midkiff and Washington 1972).  Synchronous scanning fluorescence spectroscopy can be used to 
identify kerosene and other aromatic-containing products in groundwater and soil samples.  This
analytical method is more efficient than chromatographic methods, and its spectra are easier to interpret
for identification purposes (Pharr et al. 1992).
High-performance liquid chromatography (HPLC), followed by GC/MS, has been used to fractionate and 
then quantitate the aliphatic and aromatic hydrocarbons present in liquid fuel precursors in order to 
determine the fuel potential of the compounds.  Kerosene has the advantage of not requiring any sample
preparation.  An alternative method for fractionating and purifying petroleum hydrocarbons prior to GC
or HPLC separation has been developed (Theobald 1988).  The method uses small, prepacked, silica or
C18 columns that offer these advantages: rapid separation (approximately 15 minutes for a run); good 
recovery of hydrocarbons (85% for the C18 column and 92% for the silica column); reusability of the
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columns; and for the silica column in particular, good separation of hydrocarbon from nonhydrocarbon 
matrices as may occur with environmental samples.
Tissues of fish from a trout stream contaminated with “aviation kerosene” were analyzed for kerosene-
range hydrocarbon residues using standard GC/FID techniques (Guiney et al. 1987b).  GC analyses of the
fish samples revealed >95% recovery.
7.3  ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of JP-5, JP-8, and Jet A fuels is available. Where adequate 
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a
program of research designed to determine the health effects (and techniques for developing methods to 
determine such health effects) of JP-5, JP-8, and Jet A fuels. 
7.3.1 Identification of Data Needs 
Methods for Determining Biomarkers of Exposure and Effect.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be 
evaluated and prioritized, and a substance-specific research agenda will be proposed. 
Exposure. While standard procedures exist for identifying or quantifying exposure to volatile
compounds based on hydrocarbon components in blood, urine, and stomach contents (Hara et al. 1988;
Kimura et al. 1988, 1991), none of these are applicable solely to jet fuels. These methods are sensitive 
enough to measure the levels at which health effects occur and may be adequate for determining
background levels in the population.  However, they cannot distinguish between exposure to JP-5, JP-8, 
and Jet A fuels and to other types of hydrocarbon mixtures.  Egeghy et al. (2003) noted a correlation to 
the levels of naphthalene in air and breath of Air Force personnel who were highly exposed to JP-8, but
noted that benzene levels in breath could not be correlated solely to exposure from JP-8.  In a similar
study, Serder et al. (2003) concluded that naphthalene and napthols (1- and 2-hydroxynaphthalene) may
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be useful urinary biomarkers of exposure to populations routinely exposed to JP-8, such as aircraft
maintenance workers.  Smith et al. (2012) also concluded that elevated urinary naphthol levels could be
used as a surrogate for short-term occupational exposure to JP-8.  The sum concentration of nonane, 
decane, undecane, and dodecane was used as a composite fingerprint of JP-8 short term exposure for Air
Force personnel regularly exposed to this fuel (Air Force 2001).
MEAA was shown to be a urinary metabolite for exposure to 2-(2-methoxyethoxy)ethanol, which is an 
additive to JP-8 (B’Hymer et al. 2005, 2012a).  Because this substance has limited industrial uses, its
addition to jet fuels makes its metabolite a possible biomarker for exposure to these fuels.
Effect. No biomarkers of effects were identified for JP-5, JP-8, and Jet A fuels because the effects 
associated with exposure to jet fuels are not unique for them (i.e., the effects may be caused by other
chemicals or hydrocarbon mixtures).  General neurologic effects such as loss of coordination, headache,
fatigue, intoxication, dizziness, difficulty concentrating, moodiness, and sleep disturbances were observed 
in people exposed to general “jet fuel” and JP-5 vapors (Knave et al. 1978; Porter 1990).  These effects 
are not used as biomarkers of effect because they are nonspecific and could also indicate exposure to 
other chemicals or hydrocarbons.  No standard procedures exist for identifying and quantifying
biomarkers of effect for JP-5 or JP-8.
Methods for Determining Parent Compounds and Degradation Products in Environmental
Media. Methods exist to detect major hydrocarbon components of JP-5, JP-8, and Jet A fuels in air
(Andrasko 1983; Baldwin 1977; NIOSH 1994a), water (Bianchi et al. 1991; Boylan and Tripp 1971;
Dell’Acqua and Bush 1973; EPA 1991b; Guiney et al. 1987b), sediment (Guiney et al. 1987b), soil (Galin
et al. 1990; Midkiff and Washington 1972), and biological media (Guiney et al. 1987b).  The most
commonly used methods are GC/FID and GC/MS. These methods are relatively sensitive, selective, and
reliable and can be used to detect the levels of the various components of jet fuels found in the
environment and the levels at which health effects occur.
7.3.2 Ongoing Studies 
No ongoing studies for JP-5, JP-8, and Jet A fuels were identified using the NIH RePORTER version 
6.1.0 or the DTIC online database.  Analytical methods are continuously being developed and updated for
individual constituents that may be contained in JP-5, JP-8, and Jet A fuels. For additional information, 
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see toxicological profiles for substances such as benzene, toluene, xylenes, and PAHs (Agency for Toxic 
Substances and Disease Registry 1995, 2007a, 2007b, 2015). 
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MRLs are substance specific estimates, which are intended to serve as screening levels, are used by
ATSDR health assessors and other responders to identify contaminants and potential health effects that
may be of concern at hazardous waste sites.
ATSDR has derived an intermediate-duration inhalation MRL of 2 mg/m3 for JP-5 vapor.  The MRL is
based on minimal LOAEL of 150 mg/m3 for liver effects in mice continuously exposed to JP-5 vapor for
90 days (Gaworski et al. 1984).  The minimal LOAEL was multiplied by the default human to mouse
blood:gas partition coefficient ratio of 1 to calculate the human equivalent concentration (LOAELHEC).  
The minimal LOAELHEC of 150 mg/m3 was divided by a total uncertainty factor of 90 (3 for the use of a
minimal LOAEL, 3 for extrapolation from animals to humans with dosimetric adjustment, and 10 for
human variability).
ATSDR has derived an intermediate-duration inhalation MRL of 3 mg/m3 for JP-8 vapor.  The MRL is
based on NOAEL of 500 mg/m3 and LOAEL of 1,000 mg/m3 for neurobehavioral effects in rats exposed 
to JP-8 vapor 6 hours/day, 5 days/week for 90 days (Ritchie et al. 2001).  The NOAEL was adjusted for
intermittent exposure and multiplied by the default human to mouse blood:gas partition coefficient ratio 
of 1 to calculate the human equivalent concentration (LOAELHEC).  The NOAELHEC of 89 mg/m3 was 
divided by a total uncertainty factor of 30 (3 for extrapolation from animals to humans with dosimetric
adjustment, and 10 for human variability).
ATSDR has derived an acute-duration oral MRL of 3 mg/kg/day for JP-8.  The MRL is based on NOAEL
of 250 mg/kg/day and LOAEL of 500 mg/kg/day for immunological effects in mice administered via
gavage JP-8 in olive oil for 14 days (Keil et al. 2004).  The NOAEL of 250 mg/kg/day was divided by a
total uncertainty factor of 100 (10 for extrapolation from animals to humans and 10 for human 
variability).
ATSDR has derived an intermediate-duration oral MRL of 0.3 mg/kg/day for JP-8.  The MRL is based on 
a LOAEL of 325 mg/kg/day for neurodevelopmental effects in the offspring of rats administered via
gavage JP-8 for 90 days prior to cohabitation and during gestation and lactation (Mattie et al. 2001). The
LOAEL of 325 mg/kg/day was divided by a total uncertainty factor of 1,000 (10 for the use of a LOAEL, 
10 for extrapolation from animals to humans and 10 for human variability).
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EPA has not derived inhalation reference concentrations (RfCs) or oral reference doses (RfDs) for JP-5, 

JP-8, or Jet A fuels (IRIS 2015).  

The international and national regulations, advisories, and guidelines regarding JP-5, JP-8, and Jet A in
 
air, water, and other media are summarized in Table 8-1.  
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Table 8-1. Regulations and Guidelines Applicable to Jet Fuels
Agency Description Information Reference
INTERNATIONAL
Guidelines:
IARC Carcinogenicity classification (jet fuel) Group 3a IARC 2013
WHO Air quality guidelines No data WHO 2010
Drinking water quality guidelines No data WHO 2011
NATIONAL
Regulations and Guidelines:
a. Air
ACGIH TLV-TWAb,c (kerosene/jet fuels) 200 mg/m3 ACGIH 2013
AIHA ERPGs No data AIHA 2013
DOE PAC-1d (JP-5 and JP-8) 290 mg/m3 DOE 2012
PAC-2 (JP-5 and JP-8) 1,100 mg/m3 
PAC-3 (JP-5 and JP-8) 1,100 mg/m3 
EPA AEGL-1 (JP-5 and JP-8) EPA 2013c
10 minutes 290 mg/m3 
30 minutes 290 mg/m3 
60 minutes 290 mg/m3 
4 hours 290 mg/m3 
8 hours 290 mg/m3 
AEGL-2 (JP-5 and JP-8)
10 minutes 1,100 mg/m3 
30 minutes 1,100 mg/m3 
60 minutes 1,100 mg/m3 
4 hours 1,100 mg/m3 
8 hours 1,100 mg/m3 
AEGL-3 (JP-5 and JP-8)
10 minutes NRe 
30 minutes NRe 
60 minutes NRe 
4 hours NRe 
8 hours NRe 
Hazardous air pollutant No data EPA 2014a
NAAQS No data EPA 2014d
NIOSH REL (kerosene) 100 mg/m3 NIOSH 2014
IDLH No data
OSHA PEL (8-hour TWA) for general industry No data OSHA 2013b
29 CFR 1910.1000,
Table Z-1
Highly hazardous chemicals No data OSHA 2013a
29 CFR 1910.119,
Appendix A
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Table 8-1. Regulations and Guidelines Applicable to Jet Fuels
Agency Description Information Reference
NATIONAL (cont.)
b. Water
EPA Designated as hazardous substances in 
accordance with Section 311(b)(2)(A) of
the Clean Water Act
No data
Drinking water contaminant candidate 
list
No data
Drinking water standards and health 
advisories
No data
National primary drinking water
standards
No data
National recommended water quality
criteria
No data
Reportable quantities of hazardous
substances designated pursuant to 
Section 311 of the Clean Water Act
No data
c. Food
FDA EAFUSf No data
d. Other
ACGIH Carcinogenicity classification
(kerosene/jet fuels)
A3g 
EPA Carcinogenicity classification No data
RfC No data
RfD No data
Identification and listing of hazardous
waste
No data
Inert pesticide ingredients applied to 
animals exemptions from the 
requirement of a tolerance
Yes
Master Testing List No data
RCRA waste minimization PBT priority
chemical list
No data
Standards for owners and operators of
hazardous waste TSD facilities;
groundwater monitoring list
No data
Superfund, emergency planning, and 
community right-to-know
Designated CERCLA hazardous
substance and reportable quantity
No data
Superfund, emergency planning, and
community right-to-know
Effective date of toxic chemical No data
release reporting
EPA 2013d
40 CFR 116.4
EPA 2009a
74 FR 51850
EPA 2012b
EPA 2009b
EPA 2014e
EPA 2013f
40 CFR 117.3
FDA 2014
ACGIH 2013
IRIS 2015
EPA 2013e
40 CFR 261,
Appendix VIII
EPA 2014b
EPA 2014c
EPA 1998
63 FR 60332
EPA 2013g
40 CFR 264,
Appendix IX
EPA 2013h
40 CFR 302.4
EPA 2013j
40 CFR 372.65
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Table 8-1. Regulations and Guidelines Applicable to Jet Fuels
Agency Description Information Reference
NATIONAL (cont.)
EPA Extremely hazardous substances No data EPA 2013i
and its threshold planning quantity 40 CFR 355,
Appendix A
TSCA chemical lists and reporting No data EPA 2013a
periods 40 CFR 712.30
TSCA health and safety data reporting No data EPA 2013b
40 CFR 716.120
NTP Carcinogenicity classification No data NTP 2011
aGroup 3: Not classifiable as to its carcinogenicity to humans.

bAs total hydrocarbon vapor for kerosene/jet fuels.  Application restricted to conditions in which there are negligible 

aerosol exposures.
 
cSkin designation:  refers to the potential significant contribution to the overall exposure by the cutaneous route,
 
including mucous membranes and the eyes, by contact with vapors, liquids, and solids (ACGIH 2013).

dPAC-1:  mild, transient health effects; PAC-2:  irreversible or other serious health effects that could impair the ability
 
to take protective action; PAC-3:  life-threatening health effects (DOE 2012).
 
eNot recommended due to insufficient data.
 
fThe EAFUS list of substances contains ingredients added directly to food that FDA has either approved as food 

additives or listed or affirmed as GRAS.
 
gA3:  confirmed animal carcinogen with unknown relevance to humans.
 
ACGIH = American Conference of Governmental Industrial Hygienists; AEGL = acute exposure guideline levels;
 
AIHA = American Industrial Hygiene Association; CERCLA = Comprehensive Environmental Response,
 
Compensation, and Liability Act; CFR = Code of Federal Regulations; DOE = Department of Energy;
 
EAFUS = Everything Added to Food in the United States; EPA = Environmental Protection Agency;
 
ERPG = emergency response planning guidelines; FDA = Food and Drug Administration; FR = Federal Register;
 
GRAS = generally recognized as safe; IARC = International Agency for Research on Cancer; IDLH = immediately
 
dangerous to life or health; IRIS = Integrated Risk Information System; NAAQS = National Ambient Air Quality
 
Standards; NIOSH = National Institute for Occupational Safety and Health; NR = not recommended; NTP = National
 
Toxicology Program; OSHA = Occupational Safety and Health Administration; PAC = protective action criteria;
 
PBT = persistent, bioaccumulative, and toxic; PEL = permissible exposure limit; RCRA = Resource Conservation and 

Recovery Act; REL = recommended exposure limit; RfC = inhalation reference concentration; RfD = oral reference
 
dose; TLV = threshold limit values; TSCA = Toxic Substances Control Act; TSD = treatment, storage, and disposal;
 
TWA = time-weighted average; USC = United States Code; WHO = World Health Organization
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10.  GLOSSARY
Absorption—The taking up of liquids by solids, or of gases by solids or liquids.
Acute Exposure—Exposure to a chemical for a duration of 14 days or less, as specified in the
Toxicological Profiles.
Adsorption—The adhesion in an extremely thin layer of molecules (as of gases, solutes, or liquids) to the 
surfaces of solid bodies or liquids with which they are in contact.
Adsorption Coefficient (Koc)—The ratio of the amount of a chemical adsorbed per unit weight of
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium.
Adsorption Ratio (Kd)—The amount of a chemical adsorbed by sediment or soil (i.e., the solid phase)
divided by the amount of chemical in the solution phase, which is in equilibrium with the solid phase, at a
fixed solid/solution ratio.  It is generally expressed in micrograms of chemical sorbed per gram of soil or
sediment.
Benchmark Dose (BMD)—Usually defined as the lower confidence limit on the dose that produces a
specified magnitude of changes in a specified adverse response.  For example, a BMD10 would be the
dose at the 95% lower confidence limit on a 10% response, and the benchmark response (BMR) would be
10%.  The BMD is determined by modeling the dose response curve in the region of the dose response
relationship where biologically observable data are feasible.
Benchmark Dose Model—A statistical dose-response model applied to either experimental toxicological 
or epidemiological data to calculate a BMD.
Bioconcentration Factor (BCF)—The quotient of the concentration of a chemical in aquatic organisms
at a specific time or during a discrete time period of exposure divided by the concentration in the
surrounding water at the same time or during the same period.
Biomarkers—Broadly defined as indicators signaling events in biologic systems or samples. They have 
been classified as markers of exposure, markers of effect, and markers of susceptibility.
Cancer Effect Level (CEL)—The lowest dose of chemical in a study, or group of studies, that produces
significant increases in the incidence of cancer (or tumors) between the exposed population and its
appropriate control.
Carcinogen—A chemical capable of inducing cancer.
Case-Control Study—A type of epidemiological study that examines the relationship between a 
particular outcome (disease or condition) and a variety of potential causative agents (such as toxic 
chemicals).  In a case-controlled study, a group of people with a specified and well-defined outcome is
identified and compared to a similar group of people without outcome.
Case Report—Describes a single individual with a particular disease or exposure.  These may suggest
some potential topics for scientific research, but are not actual research studies.
Case Series—Describes the experience of a small number of individuals with the same disease or
exposure. These may suggest potential topics for scientific research, but are not actual research studies.
***DRAFT FOR PUBLIC COMMENT***
    
 
  
 
 
 
  
 
   
 
 
      
     
 
 
 
   
    
 
   
 
 
   
    
  
 
 
    
 
 
   
  
     
 
 
   
    
      
 
   
 
 
    
   
  
 
   
  
 
   
 
 
 
    
  
 
 
 
 
 
  
260JP-5, JP-8, AND JET A FUELS
10.  GLOSSARY
Ceiling Value—A concentration of a substance that should not be exceeded, even instantaneously.
Chronic Exposure—Exposure to a chemical for 365 days or more, as specified in the Toxicological
Profiles.
Cohort Study—A type of epidemiological study of a specific group or groups of people who have had a
common insult (e.g., exposure to an agent suspected of causing disease or a common disease) and are
followed forward from exposure to outcome.  At least one exposed group is compared to one unexposed 
group.
Cross-sectional Study—A type of epidemiological study of a group or groups of people that examines
the relationship between exposure and outcome to a chemical or to chemicals at one point in time.
Data Needs—Substance-specific informational needs that if met would reduce the uncertainties of human 
health assessment.
Developmental Toxicity—The occurrence of adverse effects on the developing organism that may result
from exposure to a chemical prior to conception (either parent), during prenatal development, or
postnatally to the time of sexual maturation.  Adverse developmental effects may be detected at any point
in the life span of the organism.
Dose-Response Relationship—The quantitative relationship between the amount of exposure to a
toxicant and the incidence of the adverse effects.
Embryotoxicity and Fetotoxicity—Any toxic effect on the conceptus as a result of prenatal exposure to
a chemical; the distinguishing feature between the two terms is the stage of development during which the 
insult occurs. The terms, as used here, include malformations and variations, altered growth, and in utero
death.
Environmental Protection Agency (EPA) Health Advisory—An estimate of acceptable drinking water
levels for a chemical substance based on health effects information.  A health advisory is not a legally
enforceable federal standard, but serves as technical guidance to assist federal, state, and local officials.
Epidemiology—Refers to the investigation of factors that determine the frequency and distribution of
disease or other health-related conditions within a defined human population during a specified period.  
Genotoxicity—A specific adverse effect on the genome of living cells that, upon the duplication of
affected cells, can be expressed as a mutagenic, clastogenic, or carcinogenic event because of specific 
alteration of the molecular structure of the genome.
Half-life—A measure of rate for the time required to eliminate one half of a quantity of a chemical from
the body or environmental media.
Immediately Dangerous to Life or Health (IDLH)—The maximum environmental concentration of a 
contaminant from which one could escape within 30 minutes without any escape-impairing symptoms or
irreversible health effects.
Immunologic Toxicity—The occurrence of adverse effects on the immune system that may result from
exposure to environmental agents such as chemicals.
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Immunological Effects—Functional changes in the immune response.
Incidence—The ratio of individuals in a population who develop a specified condition to the total
number of individuals in that population who could have developed that condition in a specified time
period. 
Intermediate Exposure—Exposure to a chemical for a duration of 15–364 days, as specified in the 
Toxicological Profiles.
In Vitro—Isolated from the living organism and artificially maintained, as in a test tube.
In Vivo—Occurring within the living organism.
Lethal Concentration(LO) (LCLO)—The lowest concentration of a chemical in air that has been reported
to have caused death in humans or animals.
Lethal Concentration(50) (LC50)—A calculated concentration of a chemical in air to which exposure for
a specific length of time is expected to cause death in 50% of a defined experimental animal population.
Lethal Dose(LO) (LDLo)—The lowest dose of a chemical introduced by a route other than inhalation that 
has been reported to have caused death in humans or animals.
Lethal Dose(50) (LD50)—The dose of a chemical that has been calculated to cause death in 50% of a 
defined experimental animal population.
Lethal Time(50) (LT50)—A calculated period of time within which a specific concentration of a chemical
is expected to cause death in 50% of a defined experimental animal population.
Lowest-Observed-Adverse-Effect Level (LOAEL)—The lowest exposure level of chemical in a study,
or group of studies, that produces statistically or biologically significant increases in frequency or severity
of adverse effects between the exposed population and its appropriate control.
Lymphoreticular Effects—Represent morphological effects involving lymphatic tissues such as the
lymph nodes, spleen, and thymus.
Malformations—Permanent structural changes that may adversely affect survival, development, or
function.
Minimal Risk Level (MRL)—An estimate of daily human exposure to a hazardous substance that is 
likely to be without an appreciable risk of adverse noncancer health effects over a specified route and
duration of exposure.
Modifying Factor (MF)—A value (greater than zero) that is applied to the derivation of a Minimal Risk
Level (MRL) to reflect additional concerns about the database that are not covered by the uncertainty
factors. The default value for a MF is 1.
Morbidity—State of being diseased; morbidity rate is the incidence or prevalence of disease in a specific 
population.
Mortality—Death; mortality rate is a measure of the number of deaths in a population during a specified 
interval of time.
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Mutagen—A substance that causes mutations.  A mutation is a change in the DNA sequence of a cell’s 
DNA.  Mutations can lead to birth defects, miscarriages, or cancer.
Necropsy—The gross examination of the organs and tissues of a dead body to determine the cause of
death or pathological conditions.
Neurotoxicity—The occurrence of adverse effects on the nervous system following exposure to a 
chemical.
No-Observed-Adverse-Effect Level (NOAEL)—The dose of a chemical at which there were no
statistically or biologically significant increases in frequency or severity of adverse effects seen between
the exposed population and its appropriate control.  Effects may be produced at this dose, but they are not
considered to be adverse.
Octanol-Water Partition Coefficient (Kow)—The equilibrium ratio of the concentrations of a chemical
in n-octanol and water, in dilute solution.
Odds Ratio (OR)—A means of measuring the association between an exposure (such as toxic substances 
and a disease or condition) that represents the best estimate of relative risk (risk as a ratio of the incidence
among subjects exposed to a particular risk factor divided by the incidence among subjects who were not
exposed to the risk factor).  An OR of greater than 1 is considered to indicate greater risk of disease in the 
exposed group compared to the unexposed group.
Organophosphate or Organophosphorus Compound—A phosphorus-containing organic compound 
and especially a pesticide that acts by inhibiting cholinesterase.
Permissible Exposure Limit (PEL)—An Occupational Safety and Health Administration (OSHA)
allowable exposure level in workplace air averaged over an 8-hour shift of a 40-hour workweek.
Pesticide—General classification of chemicals specifically developed and produced for use in the control
of agricultural and public health pests.
Pharmacokinetics—The dynamic behavior of a material in the body, used to predict the fate
(disposition) of an exogenous substance in an organism.  Utilizing computational techniques, it provides
the means of studying the absorption, distribution, metabolism, and excretion of chemicals by the body.
Pharmacokinetic Model—A set of equations that can be used to describe the time course of a parent
chemical or metabolite in an animal system.  There are two types of pharmacokinetic models:  data-based
and physiologically-based.  A data-based model divides the animal system into a series of compartments,
which, in general, do not represent real, identifiable anatomic regions of the body, whereas the 
physiologically-based model compartments represent real anatomic regions of the body.
Physiologically Based Pharmacodynamic (PBPD) Model—A type of physiologically based dose-
response model that quantitatively describes the relationship between target tissue dose and toxic end
points.  These models advance the importance of physiologically based models in that they clearly
describe the biological effect (response) produced by the system following exposure to an exogenous
substance. 
Physiologically Based Pharmacokinetic (PBPK) Model—Comprised of a series of compartments
representing organs or tissue groups with realistic weights and blood flows. These models require a
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variety of physiological information: tissue volumes, blood flow rates to tissues, cardiac output, alveolar
ventilation rates, and possibly membrane permeabilities.  The models also utilize biochemical
information, such as air/blood partition coefficients, and metabolic parameters.  PBPK models are also
called biologically based tissue dosimetry models.
Prevalence—The number of cases of a disease or condition in a population at one point in time. 
Prospective Study—A type of cohort study in which the pertinent observations are made on events 
occurring after the start of the study.  A group is followed over time.
q1*—The upper-bound estimate of the low-dose slope of the dose-response curve as determined by the
multistage procedure.  The q1* can be used to calculate an estimate of carcinogenic potency, the 
incremental excess cancer risk per unit of exposure (usually μg/L for water, mg/kg/day for food, and 
μg/m3 for air).
Recommended Exposure Limit (REL)—A National Institute for Occupational Safety and Health
(NIOSH) time-weighted average (TWA) concentration for up to a 10-hour workday during a 40-hour
workweek.
Reference Concentration (RfC)—An estimate (with uncertainty spanning perhaps an order of
magnitude) of a continuous inhalation exposure to the human population (including sensitive subgroups)
that is likely to be without an appreciable risk of deleterious noncancer health effects during a lifetime.
The inhalation reference concentration is for continuous inhalation exposures and is appropriately
expressed in units of mg/m3 or ppm.
Reference Dose (RfD)—An estimate (with uncertainty spanning perhaps an order of magnitude) of the
daily exposure of the human population to a potential hazard that is likely to be without risk of deleterious
effects during a lifetime. The RfD is operationally derived from the no-observed-adverse-effect level
(NOAEL, from animal and human studies) by a consistent application of uncertainty factors that reflect
various types of data used to estimate RfDs and an additional modifying factor, which is based on a 
professional judgment of the entire database on the chemical. The RfDs are not applicable to
nonthreshold effects such as cancer.
Reportable Quantity (RQ)—The quantity of a hazardous substance that is considered reportable under
the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).  Reportable
quantities are (1) 1 pound or greater or (2) for selected substances, an amount established by regulation 
either under CERCLA or under Section 311 of the Clean Water Act.  Quantities are measured over a 
24-hour period.
Reproductive Toxicity—The occurrence of adverse effects on the reproductive system that may result
from exposure to a chemical. The toxicity may be directed to the reproductive organs and/or the related
endocrine system.  The manifestation of such toxicity may be noted as alterations in sexual behavior, 
fertility, pregnancy outcomes, or modifications in other functions that are dependent on the integrity of
this system.
Retrospective Study—A type of cohort study based on a group of persons known to have been exposed 
at some time in the past.  Data are collected from routinely recorded events, up to the time the study is
undertaken.  Retrospective studies are limited to causal factors that can be ascertained from existing
records and/or examining survivors of the cohort.
Risk—The possibility or chance that some adverse effect will result from a given exposure to a chemical.
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Risk Factor—An aspect of personal behavior or lifestyle, an environmental exposure, or an inborn or
inherited characteristic that is associated with an increased occurrence of disease or other health-related
event or condition.
Risk Ratio—The ratio of the risk among persons with specific risk factors compared to the risk among
persons without risk factors.  A risk ratio greater than 1 indicates greater risk of disease in the exposed
group compared to the unexposed group.
Short-Term Exposure Limit (STEL)—The American Conference of Governmental Industrial
Hygienists (ACGIH) maximum concentration to which workers can be exposed for up to 15 minutes
continually.  No more than four excursions are allowed per day, and there must be at least 60 minutes
between exposure periods.  The daily Threshold Limit Value-Time Weighted Average (TLV-TWA) may
not be exceeded.
Standardized Mortality Ratio (SMR)—A ratio of the observed number of deaths and the expected 
number of deaths in a specific standard population.
Target Organ Toxicity—This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited 
exposure to those assumed over a lifetime of exposure to a chemical.
Teratogen—A chemical that causes structural defects that affect the development of an organism.
Threshold Limit Value (TLV)—An American Conference of Governmental Industrial Hygienists 
(ACGIH) concentration of a substance to which most workers can be exposed without adverse effect.  
The TLV may be expressed as a Time Weighted Average (TWA), as a Short-Term Exposure Limit
(STEL), or as a ceiling limit (CL).
Time-Weighted Average (TWA)—An allowable exposure concentration averaged over a normal 8-hour
workday or 40-hour workweek.
Toxic Dose(50) (TD50)—A calculated dose of a chemical, introduced by a route other than inhalation, 
which is expected to cause a specific toxic effect in 50% of a defined experimental animal population.
Toxicokinetic—The absorption, distribution, and elimination of toxic compounds in the living organism.
Uncertainty Factor (UF)—A factor used in operationally deriving the Minimal Risk Level (MRL) or
Reference Dose (RfD) or Reference Concentration (RfC) from experimental data.  UFs are intended to
account for (1) the variation in sensitivity among the members of the human population, (2) the
uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in extrapolating from
data obtained in a study that is of less than lifetime exposure, and (4) the uncertainty in using lowest-
observed-adverse-effect level (LOAEL) data rather than no-observed-adverse-effect level (NOAEL) data.
A default for each individual UF is 10; if complete certainty in data exists, a value of 1 can be used;
however, a reduced UF of 3 may be used on a case-by-case basis, 3 being the approximate logarithmic
average of 10 and 1.
Xenobiotic—Any chemical that is foreign to the biological system.
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APPENDIX A.  ATSDR MINIMAL RISK LEVELS AND WORKSHEETS
The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) [42 U.S.C. 
9601 et seq.], as amended by the Superfund Amendments and Reauthorization Act (SARA) [Pub. L. 99– 
499], requires that the Agency for Toxic Substances and Disease Registry (ATSDR) develop jointly with
the U.S. Environmental Protection Agency (EPA), in order of priority, a list of hazardous substances most
commonly found at facilities on the CERCLA National Priorities List (NPL); prepare toxicological 
profiles for each substance included on the priority list of hazardous substances; and assure the initiation 
of a research program to fill identified data needs associated with the substances.
The toxicological profiles include an examination, summary, and interpretation of available toxicological
information and epidemiologic evaluations of a hazardous substance.  During the development of
toxicological profiles, Minimal Risk Levels (MRLs) are derived when reliable and sufficient data exist to
identify the target organ(s) of effect or the most sensitive health effect(s) for a specific duration for a 
given route of exposure.  An MRL is an estimate of the daily human exposure to a hazardous substance
that is likely to be without appreciable risk of adverse noncancer health effects over a specified duration
of exposure. MRLs are based on noncancer health effects only and are not based on a consideration of
cancer effects. These substance-specific estimates, which are intended to serve as screening levels, are 
used by ATSDR health assessors to identify contaminants and potential health effects that may be of
concern at hazardous waste sites.  It is important to note that MRLs are not intended to define clean-up or
action levels.
MRLs are derived for hazardous substances using the no-observed-adverse-effect level/uncertainty factor
approach. They are below levels that might cause adverse health effects in the people most sensitive to 
such chemical-induced effects. MRLs are derived for acute (1–14 days), intermediate (15–364 days), and 
chronic (365 days and longer) durations and for the oral and inhalation routes of exposure.  Currently, 
MRLs for the dermal route of exposure are not derived because ATSDR has not yet identified a method
suitable for this route of exposure.  MRLs are generally based on the most sensitive chemical-induced end 
point considered to be of relevance to humans.  Serious health effects (such as irreparable damage to the 
liver or kidneys, or birth defects) are not used as a basis for establishing MRLs.  Exposure to a level
above the MRL does not mean that adverse health effects will occur.
MRLs are intended only to serve as a screening tool to help public health professionals decide where to 
look more closely.  They may also be viewed as a mechanism to identify those hazardous waste sites that
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APPENDIX A
are not expected to cause adverse health effects.  Most MRLs contain a degree of uncertainty because of
the lack of precise toxicological information on the people who might be most sensitive (e.g., infants,
elderly, nutritionally or immunologically compromised) to the effects of hazardous substances.  ATSDR
uses a conservative (i.e., protective) approach to address this uncertainty consistent with the public health 
principle of prevention.  Although human data are preferred, MRLs often must be based on animal studies
because relevant human studies are lacking. In the absence of evidence to the contrary, ATSDR assumes 
that humans are more sensitive to the effects of hazardous substance than animals and that certain persons 
may be particularly sensitive. Thus, the resulting MRL may be as much as 100-fold below levels that 
have been shown to be nontoxic in laboratory animals.
Proposed MRLs undergo a rigorous review process:  Health Effects/MRL Workgroup reviews within the
Division of Toxicology and Human Health Sciences, expert panel peer reviews, and agency-wide MRL
Workgroup reviews, with participation from other federal agencies and comments from the public.  They
are subject to change as new information becomes available concomitant with updating the toxicological
profiles. Thus, MRLs in the most recent toxicological profiles supersede previously published levels.  
For additional information regarding MRLs, please contact the Division of Toxicology and Human 
Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road NE, Mailstop 
F-57, Atlanta, Georgia 30329-4027.
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APPENDIX A
MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical Name: JP-5 vapor
CAS Number: 8008-20-6
Date: October 2015
Profile Status: Final Draft for Pre-Public Comment
Route: [X] Inhalation   [ ] Oral
Duration: [ ] Acute [X] Intermediate   [ ] Chronic
Graph Key: 23
Species: Mouse
Minimal Risk Level:  2 [ ] mg/kg/day  [X] mg/m3 
Reference:  Gaworski CL, MacEwen JD, Vernot EH, et al.  1984.  Comparison of the subchronic
inhalation toxicity of petroleum and oil shale JP-5 jet fuels.  In:  MacFarland HN, Holdsworth CE, 
MacGregor JA, et al., eds.  Advances in modern environmental toxicology.  Volume VI:  Applied 
toxicology of petroleum hydrocarbons.  Princeton, NJ:  Princeton Scientific Publishers, 33-47. 
Experimental design:  Groups of approximately 35 female C57BL/6 mice were exposed by inhalation to 
petroleum-based JP-5 vapor at 0, 150, or 750 mg/m3 continuously for 90 days.  End points evaluated 
included:  clinical signs, body weight (measured monthly), and histopathological examination of major
tissues (adrenals, anus, bladder, brain, colon, duodenum, esophagus, gall bladder, heart, ileum, kidneys, 
larynx, liver, lungs and bronchi, mammary gland, mandibular lymph node, nasal cavity, ovaries, pancreas, 
parathyroids, pituitary, prostate, salivary gland, sciatic nerve, seminal vesicles, skin, spleen, bone­
sternebrae, vertebrae or femur plus marrow, stomach, testes, thigh muscle, thymus, thyroid, trachea, and 
uterus).
Effect noted in study and corresponding doses:  No effect on body weight gain was noted.  The only
remarkable finding in mice was hepatocellular fatty changes and vacuolization at 150 and 750 mg/m3. 
The incidences were 8/37 (22%), 29/33 (88%), and 23/34 (68%) in the 0, 150, and 750 mg/m3 groups, 
respectively.
Dose and end point used for MRL derivation: 
[ ] NOAEL   [X] minimal LOAEL
150 mg/m3; hepatocellular fatty changes and vacuolization.
Uncertainty Factors used in MRL derivation:
[x]  3 for use of a minimal LOAEL
[x]  3 for extrapolation from animals to humans with dosimetric adjustments
[x]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose?  Not applicable.
If an inhalation study in animals, list conversion factors used in determining human equivalent dose:  A 
human equivalent concentration (HEC) of 150 mg/m3 was calculated by multiplying the mouse LOAEL
by the ratio of the blood:gas partition coefficients in humans and animals.  Because blood:gas partition 
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coefficients are not measurable for a complex mixture such as JP-5, the default ratio of 1 was used (EPA
1994).  
150 mg/m3 x 1 = 150 mg/m3 
Was a conversion used from intermittent to continuous exposure? Not applicable.
Other additional studies or pertinent information that lend support to this MRL: The intermediate-
duration toxicity of inhaled JP-5 has been investigated in rats, mice, and dogs. In male rats, the most
sensitive effect is an increase in the occurrence of hyaline droplets in the proximal renal tubules, which
was observed in rats continuously exposed to ≥150 mg/m3 JP-5 vapor (Gaworski et al. 1984).  This effect, 
which is only observed in male rats, is due to an accumulation of alpha2u-globulin in hyaline droplets and 
is not considered relevant to humans (EPA 1991c; Flamm and Lehman-McKeeman 1991; Hard et al.
1993; Swenberg 1993).  No adverse effects were observed in female rats exposed to ≤750 mg/m3 JP-5 
vapor (Gaworski et al. 1984).  Similar to mice, the liver appears to be the most sensitive target of toxicity
in dogs; diffuse hepatocellular swelling was observed in male and female dogs continuously exposed to 
≥150 mg/m3 JP-5 vapor (Gaworski et al. 1984). The nervous system was the only other target examined
in intermediate JP-5 studies.  An evaluation of neurobehavioral performance in rats found increased 
forelimb grip strength in rats similarly exposed to 1,200 mg/m3 JP-5 vapor (Rossi et al. 2001); no 
alterations in other neurobehavioral tests were found.  
Studies with JP-8 have also identified the immune system as a sensitive target of toxicity; based on the 
similarity between JP-5 and JP-8, it is likely that the immune system will also be a relevant target of JP-5.  
The lowest reliable LOAEL for immunotoxicity following acute-duration inhalation exposure to JP-8 was 
1,000 mg/m3 identified in rats exposed to JP-8 vapor and aerosol 1 hour/day for 7 days (Hilgaertner et al. 
2011). 
Agency Contacts (Chemical Managers): John Risher and Obaid Faroon
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MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical Name: JP-8 vapor
CAS Number: 8008-20-6
Date: October 2015
Profile Status: Final Draft for Pre-Public Comment
Route: [X] Inhalation   [ ] Oral
Duration: [ ] Acute [X] Intermediate   [ ] Chronic
Graph Key: 31
Species: Rat
Minimal Risk Level: 3    [ ] mg/kg/day  [X] mg/m3 
Reference:  Ritchie GD, Rossi J, Nordholm AF, et al.  2001. Effects of repeated exposure to JP-8 jet fuel 
vapor on learning of simple and difficult operant tasks by rats.  J Toxicol Environ Health, Part A 64: 385­
415.
Experimental design:  Groups of male Sprague-Dawley rats (16/group) were exposed whole-body to 0, 
500, or 1,000 mg/m3 JP-8 fuel vapors 6 hours/day, 5 days/week for 6 weeks.  Sixty-five days after
exposure termination, the rats underwent simple and difficult operant tasks (lever acquisition, fixed ratio, 
lever spatial reversal, stimulus reversal, and incremental repeated acquisition in order of increasing
difficulty).  After the neurobehavioral testing, 4 rats/group were killed and the brains were dissected and 
processed for determination of neurotransmitters and their metabolites.
Effect noted in study and corresponding doses:  Exposure to 1,000 mg/m3 JP-8 fuel vapors induced 
significant deficits in acquisition or performance of the two most difficult tasks, but not in the simple
learning tasks compared to rats in the low-exposure group.  Learning/performance of complex tasks in the
low-exposure group generally exceeded performance of control rats, while learning by high-exposure rats
was almost always inferior to control rats, suggesting possible neurobehavioral hormesis.  Neurochemical
analyses showed significantly increased levels of dopamine in the cerebral cortex and DOPAC (major
dopamine metabolite) in the brainstem for as long as 180 days post-exposure in both exposed groups
relative to controls. This could have resulted from solvent-induced reductions in cyclic guanosine
monophosphate (GMP) that is involved in signal transduction in specific brain regions.
Dose and end point used for MRL derivation: 
[X] NOAEL   [ ] LOAEL
The MRL is based on a NOAEL of 500 mg/m3 and LOAEL of 1,000 mg/m3 for neurotoxicity.
Uncertainty Factors used in MRL derivation:
[ ]  10 for use of a LOAEL
[X]  3 for extrapolation from animals to humans with dosimetric adjustments
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose? Not applicable.
***DRAFT FOR PUBLIC COMMENT***
    
 
 
 
 
    
  
  
 
  
 
      
 
 
    
 
     
 
 
 
    
  
   
  
     
        
      
    
 
 
   
    
    
    
    
   
   
  
   
     
 
 
   
        
   
 
  
  
 
 
 
 
  
A-6JP-5, JP-8, AND JET A FUELS
APPENDIX A
If an inhalation study in animals, list conversion factors used in determining human equivalent dose:  A 
NOAELHEC of 89 mg/m3 was calculated by multiplying the NOAELADJ by the ratio of the blood:gas
partition coefficients in humans and animals.  Because blood:gas partition coefficients are not measurable 
for a complex mixture such as JP-8, the default ratio of 1 was used (EPA 1994).  
89 mg/m3 x 1 = 89 mg/m3 
Was a conversion used from intermittent to continuous exposure? The NOAEL of 500 mg/m3 was 
adjusted for intermittent exposure:
NOAELADJ = 500 mg/m3 x 6 hours/24 hours x 5 days/7 days = 89 mg/m3 
Other additional studies or pertinent information that lend support to this MRL:  Two studies have 
examined the systemic toxicity of JP-8 following intermediate-duration inhalation exposure.  Mattie et al. 
(1991) reported an increase in hyaline nephropathy in male rats continuously exposed to ≥500 mg/m3 
JP-8 vapor for 90 days.  No other effects were observed in the male rats and no effects were observed in 
the female rats; the highest concentration tested was 1,000 mg/m3. In contrast, Hanas et al. (2010)
reported a number of adverse effects in male rats exposed to JP-8 vapor 6 hours/day for 91 days.  At
250 mg/m3 proximal tubular damage was observed in the kidneys; enlarged alveolar capillaries,
myocardial scarring, reduction in fat cells/globules in bone marrow, and dilated sinusoids and fatty
hepatocytes were observed at 500 mg/m3. Interpretation of the results of the Hanas et al. (2010) study is
limited by the small number of animals tested (3/group). The renal effects observed in the Mattie et al.
(1991) and Hanas et al. (2010) studies are characteristic of alpha2u-globulin nephropathy, which is not
considered a relevant effect in humans (EPA 1991c; Flamm and Lehman-McKeeman 1991; Hard et al. 
1993; Swenberg 1993).
A 6-week study conducted by Rossi et al. (2001) also evaluated the neurotoxicity of JP-8 in rats exposed 
for 6 weeks.  An alteration in a novel appetitive stimulus test was observed in rats exposed to 
1,000 mg/m3 JP-8 vapor; the investigators suggested that this test quantified dopamine system
sensitization in the rat.  No other alterations in neurobehavioral tests were found. Studies by Fechter et al.
(2012) and Guthrie et al. (2014) evaluated the potential of JP-8 to damage the auditory system.  No 
significant alterations in auditory function was observed in rats exposed to 1,500 mg/m3 JP-8 vapor for
4 weeks (Fechter et al. 2012); however, if the rats were also exposed to non-damaging noise, there was 
damage to the auditory function.  Central auditory processing dysfunction was observed in rats exposed to 
1,000 mg/m3 JP-8 vapor for 4 weeks; however, no damage to peripheral auditory function, including
damage to cochlear hair cells, was observed (Guthrie et al. 2014).
In addition to these studies, three University of Arizona studies have reported edema and inflammation of
the terminal bronchioles in rats exposed 1 hour/day for 28 or 56 days to JP-8 aerosols and vapors (Hays et
al. 1995; Pfaff et al. 1995, 1996).  Hays et al. (1995) also found increased lung epithelial permeability and 
alveolar permeability. None of the three studies measured the vapor component of the test atmosphere
(see Section 3.2.1 for a discussion of these studies).
Agency Contacts (Chemical Managers): John Risher and Obaid Faroon
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MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical Name: JP-8
CAS Number: 8008-20-6
Date: October 2015
Profile Status: Final Draft for Pre-Public Comment
Route: [ ] Inhalation   [X] Oral
Duration: [X] Acute [ ] Intermediate [ ] Chronic
Graph Key: 11
Species: Mouse
Minimal Risk Level:  3 [X] mg/kg/day  [ ] mg/m3 
Reference: Keil D, Dudley A, EuDaly JG, et al.  2004.  Immunological and hematological effects
observed in B6C3F1 mice exposed to JP-8 jet fuel for 14 days. J Toxicol Environ Health Part A 67:1109­
1129.
Experimental design:  The study examined the effects of JP-8 fuel on humoral and cell-mediated and 
hematological parameters in female B6C3F1 mice.  Groups of mice (4–6/group) were administered doses
of JP-8 fuel ranging from 250 to 2,000 mg/kg/day by gavage in olive oil for 14 days.  End points
monitored included body weight; weight of the liver, kidneys, spleen, and thymus; spleen and thymus
cellularity; lymphocyte proliferation; natural killer (NK) cell activity; antibody plaque-forming cells 
assay; splenic and thymic CD4/CD8 subpopulations; and bone marrow cellularity and colony-forming
units.
Effect noted in study and corresponding doses: There were no clinical signs during the study.  There was 
a trend for increase in body weight gain, but there was no statistical significance. Relative kidney weight
was not affected, but liver weight was significantly increased at ≥1,000 mg/kg/day (23%). Significant 
hematological alterations included decreases in hemoglobin levels, hematocrit levels, and red blood cell
counts and increases in mean corpuscular volume at 2,500 mg/kg/day; mean corpuscular volume was also 
increased at 1,500 and 2,000 mg/kg/day.  All of these changes were ≤7% relative to controls and probably 
of no toxicological significance.  There were no significant changes in peripheral blood differential count.
An increase in colony forming units was observed in the bone marrow of mice administered 
2,000 mg/kg/day, but there were no alterations in bone marrow cellularity. A significant decrease in
cellularity was observed in the thymus at 2,000 mg/kg/day; no alterations were observed in the spleen.
No significant alterations in mitogen-induced T or B cell proliferation or alterations in NK activity were 
observed.  In response to sheep red blood cells (SRBCs), there were significant suppression of IgM 
antibody production (when assess using antibody plague-forming cell response) at doses ≥500 mg/kg/day.  
However, there were no significant alterations when serum levels of anti-SRBC IgM when measured by
ELISA or hemagglutination. In the spleen, there were no alterations in the percentage of individual T-cell
phenotypes or the ratio of CD4+ to CD8+ cells; however, decreases in CD4-/CD8- cells were observed at
1,000 and 2,000 mg/kg/day.  In contrast, there were significant decreases in the absolute values of CD8+, 
CD4+, and CD4+/CD8+ T-cell subpopulations in the thymus in mice administered 2000 mg/kg/day.
Dose and end point used for MRL derivation: 
[X ] NOAEL   [ ] LOAEL
The MRL is based on a NOAEL of 250 mg/kg/day and LOAEL of 500 mg/kg/day for an impaired 
response to SRBCs.
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Uncertainty Factors used in MRL derivation:
[ ]  10 for use of a LOAEL
[X]  10 for extrapolation from animals to humans 
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose?  Not applicable.
If an inhalation study in animals, list conversion factors used in determining human equivalent dose: Not
applicable.
Was a conversion used from intermittent to continuous exposure? Not applicable.
Other additional studies or pertinent information that lend support to this MRL: The available data on the 
acute-toxicity of JP-8 primarily focused on immunotoxicity.  Altered immune function (response to 
SRBCs) was observed in mice administered 1,000 mg/kg/day JP-8 for 7 days (Dudley et al. 2001) or
500 mg/kg/day for 14 days (Keil et al. 2004; Peden-Adams et al. 2001).  At higher doses, decreases in
thymus weight and cellularity were observed (Dudley et al. 2001).  Impaired immune response was also 
observed in the offspring of mice administered 1,000 mg/kg/day on GDs 6–15 (Keil et al. 2003).  In 
another developmental toxicity study (Cooper and Mattie 1996), a decrease in fetal body weight was
observed at a dose (1,000 mg/kg/day) that also resulted in decreased maternal weight gain and mortality.  
Although the acute-duration studies did not examine the potential for systemic toxicity, intermediate-
duration JP-8 oral studies suggest that systemic effects such as liver toxicity would occur at higher doses 
than the LOAEL for immunotoxicity (Mattie et al. 1995, 2000).
Agency Contacts (Chemical Managers): John Risher and Obaid Faroon
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MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical Name: JP-8
CAS Number: 8008-20-6
Date: October 2015
Profile Status: Final Draft for Pre-Public Comment
Route: [ ] Inhalation [X] Oral
Duration: [ ] Acute   [X] Intermediate   [ ] Chronic
Graph Key: 28
Species: Rat
Minimal Risk Level:  0.3 [X] mg/kg/day [ ] mg/m3 
Reference: Mattie DR, Cooper JR, Sterner TR, et al.  2001. Developmental neurobehavioral effects on
JP-8 jet fuel on pups from female Sprague-Dawley rats exposed by oral gavage. Wright-Patterson, AFB:
OH:  Air Force Research Laboratory. 22.  ARFL-HE-WP-TR-2001-0186.  ADA428272.  
Experimental design: The study examined neurobehavioral parameters in pups from rats exposed to JP-8 
fuel for a total of 21 weeks (90 days followed by cohabitation, gestation, delivery, and lactation).  Groups
of rats (35/groups) were administered 0, 325, 750, or 1,500 mg/kg neat JP-8 fuel by gavage.  Litters were 
standardized to four male and four female pups on PND 4.  Pup weights were recorded on PNDs 1, 4, 14, 
21, and 90.  Male pups were checked for descent of testes on PND 21 or 22. Female pups were checked
for vaginal opening on PND 30. The following neurobehavioral tests were conducted: surface righting
(beginning PND 4), negative geotaxis (beginning PND 5), swimming development (PNDs 6–20), and 
water maze (PNDs 70 and 77)
Effect noted in study and corresponding doses:  The results showed a significant alteration in the total 
score for the swimming development test at ≥325 mg/kg/day on PND 8 and at 750 and 1,500 mg/kg/day 
on PND 14; however, no significant alterations in total score were observed on PNDs 10, 12, 16, 18, or
20. The alterations in the total scores were primarily due to swimming direction scores; significant 
decreases in direction scores were observed on PND 6 (750 and 1,500 mg/kg/day), PND 8 
(≥325 mg/kg/day), and PND 14 (750 and 1,500 mg/kg/day); no alterations in angle of head or limb usage
scores were observed at any time point.  No significant alterations in surface righting (tested on PND 4),
negative geotaxis (tested on PND 5), or water maze performance (tested on PNDs 70 and 77) were
observed. The investigators suggested that the results in the swimming development test were indicative 
of a possible developmental delay in motor coordination; however, the delay did not affect motor ability
at later ages.
Dose and end point used for MRL derivation: 
[ ] NOAEL   [ X] LOAEL
The MRL is based on a LOAEL of 325 mg/kg/day for neurodevelopmental effects.
Uncertainty Factors used in MRL derivation:
[X]  10 for use of a LOAEL
[X]  10 for extrapolation from animals to humans
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose? Not applicable.
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If an inhalation study in animals, list conversion factors used in determining human equivalent dose: Not
applicable.
Was a conversion used from intermittent to continuous exposure? Not applicable.
Other additional studies or pertinent information that lend support to this MRL:  Two studies have 
evaluated the intermediate-duration oral toxicity of JP-8 (Mattie et al. 1995, 2000).  Administration of
750 mg/kg/day resulted in increases in serum ALT and AST activities in male rats, stomach hyperplasia 
in male and female rats, hypoglycemia in male rats, perianal dermatitis in male rats, and hyaline droplet
formation in the kidneys of male rats; perianal dermatitis was also observed in female rats at
1,500 mg/kg/day.  The third study in the intermediate-duration database was the Mattie et al. (2001)
developmental study, which was the basis of the MRL.
Acute-duration oral studies suggest that the immune system is also a sensitive target of JP-8 toxicity; 
however, this end point has not been investigated following intermediate-duration exposure.  The lowest
LOAEL for immune effects identified in oral exposure studies was 500 mg/kg/day for an impaired 
response to SRBCs (Keil et al. 2004).  Since the LOAEL for neurodevelopmental is similar to this
LOAEL, the intermediate MRL should be protective for potential immune effects.
Agency Contacts (Chemical Managers): John Risher and Obaid Faroon
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APPENDIX B.  USER'S GUIDE
Chapter 1
Public Health Statement
This chapter of the profile is a health effects summary written in non-technical language. Its intended
audience is the general public, especially people living in the vicinity of a hazardous waste site or
chemical release.  If the Public Health Statement were removed from the rest of the document, it would
still communicate to the lay public essential information about the chemical.
The major headings in the Public Health Statement are useful to find specific topics of concern. The 
topics are written in a question and answer format. The answer to each question includes a sentence that
will direct the reader to chapters in the profile that will provide more information on the given topic.
Chapter 2
Relevance to Public Health
This chapter provides a health effects summary based on evaluations of existing toxicologic,
epidemiologic, and toxicokinetic information.  This summary is designed to present interpretive, weight­
of-evidence discussions for human health end points by addressing the following questions:
1.	 What effects are known to occur in humans?
2.	 What effects observed in animals are likely to be of concern to humans?
3.	 What exposure conditions are likely to be of concern to humans, especially around hazardous
waste sites?
The chapter covers end points in the same order that they appear within the Discussion of Health Effects
by Route of Exposure section, by route (inhalation, oral, and dermal) and within route by effect.  Human 
data are presented first, then animal data.  Both are organized by duration (acute, intermediate, chronic).  
In vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also 
considered in this chapter. 
The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using
existing toxicokinetic, genotoxic, and carcinogenic data.  ATSDR does not currently assess cancer
potency or perform cancer risk assessments. Minimal Risk Levels (MRLs) for noncancer end points (if
derived) and the end points from which they were derived are indicated and discussed.
Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to public 
health are identified in the Chapter 3 Data Needs section.
Interpretation of Minimal Risk Levels
Where sufficient toxicologic information is available, ATSDR has derived MRLs for inhalation and oral
routes of entry at each duration of exposure (acute, intermediate, and chronic). These MRLs are not
meant to support regulatory action, but to acquaint health professionals with exposure levels at which 
adverse health effects are not expected to occur in humans.
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MRLs should help physicians and public health officials determine the safety of a community living near
a chemical emission, given the concentration of a contaminant in air or the estimated daily dose in water.  
MRLs are based largely on toxicological studies in animals and on reports of human occupational
exposure.
MRL users should be familiar with the toxicologic information on which the number is based.  Chapter 2, 
"Relevance to Public Health," contains basic information known about the substance.  Other sections such 
as Chapter 3 Section 3.9, "Interactions with Other Substances,” and Section 3.10, "Populations that are
Unusually Susceptible" provide important supplemental information.
MRL users should also understand the MRL derivation methodology.  MRLs are derived using a
modified version of the risk assessment methodology that the Environmental Protection Agency (EPA)
provides (Barnes and Dourson 1988) to determine reference doses (RfDs) for lifetime exposure.
To derive an MRL, ATSDR generally selects the most sensitive end point which, in its best judgement,
represents the most sensitive human health effect for a given exposure route and duration.  ATSDR
cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is available 
for all potential systemic, neurological, and developmental effects.  If this information and reliable
quantitative data on the chosen end point are available, ATSDR derives an MRL using the most sensitive 
species (when information from multiple species is available) with the highest no-observed-adverse-effect
level (NOAEL) that does not exceed any adverse effect levels.  When a NOAEL is not available, a 
lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty factor
(UF) of 10 must be employed.  Additional uncertainty factors of 10 must be used both for human 
variability to protect sensitive subpopulations (people who are most susceptible to the health effects 
caused by the substance) and for interspecies variability (extrapolation from animals to humans).  In 
deriving an MRL, these individual uncertainty factors are multiplied together.  The product is then 
divided into the inhalation concentration or oral dosage selected from the study. Uncertainty factors used
in developing a substance-specific MRL are provided in the footnotes of the levels of significant exposure 
(LSE) tables.
Chapter 3
Health Effects
Tables and Figures for Levels of Significant Exposure (LSE)
Tables and figures are used to summarize health effects and illustrate graphically levels of exposure 
associated with those effects. These levels cover health effects observed at increasing dose 
concentrations and durations, differences in response by species, MRLs to humans for noncancer end
points, and EPA's estimated range associated with an upper-bound individual lifetime cancer risk of 1 in 
10,000 to 1 in 10,000,000.  Use the LSE tables and figures for a quick review of the health effects and to 
locate data for a specific exposure scenario. The LSE tables and figures should always be used in
conjunction with the text. All entries in these tables and figures represent studies that provide reliable,
quantitative estimates of NOAELs, LOAELs, or Cancer Effect Levels (CELs).
The legends presented below demonstrate the application of these tables and figures.  Representative 
examples of LSE Table 3-1 and Figure 3-1 are shown.  The numbers in the left column of the legends
correspond to the numbers in the example table and figure.
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LEGEND
See Sample LSE Table 3-1 (page B-6)
(1)	 Route of Exposure.  One of the first considerations when reviewing the toxicity of a substance 
using these tables and figures should be the relevant and appropriate route of exposure.  Typically
when sufficient data exist, three LSE tables and two LSE figures are presented in the document.  
The three LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, 
and dermal (LSE Tables 3-1, 3-2, and 3-3, respectively).  LSE figures are limited to the inhalation
(LSE Figure 3-1) and oral (LSE Figure 3-2) routes.  Not all substances will have data on each
route of exposure and will not, therefore, have all five of the tables and figures.
(2)	 Exposure Period. Three exposure periods—acute (less than 15 days), intermediate (15– 
364 days), and chronic (365 days or more)—are presented within each relevant route of exposure.
In this example, an inhalation study of intermediate exposure duration is reported.  For quick
reference to health effects occurring from a known length of exposure, locate the applicable 
exposure period within the LSE table and figure.
(3)	 Health Effect. The major categories of health effects included in LSE tables and figures are 
death, systemic, immunological, neurological, developmental, reproductive, and cancer.  
NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer.
Systemic effects are further defined in the "System" column of the LSE table (see key number
18).
(4)	 Key to Figure. Each key number in the LSE table links study information to one or more data
points using the same key number in the corresponding LSE figure.  In this example, the study
represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL
(also see the two "18r" data points in sample Figure 3-1).
(5)	 Species. The test species, whether animal or human, are identified in this column.  Chapter 2,
"Relevance to Public Health," covers the relevance of animal data to human toxicity and 
Section 3.4, "Toxicokinetics," contains any available information on comparative toxicokinetics.  
Although NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent
human doses to derive an MRL.
(6)	 Exposure Frequency/Duration. The duration of the study and the weekly and daily exposure
regimens are provided in this column.  This permits comparison of NOAELs and LOAELs from
different studies.  In this case (key number 18), rats were exposed to “Chemical x” via inhalation
for 6 hours/day, 5 days/week, for 13 weeks.  For a more complete review of the dosing regimen, 
refer to the appropriate sections of the text or the original reference paper (i.e., Nitschke et al.
1981).
(7)	 System. This column further defines the systemic effects. These systems include respiratory,
cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and
dermal/ocular. "Other" refers to any systemic effect (e.g., a decrease in body weight) not covered 
in these systems.  In the example of key number 18, one systemic effect (respiratory) was 
investigated.
(8)	 NOAEL.  A NOAEL is the highest exposure level at which no harmful effects were seen in the 
organ system studied.  Key number 18 reports a NOAEL of 3 ppm for the respiratory system, 
which was used to derive an intermediate exposure, inhalation MRL of 0.005 ppm (see 
footnote "b").
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(9)	 LOAEL. A LOAEL is the lowest dose used in the study that caused a harmful health effect.  
LOAELs have been classified into "Less Serious" and "Serious" effects.  These distinctions help
readers identify the levels of exposure at which adverse health effects first appear and the 
gradation of effects with increasing dose.  A brief description of the specific end point used to 
quantify the adverse effect accompanies the LOAEL. The respiratory effect reported in key
number 18 (hyperplasia) is a Less Serious LOAEL of 10 ppm.  MRLs are not derived from
Serious LOAELs.
(10)	 Reference.  The complete reference citation is given in Chapter 9 of the profile.
(11)	 CEL.  A CEL is the lowest exposure level associated with the onset of carcinogenesis in
experimental or epidemiologic studies.  CELs are always considered serious effects. The LSE
tables and figures do not contain NOAELs for cancer, but the text may report doses not causing
measurable cancer increases.
(12)	 Footnotes.  Explanations of abbreviations or reference notes for data in the LSE tables are found 
in the footnotes.  Footnote "b" indicates that the NOAEL of 3 ppm in key number 18 was used to 
derive an MRL of 0.005 ppm.
LEGEND
See Sample Figure 3-1 (page B-7)
LSE figures graphically illustrate the data presented in the corresponding LSE tables.  Figures help the
reader quickly compare health effects according to exposure concentrations for particular exposure
periods.
(13)	 Exposure Period. The same exposure periods appear as in the LSE table.  In this example, health
effects observed within the acute and intermediate exposure periods are illustrated.
(14)	 Health Effect. These are the categories of health effects for which reliable quantitative data 
exists. The same health effects appear in the LSE table.
(15)	 Levels of Exposure.  Concentrations or doses for each health effect in the LSE tables are 
graphically displayed in the LSE figures.  Exposure concentration or dose is measured on the log
scale "y" axis.  Inhalation exposure is reported in mg/m3 or ppm and oral exposure is reported in 
mg/kg/day.
(16)	 NOAEL. In this example, the open circle designated 18r identifies a NOAEL critical end point in
the rat upon which an intermediate inhalation exposure MRL is based.  The key number 18 
corresponds to the entry in the LSE table.  The dashed descending arrow indicates the
extrapolation from the exposure level of 3 ppm (see entry 18 in the table) to the MRL of
0.005 ppm (see footnote "b" in the LSE table).
(17)	 CEL. Key number 38m is one of three studies for which CELs were derived.  The diamond 
symbol refers to a CEL for the test species-mouse.  The number 38 corresponds to the entry in the
LSE table.
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(18)	 Estimated Upper-Bound Human Cancer Risk Levels. This is the range associated with the upper-
bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000.  These risk levels are derived 
from the EPA's Human Health Assessment Group's upper-bound estimates of the slope of the
cancer dose response curve at low dose levels (q1*).
(19)	 Key to LSE Figure. The Key explains the abbreviations and symbols used in the figure.
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1
2
12
→	 Table 3-1. Levels of Significant Exposure to [Chemical x] – Inhalation
LOAEL (effect)Exposure 
Less serious Serious (ppm)Key to 	 frequency/ NOAEL
(ppm)figurea Species duration System (ppm)	 Reference
→	 INTERMEDIATE EXPOSURE
5 6 7 8 9 10
3 → Systemic ↓
18 Rat
→4
CHRONIC EXPOSURE
Cancer
38 Rat
39 Rat
40 Mouse
↓ ↓ ↓
13 wk Resp 3b 
5 d/wk
6 hr/d
18 mo
5 d/wk
7 hr/d
89–104 wk
5 d/wk
6 hr/d
79–103 wk
5 d/wk
6 hr/d
↓
10 (hyperplasia)
11
↓
20	 (CEL, multiple
organs)
10	 (CEL, lung tumors,
nasal tumors)
10	 (CEL, lung tumors,
hemangiosarcomas)
↓
Nitschke et al. 1981
Wong et al. 1982
NTP 1982
NTP 1982
→	 a The number corresponds to entries in Figure 3-1.
b Used to derive an intermediate inhalation Minimal Risk Level (MRL) of 5x10-3 ppm; dose adjusted for intermittent exposure and divided 
by an uncertainty factor of 100 (10 for extrapolation from animal to humans, 10 for human variability).
 
 
 
 
 
 
   
 
   
    
 
 
B
-7 
JP
-5, JP
-8, A
N
D
 JE
T A
 FU
E
LS
 
A
PP
E
N
D
IX B
 
Chronic (≥ 365 days) Intermediate (15-364 days)
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ACGIH American Conference of Governmental Industrial Hygienists
ACOEM American College of Occupational and Environmental Medicine
ADI acceptable daily intake
ADME absorption, distribution, metabolism, and excretion
AED atomic emission detection
AFID alkali flame ionization detector
AFOSH Air Force Office of Safety and Health
ALT alanine aminotransferase
AML acute myeloid leukemia
AOAC Association of Official Analytical Chemists
AOEC Association of Occupational and Environmental Clinics
AP alkaline phosphatase
APHA American Public Health Association
AST aspartate aminotransferase
atm atmosphere
ATSDR Agency for Toxic Substances and Disease Registry
AWQC Ambient Water Quality Criteria
BAT best available technology
BCF bioconcentration factor
BEI Biological Exposure Index
BMD/C benchmark dose or benchmark concentration
BMDX dose that produces a X% change in response rate of an adverse effect
BMDLX 95% lower confidence limit on the BMDX 
BMDS Benchmark Dose Software 
BMR benchmark response
BSC Board of Scientific Counselors
C centigrade
CAA Clean Air Act
CAG Cancer Assessment Group of the U.S. Environmental Protection Agency
CAS Chemical Abstract Services
CDC Centers for Disease Control and Prevention
CEL cancer effect level
CELDS Computer-Environmental Legislative Data System
CERCLA Comprehensive Environmental Response, Compensation, and Liability Act
CFR Code of Federal Regulations
Ci curie
CI confidence interval
CL ceiling limit value
CLP Contract Laboratory Program
cm centimeter
CML chronic myeloid leukemia
CPSC Consumer Products Safety Commission
CWA Clean Water Act
DHEW Department of Health, Education, and Welfare
DHHS Department of Health and Human Services
DNA deoxyribonucleic acid
DOD Department of Defense
DOE Department of Energy
DOL Department of Labor
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DOT Department of Transportation
DOT/UN/ Department of Transportation/United Nations/
NA/IMDG North America/Intergovernmental Maritime Dangerous Goods Code
DWEL drinking water exposure level
ECD electron capture detection
ECG/EKG electrocardiogram
EEG electroencephalogram
EEGL Emergency Exposure Guidance Level
EPA Environmental Protection Agency
F Fahrenheit
F1 first-filial generation
FAO Food and Agricultural Organization of the United Nations
FDA Food and Drug Administration
FEMA Federal Emergency Management Agency
FIFRA Federal Insecticide, Fungicide, and Rodenticide Act
FPD flame photometric detection
fpm feet per minute
FR Federal Register
FSH follicle stimulating hormone
g gram
GC gas chromatography
gd gestational day
GLC gas liquid chromatography
GPC gel permeation chromatography
HPLC high-performance liquid chromatography
HRGC high resolution gas chromatography
HSDB Hazardous Substance Data Bank
IARC International Agency for Research on Cancer
IDLH immediately dangerous to life and health
ILO International Labor Organization
IRIS Integrated Risk Information System
Kd adsorption ratio
kg kilogram
kkg metric ton
Koc organic carbon partition coefficient
Kow octanol-water partition coefficient
L liter
LC liquid chromatography
LC50 lethal concentration, 50% kill
LCLo lethal concentration, low
LD50 lethal dose, 50% kill
LDLo lethal dose, low
LDH lactic dehydrogenase
LH luteinizing hormone
LOAEL lowest-observed-adverse-effect level
LSE Levels of Significant Exposure
LT50 lethal time, 50% kill
m meter
MA trans,trans-muconic acid
MAL maximum allowable level
mCi millicurie
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MCL maximum contaminant level
MCLG maximum contaminant level goal
MF modifying factor
MFO mixed function oxidase
mg milligram
mL milliliter
mm millimeter
mmHg millimeters of mercury
mmol millimole
mppcf millions of particles per cubic foot
MRL Minimal Risk Level
MS mass spectrometry
NAAQS National Ambient Air Quality Standard
NAS National Academy of Science
NATICH National Air Toxics Information Clearinghouse
NATO North Atlantic Treaty Organization
NCE normochromatic erythrocytes
NCEH National Center for Environmental Health
NCI National Cancer Institute
ND not detected
NFPA National Fire Protection Association
ng nanogram
NHANES National Health and Nutrition Examination Survey
NIEHS National Institute of Environmental Health Sciences
NIOSH National Institute for Occupational Safety and Health
NIOSHTIC NIOSH's Computerized Information Retrieval System
NLM National Library of Medicine
nm nanometer
nmol nanomole
NOAEL no-observed-adverse-effect level
NOES National Occupational Exposure Survey
NOHS National Occupational Hazard Survey
NPD nitrogen phosphorus detection
NPDES National Pollutant Discharge Elimination System
NPL National Priorities List
NR not reported
NRC National Research Council
NS not specified
NSPS New Source Performance Standards
NTIS National Technical Information Service
NTP National Toxicology Program
ODW Office of Drinking Water, EPA
OERR Office of Emergency and Remedial Response, EPA
OHM/TADS Oil and Hazardous Materials/Technical Assistance Data System
OPP Office of Pesticide Programs, EPA
OPPT Office of Pollution Prevention and Toxics, EPA
OPPTS Office of Prevention, Pesticides and Toxic Substances, EPA
OR odds ratio
OSHA Occupational Safety and Health Administration
OSW Office of Solid Waste, EPA
OTS Office of Toxic Substances
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OW Office of Water
OWRS Office of Water Regulations and Standards, EPA
PAH polycyclic aromatic hydrocarbon
PBPD physiologically based pharmacodynamic
PBPK physiologically based pharmacokinetic 
PCE polychromatic erythrocytes
PEL permissible exposure limit
pg picogram
PHS Public Health Service
PID photo ionization detector
pmol picomole
PMR proportionate mortality ratio
ppb parts per billion
ppm parts per million
ppt parts per trillion
PSNS pretreatment standards for new sources
RBC red blood cell
REL recommended exposure level/limit
RfC reference concentration
RfD reference dose
RNA ribonucleic acid
RQ reportable quantity
RTECS Registry of Toxic Effects of Chemical Substances
SARA Superfund Amendments and Reauthorization Act
SCE sister chromatid exchange
SGOT serum glutamic oxaloacetic transaminase
SGPT serum glutamic pyruvic transaminase
SIC standard industrial classification
SIM selected ion monitoring
SMCL secondary maximum contaminant level
SMR standardized mortality ratio
SNARL suggested no adverse response level
SPEGL Short-Term Public Emergency Guidance Level
STEL short term exposure limit
STORET Storage and Retrieval
TD50 toxic dose, 50% specific toxic effect
TLV threshold limit value
TOC total organic carbon
TPQ threshold planning quantity
TRI Toxics Release Inventory
TSCA Toxic Substances Control Act
TWA time-weighted average
UF uncertainty factor
U.S. United States
USDA United States Department of Agriculture
USGS United States Geological Survey
VOC volatile organic compound
WBC white blood cell
WHO World Health Organization
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> greater than
≥ greater than or equal to
= equal to
< less than
≤ less than or equal to
% percent
α alpha
β beta
γ gamma
δ delta
μm micrometer
μg microgram
q1* cancer slope factor
– negative
+ positive
(+) weakly positive result
(–) weakly negative result
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